,processed_text
0,introduction clear asthma frequent chronic disease childhood risk severe sars cov- infection pediatric population sars cov- infection affect lung function patient purpose aim investigate course consequence sars cov- infection child asthma determine risk factor decline lung function test method retrospective study asthmatic child coronavirus disease  covid- compare random control group asthmatic patient covid- addition clinical course effect lung function test covid- child asthma evaluate result eighty patient covid-  include study fever fatigue cough frequent symptom covid- severity covid-  patient .% mild clinical condition  moderate disease .% severe disease critically ill disease patient diagnose multisystem inflammatory syndrome child mis c patient suffer pneumothorax lung function test patient covid- infection analyze significant difference find fev .% vs .% p=. fvc% .% vs .% p=. fev fvc .% vs .% p=. value .% vs .% p/=% decrease fef- covid- infection conclusion covid- infection lead dysfunction small airway asthmatic child obesity independent risk factor decrease fef- long term effect covid- infection especially small airway require close monitoring child asthma article protect
1,march world health organization declare coronavirus disease  covid- pandemic till affect million spain million person world total million death spain observe hospitalize covid- patient covid- associate comorbidity show people underlie chronic illness likely grow seriously ill individual covid- past medical history cardiovascular disorder cancer obesity chronic lung disease diabetes neurological disease bad prognosis likely develop acute respiratory distress syndrome pneumonia covid- affect respiratory system variety way spectrum level disease severity depend person immune system age comorbiditie symptom range mild cough shortness breath fever critical disease include respiratory failure shock multi organ system failure covid- infection cause overall worsening previous respiratory disease asthma chronic obstructive pulmonary disease copd interstitial lung disease etc review aim provide information impact covid- disease pre exist lung comorbiditie
2,consequence sars cov- infection include short term long term mild severe clinical symptom cardiovascular system include endothelial cell vascular smooth muscle cell cardiac myocyte important target sars cov- february finding large cohort individual diagnose covid- set control cohort evaluate risk -month cardiovascular disease burden individual covid- increase risk heart failure increase risk myocardial infarction increase risk ischemic stroke compare control result independent gender race age cardiovascular risk factor include diabetes obesity hypertension hyperlipidemia chronic kidney disease  april world health organization report  million people  million people uk  million people worldwide infect sars cov- editorial aim present currently know cardiovascular outcome year follow sars cov- infection highlight primary care physician mindful covid- infection status patient evaluate cardiovascular health
3,background severe acute respiratory syndrome coronavirus  sars cov- etiological agent coronavirus disease  covid- pandemic risk factor associate severity disease presence metabolic disorder reason aim research identify comorbiditie laboratory parameter covid- patient admit intensive care unit icu compare patient require invasive mechanical ventilation imv require imv order determine clinical characteristic associate covid- severity method carry cross sectional study  patient admit icu april  st july  st comorbiditie laboratory parameter associate sars cov- infection severity identify datum patient group main group patient require imv patient require imv nonparametric mann whitney u test continuous datum chi  test categorical datum compare variable group result  covid- patient admit icu  require imv  require imv comorbiditie find patient high prevalence type  diabetes mellitus tdm hypertension obesity observe patient require imv vs. require imv p concern laboratory parameter glucose interleukin  il- lactate dehydrogenase ldh c reactive protein crp significantly high patient require imv require imv p conclusion study perform mexican population indicate comorbiditie tdm hypertension obesity elevated level glucose il- ldh crp associate covid- severity
4,immune response sars cov- ensue inflammation pose huge challenge host nicotinamide adenine dinucleotide nad(+ metabolism human depend vitamin b biosynthesis nad(+ indispensable metabolic nad(+)-consume signal reaction balance utilization resynthesis vitally important extra pulmonary symptom covid- strikingly resemble pellagra vitamin b deficiency e.g. diarrhoea dermatitis oral cavity tongue manifestation loss smell taste mental confusion develop country pellagra successfully eradicate vitamin b fortification program conceivably suspect cause covid- symptom deregulation nad(+ metabolism response sars cov- infection special emphasis difference nad(+ biosynthetic pathway efficiency condition predispose development covid- sars cov- infection induce nad(+ depletion elevated level metabolite contribute development systemic disease acute liberation nicotinamide nam antiviral nad(+)-consuming reaction potentiate nam drain cooperatively mediate nicotinamide n methyltransferase aldehyde oxidase nam drain compromise nad(+ salvage pathway fail safe function robustness host nad(+ salvage pathway prior sars cov- infection important determinant covid- severity persistence certain symptom resolution infection
5,aim study aim review indicate discuss impact cardiovascular risk factor obesity diabetes lipid profile hypertension smoking course mortality covid- infection background coronavirus disease  covid- pandemic spread world major public health crisis coronaviruse know affect cardiovascular system strong correlation cardiovascular risk factor severe clinical complication include death covid- patient mention risk factor widespread constitute significant worldwide health problem modifiable awareness connection covid- progress crucial impact current possible upcoming infection data collection search research paper describe impact select cardiovascular risk factor course severity complication mortality covid- infection form pubmed google scholar database term example covid- cardiovascular disease mortality covid- hypertension diabetes mellitus obesity dyslipidemia cardiovascular risk factor covid- mortality related term list subtitle publication select accord time publication january  december pubmed database obtain  result study seek manually search reference list relevant article relevant article select base title abstract text article exclude clearly relate subject matter publish english type article mainly randomized control trial systematic review additional criterion researcher co morbidity age patient study group review publication  select work subheading include finding result intention review summarize current knowledge comorbiditie development covid- infection try focus course mortality abovementioned virus disease patient concomitant cv risk factor unfortunately unable assess quality datum screen paper study choose heterogenicity group conduct study different endpoint include different group patient term nationality age race clinical status decide divide main subject research separately describe subtitle obesity lipid profile hypertension diabetes smoking believe study include gather interesting modern present day clinical datum approach covid- infection specific division patient
6,angiotensin convert enzyme  ace receptor identify entry receptor severe acute respiratory syndrome coronavirus  sars cov- abundantly express organ respect role circulate ace receptor expression pathogenesis sars cov- infection debate disease hypertension pharmacotherapie include ace inhibitor angiotensin receptor blocker affect ace receptor expression modulate severity outcome coronavirus disease  covid- test hypothesis treatment ace inhibitor ramipril affect organ specific ace receptor mrna protein expression serum metabolome biobreeding bb rat male biobreeding rat randomly divide ramipril mg kg body weight treatment group control group n n  group period seven day ramipril treatment result reduction acylcarnitine c c  metabolite different organ study lung ramipril treatment significantly increase ace mrna ace receptor membrane protein level increased ace receptor lung expression ramipril treatment associate difference ace serum concentration experimental group datum provide experimental vivo evidence ace inhibitor ramipril selectively increase pulmonary ace receptor mrna protein level reduce acylcarnitine
7,background summarize modifiable factor coronavirus disease  covid- suggest mendelian randomization study method systematic review search pubmed embase medline inception  november mendelian randomization study english select study assess association genetically predict exposure covid related outcome severity hospitalization susceptibility risk bias include study evaluate base consideration main assumption instrumental variable analysis result identify  study systematic search  mendelian randomization study include include study explore wide range socio demographic factor lifestyle attribute anthropometric biomarker predisposition disease druggable target covid- risk mendelian randomization study suggest increase smoking obesity inflammatory factor associate high risk covid- predisposition ischaemic stroke combine bipolar disorder schizophrenia attention deficit hyperactivity disorder chronic kidney disease idiopathic pulmonary fibrosis potentially associate high covid- risk druggable target high protein expression histo blood group abo system transferase abo interleukin il)- lower protein expression oligoadenylate synthetase  oas associate high risk covid- strong genetic evidence support role vitamin d glycaemic trait predisposition cardiometabolic disease covid- risk conclusion review summarize modifiable factor intervention e.g. smoking obesity inflammatory factor proteomic signature e.g. oas il- help identify drug treat covid-
8,mucormycosis angioinvasive disease cause mold fungus genus rhizopus mucor india report surge case covid  associate mucormycosis past month increase frequency risk factor like corticosteroid therapy uncontrolled diabetes neutropenia obesity study show eukaryote cell membrane contain cholesterol fungal cell wall contain ergosterol lanosterol precursor ergosterol essential mitochondrial dna maintenance fungus cholesterol human current study base hypothesis fungus use human cholesterol raw material maintain cell function accentuate multiplication indirectly show association deranged lipid parameter individual severity mucormycosis present study aim estimate lipid parameter correlate serum lipid parameter clinical profile stage disease duration onset mucormycosis patient covid associate mucormycosis material cross sectional study conduct  patient diagnose covid  associate mucormycosis admit hospital attach bmcri july  september serum fast lipid profile biochemical parameter determine correlation lipid level clinical profile onset staging mucormycosis patient obtain observation age distribution vary yr yr majority male patient mucormycosis severity stage nasal block .% find common symptom follow headache(.% patient mucormycosis frequent associate comorbidity diabetes mellitus dm follow hypertension htn follow dm htn follow ischemic heart disease ihd follow dm htn ihd study show statistically significant correlation severity mucormycosis increase progressive worsen lipid parameter show statistically significant correlation patient increase tc ldl vldl tg level short covid  onset mucormycosis onset duration conclusion study show positive correlation serum lipid profile staging mucormycosis negative correlation lipid level duration onset covid  onset mucormycosis serum lipid profile excellent marker predict severity prognosis covid  associate mucormycosis
9,background coronavirus disease  covid- pandemic tertiary hospital south africa world wide describe limited datum publish finding article aim describe patient admit large district hospital cape town south africa wave severe acute respiratory syndrome coronavirus  sars cov- infection compare clinical feature investigate survivor deceased covid- patient method single centre retrospective review clinical record laboratory datum patient admit positive sars cov- polymerase chain reaction pcr april  august result total  patient positive sars cov- pcr admit study centre night long patient  die covid- median age patient die covid-  year  year survivor hypertension diabetes mellitus obesity common comorbiditie patient survive die covid- major difference compare severity infiltrate chest x ray cxr covid- survivor deceased patient half deceased patient die  day follow admission hospital substantial number patient die covid- associate acute kidney injury n conclusion acute kidney injury high prevalence patient die covid- delay transfer intensive care unit icu limited icu capacity disease severity contribute substantial number patient die  day admission
10,objective describe cerebrovascular manifestation patient hospitalize treatment severe covid- highlight comorbiditie observe play relevant role risk factor severe outcome method case series retrospective analyze june november patient admit emergency department positive nasopharyngeal swab polymerase chain reaction assay sars cov- present neurological symptom positive finding brain imaging study result sample clinical severity symptom varied mild critical ischemic stroke observe patient hemorrhagic event occur case patient evolve large parenchymal hemorrhage present petechial bleed foci case observe subarachnoid hemorrhage associate bilateral hypodensity globus pallidus typical posterior reversible encephalopathy syndrome finding observe patient brain compute tomography conclusion patient neurovascular complication relate covid- positive finding brain imaging neurological symptom pathological entity observe draw attention neurological risk patient sars cov- infection include bad outcome individual medical history include clinical comorbiditie especially hypertension obesity
11,background old adult aret ahigh risk severe coronavirus disease  covid- require intensive care unit icu admission age selection criterion case icu bed scarcity seek compare proportion clinical feature mortality patient year old young icu patient covid- method patient consecutively admit covid icu age admission criterion march  april include demographic clinical laboratory characteristic record illness severity charlson comorbidity index cci calculate patients>/= year old compare younger result  patient year male  were>/= year old compare young old patient high illness severity score apache ii  versus  p/= year old represent considerable proportion compare young one high mortality age severity illness cci certain comorbiditie independent risk factor mortality
12,introduction interest revolve coronavirus disease  covid- reinfection escalate rapidly definition reinfection denote severe acute respiratory syndrome coronavirus  sars cov- pcr redetection covid- recurrence month initial symptom main aim current systematic review evaluate feature covid- relapse patient material method study string term develop skilled librarian systematical search pubmed web science embase eligible study clinical survey type include january  march eligible study consist positive assessment separate negative result rt pcr result study include  case covid- reinfection child likely covid- relapse patient age group year asthenia .% headache .% cough .% prevalent symptom sars cov- infection asthenia .% myalgia .% headache .% frequent second common treatment option covid- infection lopinavir ritonavir oxygen support .% oseltamivir treatment second infection antibiotic dexamethasone remdesivir addition obesity .% kidney failure hypertension .% common comorbiditie unfortunately approximately .% patient die conclusion find potency covid- recurrence outstanding issue feature regard covid- management furthermore second covid- similar clinical feature clinically practical comparison symptom severity epoch infection uniform datum require suggest future study undertake homogenous approach establish clinical pattern reinfection phenomenon
13,interim result large multinational trial coronavirus disease  covid- combination antiviral drug appear little effect -day mortality hospital course vivid interest find alternate purpose drug nutrition supplement halt slow disease severity review multiple preclinical study partially support clinical evidence show quercetin possible therapeutic prophylaxis efficacy severe acute respiratory syndrome coronavirus sars cov comorbiditie like chronic obstructive pulmonary disease copd diabetes mellitus obesity coagulopathy hypertension currently  interventional clinical trial underway assess efficacy quercetin antiviral drug nutritional supplement prophylaxis treatment option covid- present review tempting suggest base circumstantial scientific evidence preliminary clinical datum flavonoid quercetin ameliorate covid- infection symptom act concert parallel independent path inhibit key factor responsible sars cov- infection mitigate clinical manifestation disease patient comorbid condition despite broad therapeutic property quercetin high power randomized clinical trial need firmly establish clinical efficacy covid-
14,objective study examine value risk stratification document diagnosis diabetes objectively measure height weight bmi covid- severity mortality large sample patient urban hospital locate southern california method datum retrospective cohort study covid- patient treat cedars sinai medical center march january analyze sociodemographic characteristic pre existing condition extract electronic medical record univariable multivariable logistic regression model identify associated risk factor regression causal mediation analysis examine role diabetes association obesity illness severity analysis stratify age result individual have bmi risk factor mortality regardless diabetes history conclusion finding clinical implication document patient elevated risk adverse outcome depth prospective study need capture glycemic regulation influence prognosis
15,year coronavirus disease  covid- pandemic despite know risk factor unable predict severity infection specific patient contradictory datum protective role immunosuppression prevent severe course infection remain uncertain want discuss influence immunosuppressive factor covid- pattern child base case report -year old boy immunosuppressive factor completely different course disease patient suffer aids syphili primary central nervous system b cell lymphoma treat radiotherapy experience light path infection present periodically appear cough x ray inflammatory change risk severe covid- transient hypoxia remdesivir administer remain generally good condition follow reveal noticeable complication second patient characterise syndrome obesity polyarteritis nodosa chronic immunosuppressive therapy develop massive pneumonia require treatment intensive care unit use mechanical ventilation remdesivir anakinra despite initial improvement general condition include degree lung involvement respiratory function develop intracerebral haemorrhage lead brain herniation ultimately death conclusion hiv infection oncological immunosuppressive treatment predispose severe course covid- syndrome obesity
16,background sars cov- infection portend broad range outcome majority asymptomatic case lethal disease robust correlate severe covid- include old age male sex poverty co morbidity obesity diabetes cardiovascular disease precise knowledge molecular biological mechanism explain association severe disease male sex lack analyze relationship serum testosterone level immune cell skew disease severity male covid- patient method biochemical hematological parameter admission sample  hospitalize male female covid- patient analyze association outcome sex longitudinal hospital course analysis subcohort  male patient analyze association outcome longitudinal analysis immune population flow cytometry  male patient study association outcome result find quantitative difference biochemical predictor disease outcome male vs. female patient longitudinal analysis subcohort male covid- patient identify serum testosterone trajectory strong predictor survival auc roc .% p patient biochemical parameter study include single point admission serum testosterone value lethal case longitudinal determination serum luteinizing hormone lh androstenedione level follow physiological feedback pattern failure reinstate physiological testosterone level associate evidence impaired t helper differentiation augmented circulate classical monocyte conclusion recovery failure reinstate testosterone level strongly associate survival death respectively covid- male patient datum suggest early inhibition central lh androgen biosynthesis axis majority patient follow recovery survivor peripheral failure lethal case observation suggestive significant role testosterone status immune response covid- warrant future experimental exploration mechanistic relationship testosterone status sars cov- infection outcome potential prophylactic therapeutic implication
17,background enormous knowledge gap management strategy clinical outcome follow kidney transplantation kt recipient recover coronavirus disease covid- method conduct multi center retrospective analysis  indian transplant centre june  december  kt recipient recover covid- infection analyze clinical biopsy confirm acute rejection ar incidence cox proportional modeling estimate multivariate adjust hazard ratio hr predictor ar perform compete risk analysis additional outcome measure include graft loss cause mortality wait time positive real time polymerase test rt pcr kt laboratory parameter quality life follow finding  kt include abo incompatible sensitize .% coexist donor covid- history  .% recipient residual radiographic abnormality incidence ar  .% .% death censor graft loss .% cause mortality median interquartile range follow  day cox hazard proportional analysis absence oxygen requirement covid- compare oxygen need hr p value use thymoglobulin use compare induction strategy hr p value low risk ar degree human leukocyte antigen hla dr mismatch high risk ar hr p value compete risk analysis death compete event hla dr mismatch oxygen requirement continue associate ar age gender obesity inflammatory marker dialysis vintage steroid use sensitization abo incompatibility associate high risk ar median duration covid- real time polymerase test negativity transplant day overall range day world health organization ordinal scale /= respectively difference quality life tacrolimus level blood count mean serum creatinine assess patient past covid- infection independent severity interpretation finding support outcome kt covid- recovery excellent absence covid- sequela follow additionally need change induction immunosuppression regimen base severity covid- funding sanofi
18,introduction current evidence indicate severity coronavirus disease  covid- low pediatric population local datum limited objective characterize clinical epidemiological aspect covid- infection patient young  year argentina population method cross sectional observational analytical study confirmed covid- patient age year see march  march   referral child hospital argentina multivariate analysis identify predictor severe case result total  covid- case include .% live metropolitan area buenos aires .% male patient median age year see epidemiological week .% history contact covid- patient .% family setting .% respiratory symptom .% general symptom .% gastrointestinal symptom .% neurological symptom .% symptom .% asymptomatic addition .% patient hospitalize .% severe critical course total  patient develop multisystem inflammatory syndrome history asthma bronchopulmonary dysplasia congenital heart disease moderate severe malnutrition obesity chronic neurological disease and/or age young  month independent predictor severity live vulnerable neighborhood protective factor conclusion half case refer history contact covid- patient family setting hospitalization base clinical criterion severity severity associate presence certain comorbiditie
19,result severe acute respiratory syndrome coronavirus surge prevalence severity non syndromic pediatric overweight nspo united states prevention intervention engagement regular moderate vigorous physical activity consistently show mitigate development maintenance nspo african american adolescent female subgroup population disparately impact nspo likely engage regular physical activity multidimensional global self concept identify possible predictor physical activity engagement dimensional linkage physical activity engagement member subgroup establish secondary analysis datum n  urban dwell african american adolescent female seek evaluate contribution select dimension global self concept engagement vigorous physical activity finding -model hierarchical regression analysis find addition socioeconomic position social desirability competence dimension global self concept significant predictive contributor physical activity engagement member study cohort specifically dimension physical appearance romantic appeal close friendship social acceptance scholastic competence research need result study important implication population health
20,background background sars cov- virus large rna virus include coronavirus group show tropism airway epithelial cell sars cov- cause acute respiratory infectious disease covid- accord report mortality covid- high elderly burden comorbiditie diabetes obstructive pulmonary disease coronary artery disease cancer hypertension hepatitis b obesity chronic kidney disease objective aim study review current literature influence importance vitamin d level course sars cov- infection material method systematic review study publish january  june  perform purpose bibliographic database pubmed scopus search follow keyword combination covid- vitamin d -hydroxy vitamin d vitamin d supplementation sars cov- result show vitamin d play important role mechanism innate immunity course acute respiratory infection overlap factor severity covid- disease vitamin d deficiency prevalence obesity age scare ethnicity lead researcher hypothesize vitamin d supplementation promise preventive therapeutic measure covid- conclusion important factor immunomodulatory character vitamin d adequate supplementation preventive therapeutic measure case sars cov- infection especially elderly people obesity chronic disease
21,background abnormal liver chemistry common finding patient coronavirus disease  covid- association abnormality severity covid- clinical outcome poorly understand aim aim assess prevalence elevated liver chemistry hospitalize patient covid- compare serum liver chemistry predict severity hospital mortality method retrospective observational study include  patient covid- hospitalize johns hopkins health system baltimore md united states demographic datum clinical characteristic laboratory finding treatment measure outcome datum collect cox regression modeling explore variable associate abnormal liver chemistry admission disease severity prognosis result total  .% abnormal alanine aminotransferase alt time admission prevalent abnormal liver chemistry aspartate aminotransferase ast .% alkaline phosphatase alp .% total bilirubin t bil .% factor associate liver injury old age asian ethnicity race overweight obesity high alt ast t bil alp level commonly associate disease severity multivariable adjust cox regression analysis reveal abnormal ast t bil associate high mortality risk liver injury indicator hospitalization abnormal ast t bil alp associate need vasopressor drug high level ast t bil decrease albumin level associate mechanical ventilation conclusion abnormal liver chemistry common time hospital admission covid- patient closely relate patient severity prognosis elevated liver chemistry specifically alt ast alp t bil level stratify risk predict need advanced therapy patient
22,background objective coronavirus disease  covid- report china year ago primarily lung infection associate cough fever spread rapidly world declare pandemic early  million people infect million death worldwide date approximately death occur covid- united states number continue rise extrapulmonary manifestation disease acute kidney injury aki cardiovascular event gastrointestinal gi indication emphasize initially subsequent study united states canada note gi involvement disease large number case group take care patient early phase pandemic observe frequent presentation gi symptom diarrhea hepatic dysfunction study examine method undertake retrospective study  consecutive adult patient hospitalize center confirmed covid- infection view elucidate gi hepatic involvement early breakout march -may illness result major comorbiditie associate illness cohort patient include hypertension htn diabetes mellitus dm obesity chronic kidney disease ckd common gi manifestation diarrhea interestingly third patient liver function abnormality common liver function abnormality elevate serum aspartate aminotransferase ast elevated ast significantly correlate p inflammatory marker d dimer lactate dehydrogenase ldh ferritin aki bi variate analysis salient observation study include high mortality frequent aki cardiovascular event male patient p liver injury cohort suspect multifactorial involve excessive cytokine release viral infiltration hepatocyte cholangiocyte play role transaminitis mean /-sd duration hospital stay day admission icu overall mortality significant difference african americans caucasians patient admit icu high mortality rate compare admit intermediate care imc)/acute care severity illness associated pulmonary complication conclusion study evaluate presence comorbiditie dm htn obesity patient hospitalize covid- community hospital mid atlantic region united states statistical analysis datum obtain cohort reveal high frequency gi symptom diarrhea predominant common initial manifestation disease serum ast elevation common correlate inflammatory marker aki male gender significantly associate development aki high frequency cardiovascular event increase mortality overall mortality note high mortality patient admit icu compare imc floor observation spur future investigation role comorbiditie development diarrhea hepatic dysfunction covid-
23,background study aim compare outbreak coronavirus disease  covid- belgium tomographic biological clinical aspect artificial intelligence ai methodology perform observational retrospective study adult patient symptomatic seven day covid- infection diagnose chest compute tomography ct and/or reverse transcription polymerase chain reaction include study wave pandemic last march second wave last october december wave subgroup define depend respiratory failure occur course disease quantitative estimation covid- lung lesion perform ai radiologist radiology resident chest ct severity score calculate ai result  patient include study find statistically significant difference obesity hypertension asthma difference predominant second wave mixed distribution central peripherical pulmonary lesion note second wave difference note mortality respiratory failure complication radiological biological element chest ct severity score risk factor mortality respiratory failure mild agreement ai visual evaluation pulmonary lesion extension k conclusion march december cohort majority parameter analyze record significant change wave ai reduce experience performance gap radiologist well establish hospitalization criterion
24, january world health organization declare current novel coronavirus disease  covid- public health emergency international concern later characterize pandemic new datum excess body mass vitamin d deficiency relate disease severity mortality aim study evaluate latitude proxy sunlight exposure vitamin d synthesis prevalent obesity european population relate covid- spread severity european covid- datum incidence fatality include information prevalence obesity social distancing obtain world data website  april adjust analysis show high covid- incidence fatality picture country high latitude period time period  november march high incidence fatality covid- observe prevalence overweight obesity high time period time period  november march covid- incidence high fatality present result provide insight target intervention preventive strategy covid-
25,year pass outbreak report time wuhan coronavirus disease  covid- severe acute respiratory syndrome sars)-cov- coronavirus rapidly evolve pandemic infectious disease stress global health care system mortality rate high particularly elderly population patient comorbiditie hypertension diabetes mellitus cardiovascular disease chronic lung disease chronic renal disease malignancy subject diabetes high risk develop severe form covid- increase mortality diabetes contribute covid- severity remain unclear hypothesize correlate effect hyperglycemia systemic inflammatory response immune system dysfunction vitamin d vd modulator immune response datum literature show vitamin d deficiency covid- patient increase covid- severity likely negative impact immune inflammatory response use vitamin d play role aspect infection particularly inflammatory state immune system function patient piece evidence highlight link vitamin d deficiency obesity diabetes factor associate covid- severity give background perform overview systematic review assess association vitamin d supplementation inflammatory marker patient diabetes furthermore vitamin d possible role covid- patient assess database medline pubmed central cochrane library systematic reviews retrieve pertinent datum aim review provide insight recent advance molecular basis relationship vitamin d immune response inflammation diabetes covid-
26,covid- endothelial disease major comorbiditie increase risk severe sars cov- infection severe covid- include old age obesity diabetes hypertension respiratory disease compromise immune system coronary artery disease heart failure associate dysfunctional endothelium genetic environmental factor epigenetic major risk factor endothelial dysfunction individual metabolic syndrome increase risk severe sars cov- infection poor covid- outcome high risk mortality old age non modifiable risk factor risk factor modifiable review identify dietary risk factor endothelial dysfunction potential dietary prevention address endothelial dysfunction sequelae important role prevent sars cov- infection severity key factor future research address review present dietary bioactive demonstrate efficacy dysfunctional endothelial cell review cover dietary bioactive efficacy sars cov- infection dietary bioactive compound prevent endothelial dysfunction sequelae especially gastrointestinal tract result effective prevention sars cov- variant infection severity key factor future food research address
27,background study aim evaluate real world effectiveness regdanvimab clinical outcome patient mild moderate coronavirus disease  covid- method retrospective observational study include  patient receive regdanvimab  diagnose mild moderate covid- august  october  admit armed forces goyang hospital collect information use regdanvimab remdesivir dexamethasone supplemental oxygen symptom severity score sss laboratory test result linear mixed effect model test effectiveness regdanvimab usage sss result laboratory test multivariate logistic regression model calculate odd ratio additional therapeutic option remdesivir dexamethasone supplemental oxygen result patient receive regdanvimab old show high rate vaccination high charlson comorbidity index initial body temperature percentage pneumonia admission use regdanvimab show interactive effect sss laboratory finding old age male sex obesity high initial body temperature presence pneumonia admission associate increase or use additional treatment use regdanvimab reduce probability require additional therapy remdesivir dexamethasone oxygen supplementation confidence interval ci .- ci .- ci respectively conclusion regdanvimab usage tolerated associate decrease probability require remdesivir dexamethasone oxygen therapy change sss significantly different drug usage
28,initial reporting december novel coronavirus sars cov- emerge global health problem official declaration pandemic world health organization estimate  million case million fatality january study prevalence covid- severe case show comorbiditie risk factor obesity increase aging chronic cardiovascular respiratory disease play role severity sars cov- infection interaction factor involvement progression infection mortality remain unclear know sars cov- damage lung morbidity acute kidney disease thyroid dysregulation recently emerge symptomatic covid- patient condition alter thyroid hormone play critical role regulate metabolic pathway role level infectivity sars cov- capability sars cov- invade affect organ system dependent access angiotensin convert enzyme ii ace commonly express host cell binding put system high risk direct viral injury inevitably create excessively high concentration anti inflammatory mediator cytokine predispose covid- patient state severe immunosuppression case report describe -year old female test positive covid- medical history hypothyroidism present unique combination acute bacterial hemorrhagic pyelonephritis ureteral obstruction experience intermittent dysuria urinary urgency hematuria past day develop chill diaphoresis nausea vomit administer acetaminophen headache ageusia anosmia accompany respiratory illness despite receive pfizer double dose vaccine month arrival computerized tomography ct scan reveal severe moderate inflammation surround enlarge kidney  mm ureteral stone blood urine culture show growth escherichia coli gram negative bacilli chest x ray display patchy appearance right infrahilar airspace reflect atelectasis diagnosis covid- additional laboratory finding profoundly elevate c reactive protein fibrinogen d dimer level abdominal ct scan reveal hemorrhagic ureteral obstruction massive swelling renal parenchyma persistent pyelonephritis hydronephrosis
29,severe acute respiratory syndrome coronavirus  sars cov- responsible current coronavirus disease  covid- pandemic affect  country cause death  million people worldwide genetic background represent factor predispose way host respond sars cov- infection sense genetic variant ace ace explain observed interindividual variability covid- outcome order improve understanding genetic variant ace ace involve severity covid- include total  individual show clinical manifestation covid- diagnose reverse transcription pcr rt pcr genomic dna extract peripheral blood saliva sample ace insertion deletion polymorphism evaluate high resolution melting method ace single nucleotide polymorphism snp rs ace snp rs rs genotype taqman probe assess association ace ace polymorphism disease severity logistic regression analysis adjust age sex hypertension type  diabetes obesity severity illness study population divide mild severe critical illness additionally individual die male result show codominant model contribution ace gene rs t t genotype critical outcome odd ratio ci p require oxygen supplementation ci p addition strong association t allele variant develop critical illness male individual ci p suggest t allele rs represent risk factor severe critical outcome covid- especially man regardless age hypertension obesity type  diabetes
30,coronavirus disease  cause severe acute respiratory syndrome coronavirus  usually mild condition case result severe sickness death understand reason grave outcome great importance coronavirus disease  periodontitis share intriguing characteristic lead systemic inflammation alteration coagulation pathway share confounding factor diabetes hypertension obesity accordingly possible association condition hypothesize literature objective review evaluate scientific evidence link disease possible underlying mechanism evidence show coronavirus disease  present oral manifestation affect periodontal tissue study show possible association coronavirus disease  severity presence periodontitis current evidence suggest association explain direct role periodontal bacteria aggravating lung infection indirect effect periodontiti induce systemic inflammation priming immune system exacerbate reaction severe acute respiratory syndrome coronavirus  infection future research need confirm observation explore possible role periodontal care play coronavirus disease  pandemic
31,covid- disease knowledge construction high transmissibility consensual treatment available identification patient high risk evolve critical form disease fundamental study aim determine risk factor associate severity covid- adult patient observational retrospective study cohort adult patient covid- admit public hospital march august medical record evaluate association possible severity predictor poisson regression primary outcome critical form disease need admission intensive care unit and/or invasive mechanical ventilation include  patient man .% progress critical form disease year old hypertension diabetes mellitus obesity frequent comorbiditie .% patient progress critical form disease hospital mortality rate critical patient independent factor associate severity disease obesity rr ci p spo fio ratio  mg l rr ci p lymphocyte rr ci p advanced age comorbiditie dependent factor strongly associate critical form disease
32,purpose outline clinical laboratorial profile patient obesity undergo bariatric surgery present positive reverse transcription polymerase chain reaction rt pcr severe acute respiratory syndrome coronavirus- sars cov- preoperative period symptom presentation method case series  patient undergo bariatric surgery present positive rt pcr sars cov- preoperative period reported symptom datum collect include demographic characteristic length hospital stay wait time surgery inflammatory marker serum level micronutrient dengue virus denv serology result total  patient undergo bariatric surgery institution study period incidence asymptomatic case sample comprise .% woman mean age year mean preoperative body mass index bmi kg m. thirty percent sample previous diagnosis diabetes .% hypertension mean time elapse positive rt pcr operation  day mean length postoperative hospital stay day mean lymphocyte count mean platelet lymphocyte ratio mean c reactive protein value mg dl ferritin mark microg l. denv igg identify patient test mean level vitamin d zinc ng ml microg dl respectively postoperative complication report conclusion include patient present laboratory marker relate disease severity important notice patient test denv specific igg detect serum
33,background infection fatality ratio ifr metric quantify likelihood individual die infect pathogen understand determinant ifr variation covid- disease cause sars cov- virus direct implication mitigation effort respect clinical practice non pharmaceutical intervention prioritisation risk group targeted vaccine delivery ifr crucial parameter covid- dynamic transmission model provide way convert population mortality rate estimate infection method estimate age specific age ifr match seroprevalence survey total covid- mortality rate population term total covid- mortality refer estimate total number death directly attributable covid- apply exclusion criterion  seroprevalence survey ifr analysis inform  age survey  age specific survey age specific observation seroprevalence report age group split total covid- mortality correspond age group bayesian hierarchical model characterise non linear age pattern report death give location remove impact vaccine estimated ifr age pattern exclude age specific observation seroprevalence death occur vaccine introduce location estimate age specific ifr non linear meta regression result age pattern standardise age ifr observation global age distribution ifr observation adjust baseline wane antibody test sensitivity model age standardise ifr function time geography ensemble  perform covariate set covariate include seven clinical predictor eg age standardise obesity prevalence measure health system performance final estimate  country territory subnational location  country territory obtain predict age standardise ifr conditional covariate reverse age standardisation finding report ifr estimate april january period introduction vaccine widespread evolution variant find substantial heterogeneity ifr age location time age specific ifr estimate form j shape low ifr occur age  year .% uncertainty interval ui increase exponentially age  year .%  year .%  year .% country high ifr july portugal .% monaco .% japan .% spain .% greece .% age ifr vary factor   country territory age standardisation country high ifr july peru .% portugal .% oman .% spain .% mexico .% subnational location high ifr include hotspot uk southern eastern state usa sub saharan african country asian country generally low age age standardise ifr population age structure account logit scale variation ifr estimate  sample country july post hoc analysis show high rate transmission care home population account high ifr location country territory find median ifr decrease interquartile range april jan interpretation estimate ifr global population help identify relative vulnerability covid- information ifr vary age time location inform clinical practice non pharmaceutical intervention like physical distancing measure underpin vaccine risk stratification ifr mortality risk form j shape respect age previous research glynn moss identify common pattern infectious disease understand experience population covid- mortality require consideration local factor ifr vary factor   country territory analysis particular presence elevated age standardise ifr country resource health care system indicate factor health care capacity important potential extenuate circumstance include outbreak care home resident variable burden severe case population prevalence comorbid condition increase severity covid- disease pre vaccine period estimate decrease median ifr  month suggest treatment covid- improve time estimate ifr pre vaccine era provide important baseline describe progression covid- mortality pattern funding bill melinda gates foundation j stanton t gillespie j e nordstrom
34,million covid- infection  thousand associate death report malaysia meta analysis prevalence covid- different clinical stage national covid- vaccination program malaysia lack address disease severity total  admit covid- patient initially record early phase study datum later pool meta analysis aim provide insight prevalence covid-  different clinical stage outset covid- pandemic malaysia conduct systematic literature search pubmed web science scopus sciencedirect database relevant study specified inclusion exclusion criterion quality assessment include study perform newcastle ottawa scale heterogeneity examine index q test funnel plot egger test perform determine publication bias meta analysis overall  study  patient include pooled prevalence rate meta analysis calculate random effect model high prevalence covid- malaysia observe stage  case .% follow stage  .% stage  .% stage  .% stage  .% third number case morbidity high percentage hypertension .% obesity diabetes mellitus .% stage  patient conclusion meta analysis suggest high prevalence covid- occur stage prevalence rate stage  appear low covid- patient implement vaccination program malaysia meta analysis datum critically useful design screening vaccination program improve disease management country
35,introduction december emergence new coronavirus disease  covid- begin wuhan china disease spread rapidly world  million register case worldwide number exponentially increase india  million register case end comorbiditie obesity increase risk hospitalization covid- infection relate immune system dysfunction epidemiological picture covid- change rapidly important discuss pattern clinical manifestation association comorbiditie conduct observational study tertiary care center north india method materials conduct hospital base prospective observational study dedicated covid- ward icu tertiary care center north india sample size  positive patient male female divide patient study different age group  year year  year patient age  year bmi kg m exclude study result  patient  .% develop severe covid- few number patient develop severe covid- normal weight group obese patient progress severe case show adjust age compare normal weight group overweight .-fold chance develop severe covid- p obese .-fold chance develop disease ors p  gender distribution association appear strong man woman similar adjustment or overweight obese patient compare normal weight patient p p female male respectively conclusion study show obese patient bmi great equal high risk develop covid- severity especially male population severity relate comorbid condition study patient chronic obstructive pulmonary disease copd gi liver disease obese severity relatively low conclusion obese male patient comorbiditie likely develop severe covid- infection
36,background prospective population base study investigate multiple determinant pre vaccination antibody response sars cov- lack method prospective population base study sars cov- vaccine naive uk adult recruit  november positive swab test result sars cov- prior enrolment information  potential sociodemographic behavioural nutritional clinical pharmacological risk factor obtain online questionnaire combined igg iga igm response sars cov- spike glycoprotein determine dry blood spot obtain november april logistic linear regression estimate adjusted odd ratio aors adjust geometric mean ratio agmrs potential determinant sars cov- seropositivity participant antibody titre seropositive participant respectively result participant  .% seropositive factor independently associate high risk sars cov- seropositivity include frontline health care occupation aor ci international travel .- number visit shop indoor public place  vs. .- p trend body mass index bmi /=  vs. /= vs.  unit week light physical exercise associate low risk .-  vs. h week seropositive participant high titre anti spike antibody associate factor include bmi /=  vs. /=  vs. .- p trend association substantially attenuate adjustment covid- disease severity conclusion high alcohol consumption low light physical exercise represent new modifiable risk factor sars cov- infection recognise association south asian ethnic origin obesity high risk sars cov- seropositivity independent sociodemographic behavioural nutritional clinical pharmacological factor investigate seropositive participant high titre anti spike antibody people south asian ancestry obese people explain great covid- disease severity group
37,introduction coronavirus disease  covid- associate high rate morbidity mortality primary hypothyroidism common comorbid condition little know association covid- severity outcome study aim identify frequency hypothyroidism hospitalize patient covid- describe difference outcome patient pre existing hypothyroidism observational multinational registry method observational cohort study enrol patient  year old laboratory confirm severe acute respiratory syndrome coronavirus- infection march  february primary outcome disease severity define world health organization scale clinical improvement ordinal outcome correspond high severity level record patient index covid- hospitalization hospital mortality hospital free day secondary outcome rate intensive care unit icu admission icu mortality result adult patient include study pre existing hypothyroidism identify  .% median age hypothyroidism group  interquartile range year female white common comorbiditie hypertension diabetes dyslipidemia obesity adjust age body mass index sex admission date quarter year march race smoking history comorbid condition coronary artery disease hypertension diabetes dyslipidemia pre existing hypothyroidism associate high odd severe disease world health organization disease severity index odd ratio confidence interval ci p hospital mortality ci p difference hospital free day estimate difference day ci p pre exist hypothyroidism associate icu admission icu mortality unadjusted adjust analysis conclusion international registry hypothyroidism identify   adult hospitalize patient covid- pre exist hypothyroidism hospitalize patient covid- associate high disease severity increase risk mortality icu admission research possible effect covid- thyroid gland function need future
38,background immunomodulatory therapy explore manage dysregulated immune response see severe covid- infection objective study evaluate efficacy intravenous immunoglobulin ivig severe critical covid- disease method retrospective study include  patient severe critical covid- admit intensive care unit icu tertiary care hospital  december primary outcome percentage patient require mechanical ventilation secondary outcome hospital mortality b -day mortality c icu length stay icu los d day discontinuation supplemental oxygen e day covid pcr negativity logistic regression linear regression perform adjusted unadjusted analysis result analyze total  patient  .% receive ivig standard treatment  .% receive standard treatment group similar term covid- severity apache ii score oxygen requirement initial management requirement invasive ventilation significantly ivig group compare non ivig group .% vs .% p /= year obesity associate well outcome need mechanical ventilation hospital mortality p ivig administration patient chronic respiratory disease associate reduce requirement mechanical ventilation p insignificant improvement mortality conclusion high dose ivig improve outcome severe critical covid- patient study underscore importance timing patient selection administer ivig
39,metabolomics target untargeted gold standard biomarker discovery target approach provide information select marker hamper determination box marker common bottleneck untargeted metabolomic identification detect biomarker study develop strategy base derivatization lc ms ms detection precursor ion scan untargeted determination specific metabolome carbonyl contain metabolite usefulness guide metabolomic approach demonstrate elucidate carbonyl contain biomarker covid- severity lc ms ms behavior  model compound o benzylhydroxylamine derivatization study precursor ion scan m z  select suitable approach untargeted detection carbonyl contain metabolite method able detect approximately  potential carbonyl contain molecule plasma include mono-/di-/tricarbonylic compound satisfactory intra day inter day repeatability rsd commonly additionally semiquantitative nature precursor ion scan method confirm comparison fully validate target method application guide metabolomics method covid- plasma sample reveal presence potential covid- severity biomarker base lc ms ms behavior biomarker elucidate -hydroxybutyrate -dihydroxybutyrate -oxobutyrate -hydroxy methylbutyrate structure confirm comparison reference material alteration biomarker covid- severity confirm target analysis large set sample result confirm guide metabolomics alternative approach untargeted detection select family metabolite approach accelerate elucidation provide new perspective establishment health disease biomarker
40,background coronavirus disease covid- remain global health problem covid- patient severe pneumonia high risk critical illness complicate acute respiratory distress syndrome inflammatory response critical cytokine storm increase severity covid- factor associate cytokine storm incompletely understand study present characteristic covid- patient explore clinical inflammatory parameter severe critically ill covid- patient intensive care unit icu method cross sectional study conduct severe covid- patient admit icu peripheral blood take laboratory examination  hour admission haematologic parameter serum electrolyte renal function liver function pancreas enzyme d dimer inflammatory cytokine interferon ifn)-gamma tumour necrosis factor tnf)-alpha interleukin il)- il- monocyte chemoattractant protein- mcp- c reactive protein crp assess study comparative analysis sex exist comorbiditie body mass index bmi covid- vaccination status result total  subject include study frequent comorbiditie find subject obesity diabetes .% subject vaccinate laboratory result indicate leucocytosis neutrophilia neutrophil lymphocyte ratio nlr mean inflammatory finding il- il- tnf alpha ifn gamma mcp- d dimer crp lipase increase lipase level high man p comorbidity group significant difference find different bmi group lipase il- mcp- level significantly high p=. respectively non vaccinated group conclusion patient severe covid- comorbiditie increase inflammatory marker
41,ongoing coronavirus disease  covid- pandemic call identification risk factor help identify people enhance risk severe disease outcome improve treatment possible establish prophylactic measure study aim determine individual obesity compare individual normal weight increase risk severe covid- conduct systematic literature search pubmed embase cochrane library critically secondary literature amstar- explore  study finding indicate individual obesity body mass index  kg m compare individual obesity experience increase risk hospitalization odd ratio admission intensive care unit invasive mechanical ventilation composite outcome severe outcome risk ratio find diverge result concern death covid- datum trend increase mortality compare individual obesity individual obesity finding suggest young individual /= year obesity augment severity covid- include tendency increase mortality contribute increase disease burden especially young individual
42,introduction recent global pandemic coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- involve  million people worldwide associate death clear information know potential risk factor covid- factor adversely influence clinical course mortality analyze role obesity type  diabetes hypertension risk factor covid- method identify article inclusion search pubmed google scholar access  june retrospective review literature analysis epidemiological datum concern obesity prevalence covid- incidence particularly italy usa results datum retrospective study prevalence show patient hypertension type  diabetes obesity severe covid- intensive care unit admission high mortality rate definitively clear independent association general prevalence obesity patient covid- general population world obesity associate severe disease mortality young  year strict connection propose use drug inhibit angiotensin convert enzyme  ace- dipeptidyl dipeptidase  dpp- influence viral activity disease severity ace- dpp- receptor mediate sars cov- entry host cell evidence exist date show case conclusion overall diabetes hypertension obesity negatively affect clinical course disease outcome patient covid- datum need confirmation study accurate data registration
43,background alpha variant b lineage sars cov- emerge dominant circulate variant uk late current literature unclear alpha variant associate increase severity link clinical datum viral genome sequence datum compare admit case sars cov- wave london investigate association alpha variant severity disease method clinical demographic laboratory viral sequence datum electronic health record system collect case positive sars cov- rna test  march   february  multisite london healthcare institution multivariate analysis logistic regression assess risk factor severity define hypoxia admission result  sars cov- rna positive case  admit wave   wave wave temporally align rise nosocomial case wave   wave alpha variant identify  november  increase rapidly comprise sequence isolate admit case wave multivariate analysis identify risk factor severity admission age ci year old p obesity ci p infection alpha variant ci p conclusion analysis hospitalise cohort increase severity disease associate alpha variant number nosocomial case similar wave despite introduction infection control intervention wave
44,importance understanding sars cov- infection child limit lack large multicenter study granular datum objective examine characteristic change time outcome severity risk factor child sars cov- national covid cohort collaborative nc design setting participant prospective cohort study encounter end date september conduct  nc facility participant include child young  year initial sars cov- testing main outcomes measures case incidence severity time demographic comorbidity severity risk factor vital sign laboratory trajectory clinical outcome acute covid- vs multisystem inflammatory syndrome child mis c delta vs pre delta variant difference child sars cov- result total  child test sars cov-  test result .% positive girl median age iqr year  child .% hospitalize  .% meet criterion severe disease mechanical ventilation vasopressor inotropic support extracorporeal membrane oxygenation .% death male sex odd ratio ci .- black african american race ci .- obesity ci .- pediatric complex chronic condition pccc subcategorie associate high severity disease vital sign laboratory test value day admission predictive peak disease severity variable associate increase odd mis c vs acute covid- include male sex ci .- black african american race ci .- young  year ci .- obesity ci .- have pediatric complex chronic condition ci child mis c inflammatory laboratory profile severe clinical phenotype high rate invasive ventilation  vs   p need vasoactive inotropic support  vs   p compare acute covid- compare child delta vs pre delta era significant change hospitalization rate vs  p low odd severe disease vs  decrease factor ci p conclusion relevance cohort study child sars cov- observe difference demographic characteristic preexist comorbiditie initial vital sign laboratory value severity subgroup take result suggest early identification child likely progress severe disease achieve readily available data element day admission work need translate knowledge improve outcome
45,background coronavirus disease  covid- important global issue december clinical course covid- know mild child adult associate hospitalization child increase emergence contagious severe acute respiratory syndrome coronavirus  sars cov- variant achievement high vaccination rate adult consider global domestic situation believe risk stratification child covid- urgently need decision making hospitalization priority child infect sars cov- vaccination priority covid- method systematic review meta analysis perform comprehensively search pubmed embase scopus koreamed database august criterion enrollment severe covid- poor outcome intensive care unit admission invasive mechanical ventilation and/or death underlie comorbiditie sars cov- infection result  screen study  article include systematic review  article include meta analysis neonate risk ratio rr confidence interval ci .- prematurity young infant rr ci .- obesity rr ci .- diabetes rr ci .- chronic lung disease rr ci .- heart disease rr ci .- neurologic disease rr ci .- immunocompromised status rr ci .- significant risk factor severe covid- child subgroup analysis age young  month rr ci .- asthma rr ci .- neurodevelopmental disorder rr ci .- risk factor severe covid- conclusion child comorbiditie obesity diabetes heart disease chronic lung disease asthma seizure disorder immunocompromised status high prevalence severe covid- neonate premature infant high risk severe covid- define high risk group severe covid- help guide hospital admission priority vaccination sars cov-
46,introduction emerge datum demonstrate increase mortality covid- patient suffer comorbid condition type ii diabetes hypertension cardiovascular disease underlie risk patient increase bodyweight obesity adverse health effect obesity factor enhance risk mortality covid- patient unexplored objective enhance fat deposition risk factor increase mortality covid- patient method collect information online database pubmed google scholar researchgate highlight systematic link obesity associated risk covid- result report study pandemic france new york currently report study mexico find individual bmi kg m kg m great risk develop critical illness covid- increase mortality conclusion study suggest obesity childhood adolescence adulthood consider profound risk factor great susceptibility severity covid- associate nutritional lifestyle cardiac respiratory renal immunological alteration potentiate complication sars cov- infection suggest check bmi pandemic situation
47,background coronavirus disease  covid- pandemic cause million death new treatment urgently need factor associate bad covid- prognosis include old age  year ethnicity male sex obesity people comorbiditie furthermore vitamin d deficiency report predictor poor prognosis patient acute respiratory failure covid- accord recent clinical case series vitamin d deficiency modifiable risk factor prospect reduce hospital stay intensive care fatal outcome vitamin d potent immunomodulatory property supplementation improve important outcome critically ill vitamin d deficient covid- patient despite evidence support association vitamin d deficiency covid- severity uncertainty direct link aim trial assess high dose vitamin d supplementation therapeutic effect vitamin d deficient patient covid- method trial design randomized placebo control double blind multi center approach choose compare high single dose vitamin d iu follow treatment usual tau vitd tau treatment usual placebo tau patient covid- vitamin d deficiency discussion vitamin d substitution patient covid- vitamin d deficiency investigate efficacy safety study aim test hypothesis patient vitamin d deficiency suffer covid- treat standardized condition hospital recover fast additionally treat high dose vitamin d supplementation late study suggest vitamin d supplementation patient covid- highly recommend positively influence course disease randomized control trial contribution new treatment guideline shall trial registration clinicaltrials.gov nct snctp
48,background infection sars cov- virus produce human disease highly variable unpredictable severity presence frequent genetic single nucleotide polymorphism snps population lead great susceptibility infection exaggerated inflammatory response sars cov- require presence ace protein enter cell ace regulator renin angiotensin system accordingly study association  snp agtr ace ace gene severity disease produce sars cov- virus method  aged .+/- year male covid- patient group base severity symptom outpatient n .% hospitalize ward n .% intensive care unit icu n .% deceased n .% comorbidity datum diabetes hypertension obesity lung disease cancer collect adjustment genotype distribution  select snp severity group analyze result snp ace associate severity disease rs andrsshowe protector effectassume overdominant model inheritance g vs. gg aa ci p g vs. aa gg ci p respectively snp rs rswere associate increase risk hospitalize severity course disease recessive model inheritance c c vs. t c t t ci p vs. gg g ci p expect old age male gender comorbiditie increase risk admit icu death vs benign outpatient course multivariable analysis demonstrate role certain genotype ace severity covid- rs rs rs r respectively hardy weinberg equilibrium hospitalize group d snp ace show p association disease association covid- disease different agtr snp evidence multivariable genotype rs show high hospitalization risk patient comorbiditie conclusion different genetic variant ace associate severe clinical course death group patient covid- ace common snp population modulate severity covid- infection independently know marker like gender age comorbiditie
49,currently pneumonia cause coronavirus disease  covid- pandemic date specific antiviral treatment disease universal access vaccine challenge observational study show covid- common country high prevalence obesity people covid- high body mass index study obesity increase risk disease severity mortality study aim review mechanism link obesity covid-
50,
51,background obesity type  diabetes td report highly enrich hospitalize covid- patient close correlation obesity td important examine obesity td independently relate covid- hospitalization objective examine causal effect obesity td hospitalize covid- patient mendelian randomization mr research design method sample mr analysis apply genetic marker obesity identify genome wide association study gwas giant consortium instrumental variable ivs obesity genetic marker td identify diagram consortium iv td mr analysis perform hospitalize covid- patient covid- host genetics initiative mr base platform result  class obesity class // show causal risk factor covid- hospitalization td increase risk hospitalization critically ill covid- independent factor conclusion obesity td primary risk factor covid- hospitalization
52,sars cov- highly pathogenic coronavirus cause disease know covid- infect  million people worldwide main form containment pandemic social isolation isolation severity covid- disease uncertainty future economic impact possible cause anxiety adverse effect pandemic literature describe possible association anxiety poor sleep quality exacerbation painful condition gastroesophageal reflux disease increase consumption drug possibility develop enhance sleep bruxism health professional mind possibility overlap different clinical condition mention need multi professional team manage patient
53,beginning covid- pandemic scientific community explore determinant covid  disease severity majority study base hospital patient high risk collider- selection bias present investigation detail risk factor associate overall mortality hospitalization intensive care unit icu admission covid- infection complete population coverage high resolution datum patient characteristic comorbid condition population base observational study comprise resident  year old stockholm region- million inhabitant real time covid- monitoring framework observation period last march  december hazard ratio hr risk factor covid- disease severity assess cox proportional hazard model total  death hospitalization  icu admission relate covid- occur study period kidney failure diabetes obesity increase risk mortality heart failure ischemic heart disease atrial fibrillation hypertension risk hospitalization follow similar pattern admission intensive care differ triage process clearly present certain co morbid condition associate low icu admission observe difference risk mortality hospitalization patient covid  raise important question potentially protective comedication address real time covid- monitoring framework
54,purpose aim study determine real influence bariatric surgery clinical evolution patient infect sars cov- postoperative period method conduct retrospective analysis include group patient present covid- bariatric surgery present  month postoperative primary outcome relate severity covid- measure follow variable presence symptom need hospitalization icu admission invasive ventilation laboratory marker inflammatory response glycemic status micronutrient analyze secondary outcome result  individual operate study period  .% present covid-  .% preoperative period  .% procedure mean age year mean preoperative bmi kg m statistically significant difference group symptom presentation .% p need hospitalization .% p icu admission .% p invasive ventilation .% p quantitative variable absolute lymphocyte count significantly low group present covid- surgery x p conclusion patient covid- sleeve gastrectomy differ statistical significance presence symptom need hospitalization icu admission invasive ventilation
55,coronavirus disease- covid- result infection sars cov- span wide spectrum illness severely ill patient highly elevated serum level certain cytokine considerable cytolytic t cell infiltrate lung observe patient bear low negligible viral burden suggest overactive immune response term cytokine storm contribute severity covid- report safety efficacy baricitinib combine remdesivir dexamethasone retrospective review  hospitalize patient covid- pneumonia tertiary academic medical center patient receive -day course baricitinib -day course remdesivir -day course dexamethasone clinical status biomarker obtain daily outcome assess include mortality duration hospitalization presence shock need supplemental oxygen need non invasive ventilation need mechanical ventilation development thrombosis obesity multiple medical comorbiditie associate hospitalization setting covid- treat patient demonstrate rapid decline c reactive protein crp ferritin d dimer gradual improvement hemoglobin platelet count clinical status   .% treat patient require mechanical ventilation initiate treatment death   .% treat patient require mechanical ventilation initiate treatment death associate low bmi finding support utility immunosuppression jak inhibition moderate severe covid- pneumonia supplementary information online version contain supplementary material available ./s---
56,coronavirus disease  covid- cause highly pathogenic emerge virus call severe acute respiratory syndrome coronavirus  sars cov- knowledge pathogenesis virus infancy investigation pathogenic mechanism sars cov- underway covid- remarkable characteristic wide range disease manifestation severity see individual different ethnic background geographical location effectively manage covid- population sars cov- detection serological response assessment analytic technique critical obtain knowledge risk individual comprehend identify variation disease severity general population level factor contribute variation disease presentation include population density gender age difference comorbid circumstance include diabetes mellitus hypertension obesity genetic factor presumably influence sars cov- infection susceptibility covid- link high risk mortality man certain ethnic group reveal host genetic characteristic affect individual risk death genetic variant involve pathologic process include virus entrance cell antiviral immunity inflammatory response entirely understand sars cov- infection characteristic present review suggest genetic polymorphism influence virus pathogenicity host immunity significant implication understanding interpret matter genetic sars cov- pathogenicity customize integrative medical care base population investigation
57,background aim molnupiravir new oral antiviral drug recently receive emergency use authorization eua usa uk india aim conduct update previous systematic review provide practical clinical guideline molnupiravir patient covid- method systematically search electronic database pubmed google scholar january key mesh keyword result final result phase  study  non hospitalize covid- patient show significant reduction composite risk hospital admission death absolute risk difference confidence interval ci p non significant relative risk reduction rrr rrr death ci  p value report number need treat prevent  death  hospitalization death composite appear closely competitive agent have eua people covid- cost wise molnupiravir comparatively cheap compare agent conclusion molnupiravir useful agent non pregnant unvaccinated adult covid- increase risk severity include hospitalization effective -day onset symptom -day course safe obvious short term effect
58,objective triad obesity high protein diet animal source disturb gut microbiota link poor clinical outcome patient covid- report effect oxidative stress result na(+ -atpase transporter signal cascade explore driver poor clinical outcome method protein protein interaction sars cov- proteome identify interactome datum na(+ -transporte atpase subunit alpha- atpa epidermal growth factor receptor erb b receptor tyrosine kinase curate datum biogrid database protein interactions datum gene expression pattern inflammatory response gene expression omnibus database cardiomyocyte post sars cov- infection number gse result atpa subunit na(+ -atpase transporter target multiple sars cov- protein furthermore receptor protein associate inflammatory response include epidermal growth factor receptor erb b receptor tyrosine kinase  interact atpa target sars cov- protein heightened interaction likely trigger cytokine release increase severity viral infection individual obesity conclusion similarity effect sars cov- protein indoxyl sulphate na(+ -atpase transporter signal cascade suggest possibility augmentation gene change see covid- infection result hyperinduction cytokine release individual obesity
59,introduction aims coronavirus disease- covid- severe course patient myasthenia gravis mg aim assess severity infection factor contribute severity group mg patient hospitalize method outpatient mg follow march  april  include study patient ask respond brief questionnaire person telemedicine electronic message result nineteen patient test positive covid- polymerase chain reaction asymptomatic  symptomatic patient  mild symptom treatment receive antiviral antibiotic anticoagulant myasthenia control infection unaffected covid- patient moderate covid- require hospitalization intensive care recovery patient old cohort severe disease patient postsurgery myasthenic exacerbation infection need intensive care intubation recover completely morbidly obese patient comorbiditie require intubation die corticosteroid increase moderate severely affected patient immunosuppressive agent generally continue hydroxychloroquine hcq covid- patient discussion patient mild covid- patient recover design study possible capture mild case have control mg infection absence comorbiditie likely affect course infection favorably influence progression
60,male severe acute respiratory syndrome coronavirus  sars cov- patient high intensive care unit icu admission rate bad disease course comprehensive analysis female male icu survival underlying factor comorbiditie risk factor and/or anti infection inflammatory therapy administration currently lack investigate association sex icu survival adjust variable multicenter observational cohort study patient sars cov- pneumonia admit seven icu region belgium netherlands germany require vital organ support pandemic wave include random intercept center mixed effect logistic regression investigate association sex icu survival model adjust age acute physiology chronic health evaluation ii apache ii score comorbiditie anti infection inflammatory therapy interaction term add investigate effect modification sex country sex obesity total  patient female include mean age year female obese smoke frequently male p value respectively apache ii score female male comparable overall icu mortality low female male vs respectively p value  respectively icu survival female sars cov- patient high male patient independent age disease severity smoking obesity comorbiditie anti infection inflammatory therapy country sex specific biological mechanism play role emphasize need address diversity sex specific prediction prognostic therapeutic approach strategy
61,covid- inflammatory syndrome cause novel coronavirus sars cov- symptom range mild infection severe acute respiratory distress syndrome ards require ventilation intensive care time data collection uk case  fatality rate necessitate  critical care admission  million case nutrition important immune function influence metabolic risk factor obesity glycaemic control recovery acute illness poor nutritional status associate bad outcome ards viral infection limited research assess pre morbid nutritional status outcome patient critically unwell covid- objectives investigate effect body mass index bmi glycaemic control vitamin d status outcome adult patient covid- admit intensive care unit icu method retrospective review patient admit central london icu march  confirmed covid- electronic patient record datum analyse patient demographic comorbiditie admission bmi serum vitamin d zinc selenium haemoglobin ac hbac concentration serum vitamin d hbac measure admission  month admission icu primary outcome interest mortality secondary outcome include time intubate icu stay duration icu relate morbidity result seventy patient  man mean age year include overall mortality  significant association mortality observe bmi category survival arm admission hbac mmol mol low vs statistically significant vitamin d status significantly associate mortality p=. patient low vitamin d iu l. serum zinc selenium vitamin b folate level measure patient respectively discussion conclusion increased adiposity deranged glucose homeostasis potentially increase risk covid- infection severity possibly relate impaired lung metabolic function increase proinflammatory prothrombotic mechanism vitamin d deficiency associate poor outcome mortality support possible role vitamin d immune function specific pulmonary inflammation covid- pathophysiology plausible association raise bmi glycaemic control vitamin d status poor prognosis see wide study service evaluation audit wave pandemic uk limited datum set available analysis association reach statistical significance research need specific nutritional marker influence critical care admission covid-
62,objective overweight obesity identify risk factor severe covid- prospective cohort study investigate association overweight early life severity covid- lack method study include swedish man bear  bmi register age  year follow january covid- case comorbiditie identify national patient intensive care cause death registry outcome include follow hospitalization intensive care unit admission death result study find case mean age year sd patient hospitalize covid-  admit intensive care unit altogether  death risk hospital admission increase high value bmi age  year despite adjustment comorbiditie odd ratio ci bmi  ci bmi /= compare bmi or intensive care unit admission ci bmi  ci bmi /= conclusion high bmi early adulthood associate severe covid- year later risk increase start bmi underline necessity preventive action overweight youth offer protection come viral pandemic
63,clinical course coronavirus disease  covid- complicate onset venous thrombosis thromboembolism vte encompass pulmonary thrombosis recent statistic attest cumulative frequency vte high covid- hospitalize patient increase nearly  depend systematic screening severe illness mechanical ventilation intensive care unit admission risk venous thrombosis limit active phase disease directly associate genetic i.e. inherit prothrombotic predisposition demographical factor male sex overweight obesity disease severity risk increase progressively hospitalization development severe illness high patient need mechanical ventilation and/or intensive care presence extent pulmonary disease coexistence multiple risk factor immobilization mechanical ventilation co- superinfection increase value inflammatory thrombotic biomarker different phenotype pulmonary thrombosis develop covid- patient cause typical embolization peripheral venous thrombosis e.g. deep vein thrombosis second type trigger local inflammation nearby pulmonary tissue attributable prothrombotic state consequent pronounce systemic inflammatory response i.e. call cytokine storm frequently observe covid- pathogenesis condition different feature discrimination essential diagnostic therapeutic purpose prognosis covid- patient develop pulmonary thrombosis considerably bad probably need frequent monitoring aggressive therapeutic management
64,background hypertension diabetes obesity common comorbiditie portend bad outcome coronavirus disease  covid- metabolic syndrome common denominator condition study aim characterize association metabolic syndrome surrogate biomarker severity covid- illness method retrospective study include adult patient test covid- academic tertiary care institution march metabolic syndrome define modify world health organization criterion outcome hospitalization intensive care unit icu admission death analyze result patient test covid-  .% positive result metabolic syndrome present   patient available datum patient metabolic syndrome tend old male african american heavy comorbiditie metabolic syndrome associate high rate hospital admission death p multivariable analysis patient metabolic syndrome increase risk hospitalization icu admission death p high ast alt tg hdl c ratio associate hospitalization icu admission mortality conclusion patient metabolic syndrome significantly bad hospitalization mortality rate covid- adjust covariate target obesity hyperglycemia dyslipidemia hypertension address modifiable risk factor reduce mortality covid-
65,objective wuhan chinese city lockdown coronavirus disease  covid- outbreak springtime purpose study investigate relationship sleep status body mass index anxiety depression college student post pandemic era university wuhan china method total  college student complete online survey december  january collect datum include gender age school native place grade major body mass index bmi score self assessment list sleep srss zung self rating anxiety scale sas zung depression self rating scale sds result  valid questionnaire .% receive respondent prevalence insomnia overweight obesity anxiety depression .% .% .% respectively female student likely insomnia anxiety male student rate insomnia overweight obesity postgraduate high undergraduate non medical student likely overweight obese medical student addition insomnia severity positively correlate anxiety severity bmi positively correlate anxiety depression severity positive correlation severity anxiety depression conclusion post pandemic era insomnia depression common problem college student wuhan suggest strengthen sleep education college student improve sleep disorder psychosomatic health
66,type  diabetes td obesity independent risk factor increase morbidity mortality associate influenza sars cov- infection skewed cellular metabolism shape immune cell inflammatory responsiveness function obesity td infection alter immune cell responsiveness level systemic proinflammatory mediator partly independent peripheral immune cell contribution link sars cov associate disease severity despite knowledge role tissue parenchymal cell drive inflammatory response specifically dominantly modify obesity e.g. adipocyte influenza sars cov- infection pathogenesis remain poorly define obesity dependent skewing adipocyte cellular metabolism uncover inflammatory clade promote existence pathogenic inflammatory adipocyte phenotype amplify sars cov- infection disease severity individual obesity individual obesity td examine knowledge gain study immune cell response obesity td infection highlight key knowledge gap underlie adipocyte cellular function sculpt grease pathogenic process associate influenza sars cov- disease severity diabetes
67,immune response dysregulation play key role severe acute respiratory syndrome coronavirus  sars cov- pathogenesis study evaluate immune endothelial blood cell profile patient coronavirus disease  covid- determine critical difference mild moderate severe covid- spectral flow cytometry examine suite immune phenotype include monocyte t cell nk cell b cell endothelial cell neutrophil alongside surface intracellular marker activation result show progressive lymphopenia depletion t cell subset cd(+ cd(+ cd(+ patient severe disease significant increase cd(+)cd(+)ki(+)ifn gamma(+ monocyte population patient moderate severe covid- previously describe enhance circulate endothelial cell cd(-)cd(+)cd(+)cd(+ circulate endothelial progenitor cd(-)cd(+)cd(+/-)cd(- neutrophil cdb(+)cdb(+ coevaluate covid- severity spearman correlation analysis demonstrate synergism age obesity hypertension upregulated cd(+ monocyte endothelial cell decrease t cell lead severe outcome sars cov- infection circulate monocyte endothelial cell represent important cellular marker monitor postacute sequela impact sars cov- infection convalescence role immune host defense high risk adult vaccination
68,evidence suggest severe coronavirus disease- covid- infection characterise pulmonary systemic microvasculature dysfunction specifically acute endothelial injury hypercoagulation increase capillary permeability diabetes characterise vascular injury confer increase risk adverse covid- outcome suggest pre existing endothelial dysfunction microvascular disease diabetes exacerbate vascular insult associate covid- lead increase severity covid- infection article evaluate current evidence explore impact microvascular complication form diabetic retinopathy nephropathy individual covid- diabete future insight gain explore microvascular injury pattern clinical outcome come influence care delivery algorithm condition
69,coronavirus disease covid- pandemic extend late  continue day degree disease relate factor include age comorbiditie obesity widely consider main factor infection mainly show individual obese severe course infection covid- review study summarize relationship risk obesity covid- detect difference reporting period pandemic china recent study obesity risk factor develop sign symptom patient covid- review benefit clinician recognize role obesity give covid- diagnosis follow treatment program
70,importance obesity established risk factor severe covid- infection know lose weight associate reduce adverse outcome covid- infection objective investigate association successful weight loss intervention improve risk severity covid- infection patient obesity design setting participant cohort study involve adult patient body mass index  high calculate weight kilogram divide height meter square undergo weight loss surgery january december cleveland clinic health system cchs patient surgical group match patient surgical intervention obesity control group source datum cchs electronic health record follow conduct march exposure weight loss surgery include roux en y gastric bypass sleeve gastrectomy main outcomes measure distinct outcome examine covid- outbreak march weight loss cause mortality assess enrollment date march covid related outcome analyze patient covid- diagnosis march march positive sars cov- test result hospitalization need supplemental oxygen severe covid- infection composite intensive care unit admission need mechanical ventilation death result total  patient median iqr age  year .% female individual median iqr body mass index  enrol overall median iqr follow duration year covid- outbreak patient surgical group compare control patient lose weight mean difference  year baseline ci percentage point p low cumulative incidence cause non covid- mortality ci .%-.% vs ci .%-.% p  enrol patient  available march assessment covid related outcome rate positive sars cov- test result comparable surgical control group ci .%-.% vs ci .%-.% p undergo weight loss surgery associate low risk hospitalization adjust hazard ratio hr ci p need supplemental oxygen adjust hr ci p severe covid- infection adjust hr ci p conclusion relevance cohort study find patient obesity substantial weight loss achieve surgery associate improve outcome covid- infection finding suggest obesity modifiable risk factor severity covid- infection
71,pre exist comorbiditie obesity metabolic disease adversely affect clinical outcome covid- chronic metabolic disorder globally rise consequence unhealthy diet refer western diet time syrian hamster model demonstrate detrimental impact continuous high fat high sugar diet covid- outcome observe increase weight loss lung pathology exudate vasculitis hemorrhage fibrin edema delay viral clearance functional lung recovery prolonged viral shedding accompany altered significantly different systemic il- il- profile dysregulate serum lipid response dominate polyunsaturated fatty acid contain phosphatidylethanolamine partially recapitulate cytokine lipid response associate severe human covid- datum support hamster model test restrictive target diet immunomodulatory therapy mediate adverse effect metabolic disease covid-
72,currently world face pandemic obesity covid- establish prevalence obesity rise dramatically cause deterioration health quality population increase susceptibility unfavourable course acute infection observe excess body mass significantly influence covid- outcome aim review present late scientific report impact excess body mass course complication covid- web science pubmed google scholar database search study report patient state covid- positive base result nasopharyngeal swab ribonucleic acid test include show thromboembolic ischemic complication stroke disseminate intravascular coagulation severe hyperglycaemia leukoencephalopathy likely appear covid- positive patient obesity compare non obese subject covid- complication cardiomyopathy dysrhythmias endothelial dysfunction acute kidney injury dyslipidaemia lung lesion acute respiratory distress syndrome bad outcome obese patient
73,background aim investigate infection rate clinical characteristic outcome covid disease cohort people live hiv madrid spain year pandemic setting observational single center study include hiv infect patient aged  year laboratory confirm severe acute respiratory syndrome coronavirus  sars cov- infection february hospital universitario  de octubre method confirmed disease define patient positive antigen test reverse transcriptase polymerase chain reaction serology sars cov- compare characteristic patient mild disease asymptomatic include moderate severe disease require admission result  hiv infect patient  .% male median age year diagnose sars cov- infection rate .% confidence interval thirty individual .% moderate severe disease .% mild disease .% asymptomatic hypertension .% obesity .% prevalent comorbiditie .%  comorbiditie patient .% rna hiv viral load copy milliliter  cd cell count cell cubic millimeter infection admit hospital require oxygen support .% invasive mechanical ventilation patient die patient take tenofovir disoproxil fumarate require admission multivariate analysis age remain independent factor moderate severe disease odd ratio confidence interval p conclusion people live hiv risk severe sars cov- infection age variable independent association moderate severe disease adjust comorbiditie factor
74,venous thromboembolism vte patient covid- intensive care unit icu frequent risk factor rf remain unidentified meta analysis crd search observational study icu report association vte rf medline embase  april reviewer independently extract datum duplicate assess certainty evidence grade approach analysis conduct random effect model produce non adjusted odd ratio analyse  rf  study patient find moderate certainty evidence association vte d dimer peak ci length hospitalization ci intubation ci identify low certainty evidence association vte crp ci d dimer ci troponin t ci requirement inotropic drug ci traditional vte rf i.e. history cancer previous vte event obesity find associate vte covid- anticoagulation associate decrease vte risk vte rf severe covid- correspond individual illness severity inflammatory coagulation parameter
75,background information cost inpatient care patient coronavirus disease  covid- limited study estimate patient cost inpatient care adult covid- patient see hospital method patient age year /= hospitalization march  covid- diagnosis code large electronic administrative discharge database include validate cost report cost calculate charge multiply cost charge ratio estimate cost inpatient care patient overall severity indicator age sex underlie medical condition acute complication covid- generalized linear model log link function gamma distribution result overall cost  patient hospitalize covid- billion estimate patient hospitalization cost survive patient estimate patient cost  intensive care unit icu admission invasive mechanical ventilation imv  icu admission  imv estimate patient cost patient die adjust cost differential high patient certain underlying condition eg chronic kidney disease liver disease cerebrovascular disease obesity acute complication eg acute respiratory distress syndrome pneumothorax intracranial hemorrhage conclusion cost inpatient care covid- patient substantial  month pandemic estimate inform policy maker planner cost effectiveness analysis public health intervention alleviate burden covid-
76,objective describe population base rate risk factor severe coronavirus disease  covid- ie icu admission invasive mechanical ventilation death hospitalize child method march  covid associated hospitalization surveillance network identify  child hospitalize laboratory confirm severe acute respiratory syndrome coronavirus  infection  state  child primarily admit covid- multivariable generalized estimating equation generate adjusted risk ratio arrs confidence interval cis association demographic medical characteristic abstract medical record severe covid- calculate age adjust cumulative population base rate severe covid- child result approximately hospitalize child severe covid- .% die hospitalization hospitalize child age year chronic lung disease arr ci neurologic disorder arr ci cardiovascular disease arr ci prematurity arr ci airway abnormality arr ci associate severe covid- hospitalize child age   year feed tube dependence arr ci diabetes mellitus arr ci obesity arr ci associate severe covid- severe covid- occur  child overall high infant hispanic child non hispanic black child conclusion result identify child potentially high risk severe covid- benefit prevention effort include vaccination rate establish baseline monitor change pediatric illness severity increase availability covid- vaccine emergence new variant
77,evidence show chronic disease associate covid- severity death study aim estimate fraction hospitalization death covid- attributable chronic disease associate poor nutrition smoking adult test positive covid- mexico analyze adult age /= test positive covid- march  december chronic disease consider obesity chronic obstructive pulmonary disease copd hypertension diabetes cardiovascular disease chronic kidney disease ckd calibrate database bias quantification method consider undiagnosed disease case estimate total impact multiple disease define multimorbidity variable accord number disease risk hospitalization death estimate poisson regression model calculate population attributable fraction pafs chronic disease account ci ci ci hospitalization adult  year old respectively covid related death ci ci ci .%-.% attributable chronic disease adult  year old respectively chronic disease link poor nutrition smoking contribute large burden hospitalization death covid- mexico particularly young adult medical structural intervention curb chronic disease incidence facilitate disease control urgently need
78,response vaccine generally vary accord individual factor vaccinate subject demographic immune status report factor associate immunogenicity mrna covid- vaccine little know adenovirus vector vaccine conduct prospective observational study assess relationship antibody level age sex body mass index bmi adverse reaction ars adenovirus vector vaccine chadox ncov- healthcare worker plan receive second injection chadox ncov- vaccine hanyang university hospital seoul korea enrol study seven day injection participant ask complete online adverse reaction survey addition anti sars cov- spike s protein receptor bind domain rbd antibody concentration measure  week second injection participant n show serologic positivity u ml  week second injection chadox ncov- vaccine furthermore anti sars cov- s protein rbd concentration similar group stratify age sex bmi presence severity ar multivariable linear regression find association antibody response chadox ncov- vaccine age bmi sex vaccine induce ar conclusion age sex obesity ars associate antibody response dose chadox ncov- vaccination
79,background clarification risk factor coronavirus disease  covid- severity strongly warrant global health recent study indicate elevated body mass index bmi associate unfavorable progression covid- assume excessive deposition visceral adipose tissue vat evidence investigate association intra abdominal fat covid- prognosis sparse investigate measure intra abdominal fat useful predict prognosis covid- method present study enrol  consecutive case covid- patient age  year chest compute tomography ct scan vat area total adipose tissue tat area vat tat ratio estimate axial ct image level upper pole right kidney severe covid- define death acute respiratory failure demand oxygen  l minute high flow nasal cannula mechanical ventilation association vat tat incidence progression severe state estimate hazard ratio hr cox regression analysis compare prediction ability covid- disease progression bmi vat tat area receiver operate characteristic curve auc assess result total  case .% study subject progress severe stage incidence develop severe covid- increase significantly vat tat hr increase ci p adjustment potential confounder positive association vat tat covid- aggravation remain significant multivariable adjust hr ci .- increase p predictive ability vat tat covid- severe significantly well bmi auc vat tat bmi p difference conclusion high ratio vat tat independent risk factor disease progression covid- patient vat tat superior bmi predict covid- morbidity covid- patient high vat tat level carefully observe high risk individual morbidity mortality
80,coronavirus disease  covid- disease produce severe acute respiratory syndrome coronavirus  sars cov- currently cause catastrophic pandemic affect human worldwide disease lethal approximately million people world january globally affected country mexico rank death united states america brazil high number deceased people explain social aspect lifestyle custom mexico relationship high proportion death comorbiditie high blood pressure hbp type  diabetes obesity metabolic syndrome official epidemiological figure report mexican government indicate .% population suffer hbp close .% adult suffer type  diabetes approximately .% population suffer obesity disbalance gut microbiota gm associate disease covid- severity presumably inflammatory dysfunction recent datum association gm dysbiosis metabolic disease suggest high level susceptibility sars cov- infection covid- morbidity mexican population primarily prevalence type  diabetes obesity metabolic syndrome
81,inflammation primary factor associate causation and/or progression lifestyle disorder include obesity type  diabetes non alcoholic fatty liver disease nafld nafld spectrum disorder start simple steatosis progress non alcoholic steatohepatitis advance fibrosis cirrhosis finally hepatocellular carcinoma perpetual cycle insult cause inflammation cellular stress emerge evidence document patient nafld severe coronavirus disease  covid- patient covid- high liver injury mortality exact cause mechanism know inflammatory cytokine storm characteristic feature severe acute respiratory syndrome coronavirus  sars cov- infection know associate high mortality covid- patient covid- pandemic major concern nafld patient contract sars cov- infection develop covid- evident patient stage nafld spectrum inflammatory cytokine storm cause and/or aggravate progression severity nafld need resolution inflammatory cytokine storm patient large body evidence demonstrate efficacy omega- long chain polyunsaturated fatty acid omega- lcpufa nafld condition anti inflammatory immunomodulatory anti viral property intervention omega- lcpufa effective pharmaconutrient standard treatment covid- useful management nafld spectrum covid- patient pre existing nafld condition resolve inflammatory cytokine storm attenuate progression challenge implementation optimistically circumvent pharmaconutrition strategy potentially helpful tackle pandemic nafld covid- subset patient
82,background patient hereditary angioedema hae postulate increase risk coronavirus disease  covid- infection inherent dysregulation plasma kallikrein kinin system limited datum available explore hypothesis objective assess interrelationship(s covid- hae method self report covid- infection complication morbidity mortality survey online questionnaire participant include subject hae c inhibitor cinh deficiency hae cinh subject hae normal c inhibitor hae nl cinh household control normal control impact hae medication examine result total  participant complete survey analyze include  subject hae cinh  subject hae nl cinh  normal control incidence report covid- significantly different normal control subject hae cinh great subject hae nl cinh p obesity positively correlate covid- overall population p similar nonsignificant trend subject hae cinh comorbid autoimmune disease risk factor covid- subject hae cinh p covid- severity complication similar group report covid- reduce subject hae cinh receive prophylactic subcutaneous cinh .% p demand icatibant .% p subject hae cinh hae medication increase risk covid- compare normal control .% p conclusion subject hae cinh take hae medication significantly high rate report covid- infection subcutaneous cinh icatibant use associate significantly reduce rate report covid- result implicate potential role complement cascade tissue kallikrein kinin pathway pathogenesis covid- patient hae cinh
83,potential relationship diabetes covid- evaluate new knowledge rapidly emerge study systematically relationship viral cell surface receptor ace axl cd dc sign l sign dpp sars cov- infection risk emphasize implication ace sars cov- infection covid- pathogenesis update way interaction diabetes covid- treatment option covid- comorbid patient perspective ace efficacy clinical chemotherapeutic option include anti diabetic drug renin angiotensin aldosterone system inhibitor lipid lower drug anticoagulant glucocorticoid covid- positive diabetic patient discuss significance different form ace mace gender covid- susceptibility severity review summarize covid- pathophysiology good strategy clinical management diabetes patient covid-
84,background absence vaccine global spread covid-  necessitate non pharmaceutical intervention curb rise case purpose article use health belief model novel rapid mobile survey examine correlate report mask wear non pharmaceutical intervention south africa august method way tabulation multivariable analysis logistic regression modeling describe correlation report mask wear factor interest sample  adult period national longitudinal survey national income dynamics study coronavirus rapid mobile survey nids cram result line health belief model result show self efficacy prevalence mask wear district affluence positively associate report mask wear report stay home significantly likely report wear mask little evidence expect severity disease contract affect decision hypertension obesity overweight measure year early significant association mask wear prevalence mask wear increase significantly august  covid- case increase lockdown restriction ease contrary health belief model find despite have high mortality risk elderly significantly low odd mask wear conclusion south africa mask wear adherence increase rapidly concern elderly low odd mask wear examine future research
85,background probable impact maintenance immunosuppressant liver transplant lt recipient coronavirus disease  covid- remain unexplored specific aim approximate prognosis lt recipient covid- standard maintenance method search separate database qualified study december  june ultimately meta analysis carry fix effect random effect model base heterogeneity result total study  lt recipient covid- pool rate severity mortality combined immunosuppressive therapy .% respectively study sufficiently show immunosuppressive therapy lt recipient covid- significantly associate non severe covid- odd ratio ci p duration lt diagnosis covid- primary disease lt obesity significantly associate severity mortality lt recipient covid- immunosuppressive therapy pool analysis find lt recipient covid- comorbiditie severe disease low mortality rate compare covid- comorbiditie conclusion conclusion lt recipient covid- undergo immunosuppressive therapy significantly associate severity mortality take risk organ rejection key consideration complete withdrawal wise mycophenolate mofetil mmf discontinue replace immunosuppressive regimen cnis- mtoris base immunosuppressive therapy select lt recipient covid- depend severity disease
86,virus potential cause disease include novel corona virus- flu small pox chicken pox acquire immunodeficiency syndrome severe acute respiratory syndrome etc objective review article summarize reason epidemic cause emerge virus bacteria control infection preventive strategy explain cause epidemic preventive measure impact lockdown health people economy country report reveal transmission infection epidemic contact infected person public prevent implement lockdown government country lockdown consider significant parameter control disease negative consequence health people prone ailment like obesity diabetes cardiac problem etc drastic decline economy country transmission disease prevent warn people severity disease avoid public transportation keep isolate strictly follow guideline lockdown encouraging regular exercise
87,background study aim assess baseline characteristic clinical outcome coronavirus disease  covid- pediatric patient rheumatic musculoskeletal disease rmd identify risk factor associate symptomatic severe disease define hospital admission intensive care admission death method observational longitudinal study conduct year sars cov- pandemic march -march pediatric patient attend rheumatology outpatient clinic tertiary referral hospital madrid spain diagnosis rmd covid- include main outcome symptomatic disease hospital admission covariate sociodemographic clinical characteristic treatment regimen run multivariable logistic regression model assess associated factor outcome result study population include  pediatric patient mean age year  patient .% asymptomatic  .% mild moderate covid-  patient .% require hospital admission median length hospital admission  day patient require intensive care death previous comorbiditie increase risk symptomatic disease hospital admission compare outpatient factor independently associate hospital admission previous use glucocorticoid p statistically significant risk factor symptomatic covid- find final model conclusion difference covid- outcome accord childhood onset rheumatic disease type find result suggest associate comorbiditie treatment glucocorticoid increase risk hospital admission
88,purpose review nutritional status affect covid- pandemic directly indirectly recent rollout coronavirus disease  covid- vaccine availability medicine remdesivir monoclonal antibody host nutritional status pivotal fight acute respiratory syndrome coronavirus  sars cov- infection outcome purpose review discuss effect covid related lockdown lifestyle behavior nutritional consequence direct sequela infection nutrition include potential nutritional intervention recent finding covid related lockdown impose radical change lifestyle behavior considerable short term long term health nutritional consequence include weight gain obesity increase cardiometabolic risk consistently link worsen prognosis extent impact dependent food insecurity overall stress disordered eating physical inactivity exposure covid relate nutrition information source covid- directly induce inflammatory response poor nutrient intake absorption lead undernutrition micronutrient deficiency impair immune system function subsequent amplify risk infection disease severity nutrition intervention nutrition support dietary supplementation home remedy use zinc selenium vitamin d omega- fatty acid show significant promise mitigate course covid- infection improve survival rate nutrition covid- relationship relate dietary change mimic vicious cycle double burden malnutrition obesity undernutrition micronutrient deficiency promote infection disease progression potential death
89,current coronavirus disease  covid- pandemic present unprecedented challenge global health majority covid- patient exhibit mild symptom patient develop severe disease need immediate hospitalization severe infection associate dysregulated immune response attribute cytokine storm epidemiological study suggest overall covid- severity morbidity correlate underlie comorbiditie include diabetes obesity cardiovascular disease immunosuppressive condition patient comorbiditie exhibit elevate level reactive oxygen specie ros oxidative stress cause increase accumulation angiotensin ii activation nadph oxidase pathway accumulate evidence suggest oxidative stress couple cytokine storm contribute covid- pathogenesis immunopathogenesis cause endotheliitis endothelial cell dysfunction activate blood clotting cascade result blood coagulation microvascular thrombosis review survey mechanism severe acute respiratory syndrome coronavirus  sars cov- induce oxidative stress consequence stress patient health shed light aspect host immunity crucial prevent disease early phase infection well understanding disease pathophysiology preventive measure aim lower ros level pave way mitigate sars cov induce complication decrease mortality
90,despite widespread prevalence case associate coronavirus disease  covid- pandemic little know spatial clustering covid- united states datum covid- case identify u.s. county high low covid- incident proportion cluster result suggest variety sociodemographic variable associate severity covid- county level incident proportion pandemic evolve community color disproportionately impact subsequently shift community color metropolitan area rural area u.s. final period show limited difference county characteristic suggest covid- infection widespread finding address systemic barrier health disparity result high incident proportion covid- cluster
91,background conceive silver lining dark cloud coronavirus disease  covid- pandemic lesson teach catastrophe leverage medical authority policy maker optimize health care globally major lesson resilient health system absorb sudden shock incite overwhelm health emergency compromise continuum care chronic disease especially cancer method present review dissect association covid- thyroid cancer tc especially differentiated tc dtc focus available datum knowledge gap current challenge future perspective result obesity incriminate term covid- severity rise incidence tc especially dtc current conceptualization pathophysiological landscape covid--(d)tc association implicate interplay obesity inflammation immunity oxidative stress covid- aggravate health burden pose d)tc vice versa clarify improve understanding harnessing pathophysiological landscape covid--(d)tc association empower mechanism guide safe evidence base risk stratify management d)tc covid- era conclusion multidisciplinary patient center decision making ensure high quality d)tc care patient covid-
92,objective determine positive expiratory pressure pep pep flute self care effective reduce respiratory symptom community dwell adult sars cov- infection early stage covid- design non drug open label randomised control trial setting capital region region zealand denmark  october   february participant community dwell adult able perform self care new sars cov- infection verify reverse transcription polymerase chain reaction test symptom covid- intervention participant randomised use pep flute self care addition usual care usual care randomisation base permute random block ratio stratify sex age /= year pep self care group instruct use pep flute time day  day intervention main outcome measures primary outcome change symptom severity baseline day assess self report copd chronic obstructive pulmonary disease assessment test cat adjust baseline value stratification factor participant complete cat test questionnaire day online secondary outcome self report urgent care visit covid- number covid- relate symptom change self rate health follow result  participant assign pep flute self care intervention n= usual care n= pep self care group median number day pep flute use  day interquartile range intention treat population group difference observe change baseline cat score point confidence interval p=. favour pep flute self care group day pep flute self care group report chest tightness dyspnoea vigour high level daily activity difference small consistent effect see secondary outcome adverse event report conclusion community dwell adult early covid- pep flute self care significant marginal uncertain clinical effect respiratory symptom severity measure cat score trial registration clinicaltrials.gov nct
93,background well understand impact covid- pandemic hospital healthcare study activity emergency department ed acute medicine department major uk hospital method electronic patient record adult patient attend ed n acute medicine n pandemic prior year analyse compare study parameter include severity primary diagnosis co morbidity admission rate length stay bed occupancy mortality focus non covid- disease result wave pandemic daily ed attendance fall medical admission medical bed occupancy return normal year ed attendance medical admission fall age range great reduction see young adult ed attendance old adult medical admission compare non covid- pandemic admission covid- admission enrich minority ethnic group dementia obesity diabetes low rate malignancy compare pre pandemic period non covid- pandemic admission hypertension cerebrovascular disease liver disease obesity few low severity ed attendance pandemic few medical admission severity category few ed attendance common non respiratory illness include cardiac diagnosis change cardiac arrest covid- common diagnosis medical admission wave few diagnosis pneumonia myocardial infarction heart failure cellulitis chronic obstructive pulmonary disease urinary tract infection sepsis stroke level rebound year later trend high level stroke pandemic pandemic wave -day mortality increase ed attendance non covid- medical admission conclusion reduced ed attendance wave pandemic suggest opportunity reduce low severity presentation ed future raise possibility harm delay miss care reassuringly recent rise attendance admission indicate deterrent effect pandemic attendance diminish
94,background coronavirus covid- pandemic highlight individual behavioural risk factor commonly associate non communicable disease ncds smoking harmful alcohol use obesity physical inactivity likely experience severe symptom covid- risk factor show increase risk ncd know broad influence communicable disease take wide focus range common communicable disease review aim synthesise research examine impact behavioural risk factor commonly associate ncd risk contracting have severe outcome communicable disease method literature search identify systematic review meta analysis examine association behavioural risk factor alcohol smoking illicit drug use physical inactivity obesity poor diet contraction severity common communicable disease include infection associate pathogen priori prospectively register protocol follow prospero registration number crd result systematic review include  meta analysis review focus tuberculosis human immunodeficiency virus hepatitis c virus hepatitis b virus invasive bacterial disease pneumonia influenza covid- review examine association behavioural risk factor communicable disease contraction  examine association communicable disease outcome examine association contraction outcome  review conclude behavioural risk factor study increase risk contract experience bad health outcome communicable disease review effect size calculate range conclusion behavioural risk factor play significant role risk contract experience severe outcome communicable disease prevention communicable disease likely successful involve prevention behavioural risk factor commonly associate ncd finding important understand risk associate communicable disease timely give covid- pandemic need improvement future pandemic preparedness address behavioural risk factor important work build resilience emerge future epidemic pandemic
95,acute inflammation critical host defense response viral infection dysregulate inflammation drive immunopathology tissue damage excessive damaging inflammation hallmark pandemic influenza virus iav infection severe acute respiratory syndrome coronavirus- sars cov- infection chronic low grade inflammation feature obesity recent year obesity recognize grow pandemic significant mortality associated cost obesity independent risk factor increase disease severity death iav sars cov- infection review focus effect obesity inflammatory response context viral respiratory infection lead increase viral pathology review fundamental inflammation initiate iav sars cov- infection link disease severity examine obesity drive chronic inflammation train immunity impact immune response iav sars cov- finally review medical non medical intervention obesity impact inflammatory response prevent disease severity obese patient projection global obesity number sign slow future pandemic preparedness require consider metabolic health population furthermore weight loss insufficient reduce risk increase respiratory virus relate mortality close attention pay patient history health new therapeutic option identify
96, novel coronavirus know severe acute respiratory syndrome coronavirus  sars cov- coronavirus disease  covid- cause global pandemic virus primarily affect upper low respiratory tract raise risk variety non pulmonary consequence severe possibly fatal cardiovascular problem datum patient moderate severe form covid- preexisting cardiovascular comorbiditie diabetes mellitus obesity hypertension heart failure coronary artery disease sars cov cause hyper inflammation hypoxia apoptosis renin angiotensin system imbalance variety cell type primarily endothelial cell profound endothelial dysfunction associate covid- cause impaired organ perfusion generate acute myocardial injury renal failure procoagulant state result thromboembolic event discuss recent result involvement endothelial dysfunction pathogenesis covid- patient cardiometabolic disease review provide insight treatment reduce severity viral infection
97,background clinical outcome covid- patient vary greatly age underlying comorbiditie aim determine demographic clinical factor particularly baseline chronic condition associate increase risk severity covid- patient population base perspective datum electronic health record ehr method retrospective observational study open cohort analyze individual mean age year woman sars cov- infection  june  december  exhaustive electronic health registry patient follow  day inclusion date death period perform multivariate logistic regression analyze association chronic disease severe infection base hospitalization cause mortality result  .% individual show severe infection old age influence factor congestive heart failure odd ratio -or- man woman diabetes chronic renal failure obesity increase likelihood severe infection sex chronic skin ulcer acute cerebrovascular disease chronic obstructive pulmonary disease urinary incontinence neoplasm man infertility obstructive sleep apnea hepatic steatosis rheumatoid arthritis menstrual disorder woman associate severe outcome conclusion age specific cardiovascular metabolic disease increase risk severe sars cov- infection man woman effect certain comorbiditie sex specific future study different setting encourage analyze profile chronic patient high risk poor prognosis target prevention shielding strategy
98,covid- pandemic cause huge socio economic loss continue threat human worldwide million death  million confirm covid- case impact physical mental social economic resource immeasurable novel disease outbreak primary requirement effective mitigation knowledge clinical manifestation disease absence unique identifying characteristic diagnosis prognosis difficult intensify misperception lead delay containment disease spread numerous clinical research study systematic review meta analysis generate considerable datum identification distinct clinical sign symptom disease progression biomarker risk factor lead adverse covid- outcome warrant depth understanding view assess  systematic review meta analysis intent understand potential independent predictor biomarker risk factor covid- severity mortality
99,importance influence sleep disorder breathing sdb sleep relate hypoxemia sars cov- viral infection covid- outcome remain unknown controversy exist continue treatment sdb positive airway pressure give concern aerosolization limited datum inform professional society recommendation objective investigate association sdb identify polysomnogram sleep relate hypoxia sars cov- positivity world health organization who)-designated covid- clinical outcome account confound include obesity underlie cardiopulmonary disease cancer smoking history design setting participant case control study conduct cleveland clinic health system ohio florida include patient test covid- march  november available sleep study record sleep index sars cov- positivity assess overlap propensity score weighting covid- clinical outcome assess institutional registry exposure sleep study identify sdb define frequency apnea hypopneas apnea hypopnea index ahi sleep relate hypoxemia percentage total sleep time oxygen saturation tst main outcomes measures outcome sars cov- infection designate covid- clinical outcome hospitalization use supplemental oxygen noninvasive ventilation mechanical ventilation extracorporeal membrane oxygenation death result  individual test sars cov-  mean sd age year  woman prior sleep study  .% test positive sars cov-  participant  black .%  white .%  race ethnicity patient positive vs negative sars cov- high ahi score median event h iqr event h vs event h iqr event h p increase tst median .% sleep time iqr sleep time vs .% sleep time iqr sleep time p overlap propensity score weighted logistic regression sdb measure associate sars cov- positivity median tst associate designate covid- ordinal clinical outcome scale adjust odd ratio ci p time event analysis show sleep relate hypoxia associate high rate hospitalization mortality adjust hazard ratio ci p conclusion relevance case control study sdb sleep relate hypoxia associate increase sars cov- positivity patient infect sars cov- sleep relate hypoxia associated risk factor detrimental covid- outcome
100,obesity prevail worldwide increase effect example american adult consider obese obese individual prone variety complication metabolic disorder include diabetes mellitus hypertension cardiovascular disease chronic kidney disease recent meta analysis clinical study patient cohort ongoing coronavirus disease  covid- pandemic indicate presence obesity relevant disorder link severe prognosis covid- give significance obesity covid- progression provide review host metabolic immune response immunometabolic dysregulation exaggerate obesity viral infection develop severe course covid- sequela study individual  month have covid- high risk metabolic comorbiditie include obesity diabetes kidney disease collectively implicate inter systemic dimension understand association obesity covid- suggest interdisciplinary intervention relief obesity covid- complication phase acute infection
101,severe acute respiratory syndrome coronavirus  sars cov- causative agent coronavirus disease- covid- respiratory disease vary severity mild severe fatal risk factor severe disease identify notably age male sex pre existing condition diabetes obesity hypertension advancement clinical care achieve past year include use corticosteroid e.g. corticosteroid immune modulatory treatment standard care patient acute severe covid- understanding mechanism underlie increase disease severity age improve past month remain incomplete furthermore molecular impact corticosteroid treatment host response acute sars cov- infection investigate study cross sectional longitudinal analysis ab soluble immune mediator transcriptional response young  year diabetic male obesity hospitalize acute severe covid- conduct additionally transcriptional profile sample obtain corticosteroid standard care compare analysis indicate severe covid- characterize robust ab response heighten systemic inflammation increase expression gene relate inflammatory pro apoptotic process reduce expression important adaptive immunity regardless age contrast covid- patient receive steroid high level systemic immune mediator lack transcriptional indicator heightened inflammatory apoptotic response overall datum suggest inflammation cell death key driver severe covid- pathogenesis absence corticosteroid therapy
102,study objective prior covid- telemedicine application emergency department ed significant inroad remote evaluation care local peak covid- pandemic new york city nyc dramatic increase telemedicine base patient encounter suspect covid- symptom response pathway develop promote standardized telemedicine approach remote evaluation assessment suspect covid- patient method pathway develop implement academic ed nyc collectively approximately telemedicine visit suspect covid- march  june protocol develop expert consensus panel board certify emergency physician pediatric emergency physician telemedicine training administrative role result pathway initiate telehealth patient suspect covid- symptom cough fever shortness breath bodyache standardized history solicit know suspect risk factor bad prognosis include age cardiovascular lung disease obesity immunosuppression live focus assessment symptom severity exercise tolerance exam rest include visual counting breath instruction palpation radial pulse saturation include pulse oximetry available exam rest reassure provider instruct repeat respiratory assessment exertion have patient walk place briskly  minute patient severe illness define resting exertional respiratory rate great  and/or oxygen saturation  percent instruct ed patient moderate illness define exertional metric respiratory rate oxygen saturation great  percent heart rate  discharge virtual urgent care visit repeat telehealth follow   hour depend number risk factor patient risk factor reassure respiratory assessment discharge telemedicine encounter reassurance standard discharge precaution escalation care conclusion designing disseminate standardized pathway help provide framework approach patient suspect covid- telemedicine future work focus patient outcome datum help guide refine standardized telehealth approach covid suspect patient
103,manage coronavirus disease  covid- patient radiological imaging complement clinical evaluation laboratory parameter aim assess sensitivity chest radiography finding detect covid- describe finding assess association positive chest radiography finding clinical laboratory finding multicentre cross sectional study conduct involve primary health care corporation register patient patient enrol -month period peak  pandemic wave qatar patient reverse transcription polymerase chain reaction confirm covid- undergo chest radiography  hour swab test positive result reverse transcription polymerase chain reaction gold standard diagnose covid- sensitivity chest radiography calculate airspace opacity distribute peripheral low lung zone patient bilateral involvement pleural effusion detect case risk have positive chest x ray finding increase age southeast asian nationality fever history fever diarrhoea patient cardiac disease obesity hypertension diabetes chronic kidney disease high risk have positive chest x ray finding statistically significant increase mean serum albumin white blood cell count neutrophil count serum c reactive protein hepatic enzyme total bilirubin increase radiographic severity score
104,introduction rapid emergence spread sars cov- late  infect million people worldwide significant morbidity mortality response health authority limit spread virus population wide inoculation prefer currently large variation disparity acquisition development deployment vaccination program country availability vaccine achieve herd immunity guarantee reinfection sars cov- emerge evidence indicate vaccine eliminate infection protect severe disease potential hospitalisation additional strategy strengthen immune system strongly consider assist reduce overall health care burden stem rate infection substantial evidence sars cov- disease severity death link exist comorbiditie cardiovascular disease obesity metabolic disorder purpose review discuss potential medium long term strategy habitual exercise relationship target comorbiditie underlying inflammation protective mechanism sars cov- disease severity conclusion conclude engagement habitual physical activity exercise strategy mitigate development comorbiditie improve response immune system potentially reduce risk symptom life threaten complication infect
105,obesity hyperlipidemia know risk factor pathological disorder include form infectious respiratory disease include current coronavirus outbreak term coronavirus disease  covid- review study effect hyperlipidemia obesity enhance inflammatory response see covid- potential therapeutic pathway relate process order well understand underlie process cytokine chemokine induce inflammation investigate immunomodulatory effect agent vitamin d reduce form glutathione adjunctive therapy covid- disease
106,coronavirus disease  covid- sweep world information covid- evolve rapidly interim guidance multiple organisation constantly update expand early discovery covid report pregnancy affect progress disease severity recently centres disease control prevention cdc report pregnancy risk factor covid- severity current case report present peripartum covid- positive mortality case
107,introduction coronavirus disease  covid- evolve global pandemic increase number report link obesity severe covid- illness death study focus increase risk mortality intensive care unit icu admission hospitalize obese patient covid- obesity associate incidence acute lung injury ali patient covid- underweight patient answer lack follow research answer question method collect analyze epidemiologic demographic clinical laboratory datum  confirm case covid- union hospital tongji medical college huazhong university science technology wuhan china january march follow april underweight define body mass index bmi low kg m normal weight .- kg m overweight .- kg m obesity kg m result patient .% underweight .% normal weight .% overweight .% obese underweight patient likely headache p obese patient likely group experience decline lymphocyte count p increase c reactive protein crp p bilateral multiple mottling ground glass opacity lung p proportion patient receive human immunoglobulin systematic corticosteroid treatment high obese group compare bmi group adjust potential confounder underweight patient .-fold high p obese patient show .-fold high odd develop ali normal weight patient p addition underweight patient time likely normal weight patient develop secondary infection p conclusion study show underweight obese patient covid- tend develop ali compare normal weight patient underweight patient likely develop secondary infection patient
108,objective primary aim article describe sars cov- infection pregnant woman wild type alpha variant period italy secondary aim compare impact virus variant severity maternal perinatal outcome design national population base prospective cohort study setting total  italian maternity hospital sample cohort  woman sars cov- infection confirm  day hospital admission method case prospectively report train clinician participate maternity unit datum describe univariate multivariate analysis main outcome measures covid- pneumonia ventilatory support intensive care unit icu admission mode delivery preterm birth stillbirth maternal neonatal mortality result find .% cohort asymptomatic .% develop covid- pneumonia .% require ventilatory support and/or icu admission maternal age year ci year ci citizenship country high migration pressure ci previous comorbiditie ci obesity ci .- associate high occurrence pneumonia preterm birth rate comparison pre pandemic period stillbirth maternal neonatal death remain stable need ventilatory support and/or icu admission woman pneumonia increase alpha variant period compare wild type period ci conclusion result consistent low risk severe covid- disease pregnant woman rare adverse perinatal outcome alpha variant period significant increase severe covid- illness research need describe impact different sars cov- viral strain maternal perinatal outcome
109,background obesity increase severity sars cov- outcome study test obesogenic ketogenic diet distinctly affect sars cov- entry protein renin angiotensin system ras rat pulmonary cardiac tissue method male sprague dawley rat feed standard chow sc high fat sucrose enrich diet hfs ketogenic diet kd  week level angiotensin convert enzyme  ace transmembrane protease serine  tmprss ras component inflammatory gene measure lung heart animal result lung hfs elevated ace tmprss level relative sc diet kd lower level protein gene expression toll like receptor  interleukin- receptor relative hfs diet alter ace tmprss heart ace abundant heart lung tissue conclusion diet induce obesity increase level viral entry protein lung provide mechanism sars cov- infectivity enhance obese individual conversely maintain low level ace tmprss exert anti inflammatory effect kd potentially attenuate severity infection migration sars cov- ace express tissue
110,study aim summarize epidemiological clinical characteristic covid- western mexico people retrospective analysis electronic database people visit sentinel center molecular sars cov- confirmatory diagnosis rt pcr april december  carry epidemiological clinical description covid- patient evaluate  .% confirm sars cov- infection mean age female comorbiditie diabetes .% obesity hypertension .% present increase odd ci ci ci respectively viral infection fever headache dry cough frequent symptom infection difference sex find patient year old prone covid- severity ci evaluate number manifest symptom increase age conclusion high sars cov- prevalence find western mexico comorbiditie frequent infected people association disease outcome observe contrast high disease severity risk find old patient continuous monitoring carry comorbiditie report aggravating factor study help health official elaboration planning effort disease management future
111,background age sex race comorbiditie insufficient explain individual remain asymptomatic sars cov- infection die sense increase risk cause long term exposure air pollution investigate understand high heterogeneity covid- infection course objective aim assess underlie effect long term exposure pm severity mortality covid- method retrospective observational study conduct  patient suffer covid- infection build set multivariate predictive model assess relationship long term exposure pm covid- outcome probability death severe covid- outcome predict function clinical variable pollutant exposure mean regularize logistic regression subsequently regularize linear regression construct predict percentage dead severe patient finally odd ratio effect estimate calculate result find long term exposure pm important variable state comorbiditie i.e. copd asthma diabetes obesity prediction covid- severity mortality pm show high effect estimate ci covid- severity mortality high effect estimate correspond age ci follow pm ci finally increase  microg m pm concentration cause increase ci patient suffer covid- severe disease increase ci death discussion result demonstrate long term pm burden guideline exacerbate covid- health outcome guideline air quality standard establish directive epa update accordingly protect human health
112,novel coronavirus disease  covid- currently lead threat public health huge challenge healthcare system globe cause severe acute respiratory syndrome coronavirus  sars cov- obesity state chronic inflammation diabetes mellitus risk factor severe sars cov- metformin commonly antidiabetic medication display immunomodulatory activity amp activate protein kinase metformin sex specific immunomodulatory cytokine reduce activity review aim summarize protective role metformin possible molecular mechanism use covid- patient include study publication relate metformin possible molecular mechanism covid- search database web science pubmed medline elsevier google scholar scopus english key term maintain proper blood glucose level oral antidiabetic drug like metformin reduce detrimental effect covid- different possible mechanism metformin mediate anti inflammatory immunomodulatory activity effect viral entry ace stability inhibition virus infection alter virus survival endosomal ph mtor inhibition influence gut microbiota fascinatingly diabetic patient covid- treatment metformin associate noticeable reduction mortality rate disease severity infected patient metformin comprehensively investigate anti inflammatory antiviral capability immunomodulatory antioxidant elucidate capability confer vascular cardiopulmonary protection covid-
113,brazilian northern region register high incidence covid- case particularly state para present study investigate risk factor associate severity covid- brazilian amazon region case epidemiological cross sectional analytical demographic study analyze datum confirm case covid- available brazilian ministry health surveillance platform conduct variable municipality residence age gender sign symptom comorbiditie include associate covid- case outcome spatial distribution perform arcgis program total case evaluate overall patient mean age year female lethality reach .% case main symptom include fever .% cough .% sore throat comorbiditie patient present cardiovascular disease diabetes neurological disease increase risk death nearly  time follow obesity times immunodeficiency time municipality high incidence rate parauapebas canaa do carajas jacareacanga similarity lower amazon marajo southwest mesoregion para state observe concern high morbidity rate obtain data demonstrate majority case occur young adult female classic influenza symptom chronic disease finally datum suggest high incidence long metropolitan region state high lethality rate brazil associate great impact disease amazonian population factor associate fragile epidemiological surveillance notification case cure
114,background evidence people live hiv elevated risk adverse covid- outcome inconclusive aim investigate association population base national covid cohort collaborative nc datum usa method include adult aged /= year covid- case health care encounter  clinical site usa datum deposit nc outcome covid- disease severity hospitalisation mortality encounter health care system begin january include provide information pre existing health condition eg comorbiditie logistic regression model employ estimate association hiv infection hiv marker cd cell count viral load hospitalisation mortality clinical severity covid- multinomial model initially adjust demographic characteristic subsequently adjust smoking obesity broad range comorbiditie interaction term add assess moderation effect demographic characteristic finding harmonised nc datum release set jan  adult covid- case  individual hiv infection total  covid- relate death occur  people hiv adjust covariate people hiv high odd covid- death adjust odd ratio ci hospitalisation low odd mild moderate covid- people hiv interaction term reveal elevated odd high old age group male black african american hispanic latinx adult low cd cell count cell mul associate adverse covid- outcome viral suppression associate reduce hospitalisation interpretation give covid- pandemic exacerbate effect health inequity public health clinical community strengthen service support prevent aggravated covid- outcome people hiv particularly pronounced immunodeficiency funding national center advance translational sciences national institute allergy infectious diseases national institutes health usa
115,background previous study show high body mass index bmi risk factor severe covid- aim present study assess high bmi affect risk death prolonged length stay los patient covid- intensive care sweden method finding observational register base study include patient covid- swedish intensive care registry admit intensive care unit icu sweden outcome assess death intensive care icu los /= day logistic regression model evaluate association odd ratio confidence interval ci bmi outcome valid weight height information retrieve patient male covid- find significant association bmi risk composite outcome death los day survivor standard deviation sd increase ci adjust sex age comorbiditie association remain adjustment severity illness simplified acute physiology score saps icu admission sd ci individual bmi  kg m double risk composite outcome high bmi associate death intensive care prolonged los survivor assess separate outcome main limitation restriction wave pandemic lack information socioeconomic status smoking conclusion large cohort swedish icu patient covid- high bmi associate increase risk death prolonged length stay icu base finding suggest individual obesity closely monitor hospitalize covid-
116,background patient infect novel covid- virus spectrum illness range asymptomatic death datum show age sex obesity strongly correlate poor outcome covid positive patient bariatric surgery treatment provide significant sustained weight loss severely obese objectives examine prior bariatric surgery correlate increase risk hospitalization outcome severity covid- infection setting university hospital method cross sectional retrospective analysis covid- database single new york city base academic institution conduct cohort covid positive patient history bariatric surgery n match ratio control cohort covid positive patient eligible bariatric surgery bmi kg m bmi kg m co morbidity time covid- diagnosis n comparison outcome include mechanical ventilation requirement decease discharge cohort chi test fisher exact test additionally overall length stay duration time intensive care unit icu compare wilcoxon rank sum test conditional logistic regression analysis determine unadjusted uor adjust odd ratio aor result total  covid positive patient include analysis categorization bariatric surgery include roux en y gastric bypass rygb n laparoscopic adjustable gastric banding lagb n laparoscopic sleeve gastrectomy lsg n body mass index bmi bariatric group kg m sd significantly low control group kg m sd p burden diabetes bariatric group compare control group p patient history bariatric surgery likely admit emergency room uor p likely require ventilator admission uor=. p short length stay icu p overall uor p likely decease discharge compare control group p conclusion history bariatric surgery significantly decrease risk emergency room admission mechanical ventilation prolong icu stay death patient covid- adjust bmi co morbidity associate obesity patient history bariatric surgery significant decrease risk emergency room admission
117,microbiota interest development therapeutic strategy sars cov- coronavirus disease  covid- impact host immune system prove communication gut microbiota pulmonary microbiota gut lung axis pathway neural connection gut brain gut brain axis important face pandemic sars cov- show affect organ presence host receptor know angiotensin convert enzyme  ace ace receptor mainly present brush border intestinal enterocyte ciliary cell type ii alveolar epithelial cell lung transport function ace link ecology gut microbe digestive tract suggest covid- relate gut microbiota severity covid- associate number comorbiditie hypertension diabetes obesity and/or old age attention pay multiple morbidity modulation microbiota comorbiditie medication paper review research context state intestinal microbiota impact cell immune system sars cov- pandemic
118,datum repercussion pulmonary function patient severe critical covid- pneumonia objective describe patient pulmonary function establish association severity disease patient severe critical pneumonia presence comorbiditie tomographic involvement persistence dyspnoea patient include  male medium age year old body mass index bmi kg/ m.  comorbidity obesity arterial hypertension diabetes mellitus twentyfive critical pneumonia spirometric alteration suggest restriction  gas exchange defect force volume capacity fvc force expiratory volume second fev carbon monoxide diffusion capacity dlco value significantly low ninety percent present degree involvement chest ct scan ground glass opacity frequent finding moderate negative correlation find severity tomographic involvement dlco level thirty patient refer degree dyspnoea patient symptom dlco kco value dyspnoea vs. p  vs.  p presence abnormal gas exchange main characteristic patient pulmonary sequela covid- study predictor evolution pulmonary sequela association severity disease
119,background post covid- syndrome pcs emerge major roadblock recovery patient infect sars cov- symptom like myalgia headache cough breathlessness fatigue prevalent make patient severely debilitated research pcs particular fatigue patient diabetes methodology prospective study include patient type  diabetes td covid- mild moderate severity match td patient suffer covid- demography anthropometry glycemic measure treatment detail covid- record symptom score chalder fatigue scale report fatigue score fs handgrip strength kg record jamar hydraulic hand dynamometer result total  patient include case control group match age duration diabetes bmi tsh serum albumin vitamin d level td patient covid- show significantly fatigue compare patient covid- group comparable handgrip strength furthermore patient td previous covid- infection fs  significant high inflammation marker acute illness post covid- increase post prandial blood glucose level lose weight reduce physical activity show significantly low handgrip strength compare fs  acute infection require careful attention nutrition glycemic control graduate physical activity protocol
120,obesity risk factor coronavirus disease  covid- infection study demonstrate prevalence individual obesity admit covid- range  determine early change micrornas mirnas associate dysregulation angiotensin convert enzyme  ace specific functional receptor severe acute respiratory syndrome coronavirus ace membrane bind enzyme catalyze conversion angiotensin ii angiotensin have cardioprotective vasorelaxation effect quantitative real time pcr analysis plasma sample circulate mirnas show upregulation mir c mir let b healthy individual obesity associate significant downregulation ace direct target mirnas individual obesity correlation analysis confirm significant negative correlation ace mirnas study show despite functional receptor inhibition downregulation ace reduce severity covid- infection contrast increase angiotensin ii follow inhibition ace increase severity disease take novel result identify upregulation mir c increase susceptibility individual obesity covid- consider mirna early molecular regulator level circulate mir c potential biomarker early identification risk severe covid-
121,background clinical feature outcome sars cov- infection diverge different country aim study describe clinical characteristic outcome cohort patient hospitalize sars cov- argentina method multicenter prospective cohort study /= year old patient confirm sars cov- infection consecutively admit  hospital argentina multivariable logistic regression model identify variable associate -day mortality admission intensive care unit icu result total  patient analyze median age  year male comorbidity common comorbiditie hypertension obesity diabetes disease severity admission classify mild moderate severe critical half patient require supplemental oxygen icu invasive ventilation overall -day mortality factor independently associate icu admission male gender ci hypertension ci obesity ci oxygen saturation year old ci oxygen saturation ci lymphopenia ci conclusion cohort validate crucial clinical datum patient hospitalize sars cov- argentina
122,background angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb widely treatment hypertension ht use drug increase infectivity novel coronavirus result additional risk morbidity mortality covid- matter interest objectives assess effect acei arb compare hypertensive clinical course outcome covid- pneumonia design retrospective setting tertiary care hospital patient method collect datum adult inpatient covid- pneumonia acei arb versus antihypertensive  march  february main outcome measures severity clinical course mortality time pcr negativity patient acei arb antihypertensive sample size  results acei arb  patient .% median age  year  patient .% antihypertensive median age  year p=. vs age acei arb user statistically significant difference acei arb user non user number patient admit intensive care case vs.  case p=. median duration stay hospital day vs. day p=. median duration icu stay day vs.  day mortality rate case vs.  p=. median day transfer icu short ace arbi non user day vs.  day p=. difference important clinically median time pcr negativity similar acei arb user non user day user  day non user p=. conclusion acei arb use probably unrelated poor prognosis covid- pneumonia inpatient acei arb prolong time pcr negativity conclude acei arb probably increase infectivity sars cov- limitation pharmacological therapy discuss detail use corticosteroid affect time pcr negativity analyze effect obesity lack datum conflict interest
123,background little know clinical factor associate covid- disease severity child adolescent method conduct retrospective cohort study  child hospital april  september  pediatric patient discharge primary diagnosis covid- assess factor associate hospitalization factor associate clinical severity eg admission inpatient floor admission intensive care unit icu admission icu mechanical ventilation shock death hospitalize result covid- encounter .% patient discharge emergency department ed  .% hospitalize clinical severity distribution hospitalize moderate .% severe .% severe .% factor associate hospitalization vs discharge ed include private payor insurance adjust odd ratio aor ci .- obesity type  diabetes mellitus type  dm aor ci .- asthma aor ci .- cardiovascular disease aor ci .- immunocompromised condition aor ci .- pulmonary disease aor ci .- neurologic disease aor ci child adolescent hospitalize covid- great disease severity associate black non white race age great  year obesity type  dm cardiovascular neuromuscular pulmonary condition conclusion child adolescent present child hospital eds covid- hospitalize receive care icu old child adolescent low risk hospitalization severe illness hospitalize difference disease severity race ethnicity presence select comorbiditie factor take consideration prioritize mitigation vaccination strategy
124,background obesity independently increase risk hospitalization viral respiratory infection include influenza virus recently severe acute respiratory syndrome coronavirus independent risk factor obesity impair immune response viral infection decrease effectiveness immunization objectives influenza proxy aim determine impact bariatric surgery bas risk hospitalization viral respiratory infection setting academic hospital united states method national nationwide inpatient sample datum collect   examine patient classify treatment control group treatment subject define patient history bas control subject patient body mass index kg m history bas. hospitalization influenza primary diagnosis identify univariate analysis multivariate regression model perform assess difference group result total subject control subject treat patient univariate analysis show hospitalization rate treatment group significantly low control group .% versus .% p confirm adjust covariable control versus treatment odd ratio p conclusion bas decrease risk hospitalization influenza prospective study need confirm result suggest result translate development similar study determine impact bas incidence severity coronavirus disease
125,background post traumatic stress disorder ptsd global problem accord definition disorder occur people undergo witness shocking terrifying hazardous event coronavirus disease covid- consequent threat fear meet definition traumatic event main aim study determine ptsd healthcare worker hcw survive covid- jeddah saudi arabia subject method analytical cross sectional study hcw work jeddah city minimum seven day positive covid- result include study screen ptsd checklist diagnostic statistical manual mental disorders dsm- pcl- self report measure assess presence severity ptsd symptom result respondent n= slight dominance female .% male .% equal distribution saudis .% non saudis .% mean age account year ptsd detect .% prevalence significantly high chronic disease .% especially diabetic obesity .% hcw job necessitate exposure positive case isolate hospital ill value statistically significant p conclusion recommendation prevalence ptsd hcw survive covid- come range hcw deal case covid- affect effort alleviate stress hcw work pandemic
126,background limited research address obesity covid- severity association paediatric patient objective determine obesity independent risk factor covid- severity paediatric patient age modify association method sars cov positive patient nyu langone health  march   january  aged year available anthropometric measurement weight length height and/or body mass index bmi modified log poisson model utilize analysis main outcome hospitalization critical illness intensive care unit icu admission result ninety .% patient obesity obesity independent risk factor critical illness adjust risk ratio arr ci association modify age obesity relate great risk critical illness adolescent year arr ci child year obesity independent risk factor hospitalization age conclusion obesity independent risk factor critical illness paediatric patient association modify age obesity relate great risk critical illness adolescent child finding crucial patient risk stratification care
127,severe acute respiratory syndrome coronavirus- causative virus coronavirus disease- covid- penetrate host tissue binding spike protein angiotensin convert enzyme- ace- receptor activation host protease enzyme prominent effect observe virus bind ace- receptor alveolar epithelium endothelium testosterone exhibit immunosuppressive effect androgen play modulatory role protease enzyme know comorbiditie include obesity pregnancy diabetes mellitus type  type hypertension cancer chronic kidney liver lung disease cerebrovascular disease heart condition human immunodeficiency virus infection immunologic disease immune suppression affect severity covid- infection polycystic ovary syndrome pcos affect reproductive age woman hirsutism observe -% patient increase testosterone level detect woman pcos syndrome associate hyperandrogenism insulin resistance increase renin angiotensin system activity diabetes metabolic syndrome remarkable number case pcos manifest chronic pro inflammatory state hyperandrogenism hyperinsulinemia cause adipocyte hypertrophy dysfunction result increase secretion pro inflammatory adipokine culminate creation chronic inflammatory state light metabolic hormonal change observe woman pcos susceptible severe covid- infection health care giver provide special care detailed counseling service
128,purpose review general population risk severe covid- associate old age male sex hypertension obesity chronic disease chronic lung disease list additional risk factor hospitalization icu admission purpose review define chronic lung disease bronchiectasis interstitial disease represent risk severe sars cov- infection patient affect common variable immunodeficiency cvid common symptomatic primary antibody defect recent finding cvid patient sars cov- infection report beginning pandemic wide range clinical presentation range asymptomatic mild moderate severe covid- meta analysis  cvid case describe large cohort case report demonstrate cvid patient chronic lung involvement increase risk severe covid- comparison cvid lung disease vs. relative risk confidence interval .-- p differently general population age metabolic comorbiditie represent risk factor severe course patient population summary underlie chronic lung disease age represent risk factor severe covid- cvid prompt therapeutic intervention adopt sars cov- positive cvid patient chronic lung disease independently age
129,evaluate association serum -hydroxyvitamin d oh)d level severity new coronavirus infection covid- hospitalize patient assess serum oh)d level  patient age year patient severe disease  patient moderate disease  patient die oh)d level range ng ml median ng ml vitamin d deficiency diagnose  patient include  severe deficiency patient severe course disease oh)d level low median ng ml vitamin d deficiency common patient moderate course median ng ml p patient die oh)d ng ml compare ng ml discharge patient p severe vitamin d deficiency associate increase risk covid- severity fatal outcome threshold oh)d level associate increase risk severe course ng ml. approximately oh)d level ng ml associate increase risk mortality covid- patient vitamin d deficiency severe vitamin d deficiency associate increase risk covid- severity fatal outcome
130,susceptibility severity coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- associate hyperandrogenism obesity preexist pulmonary metabolic renal cardiac condition polycystic ovary syndrome pcos common endocrine disorder premenopausal woman associate obesity hyperandrogenism cardiometabolic dysregulation analyze cardiac renal circulatory urinary sars cov- viral entry protein ace tmprss tmprss furin cathepsin l adam androgen receptor ar expression peripubertal androgen exposure model pcos peripubertal female mouse treat dihydrotestosterone dht low lfd high hfd fat diet  day hfd exacerbate dht induce increase body weight fat mass cardiac renal hypertrophy heart dht upregulate ar protein lfd hfd ace hfd adam lfd kidney ar protein expression upregulate dht hfd ace adam upregulate dht diet renal tmprss furin cathepsin l upregulate dht differentially modulate diet dht upregulate urinary ace diet treatment modify serum ace renal ar mrna expression positively correlate ace tmprss furin cathepsin l adam finding suggest woman pcos population high risk covid associated cardiac renal complication furthermore study suggest weight loss lifestyle modification i.e. diet potentially mitigate covid associate deleterious cardiorenal outcome woman pcos
131,background derangement liver blood test lbt frequent patient coronavirus disease  covid- aim evaluate prevalence deranged lbt association b clinical severity admission c -day outcome hospitalize patient covid- method consecutive patient covid- hospitalize regional referral center -month period include clinical severity covid- hospital admission -day outcome need intensive care mechanical ventilation death analyze result derangement lbt occur .% patient frequently elevation ast .% ggt .% alt .% elevated ast alt ggt low albumin associate severe disease admission multivariate cox regression analysis adjust age sex obesity presence chronic liver disease ast remained associate risk die hr elevation x uln x uln respectively independently comorbidity burden covid- severity admission patient severe liver injury frequently experience define adverse outcome conclusion deranged lbt common patient hospitalize covid- predictor adverse clinical outcome
132,coronavirus disease covid- cause novel severe acute respiratory syndrome coronavirus  sars cov- characterize wide spectrum clinical phenotype range asymptomatic symptomatic mild moderate presentation severe disease covid- susceptibility severity recovery demonstrate high variability worldwide variance host genetic architecture underlie inter individual population scale difference covid- presentation perform genome wide association analysis employ genotyping datum ancestrydna covid- patient european descent asymptomatic subject control group identify  genetic variant significantly distinct asymptomatic acutely symptomatic covid- patient multiple testing correct p value variant find associate pathway govern host immunity interferon interleukin cytokine signalling know covid- comorbiditie obesity cholesterol metabolism ancestry analysis reveal asymptomatic covid- patient possess discernibly high proportion ancestral north eurasian ane eastern hunter gatherer ehg ancestry introduce europe bell beaker culture yamnaya related low fraction western hunter gatherer whg ancestry severely symptomatic patient high fraction whg low ane ehg ancestral component delineate likely ancestral difference group
133,objective compare demographic clinical characteristic severity patient infect different sars cov- variant phase covid- epidemic marseille method single centre retrospective cohort study conduct  patient infect sars cov- nextstrain clade b c phase february pangolin lineage b name marseille- b marseille- variant second phase june december b alpha b beta p. gamma a. marseille- variant phase january -today outcome occurrence clinical failure include hospitalisation transfer intensive care unit death result phase major difference observe regard age gender distribution prevalence chronic disease clinical symptom variant circulate give phase b b variant associate severe outcome infection occur second phase associate high rate death compare infection phase patient second phase likely hospitalise phase patient infect phase frequently obese conclusion large cohort study recommend evaluate transmissibility well characterise clinical severity emerge variant
134,background coronavirus disease  covid- pandemic recently lead worldwide research effort identify subject great risk develop severe illness overall obesity display strong correlation critical illness major severity covid- manifestation summary obesity metabolic disorder closely link chronic systemic inflammation adipose tissue constitute source cytokine configure low grade inflammation hypercoagulation status addition diagnosis care obese patient complicate excess weight ventilation difficulty key message review aim examine intersection obesity adverse outcome covid- order investigate preventive and/or therapeutic potential management obesity relate covid- complication
136,coronavirus disease  covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- unmask mankind vulnerability biological threat high age major risk factor disease severity covid- predispose risk factor mortality relate low cardiorespiratory metabolic fitness include obesity cardiovascular disease diabetes hypertension reach physical activity pa guideline goal contribute protect numerous immune inflammatory disorder addition multi morbidity mortality elevated level cardiorespiratory fitness non obese regular pa improve immunological function mitigate sustained low grade systemic inflammation age relate deterioration immune system immunosenescence regular pa non obese improve antibody response vaccination review highlight potential physiological cellular molecular mechanism affect regular pa increase host antiviral defense determine course outcome covid- immune system regular pa relation covid- discuss cardiovascular respiratory renal hormonal system skeletal muscle epigenetic mitochondrial function
138,symptom relate gastro esophageal reflux disease gerd previously show link increase risk  coronavirus disease covid- aim interrogate possibility share genetic basis gerd covid- outcome publish gwas datum gerd  case  control covid- susceptibility  case million control examine genetic relationship gerd covid- outcome risk develop severe covid- covid- hospitalization overall covid- risk estimate genetic correlation gerd covid- outcome follow mendelian randomization mr analyse assess genetic causality conditional analysis conduct examine known covid- risk factor obesity smoking type ii diabetes coronary artery disease explain relationship gerd covid- find small moderate genetic correlation gerd covid- outcome rg mr analysis reveal ci severe covid- risk covid- hospitalization overall risk covid- doubling odd develop gerd genetic correlation association gerd covid- show mild attenuation null obesity smoking adjust susceptibility gerd risk covid- hospitalization genetically correlate mr finding support potential causal role genetic association gerd covid- partially attenuate obesity account consistent obesity major risk factor disease
139,background sars cov- pandemic increase number patient need invasive mechanical ventilation endotracheal tube tracheostomy tracheomalacia rare potentially severe complication mechanical ventilation significantly complicate weaning process aim study describe strategy airway management mechanically ventilate patient respiratory failure sars cov- incidence severe tracheomalacia investigate factor associate occurrence method retrospective single center study perform italian teaching hospital adult subject admit icu february june treat invasive mechanical ventilation respiratory failure cause sars cov- include clinical datum collect day icu admission information airway management collect daily result total  subject include study admission ards severity mild moderate severe case overall mortality tracheostomy perform  open surgical technique  percutaneous ciaglia technique  subject tracheostomy perform compare subject long duration mechanical ventilation long icu hospital stay tracheomalacia diagnose  factor associate tracheomalacia female sex obesity tracheostomy conclusion population approximately subject ards sars cov- tracheostomize tracheostomized subject long icu hospital stay population diagnose tracheomalacia percentage  time high report available literature underlie mechanism fully understand
140,introduction give ongoing coronavirus disease  covid- pandemic consequent global healthcare crisis urgent need well understand risk factor symptom deterioration mortality patient covid- systematic review aim meet need determine predictive value chronic disease covid- severity mortality method search pubmed embase web science cumulative index nursing allied health complete identify study publish december december seventeen observational study  country involve patient include assess risk bias include study perform cumulative meta analysis result find covid- patient hypertension common condition associate high severity intensive care unit icu admission acute respiratory distress syndrome mortality chronic obstructive pulmonary disease strong predictor covid- severity admission icu mortality asthma associate reduce risk covid- mortality patient obesity high risk experience severe symptom covid- mortality patient cerebrovascular disease chronic liver disease chronic renal disease cancer likely severe covid- case great probability mortality conclusion covid- patient chronic disease likely experience severe symptom icu admission face high risk mortality aggressive strategy combat covid- pandemic target patient chronic disease priority
141,cytokine chemokine growth factor present different expression profile relate prognosis covid- analyze clinical parameter assess expression biomarker patient different disease severity hospitalize peruvian cohort determine associate bad prognosis measure anti spike igg antibody elisa  cytokine quantitative suspension array technology  sera sample analyze difference patient moderate severe fatal covid- logistic regression baseline longitudinal sample significant difference find clinical parameter hemoglobin neutrophil lymphocyte c reactive protein crp creatinine d dimer level high anti spike igg antibody concentration associate fatal patient outcome hospitalization il- il- mip alpha gm csf mcp- il- il- ilra tnfalpha il- level increase fatal patient group multivariable analysis reveal increase gm csf mcp- il- il- value associate fatal outcome longitudinal analysis identify il- mcp- main risk factor relate mortality hospitalize covid- patient peruvian cohort identify validate biomarker relate covid- outcome study need identify novel criterion stratification sars cov- infected patient hospital entry background severe form sars cov- infection large number innate adaptive immune cell activate begin produce pro inflammatory cytokine establish exacerbate feedback loop inflammation method total  patient laboratory confirm covid- admit hospital nacional guillermo almenara irigoyen lima peru enrol august october  moderate disease  severe disease  die measure  cytokine chemokine quantitative suspension array technology anti spike igg antibody commercial elisa evaluate parameter peripheral blood day patient discharge death patient information clinical parameter relate obtain respective clinical history result frequency obesity differ  group frequent patient die significant difference clinical parameter hemoglobin segment neutrophil lymphocyte c reactive protein creatinine d dimer level great anti spike igg antibody concentration associate fatal outcome univariate analysis high baseline concentration il- mip alpha gm csf mcp- il- il- ilra tnfalpha il- il p correlate severity multivariable analysis show increase concentration  biomarker gm csf mcp- il- il- associate fatal outcome longitudinal analysis show il- hazard ratio hr confidence interval ci mcp- hr ci .- relate mortality hospitalize covid- patient conclusion cytokine chemokine growth factor profile identify validate related severity outcome covid- finding useful identify novel criterion covid- patient stratification hospital entry
143,objective study aim investigate relationship chest compute tomography ct scan finding sequential organ failure assessment sofa score c reactive protein crp comorbidity mortality intensive care unit icu patient coronavirus disease  covid- method adult patient year old covid- consecutively admit imam reza hospital tabriz east azerbaijan province north west iran march  august  screen total  patient include demographic clinical mortality datum gather severity disease evaluate sofa score system crp level measure chest ct scan perform result patient multifocal bilateral ground glass opacity ggo pattern chest ct scan significant correlation sofa score admission multifocal bilateral ggo p p respectively significant relationship observe unilateral bilateral ggo pattern crp p p respectively significant relationship ggo pattern comorbiditie include overweight obesity heart failure cardiovascular disease malignancy p  conclusion multifocal bilateral ggo common pattern chest ct scan characteristic significantly relate sofa score crp comorbidity icu patient covid- relationship mortality significant
144,background coronavirus disease- covid- result infection sars cov- span wide spectrum illness severely ill patient highly elevated serum level certain cytokine considerable cytolytic t cell infiltrate lung observe patient bear low negligible viral burden suggest overactive immune response term cytokine storm contribute severity covid- report safety efficacy baricitinib combine remdesivir dexamethasone  hospitalize patient covid- pneumonia tertiary academic medical center method retrospective review  patient hospitalize covid- pneumonia patient receive -day course baricitinib -day course remdesivir -day course dexamethasone clinical status biomarker obtain daily outcome assess include mortality duration hospitalization presence shock need supplemental oxygen need non invasive ventilation need mechanical ventilation development thrombosis result obesity multiple medical comorbiditie associate hospitalization setting covid- treat patient demonstrate rapid decline c reactive protein crp ferritin d dimer gradual improvement hemoglobin platelet count clinical status   .% treat patient require mechanical ventilation initiate treatment death   .% treat patient require mechanical ventilation initiate treatment death associate low bmi conclusion finding support utility immunosuppression jak inhibition moderate severe covid- pneumonia
145,patient covid- asymptomatic present mild severe symptom lead respiratory cardiovascular complication death type  diabetes mellitus tdm obesity consider risk factor covid- poor prognosis parallel covid- severe patient exhibit dyslipidemia alteration neutrophil lymphocyte ratio nlr associate disease severity mortality investigate alteration cause infection result preexisting comorbiditie work analyze dyslipidemia hemogram profile covid- patient accord severity compare patient tdm obesity comorbiditie dyslipidemia marked decrease hdl level increase nlr accompany disease severity non tdm non obese patient indicate covid- cause observe alteration decrease hemoglobin involve covid- severity hemoglobin concentration associate metabolic disease erythrogram patient evaluate verify drop hemoglobin erythrocyte number severe patient independently tdm obesity explain need artificial ventilation severe case control parameter especially hdl level nlr hemoglobin concentration good strategy prevent covid- complication death
146,background aim diabetes obesity hypertension common comorbiditie associate increase severity mortality rate corona virus disease covid)- method narrative review pubmed database discuss epidemiological datum pathophysiological link diabetes covid- potential effect glycaemic control antidiabetic drug prevalence outcome covid- role telemedicine diabetes self management post covid- era result diabetes link covid- morbidity mortality research need elucidate association meantime physician aware potential rise prevalence diabetes unhealthy lifestyle change pandemic severity complication focus achieve optimal diabetes prevention management telemedicine diabetes self management help direction dipeptidyl peptidase  dpp inhibitor glucagon like peptide- glp- receptor agonist sodium glucose transporter  sglt inhibitor affect viral entry infection covid- outcome show observational study conclusion diabetes associate covid- development progression certain antidiabetic drug influence covid- prevention management result ongoing randomized clinical trial shed light field
147,impact overlap risk factor coronavirus disease covid- severity unclear evaluate impact type  diabetes td obesity covid- severity conduct cohort study anonymize covid- patient datum covid- research database january  november mean age year patient male datum age race sex td complication antidiabetic medication prescription body mass index  kg m obesity analyse cox proportional hazard model hospitalization risk critical care  day covid- diagnosis main outcome risk score age  year male sex td obesity participant .% obesity  .% td td obesity male sex significantly associate covid- hospitalization risk hospitalization risk score compare hospitalization risk score  critical care risk score hazard ratio confidence interval p p respectively risk score complication diabetes obesity increase hospitalization critical care risk covid- patient
148,objective role overcrowded multigenerational household risk factor covid- remain unmeasured objective study examine quantify association overcrowded multigenerational household covid- new york city nyc study design cohort study method conduct bayesian ecological time series analysis zip code tabulation area zcta level nyc assess zcta high proportion overcrowded define proportion estimate number housing unit occupant room multigenerational household define estimate percentage residence occupy grandparent grandchild  year age independently associate high suspect covid- case rate nyc department health syndromic surveillance datum march  main measure adjust incidence rate ratio irr suspect covid- case population final model control zcta level sociodemographic factor median income poverty status white race essential worker prevalence clinical condition relate covid- severity obesity hypertension coronary heart disease diabetes asthma smoking status chronic obstructive pulmonary disease spatial clustering result suspect covid- case present emergency department  zcta nyc adjust covid- case rate increase irr ci zcta quartile versus percent overcrowdedness increase irr ci quartile versus percent live multigenerational housing interaction exposure significant betainteraction ci conclusion overcrowdedness multigenerational housing independent risk factor suspected covid- early phase surge covid case social distancing measure increase house bind population inadvertently temporarily increase sars cov- transmission risk covid- disease population
149,severe acute respiratory syndrome coronavirus  sars cov- infect broad range human tissue host receptor angiotensin convert enzyme  ace individual comorbiditie associate severe covid- display high level ace lung compare comorbiditie condition cell stress elevated glucose level hypoxia increase expression ace show patient barrett esophagus high expression ace tissue compare normal squamous esophagus low ph associate drive increase expression human primary monocyte cultured reduce ph display increase ace expression high viral load sars cov- infection show independent cohort covid- patient previous use proton pump inhibitor associate high risk death compare drug work suggest ph great influence sars cov- infection covid- severity
150,epidemiological study suggest individual comorbid condition include diabetes chronic lung inflammatory vascular disease high risk adverse covid- outcome genome wide association study identify loci associate increase susceptibility severity covid- clear association genetically determined phenome wide association phewas approach investigate role genetically determined covid- susceptibility disease relate outcome phewas analysis perform order identify trait disease relate covid- susceptibility severity evaluate predictive covid- risk score utilise phenotypic datum individual uk biobank include hospital episode statistics general practice datum identify spectrum association genetically determined covid- susceptibility severity number trait covid- risk associate increase risk phlebitis thrombophlebitis p identify significant signal covid- susceptibility blood clot leg p increase risk blood clot lung p e- study identify significant association genetically determine covid- increase blood clot event leg lung report association covid- susceptibility severity disease add identification stratification individual increase risk adverse outcome long term effect
151,introduction assess risk factor consequence infection severe acute respiratory syndrome coronavirus  sars cov- pregnancy essential guide clinical care previous study sars cov- infection pregnancy hospitalize patient exaggerated risk estimate severe outcome case sars cov- infection pregnant population include objective study identify risk factor outcome sars cov- infection pregnancy independent severity infection universally test population identify risk factor outcome severe infection require hospital admission material method prospective population base cohort study denmark datum danish national patient register danish microbiology database prospectively register datum medical record include pregnancy march  october  compare woman positive sars cov- test pregnancy non infected pregnant woman case sars cov- infection pregnancy identify prospectively register linkage ensure case identify case pregnant infection main outcome measure pregnancy delivery maternal neonatal outcome severe infection define hospital admission coronavirus disease  covid- symptom result  pregnancy  woman sars cov- infection pregnancy correspond incidence  pregnancy  .% require hospital admission covid- risk factor infection asthma odd ratio ci foreign bear ci risk factor hospital admission covid- include obesity ci smoking ci infection gestational age ga  week ga week ci ga week ci have asthma ci find difference obstetrical neonatal outcome conclusion   woman sars cov- infection pregnancy require admission hospital covid- risk factor admission comprise obesity smoking asthma infection ga  week severe adverse outcome sars cov- infection pregnancy rare
152,introduction patient clinical condition show associate coronavirus disease covid- severity outcome impact hospital cost know economic evaluation covid- admission aim assess direct fix hospital cost describe particularity different clinical demographic condition outcome large public hospital latin america locate sao paulo brazil institute exclusively dedicate covid- patient response pandemic method partial economic evaluation perform hospital s perspective prospective observational cohort study assess hospitalization cost suspect confirm covid- patient admit march  june hospital das clinicas university sao paulo medical school hcfmusp follow discharge death external transfer micro- macro cost methodology describe analyze total cost associate patient underlie medical condition itinerary outcome cost component different hospital sector result average cost  admission .% involve intensive care unit stay us$ overhead cost main component sex age underlying hypertension us$ diabetes us$ obesity us$ chronic renal failure us$ rheumatic us$ hematologic us$ neurologic us$ disease associate high cost age stratum year reverse transcription polymerase chain reaction rt pcr)-confirmed covid- comorbiditie use mechanical ventilation dialysis surgery outcome remained associate high cost conclusion knowledge covid- hospital cost aid development comprehensive approach decision making planning future risk management
153,recent appearance sars cov- responsible ongoing coronavirus disease  covid- pandemic bring light importance understand highly pathogenic agent prevent future pandemic virus single strand positive sense rna family coronaviridae epidemic cause virus sars cov- mers cov. pandemic crucial focus highlight understand risk factor contribute disease severity predict covid- outcome imperative understand virology sars cov- immunological response elicit clinical manifestation progression covid- review provide clinical datum base analysis multiple risk factor sex race hla genotype blood group vitamin d deficiency obesity smoking asthma contribute inflammatory overactivation cytokine storm frequently see covid- patient focus il- pathway draw comparison virulence pathophysiology sars mers establish parallel immune response discuss potential therapeutic approach limit disease progression patient high risk profile cover late information approve upcoming covid- vaccine paper provide perspective emerge variant associate opportunistic infection black mold fungus add mortality part world india compilation exist covid- study datum provide excellent reference tool research clinical public health community
154,abstract current global health crisis severe acute respiratory syndrome coronavirus  sars cov- prompt medical community investigate effect underlie medical condition include sleep disorder breathing inpatient care obstructive sleep apnea osa common form sleep disorder breathing complicate numerous acquire condition particularly inpatient critical care setting viral pneumonia major contributor intensive care unit icu admission present severely patient underlie pulmonary disease especially obesity osa review summarize recent datum complication osa obesity highlight impact clinical outcome hospitalize patient additionally highlight pertinent evidence complication osa organ system approach finally review discuss impatient treatment approach osa particularly relation sars cov- pandemic
155,respiratory symptom covid- manifestation metalloproteinase mmps essential role lung physiology seek characterize plasmatic level matrix metalloproteinase-  mmp- mmp- patient severe covid- investigate association plasma mmp- mmp- level clinical outcome mortality mmp- mmp- level plasma patient covid- treat icu covid- group control patient measure zymography study group match age sex hypertension diabetes bmi obesity profile mmp- level low mmp- level high covid- group p compare control mmp- level covid- patient affect comorbidity hypertension obesity mmp- level affect hypertension p unaffected obesity status notably hypertensive covid- patient high mmp- level compare non hypertensive covid- group albeit low control p association mmp- mmp- plasmatic level corticosteroid treatment acute kidney injury find covid- patient survival analysis show covid- mortality associate increase mmp- mmp- level age hypertension bmi mmp- mmp- well predictor mortality hospitalization saps sofa score hospital admission conclusion significant association mmp- mmp- level covid- find notably mmp- mmp- level predict risk hospital death suggest possible pathophysiologic prognostic role
156,th st century incidence non communicable disease ncds know chronic disease increase worldwide change dietary physical activity pattern genetic condition main factor modulate metabolism individual lead development ncd obesity diabetes metabolic associate fatty liver disease mafld cardiovascular disease cvds classify group chronic disease understand underlie molecular mechanism disease lead develop accurate effective treatment reduce mitigate prevalence population give global relevance ncd ongoing research progress article review current understanding ncd related risk factor focus obesity diabetes mafld cvds summarize knowledge pathophysiology highlight currently available emerge therapeutic strategy especially pharmacological intervention disease play important role contamination sars cov- virus progression severity symptom coronavirus disease  covid- briefly explore relationship ncd covid-
157,angiotensin convert enzyme  ace prove main host cell receptor binding severe acute respiratory syndrome coronavirus  sars cov- virus responsible covid- pandemic sars cov- spike s protein bind ace initiate process replication enzyme widely present human organ tissue heart lung pathophysiology ace sars cov- infection complex associate factor condition severe covid- patient age male gender comorbiditie cardiovascular disease chronic respiratory disease obesity diabete present comprehensive review aim correlate level expression ace patient comorbiditie poor outcome covid- disease significantly high level expression ace observe myocardial lung tissue heart failure copd patient respectively age dependent increase sars cov- receptor respiratory epithelium responsible increase severity covid- lung disease elderly people role ace highlight damage arise sars cov- invasion association observe renin angiotensin aldosterone system raas inhibitor severity covid-
158,coronavirus disease- covid- worrisome pandemic st century having entail devastating consequence society year different study display exist association pregnancy covid- severity physiological change occur gestation recent datum identify maternal country origin important determinant covid- presentation pregnant woman explanation fact remain fully elucidate purpose work analyze possible relationship human development index hdi maternal country origin morbimortality pregnant woman newborn conduct multicentric ambispective observational case control study (: ratio compare hdi country group high hdi group hdi group hdi group -low hdi total  pregnant woman confirm sarv cov- infection case enrol pair control total number  participant  tertiary care center woman sars cov- infection case produce perinatal mortality overall maternal morbidity covid- maternal morbidity c section hypertensive maternal morbidity perinatal morbidity result describe inverse association hdi maternofetal morbidity mortality country hdi low  show high rate patient maternal covid related morbidity .% vs. .% p need oxygen therapy .% vs. .% p maternal icu admission .% vs. .% p compare risk factor overweight obesity preexisting obstetric comorbiditie hdi emerge independent risk factor explain increase maternal perinatal morbidity mortality detect group case research need establish confirm real impact factor component pregnancy outcome
159,hypoxemia hallmark coronavirus disease  covid- severity seek determine predictor hypoxemia relate adverse outcome patient hospitalize covid- large hospital jerusalem israel  march  july patient categorize develop reduce arterial oxygen saturation spo  h arrival emergency department overall  hospitalize patient covid- retrospectively analyze patient reduce spo significantly old comorbiditie high body surface area bsa body mass index bmi low lymphocyte count impaired renal function elevate liver enzyme c reactive protein crp d dimer level compare preserved spo. multivariable regression analysis old age odd ratio year p high bsa m p bmi  kg m p low lymphocyte count  x /mul decrease p elevated crp  mg dl increase p find independent predictor low spo. severe hypoxemia require ventilatory support old age pre existing comorbiditie include underlie renal dysfunction heart failure find significantly associate hospital mortality finding suggest assessment predictor hypoxemia early time hospitalization covid- helpful risk stratification management
160,age immune system characterize low grade chronic systemic inflammatory state inflammage mark elevated serum level inflammatory molecule interleukin il)- c reactive protein crp inflammatory marker report strong predictor development severity type  diabetes obesity covid- level marker positively associate advanced glycation end product age generate non enzymatic glycation oxidation protein lipid normal aging metabolism base observation clinically important elucidate dietary age modulate inflammation increase risk age exacerbate disease present narrative review discuss potential pro inflammatory property dietary age focus inflammatory mediator crp il- ferritin relation age general type  diabetes particular addition underlie mechanism include relate gut microbiota receptor age role age play affect physiology healthy elderly obese individual diabetic discuss regard great susceptibility covid-
161,obesity rapidly significant public health issue prevalence obesity continue rise economic burden result direct indirect cost likewise coronavirus disease  covid- global pandemic rise infection rate carry significant economic cost associate treatment disease reduction economic activity government regulation covid- pandemic detrimental impact obesity create increasingly obesogenic environment reduce access bariatric care treatment obesity relate disease article form compelling argument resumption bariatric service soon safe bariatric surgery bring significant additional medical economic benefit medically obesity risk factor increase severity covid- infection treatment obesity priority current pandemic additionally bariatric surgery show cost save procedure long term significant economic benefit reduce cost obesity future recover economic collapse follow global pandemic
162,aim coronavirus covid- global pandemic require global response objective paper identify common factor covid- case death  affected country method perform ordinary square wide range socio economic environmental climatic health indicator explain number case death result finding obesity significant global denominator number covid- case death ii percentage population age  number hospital bed  population inversely correlate mortality covid- conclusion obesity increase vulnerability covid- infection mortality global awareness obesity social investment health infrastructure pre requisite pandemic adaptive future study limit cross sectional datum april
163,outbreak novel highly infectious severe acute respiratory syndrome coronavirus- sars cov- result hundred million infection million death globally infected individual progress coronavirus disease- covid- experience upper low respiratory complication range severity lead wide spread inflammation generalized hypoxia hypoxemia impact multiple organ system include central peripheral nervous system sars cov- outbreak multiple report continue emerge detail neurological symptom range relatively mild e.g. impaired taste and/or smell severe e.g. stroke suggest sars cov- neurotropic and/or contribute nervous system injury direct and/or indirect mechanism gain insight type neurological complication associate sars cov- infection possible relationship age sex covid- severity comorbiditie perform systematic review case report series publish  april  infected patient neurological manifestation meta analysis conduct individual patient datum report datum extract report neurological injury occur lifespan context infection know comorbiditie disease severity include asymptomatic patient old individual susceptible develop life threaten covid- cerebrovascular disease cvd stroke mild inverse correlation age see cns inflammatory disease encephalitis taste and/or smell disorder report increase age associate comorbid cardiovascular risk factor include hypertension diabetes mellitus lipid disorder obesity obesity correlate development critical covid- discussion potential pathophysiological mechanism neurological symptom arise long term consequence infection nervous system provide
164,novel coronavirus disease covid- hit healthcare system worldwide risk severe infection mortality increase advance age especially subject comorbiditie cardiovascular disease hypertension diabetes obesity cancer cardiovascular complication myocardial injury heart failure thromboembolism frequently observe covid- case biomarker troponin ntprobnp d dimer identify prognostic indicator disease severity bad outcome currently specific therapy sars cov- medication investigation aim review explore intertwine relationship covid- disease cardiovascular system focus elderly population available supportive treatment relate concern elderly patient comorbiditie polypharmacotherapy explore
165,background inflammatory biomarker portend disease severity nonpregnant individual sars cov- infection currently limited datum available mixed result elucidate inflammatory biomarker associate clinical phenotype pregnant patient objective aim compare laboratory finding pregnant patient sars cov- infection symptom status disease severity study design retrospectively evaluate pregnant patient positive sars cov- infection confirm polymerase chain reaction testing urban academic hospital march  october perform reported symptom universal screening admission hospital patient sars cov- infection recommend baseline laboratory testing include leukocyte neutrophil lymphocyte count aspartate aminotransferase alanine aminotransferase high sensitivity c reactive protein procalcitonin lactate dehydrogenase d dimer ferritin perform multivariable logistic regression evaluate peak laboratory abnormality significantly associate symptomatic sars cov- infection disease severity gestational age diagnosis maternal age obesity covariate sensitivity specificity laboratory abnormality calculate identify symptomatic vs asymptomatic infection severe critical disease vs mild moderate disease result identify  pregnant patient sars cov- infection  symptomatic  symptomatic severe critical disease laboratory datum available  patient  symptomatic compare asymptomatic individual symptomatic individual likely exhibit elevate high sensitivity c reactive protein level adjust gestational age adjust odd ratio confidence interval sensitivity specificity symptomatic individual transaminitis adjust odd ratio confidence interval elevate procalcitonin level adjusted odd ratio confidence interval elevated lactate dehydrogenase level adjusted odd ratio confidence interval .- independently associate severe critical disease mild moderate disease adjust maternal age obesity differentiate disease severity sensitivity rate transaminitis procalcitonin elevation lactate dehydrogenase elevation respectively specificity rate respectively conclusion inflammatory biomarker pregnant patient sars cov- infection exhibit vast heterogeneity poor discriminative ability limited clinical utility large registry study evaluate inflammatory biomarker useful risk stratification prognostication pregnant patient sars cov- infection take account physiology pregnancy
166,male sex repeatedly identify risk factor death intensive care admission unclear sex hormone associate disease severity covid- patient study analyse sex hormone level estradiol testosterone male female covid- patient n admit intensive care unit icu comparison control non covid- patient icu n non covid- patient prevalent comorbidity coronary heart disease present covid- cohort n healthy individual n detect significantly elevate estradiol level critically ill male covid- patient compare control cohort testosterone level significantly reduce critically ill male covid- patient compare control cohort statistically significant difference sex hormone level detect critically ill female covid- patient albeit similar trend elevated estradiol level observe linear regression analysis reveal broad range cytokine chemokine analyse ifn gamma level positively associate estradiol level male female covid- patient furthermore male covid- patient elevated estradiol level likely receive ecmo treatment identify disturbance sex hormone metabolism present hallmark critically ill male covid- patient
167,pulmonary manifestation cause severe acute respiratory syndrome sars coronavirus  sars cov- emerge endocrine phenotype heavily impact severity syndrome recently associate coronavirus disease  covid- patient pituitary disease pituitary gland involve covid- clinical presentation and/or severity cause pituitary apoplexy hypopituitarism frequently burden metabolic complication include arterial hypertension hyperglycemia obesity vertebral fracture associate poor outcome increase mortality patient infect sars cov-.this review discuss hypopituitarism condition bidirectional relationship covid- frequent presence metabolic comorbiditie direct indirect pituitary damage se potential risk factor covid- finally address current recommendation clinical management vaccine patient hypopituitarism adrenal insufficiency
168,background coronavirus pandemic spread people infect severe acute respiratory syndrome coronavirus short- medium term effect infection describe description long term sequela lack literature method patient heal coronavirus disease  covid- february   consider inclusion study regardless severity disease acute phase eligible patient consecutively contact semistructured interview administer february march  train medical staff result patient eligible accept participate study enrol survey patient report  symptom prevalent symptom fatigue pain sleep disorder sensory alteration present survey patient case affect sensory alteration overall sample symptom report anosmia dysgeusia high prevalence generally observe increase age relevant difference observe compare young versus middle aged adult conclusion  month acute infection covid- survivor suffer symptom identify short follow frequent symptom include fatigue pain sleep disorder severe impairment acute phase predict severe complication
169,background covid- diabetic adult increase risk severe form irrespective obesity patient type ii diabetes fat distribution characterize visceral ectopic adipose tissue expansion result systemic inflammation play role drive covid- cytokine storm aim determine cardiac adipose tissue combine interleukin- level predict adverse short term outcome death icu requirement covid- diabetic patient  day admission method eighty consecutive patient type ii diabetes admit covid- include interleukin- measurement chest compute tomography total cardiac adipose tissue index cati measurement perform admission primary outcome death  day follow admission intensive care requirement early death icu r define secondary endpoint association cati il- threshold value predict primary secondary endpoint determine result enrol patient median age  year iqr male median body mass index bmi  kg m iqr  patient die covid-  require intensive care  conventional care day  admission increased cati il- level significantly relate increase early mortality respectively p p /=  sensitivity specificity auc early mortality p conclusion cardiac adipose tissue index il- determination admission help physician well identify diabetic patient potentially severe lethal short term course irrespective obesity diabetic patient high cati admission fortiori associate high il- level relevant target population promptly initiate anti inflammatory therapy
170,background age risk factor covid severity study perform hospitalize patient sars cov infection show representation old patient consequently properly define covid- young patient require hospital admission aim present study analyze clinical characteristic risk factor development respiratory failure young  year hospitalize patient covid- method retrospective nationwide cohort study include hospitalize patient   year old confirmed covid- march july patient datum obtain semi covid registry respiratory failure define ratio partial pressure arterial oxygen fraction inspire oxygen pao fio ratio ci p=. fever ci p=. lymphocyte  u ci p=. ast mg dl ci p=. sodium  mg dl ci p conclusion young patient covid- require hospital admission show notable incidence respiratory failure obesity sahs alcohol abuse certain laboratory parameter independently associate development complication patient suffer respiratory failure high mortality high incidence major cardiac event venous thrombosis hospital stay
171,purpose review collate good evidence strand epidemiological genetic comparison historical datum mechanistic information ask obesity important causal potentially modifiable risk factor severe covid- outcome recent finding study provide powerful evidence body mass index bmi strong linear risk factor severe covid- outcome recent study suggest ~-% high risk covid- hospitalisation kg m high bmi genetic datum concur hazard ratio increase kg m high bmi bmi covid- link differ markedly prior bmi infection association support likely causal multiple biologically plausible pathway excess adiposity appear important modifiable risk factor adverse covid- outcome ethnicity pandemic worsen obesity level imperative medical system worldwide meet challenge upscale investment obesity prevention treatment
172,severe acute respiratory syndrome coronavirus  sars cov- appear high pathogenicity patient obesity obesity term body mass index great  kg m demonstrate important comorbidity disease severity coronavirus disease  covid- pandemic associate adverse event unravel mechanism phenomenon assist scientist clinician policymaker respond appropriately covid- pandemic review systemically delineate potential mechanistic link obesity worsen covid- altered physiology underlie disease metabolism immunity cytokine storm thrombosis problematic ventilation cause obesity preexisting medical disorder exacerbate organ dysfunction patient obesity chronic metabolic disorder include dyslipidemia hyperglycemia vitamin d deficiency polymorphism metabolism relate gene obesity probably aid sars cov- intrusion impair antiviral response obesity induce inadequate antiviral immunity interferon natural killer cell invariant natural killer t cell dendritic cell t cell b cell early stage sars cov- infection lead delay viral elimination increase viral load expedite viral mutation cytokine storm defective antiviral immunity probably contribute tissue damage pathological progression result severe symptom poor prognosis prothrombotic state drive large endothelial dysfunction platelet hyperactivation hypercoagulability impaired fibrinolysis obesity increase risk severe covid- mechanism susceptibility severe condition open possibility host direct therapy population obesity bridge work field researcher gain holistic view path forward therapeutic opportunity break vicious cycle obesity devastating complication emerge pandemic
173,covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- result life threaten disease minority patient especially elderly people co morbidity obesity diabetes severe disease characterize dysregulate cytokine release pneumonia acute lung injury rapidly progress acute respiratory distress syndrome disseminate intravascular coagulation multisystem failure death mechanistic understanding covid- progression remain unclear review evidence sars cov- directly indirectly activate inflammasome large multiprotein assembly broadly responsive pathogen associate stress associate cellular insult lead secretion pleiotropic il- family cytokine il beta il- pyroptosis inflammatory form cell death discuss potential mechanism inflammasome activation clinical effort currently way suppress inflammation prevent ameliorate severe covid-
174,objective investigate combine association obesity diabetes mellitus dm cardiovascular disease cvd severe covid- outcome adult elderly inpatient design cross sectional study base registry datum brazil influenza surveillance system setting public private hospital brazil participant eligible population include  inpatient age year positive reverse transcription pcr test sars cov-  june main outcome measures severe covid- outcome non invasive invasive mechanical ventilation use intensive care unit icu admission death multivariate analysis conduct separately adult year elder /= year test combine association obesity dm and/or cvd degree obesity outcome result sample  adult  elder include adult obesity dm and/or cvd show high prevalence invasive prevalence ratio ci non invasive mechanical ventilation use icu admission death compare group obesity dm cvd elder obesity dm cvd high prevalence icu admission death age group obesity combine dm and/or cvd show high prevalence outcome dm and/or cvd dose response association observe obesity death adult class class ii class iii conclusion combine association obesity diabetes and/or cvd severe covid- outcome strong adult elder obesity combine dm and/or cvd impact risk covid- severity dm and/or cvd age group study support independent relationship obesity severe outcome include dose response association degree obesity death adult
175,background coronavirus disease  covid- leave significant impact world health economic political system november  million people infect worldwide million death global spotlight currently focus combat pandemic mean range find treatment exist therapeutic agent invent vaccine aid halt loss life aim collect systematic review meta analysis publish relate covid- well identify available evidence highlight gap knowledge elucidate meta analysis umbrella review perform method explore study base systematic review meta analysis key term include severe acute respiratory syndrome sars sars virus coronavirus disease covid- sars coronavirus- include study extract embase medline cochrane database publication timeframe include study range january october study publish language english consider systematic review finalize text article freely accessible public domain result search embase medline cochrane database result  result respectively comprise  study  duplicate subsequently remove leave  study inclusion criterion systematic review meta analysis  result exclude review article scope review rapid review panel review guideline produce total  study screen article categorize include article main group clinical presentation epidemiology screening diagnosis severity assessment special population treatment subsequently second subclassification follow group gastrointestinal cardiovascular neurological stroke thrombosis anosmia dysgeusia ocular manifestation nephrology cutaneous manifestation d dimer lymphocyte anticoagulation antiviral convalescent plasma immunosuppressant corticosteroid hydroxychloroquine renin angiotensin aldosterone system technology diabetes mellitus obesity pregnancy child mental health smoking cancer transplant conclusion include article clear research need treatment option vaccine study datum heterogeneous statistical analysis well apply provide robust clinical evidence study design recommendation management covid-
176,background novel coronavirus disease covid- declare global pandemic world health organization march constitute health challenge century globally causative organism initially name  novel coronavirus ncov subsequently rename severe acute respiratory syndrome coronavirus  sars cov- pandemic far infect million kill million people worldwide diabetes mellitus dm lead cause morbidity worldwide objective examine critical role diabetes play pathogenesis prognosis covid- assess emerge therapy available fight pandemic method author conduct systematic review literature examine role diabetes comorbidity pathogenesis prognosis covid- result experimental observational datum early  suggest people covid- comorbiditie dominant diabetes cardiovascular disease hypertension empirical evidence indicate diabetic patient infect covid- disease bad outcome concern morbidity mortality conclusion combination underlie chronic condition hypertension obesity cardiovascular disease altered ace receptor expression immune dysregulation cytokine storm alveolar endothelial dysfunction increase systemic coagulation individual diabetes risk covid- severity study need elucidate glucose lower drug modulate host immune response diabetic individual especially follow administration potential covid- vaccine
177,background weak muscle strength associate wide range adverse health outcome individual weak muscle strength risk hospitalization severe covid- unclear objective study investigate independent association muscle strength covid- hospitalization method datum adult  year age old analyse logistic model adjust chronic condition body mass index age sex hand grip strength repeatedly measure   handheld dynamometer covid- hospitalization lockdown self report summer  indicator covid- severity result study base survey health age retirement europe share include  old adult year  female  test positive severe acute respiratory syndrome coronavirus  .%  .% hospitalize covid- result show high grip strength associate low risk covid- hospitalization adjust odd ratio increase  standard deviation grip strength confidence interval ci p result show age  period ci p obesity ci p associate high risk covid- hospitalization sensitivity analysis different measurement grip strength robustness analysis base rare event logistic regression different sample participant i.e. covid- patient consistent main result conclusion muscle strength independent risk factor covid- severity adult  year age old
178,background coronavirus disease  covid- cause highly contagious virus call severe acute respiratory syndrome coronavirus  emerge china end  major threat health world health expert learn detailed knowledge natural course severity covid- study aim assess prevalence association severity disease demographic characteristic initial present symptom comorbiditie covid- patient treatment center myanmar method cross sectional study conduct hmawbi indine treatment center yangon region myanmar november december datum collect standardized case report form total  confirm covid- inpatient include study odd ratio confidence interval ci measure association independent associate factor severity disease investigate logistic regression analysis result total .% symptomatic patient common present symptom fever .% loss smell cough .% .% covid- patient comorbiditie common comorbiditie hypertension .% diabetes mellitus .% heart disease respectively severity .% patient sign severe pneumonia associate factor severe pneumonia aged  year old adjust odd ratio aor ci overweight obesity aor ci current smoking aor ci conclusion study fifth patient develop severe pneumonia covid- patient aged  year old overweight obesity current smoker monitor carefully course treatment reduce disease severity
179,native hawaiian pacific islander nhpi population suffer disproportionately high rate chronic condition type  diabetes arise metabolic dysfunction associate obesity inflammation addition global coronavirus disease  pandemic compound effect health inequity observe indigenous population include nhpi community reversible lifestyle habit diet protective contribute increase prevalence health inequity population immunoepigenetic microbiome axis axis offer insight connection diet epigenetic microbiome composition immune function response viral infection epigenetic mechanism regulate inflammatory state associate metabolic disease include diabetes impact diet furthermore diet modulate gut microbiome influence microbial diversity richness dysbiosis microbiome associate chronic disease high fiber diet facilitate favorable microbiome composition turn increase production intermediate metabolite name short chain fatty acid scfas act metabolic immune pathway contrast low fiber diet typically associate westernized lifestyle decrease abundance microbial derive scfa decrease abundance characteristic metabolic syndrome activation chronic inflammatory state have large implication disease pathogenesis communicable non communicable disease native hawaiians pacific islanders thrive healthy traditional diet sensitive non indigenous people metabolic perturbation westernized diet impinge immunoepigenetic gut microbiome axis recent study conduct maunakea lab university hawai'i manoa john a. burns school medicine help elucidate connection diet microbiome composition metabolic syndrome epigenetic regulation immune function well understand disease pathogenesis potentially research point way prevent pre disease condition novel biomarker discovery community base approach
180,coronavirus disease  covid- cause novel virus sars cov- severe old adult age underlie condition obesity diabetes high blood pressure malignancy associate aging consider risk factor covid- mortality rapidly expand body evidence bring scenario observation hyperinflammatory reaction associate covid- pathogenesis advanced glycation end product age generate glycation protein dna lipid play crucial role pathogenesis age relate disease mention covid- risk factor interestingly receptor age rage mainly express type  epithelial cell alveolar sac critical role sars cov associate hyper inflammation lung injury discuss hypothesis age interaction rage molecule modulate covid- pathogenesis related comorbiditie especially elderly
181,background aim metabolic syndrome mets chronic low grade inflammatory disease study aim investigate impact mets risk severity covid- method result investigate nationwide cohort covid- include patient undergo test severe acute respiratory syndrome coronavirus  sars cov- korea covid- group include  patient positive sars cov- test result age- sex match control group include subject negative sars cov- test result endpoint sars cov- positivity severity covid- prevalence mets .% covid- control group respectively presence mets associate risk develop covid- component mets central obesity associate high risk covid- infection adjust odd ratio aor confidence interval ci .- p presence mets significantly associate severe covid- aor ci .- p individual component mets prediabete diabetes mellitus associate high risk severe covid- aor ci .- p risk severe covid- linearly increase accord number metabolic component p trend conclusion nationwide cohort study individual mets significant increase risk severe covid- infection patient particularly central obesity insulin resistance deserve special attention amid covid- pandemic
182,background coronavirus disease  covid- pandemic lead global research predict great risk develop severe disease mortality aim meta analysis determine association obesity severity mortality covid- method search pubmed embase cochrane library web science database study evaluate association obesity covid- odd ratio ors confidence interval cis calculate random- fix effect model meta regression analysis conduct estimate regression coefficient result study involve patient include compare nonobese patient obese patient significantly increase risk infection ci hospitalization ci clinically severe disease ci mechanical ventilation ci intensive care unit icu admission ci mortality ci conclusion patient obesity great risk infection hospitalization clinically severe disease mechanical ventilation icu admission mortality covid- important increase awareness association obesity covid- patient
183,efficacy hydroxychloroquine hcq treat sars cov- infection harshly debate observational experimental study report contrast result clarify role hcq covid- patient carry retrospective observational study unselected patient hospitalize covid- italy february patient characteristic collect entry include age sex obesity smoking status blood parameter history diabetes cancer cardiovascular chronic pulmonary disease medication use identify subtype patient similar characteristic hierarchical clustering base gower distance multivariable cox regression cluster test association mortality modification effect treatment hcq identify cluster young patient low circulate inflammation level well renal function  generally old comorbid subject prevalently man smoker group increase death risk adjust hcq hr[ci% hcq show independent inverse association .[.- significant influence cluster hcq interaction p drive differential association hcq mortality high .[.- low risk cluster effect survive adjustment additional medication use concordant association disease severity outcome finding suggest particularly beneficial effect hcq low risk covid- patient contribute clarify current controversy hcq efficacy covid- treatment
184,infection severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease  covid- commonly present pneumonia covid- recognize involve multiple organ system vary severity duration july finding retrospective population study national covid cohort collaborative nc consortium publish include analysis machine learning method adult sars cov- infection  medical center study stratified patient covid- accord world health organization clinical progression scale cps severe clinical outcome identify requirement invasive ventilatory support extracorporeal membrane oxygenation ecmo patient mortality machine learning analysis show factor strongly associate severity clinical course patient covid- ph. separate multivariable logistic regression model show independent factor associate severe clinical outcome include age dementia male gender liver disease obesity editorial aim present rationale finding large population cohort adult patient covid- date highlight importance large population study sophisticated analytical method include machine learning
186,background mechanism underlie association obesity coronavirus disease  covid- severity remain unclear verify obesity correlate severe covid- military health system mhs beneficiary compare immunological virological phenotype severe acute respiratory syndrome coronavirus  sars cov- infection obese nonobese participant method covid infect mhs beneficiary enrol anthropometric clinical demographic datum collect compare sars cov- peak igg humoral response reverse transcription polymerase chain reaction viral load obese nonobese patient stratify hospitalization utilize logistic regression model result datum  covid- patient analyze obese severely obese obesity independently associate hospitalization adjust odd ratio aor confidence interval ci .- need oxygen therapy aor ci outpatient severely obese log high nucleocapsid n genome equivalent ge)/reaction log high n ge reaction nonobese p p respectively note correlation body mass index peak anti spike protein igg inpatient outpatient coefficient p conclusion obesity strong correlate covid- severity mhs beneficiary finding offer new pathophysiological insight relationship obesity covid- severity
187,background aim worldwide outbreak coronavirus disease  covid- cause substantial public health burden increase number study link obesity severe covid- consequence mortality challenge health system worldwide especially emerge country like brazil aim search literature present current intersection obesity covid- brazilian population method article initially search duplicate removal finally include analysis result finding emphasize magnitude covid- infection brazil impact obesity risk factor aggravate prognosis outpatient hospitalize patient demonstrate social aspect covid- act enhance obesity condition latin american country conclusion careful look available datum help understand well dynamic obesity covid- focus brazilian population eventually guide management strategy therapy covid- future
188,background february million texans diagnose covid- young adult risk sars cov- exposure work academic social setting study investigate demographic clinical risk factor severe disease readmission young adult year old diagnose hospital encounter houston texas usa method finding retrospective registry base chart review conduct investigate demographic clinical risk factor severe covid- patient age positive sars cov- test large metropolitan healthcare system houston texas usa cohort young adult patient diagnose covid- infection hospital encounter include  pregnant woman score  charlson comorbidity index  obese kg m  day diagnostic encounter  patient diagnose pneumonia  receive severe disease diagnosis  return hospital discharge home multivariable logistic regression analysis increase age adjust odd ratio aor confidence interval ci p male gender aor ci p hispanic ethnicity aor ci p obesity ci p asthma history aor ci p congestive heart failure aor ci p cerebrovascular disease aor ci p diabetes aor ci p predictive severe disease diagnosis  day non hispanic black race aor ci p obesity aor ci p asthma history aor ci p myocardial infarction history aor ci p household exposure aor ci p predictive -day readmission conclusion investigation demonstrate significant risk severe disease readmission young adult population especially marginalize community people comorbiditie include obesity asthma cardiovascular disease diabete health authority emphasize covid- awareness prevention young adult continue investigate risk factor severe disease readmission long term sequalae
189,underlying disease associate severe course adult laboratory abnormality widely report sufficient datum clinical course coronavirus disease  covid- child pre existing comorbid condition laboratory finding aim describe independent risk factor estimate severity covid- child child  month  year old hospitalize period march -december result covid- include study patient categorize mild group moderate severe critically group severity base criterion demographic characteristic comorbiditie laboratory variable group compare total  child confirm covid- infection include study common associated disease obesity asthma bronchiale observe disease progress severely patient underlie disease especially obesity asthma bronchiale patient obesity odd ratio confidence interval ci p patient asthma bronchiale ci p group  patient presence lymphopenia hypoalbuminemia elevation serum level c reactive protein procalcitonin uric acid detect result statistically significant p value p p p p p respectively strong predictor moderate severe covid- infection child uric acid odd ratio ci p lymphocyte odd ratio ci p child susceptible covid- pre existing comorbid condition predispose severe disease addition lymphopenia high uric acid indicator covid- infection progress severely
190,severe acute respiratory syndrome coronavirus  sars cov- new emerge respiratory virus cause evolve pneumonia outbreak world sars cov- infected patient diabetes mellitus dm obesity metabolic disease associate high severity sars cov- related complication characterize acute lung injury require assist ventilation fibrosis development survive patient different factor potentially responsible exacerbate response sars cov- infection patient dm base line increase inflammation oxidative stress represent preexisting risk factor virus induce damage factor likely find obese patient addition propose massive injury alveolar epithelial type  cell express sars cov- receptor angiotensin convert enzyme  ace lead activation stromal niche represent lipofibroblasts lif lif instrumental maintain self renewal stem cell lif propose transdifferentiate myofibroblast myf follow injury cell contribute fibrosis hypothesize lif activity impact dm obesity age- gender dependent manner render prone transition profibrotic myf status context severe covid- pneumonia understand cumulative effect dm and/or obesity context sars cov- infection cellular level crucial efficient therapeutic solution
191,purpose review social isolation loneliness long identify risk factor poor physical mental health increase mortality factor show impact dietary behavior physical activity play role precipitate maintain obesity know impact social isolation result covid- pandemic social distancing major component public health initiative narrative review examine exist literature relationship social isolation loneliness mental health weight relate covid- pandemic recent finding individual obesity high risk worsen course covid- hospitalization death population significantly impact dietary physical activity consequence result lockdown social distancing isolation pandemic lead significant lifestyle disruption early study largely rely cross sectional study convenience sample future research need study impact rigorously particularly population great risk
192,background late  viral disease novel coronavirus report wuhan china rapidly develop explode pandemic pose severe threat human health world insufficient treatment option management global disease shortage vaccine important aspect help defeat coronavirus infection have healthy strong resilient immune system nutrition metabolic disorder obesity diabete play crucial role community health situation general especially new pandemic enormous impact lifestyle metabolic disorder immune status coronavirus disease  covid- severity recovery reason important consider impact lifestyle consumption define healthy diet pandemic aim review summarise recent finding effect nutrition covid- susceptibility disease severity treatment understand specific dietary feature help improve public health strategy reduce rate severity covid-
193,background patient prader willi syndrome pws comorbiditie especially obesity constitute risk factor severe form covid- aim assess prevalence medical course sars cov- infection child adult pws november  january perform detailed medical survey  adult  child pws follow french reference center result obtain response  adult  child march  january  adult  child .% pws sars cov- infection mean age adult year mean body mass index kg m obesity diabetes  child obesity diabetes similar general population frequent symptom covid- asthenia fever cough headache shortness breath patient favorable outcome conclusion pws risk factor severe covid- child adult contrary evolution sars cov- infection adult pws favorable expect give comorbiditie
194,objective describe mortality hospital patient covid- compare risk factor survivor non survivor design prospective cohort adult inpatient set tertiary healthcare teaching hospital guadalajara mexico participant patient confirm covid- hospitalise  march  september  include end study  november primary outcome measures patient survival analyse kaplan meier method comparison factor log rank test mortality risk factor analyse multivariate cox proportional hazard model result thousand patient include  die  alive discharge .% remain hospitalise predominance man high frequency overweight obesity hypertension diabetes lung cardiovascular kidney disease significantly frequent non survivor overweight obesity different group severity disease manchester triage system quick sequential organ failure assessment significantly bad non survivor significantly old vs  year respectively haematological biochemical coagulation inflammatory biomarker altered survivor mortality predictor invasive mechanical ventilation imv p admission intensive care unit icu p age p manchester triage system urgent p=. immediate urgent p=. baseline c reactive protein crp p=. antecedent kidney disease p=. conclusion mortality hospitalise patient covid- emerge country centre high develop country patient display high frequency risk factor poor outcome need imv icu admission old age severe disease admission antecedent kidney disease high crp level significantly predict mortality
195,coronavirus disease  covid- pandemic claim million life globally obesity associate increase severity mortality covid- molecular mechanism obesity exacerbate covid- pathology define level free fatty acid ffa elevate obese subject study design examine excess level different ffa affect progression covid- biological molecule associate palmitic acid pa covid- retrieve qiagen knowledge base ingenuity pathway analysis tool analyze dataset explore potential pathway affect different ffa study find  canonical pathway affect pa coronavirus pathogenesis pathway mediate key inflammatory mediator include ptgs cytokine include ilbeta il chemokine include ccl ccl transcription factor include nfkappab translation regulator include eefa apoptotic mediator include bax contrast n- fatty acid attenuate pa activation coronavirus pathogenesis pathway inhibit activity mediator ilbeta ccl ptgs bax furthermore pa modulate expression ace main cell surface receptor sars cov- spike protein
196,coronavirus  covid- pandemic present new challenge healthcare community sheer number individual affect range symptom presentation early finding show increase age independent risk factor covid- severity diabetes hypertension find strong independent risk factor severe covid- later discover obesity strong risk factor severe disease possible mechanism increase risk associate metabolic disease include increase prevalence acute respiratory syndrome immune cell dysfunction chronic inflammatory state associate obesity diabetes acknowledge risk factor consequence address vaccination strategy healthcare disparity
197,objective aim study describe main clinical phenotype laboratory finding severity coronavirus disease  covid- patient hospitalize high specialty medical unit  mexican social security institute method prospective observational cohort study total  patient hospitalize severe acute respiratory syndrome coronavirus  sars cov- infection high specialty medical unit  torreon coahuila mexico th august th case confirm covid- positive rt qpcr test clinical phenotype laboratory test evaluate determine degree severity disease frequent comorbiditie result clinical characteristic total  hospitalize patient female  male median age  year confirm covid- diagnosis study severity disease classify moderate grade .% severe grade .% critical grade frequent underlying pathology coexist overweight n .% obesity n .% diabetes n .% hypertension n .% patient present pathology association find diabetes odd ratio confidence interval ci p high level d dimer ci p conclusion retrospective cohort study patient covid- specialty hospital northeast region mexico observe clinical phenotype d dimer elevation compatible inflammatory state degree severity find hospitalize patient underlie chronic medical condition diabetes elevated d dimer level significantly associate increase mortality covid- age sex male factor highly associate mortality
198,importance national covid cohort collaborative nc centralized harmonized high granularity electronic health record repository large representative covid- cohort date multicenter datum set support robust evidence base development predictive diagnostic tool inform clinical care policy objective evaluate covid- severity risk factor time assess use machine learning predict clinical severity design setting participant retrospective cohort study  adult sars cov- infection polymerase chain reaction antigen adult patient sars cov- infection serve control  medical center nationwide january december patient stratify world health organization covid- severity scale demographic characteristic difference group time evaluate multivariable logistic regression random forest xgboost model predict severe clinical course death discharge hospice invasive ventilatory support extracorporeal membrane oxygenation main outcomes measures patient demographic characteristic covid- severity world health organization covid- severity scale difference group time multivariable logistic regression result cohort include  adult test positive sars cov- mean sd age year .% female  adult control test negative sars cov- mean sd age year .% female  adult sars cov-  .% hospitalize  .% severe clinical course invasive ventilatory support extracorporeal membrane oxygenation death discharge hospice hospitalize patient mortality overall decrease .% march april  .% september october  p monthly trend  input available hospital day study predict severe clinical course random forest xgboost model area receiver operating curve stable time factor strongly associate clinical severity ph result consistent machine learning method separate multivariable logistic regression model build inference age odd ratio year ci .- male sex ci .- liver disease ci .- dementia ci .- african american ci asian ci .- race obesity ci .- independently associate high clinical severity conclusion relevance cohort study find covid- mortality decrease time  patient demographic characteristic comorbiditie associate high clinical severity machine learning model accurately predict ultimate clinical severity commonly collect clinical datum  hour hospital admission
199,purpose  novel coronavirus covid- emerge pandemic disease course vary asymptomatic infection critical disease result death recognition prognostic factor essential grow prevalence high clinical cost meta analysis aim evaluate global prevalence obesity covid- patient investigate obesity risk factor covid- covid- severity poor clinical outcome include hospitalization intensive care unit icu admission need mechanical ventilation mortality method study protocol register prospero crd systematic search scopus medline web sciences conduct  december   june  find pertinent study selection  study  different country include quantitative analysis pooled odd ratio confidence interval cis calculate assess association result prevalence obesity ci patient covid- obesity significantly associate susceptibility covid- ci moderate certainty covid- severity ci low certainty furthermore obesity significant risk factor hospitalization ci low certainty mechanical ventilation ci low certainty intensive care unit icu admission ci low certainty death ci low certainty covid- patient subgroup analysis association support majority subgroup conclusion obesity associate covid- need hospitalization mechanical ventilation icu admission death covid- level evidence level systematic review meta analysis
200,recent study report sex difference patient coronavirus disease- covid- aim analyze sex difference clinical characteristic risk factor disease severity hospitalize patient covid- beijing adult case diagnose covid- admit beijing ditan hospital capital medical university include sample median age patient  year mean body mass index bmi male relatively high compare female p proportion male patient coronary heart disease chd nonalcoholic fatty liver disease nafld history smoking drinking high female male patient develop clinical symptom obtain abnormal laboratory test result aware care seeking female patient significant difference clinical complication outcome group age odd ratio confidence interval ci p bmi ci p consider risk factor refractory pneumonia multivariate regression analysis finding current study show sars cov- likely affect old male comorbiditie research factor underlie obesity disease severity provide mechanistic insight covid- development
201,continue rise sars cov infection globally emergence wave different country understand characteristic susceptibility infection clinical severity outcome remain vital retrospective study datum extract patient de identify mount sinai health system covid- database assess risk mortality base presence comorbiditie organ specific sequela cov positive patient prevalence cardiovascular metabolic comorbiditie high sars cov+ individual diabetes obesity coronary artery disease hypertension atrial fibrillation heart failure increase overall mortality risk asthma ethnicity modify risk mortality associate comorbiditie regard secondary complication setting infection individual acute kidney injury acute myocardial injury show increase mortality risk cerebral infarct acute venous thromboembolic event associate increase risk mortality biomarker cardiovascular injury coagulation inflammation compare deceased survive individual find cardiac coagulation biomarker elevate fall normal range deceased patient inflammatory marker evaluate increase deceased patient summary identify comorbiditie sequelae peripheral blood biomarker associate elevated clinical severity poor outcome covid- patient overall finding detail granularity previously report factor impact susceptibility clinical severity mortality course covid- disease
202,novel severe acute respiratory syndrome sars coronavirus- cause covid- disease result severe morbidity mortality especially vulnerable group pregnancy virtue physiological anatomical adaptation increase risk severe infection especially respiratory tract single strand rna virus transmit droplet soiled fomite degree disease severity- asymptomatic mild moderate severe critical infection pregnancy asymptomatic mildly symptomatic woman consequence mother pregnancy minimal additional risk factor diabetes hypertension cardiorespiratory disease obesity ethnic minority background woman symptom present fever unproductive cough sore throat myalgia nasal congestion loss smell taste associated leukocytosis lymphopenia diagnosis rt pcr nasopharyngeal flock swab saliva pathognomonic feature ground glass appearance pulmonary infiltrate chest x ray ct scan management pregnancy non pregnant woman covid- indication elective delivery assist delivery second stage moderate severe critical disease require shorten stage covid- indication interrupt pregnancy caesarean section perform facilitate ventilation support resuscitation severe disease pain relief labour different regional analgesia prefer operative delivery postpartum thromboprophylaxis consider breast feeding encourage appropriate precaution minimize vertical transmission pregnant lactate woman encourage receive mrna base vaccine evidence adverse outcome
203,objective measure association race ethnicity comorbiditie insurance status need hospitalization symptomatic emergency department patient severe acute respiratory syndrome coronavirus  sars cov- infection method study cohort study symptomatic patient present single emergency department ed laboratory confirm sars cov- infection march -august collect patient level information demographic insurance status comorbiditie level care mortality structured chart review compare characteristic patient categorize home discharge general hospital ward admission intensive care unit icu admission death  day index visit univariate multivariable logistic regression analysis perform report odd ratio confidence interval ci hospital admission versus ed discharge home icu care versus general hospital ward admission result total  patient present ed symptom include analysis  .% patient discharge home  .% patient admit general hospital ward  .% admit icu die patient require admission likely black public insurance medicaid and/or medicare patient admit icu die likely age  year male multivariable logistic regression old age public insurance diabetes hypertension obesity heart failure hyperlipidemia independent predictor hospital admission compare need icu care versus general hospital ward admission univariate logistic regression patient medicaid ci medicare ci medicaid medicare ci history chronic obstructive pulmonary disease ci hypertension ci heart failure ci .- likely admit icu die black ci hispanic latino ci patient likely admit icu association statistically significant multivariable logistic regression old age male sex public insurance heart failure independent predictor icu care death conclusion comorbiditie public insurance predictor severe illness patient sars cov- study suggest disparity severity see covid- black patient attributable low socioeconomic status chronic health condition
204,novel coronavirus begin spread china wuhan gradually spread country lead announcement world health organization march new pandemic important point present world health organization disease well understand risk factor exacerbate course disease worsen prognosis high majority cardio metabolic risk factor like obesity hypertension diabetes dyslipidemia population  year old high cardio metabolic risk factor age people worsen prognosis coronavirus disease  covid- mortality study aim review article beginning pandemic impression cardio metabolic risk factor covid- effectiveness covid- manage disease factor study article include hypertension diabetes mellitus dyslipidemia obesity exacerbate course covid- disease different mechanism inflammatory process cause coronavirus create vicious cycle control disease patient
205,obesity foremost risk factor coronavirus infection result severe illness mortality pandemic progress obesity know predisposed chronic inflammatory condition dynamic obesity impact immunity change disease severity pneumonia especially acute respiratory distress syndrome primary cause death sars cov- infection adipocyte adipose tissue secret leptin proportion individual body fat mass increase circulate plasma leptin typical characteristic obesity correlate leptin resistant state leptin consider pleiotropic molecule regulate appetite immunity immunity leptin function cytokine coordinate host innate adaptive response promote th type immune response leptin induce proliferation function antigen present cell monocyte t helper cell subsequently influence pro inflammatory cytokine secretion cell tnf alpha il- il- leptin scarcity resistance link dysregulation cytokine secretion lead autoimmune disorder inflammatory response increase susceptibility infectious disease leptin activity leptin long last super active antagonist dysregulation patient obesity contribute high mortality rate patient sars cov- infection review systematically discuss interplay mechanism leptin inflammatory cytokine contribution fatal outcome covid- patient obesity
206,relationship covid- diabetes mellitus complicated bidirectional hand diabetes mellitus consider important risk factor severe course covid- factor present diabetes mellitus likely contribute risk old age proinflammatory hypercoagulable state hyperglycemia underlying comorbiditie hypertension cardiovascular disease chronic kidney disease obesity hand severe covid- infection treatment steroid specific negative impact diabetes lead worsen hyperglycemia increase insulin resistance reduce beta cell secretory function worsen hyperglycemia turn adversely affect course covid- knowledge gradually surface pandemic progress challenge understand interrelationship covid- diabete remain
207,background grip strength main component physical functioning sarcopenia physical frailty objective explore role grip strength measurement admission predict disease severity covid- method demographic datum smoking status comorbiditie covid- related symptom grip strength laboratory compute tomography ct finding admission note smedley hand dynamometer maximum grip strength value kg measurement dominant record low grip strength define standard deviation gender specific peak mean value healthy young adult oxygen saturation /=% extensive lung involvement ct moderate illness group pneumonia ct score mild illness group normal ct finding result study population include  patient f  m distribution mild moderate severe disease group .% .% respectively cough fever dyspnea hypertension obesity cardiovascular disease cvd chronic obstructive pulmonary disease copd frequent c reactive protein crp ferritin d dimer neutrophil level high severe group p absolute grip strength value low frequency have low grip strength high severe group p find significant difference stem severe group combine mild moderate group non severe compare severe vs. non severe group binary logistic regression analysis age gender body mass index smoking status presence comorbiditie low grip strength abnormal laboratory finding take analysis age odd ratio confidence interval ci obesity ci copd ci crp level ci low grip strength ci observe independent predictor severe covid- disease p conclusion addition know independent risk factor i.e. age obesity copd crp level low grip strength independently increase time severity covid-
208, march coronavirus disease  covid- declare pandemic world health organization study focus narrative review illness year pandemic relation obesity database search study publish  december total  article scientific literature find  article include year narrative review mean bmi value severe covid- patient range kg m versus kg m non severe patient article term obesity overweight indicate bmi value patient common useful anthropometric parameter define index confuse classification different west compare asian korean criterion base adult propose new term call covid obesity define importance anthropometric parameter relation pandemic
209,severe acute respiratory syndrome coronavirus  sars cov- give rise coronavirus disease  covid- pandemic strong correlation demonstrate bad covid- outcome age metabolic syndrome mets primarily derive obesity induce systemic chronic low grade inflammation numerous complication include type  diabetes mellitus tdm majority covid- death occur people age individual mets inclined manifest adverse disease consequence mortality covid- review examine prevalence molecular mechanism underlie enhance risk covid- elderly people individual mets. subsequently discuss current progress treat covid- include development new covid- vaccine antiviral goal elaborate prophylactic therapeutic treatment option vulnerable population
210,objective vitamin d deficiency associate increase risk covid- severity multi center randomized clinical trial aim determine effect  iu versus  iu daily oral vitamin d supplementation recovery symptom clinical parameter mild moderate covid- patient sub optimal vitamin d status study design setting total  reverse transcriptase polymerase chain reaction rt pcr sars cov- positive adult hospitalize mild moderate covid- disease allocate receive daily  week  iu oral vitamin d n  male  female  iu oral vitamin d standard control n  male  female anthropometric measure blood sample take pre- post supplementation fast blood glucose lipid serum oh)d inflammatory marker measure covid- symptom note admission monitor recovery result vitamin d supplementation  week cause significant increase serum oh)d level  iu group adjust p group comparison show significant decrease bmi il- level overtime group p value clinically significant group comparison kaplan meier survival analysis reveal  iu group significantly short time recovery day  iu group resolve cough adjust age sex baseline bmi d dimer versus p ageusia loss taste versus p conclusion  iu daily oral vitamin d supplementation  week reduce time recovery cough gustatory sensory loss patient sub optimal vitamin d status mild moderate covid- symptom use  iu vitamin d adjuvant therapy covid- patient suboptimal vitamin d status short duration recommend
211,introduction severe covid- illness adult link underlie medical condition study identify frequent underlying condition attributable risk severe covid- illness method datum  hospital premier healthcare database special covid- release phd sr describe hospitalize patient age  year old covid- march  march multivariable generalized linear model estimate adjusted risk intensive care unit admission invasive mechanical ventilation death associate frequent condition total number condition result hospitalize adult phd sr .% patient covid- .%  underlie medical condition essential hypertension .% disorder lipid metabolism .% obesity .% common strong risk factor death obesity adjust risk ratio arr ci .- anxiety fear relate disorder arr ci .- diabete complication arr ci .- total number condition arrs death range ci .- patient  condition ci .- patient  condition compare patient condition conclusion certain underlie condition number condition associate severe covid- illness hypertension disorder lipid metabolism frequent obesity diabete complication anxiety disorder strong risk factor severe covid- illness careful evaluation management underlying condition patient covid- help stratify risk severe illness
212,background systematic review meta analysis aim compare level von willebrand factor vwf antigen patient coronavirus disease  covid- poor outcome compare good outcome explore factor affect difference term vwf antigen group method comprehensive literature search pubmed embase scopus database undertake inception  april primary outcome poor outcome composite mortality severity covid- result study include total  patient include systematic review meta analysis vwf antigen high patient poor outcome standardized mean difference smd p i()=. p subgroup analysis study report vwf antigen level percentage mean difference p i()=. p meta regression show smd poor outcome good outcome affect platelet count coefficient p=. d dimer level coefficient p=. factor viii level coefficient p=. age coefficient p=. gender coefficient p=. obesity coefficient p=. hypertension coefficient p=. diabetes coefficient p=. malignancy coefficient p=. conclusion meta analysis show level vwf antigen significantly high patient covid- poor outcome signal mark endotheliopathy meta regression show difference large platelet count d dimer level factor viii level increase
213,introduction debatable fact estimate risk severity coronavirus disease covid- liver transplant recipient assess impact immunosuppressive therapy clinical course incidence liver failure material method present prospective study liver transplant recipient severe acute respiratory syndrome coronavirus sars cov- infection admit treatment department clinic abdominal surgery military medical academy sofia diagnosis confirm positive reverse transcription polymerase chain reaction rt pcr test sars cov- infection naso pharyngeal swab covid- severity estimate mild oxygen saturation spo room air imaging finding pneumonia moderate spo imaging suggestive pneumonia severe need high flow oxygen supplementation result liver transplant recipient covid- admit treat department male mean age year liver transplantation perform year patient different clinical form disease register mild n= moderate n= severe n= patient severe disease comorbiditie hypertension diabetes obesity patient mild moderate disease receive dual immunosuppressive therapy tacrolimus mycophenolate mofetil severe disease tacrolimus dose reduction tacrolimus undertake follow serum level evaluation change dose mycophenolate mofetil dual therapy patient severe disease die respiratory failure lead case fatality rate .% conclusion early diagnosis hospitalization possible essential prompt initiation treatment prevention complication development severe form covid- liver transplant recipient especially patient comorbiditie hypertension diabetes obesity course treatment dose reduction immunosuppressive therapy discontinuation especially calcineurin inhibitor mono- dual therapy regimen
214,purpose review highlight epidemiology pathophysiology hypertension obesity covid- infection recent finding hypertension obesity emerge significant risk factor contract covid- virus subsequent severity illness ace receptor expression dysregulation raas pathway play important role pathophysiology association pro inflammatory state cytokine dysregulation see obesity pattern see historically viral illness understand mechanism association covid- hypertension obesity important develop effective targeted therapy monitor vaccine response efficacy research need apply grow knowledge pathophysiology covid- hypertension obesity prevention treatment intervention focus lifestyle modification manage hypertension obesity potentially positive impact contain pandemic future viral illness outbreak
215,background unclear suggest link covid- pregnancy preeclampsia independent association cause common risk factor objective study aim quantify independent association covid- pregnancy preeclampsia determine effect variable maternal neonatal morbidity mortality study design large longitudinal prospective unmatched diagnose diagnose observational study assess effect covid- pregnancy mother neonate consecutive diagnose woman concomitantly enrol immediately diagnose woman identify stage pregnancy delivery level care minimize bias woman neonate follow hospital discharge standardized intergrowth-(st protocol electronic datum management system total  institution  country contribute study sample independent association  entity quantify risk factor know associate preeclampsia analyze group outcome compare woman covid- preeclampsia condition  condition result enrol  pregnant woman  .% enrol covid- diagnose  .% covid- diagnose group woman  preeclampsia   .% covid- diagnose group   .% diagnose group risk ratio confidence interval adjustment sociodemographic factor condition associate covid- preeclampsia risk ratio preeclampsia remain significant woman risk ratio confidence interval nulliparous woman specifically risk ratio confidence interval trend statistical significance parous woman risk ratio confidence interval risk ratio preterm birth woman diagnose covid- preeclampsia confidence interval confidence interval nulliparous woman compare woman condition diagnose composite adverse perinatal outcome show stepwise increase risk ratio covid- preeclampsia preeclampsia covid- covid- preeclampsia risk ratio confidence interval risk ratio confidence interval risk ratio confidence interval .- respectively similar finding find composite adverse maternal outcome risk ratio confidence interval confidence interval confidence interval association covid- gestational hypertension direction effect preterm birth adverse perinatal maternal outcome similar preeclampsia confine nulliparous woman low risk ratio conclusion covid- pregnancy strongly associate preeclampsia especially nulliparous woman association independent risk factor preexisting condition covid- severity factor association condition associate independently additive fashion preterm birth severe perinatal morbidity mortality adverse maternal outcome woman preeclampsia consider particularly vulnerable group regard risk pose covid-
216,covid- calamitous effect global community despite intense study immunologic response infection partially understand addition old age ethnicity patient comorbiditie include obesity diabetes hypertension coronary artery disease malignancy renal pulmonary disease experience severe outcome patient primary immunodeficiency pid secondary immunodeficiency appear increase risk covid- addition vulnerability sars cov- patient pid chronic pulmonary disease respond vaccine exacerbate long term risk patient common variable immunodeficiency disorder frequent symptomatic pid adult child spectrum b- t cell defect possible stratify risk severe covid- base age ethnicity severity t cell defect presence comorbiditie patient common variable immunodeficiency disorder immunodeficiency risk chronic covid- dangerous stalemate suboptimal immune response sars cov- intra host viral evolution result rapid emergence vaccine resistant mutant variant high consequence public health emergency vaccination prevention chronic covid- immunodeficient patient utmost priority have reliable diagnostic assay t cell immunity sars cov- critical evaluate response vaccine patient new treatment sars cov- nzace patari likely particularly beneficial immunodeficient patient especially fail mount robust t cell response covid- vaccine
217,background comorbiditie increase risk coronavirus disease  covid- hospitalization mortality comorbiditie common patient inflammatory bowel disease ibd seek investigate effect comorbiditie patient infection severity aim evaluate association individual comorbiditie covid- infection severity patient ibd method datum obtain secure ibd international registry create evaluate covid- outcome patient ibd multivariable regression analyze association non ibd comorbiditie composite primary outcome covid relate hospitalization death comorbiditie model individually adjust potential confounder determine independent effect comorbiditie fit model include comorbiditie covariate result analyze patient  country mean age year .% male total  patient .% experience severe covid- comorbiditie history stroke obesity associate severe infection initial analysis adjust odd ratio range model include comorbiditie significantly associate composite outcome initial analysis confounder comorbiditie remain significant high risk chronic kidney disease chronic obstructive pulmonary disease conclusion non ibd comorbiditie associate threefold increase risk covid- hospitalization death patient ibd datum risk stratify guide treatment lifestyle decision ongoing pandemic
218,objective describe impact obesity disease severity outcome coronavirus disease  covid- hospitalize child method retrospective cohort study society critical care medicine viral respiratory illness universal study registry include child hospitalize covid- march  january obesity define centers disease control prevention bmi world health organization weight length criterion critical illness definition adapt national institutes health criterion critical covid multivariate mixed logistic linear regression perform calculate adjust odd ratio critical illness adjust impact obesity hospital length stay result datum  patient .% united states  site analyze include  .% obesity  .% high proportion patient obesity adolescent hispanic ethnicity comorbiditie obesity likely diagnose multisystem inflammatory syndrome child .% vs .% p high icu admission rate vs p critical illness .% vs .% p obesity impact acute covid- severity multisystem inflammatory syndrome child presentation adjusted odd ratio critical illness obesity confidence interval patient obesity long adjust length stay exponentiated parameter estimate confidence interval compare patient obesity increase mortality risk covid- .% vs .% p conclusion large multicenter cohort high proportion hospitalize child covid- obesity comorbidity furthermore obesity significant independent association critical illness
219,covid- major public health pandemic risk factor severe infection poor outcome include cardiovascular disease obesity type  diabetes mellitus non alcoholic fatty liver disease nafld lifestyle intervention include diet physical activity modification current recommend treatment nafld communication author discuss crossover link nafld severe covid- infection impact essential public health measure suppress spread covid- exercise physical activity participation patient nafld future exercise prescription potential use digital technology address nafld healthcare need covid- era explore
220,role immune system protect individual pathogenic organism nutrition multiple factor determine immune response good nutrition important support immune response immunity impair old people particularly frail live obesity malnourished low intake micronutrient immune impairment associate nutritional inadequacy increase susceptibility infection permit infection severe fatal adverse impact poor nutrition immune system include inflammatory component explanation high risk severe outcome infection sars cov- see old people live obesity study individual micronutrient include vitamin d zinc suggest role reduce severity infection sars cov- good nutrition important promote diverse gut microbiota turn support immune system importance nutrition support immune response apply assure robust response vaccination lesson study nutrition immunity relevant battle sars cov-
221,identification great risk death substantial threat covid- benefit novel approach epidemiology leverage large dataset complex machine learn model provide data drive intelligence guide decision intensive care unit admission icua objective study fold substantive methodological substantively evaluate association demographic health record relate different outcome severe covid- viz death icua methodologically compare interpretation base logistic regression gradient boost decision tree gbdt prediction interpret mean shapley impact covariate different association factor e.g. obesity chronic respiratory disease death icua guide review practice shapley explanation gbdts identify vary effect factor patient emphasise importance individual patient assessment result study relevant evaluation complex automate clinical decision system optimise prediction score whilst remain interpretable clinician mitigate potential bias
222,objective severe acute respiratory syndrome coronavirus  angiotensin convert enzyme  receptor harm testis function objective analyse prevalence low serum testosterone lt impaired fertility potential leydig sertoli cell dysfunction respectively coronavirus disease  covid- male survivor evaluate acute infection relate associate factor explore association post acute covid- syndrome pcs quality life qol materials method male adult recover polymerase chain reaction confirm covid- offer structured evaluation week recovery main outcome measure(s follow lt define total testosterone tt  ng ml tt level ng ml calculate free testosterone ng dl sertoli cell dysfunction define inhibin b  pg ml secondary outcome associate factor analyse multiple logistic regression odd ratio confidence interval ci qol evaluate sf- v result patient evaluate median interquartile range  day disease onset recover severe pneumonia lt detect  patient .% ci low level inhibin b detect  patient .% ci multivariate adjustment obesity hypokalaemia associate lt age  independent predictor sertoli cell dysfunction lt sertoli cell dysfunction associate pcs patient lt low score domain qol conclusion prevalence male lt impaired fertility potential covid- survivor high medium term traditional risk factor severity marker covid- predictive
223,objective obesity report risk factor severe coronavirus disease  covid- recent study relationship body mass index bmi covid- severity fatality unclear research design method study include covid- patient release isolation die april nationwide datum provide korean centers disease control prevention agency bmi categorize follow /=  kg m. define fatal illness patient die result participant bmi .- kg m common .% follow .- kg m .% .- kg m .%  kg m /=  kg m diabetes mellitus chronic kidney disease cancer dementia independent risk factor fatal illness particular bmi /=  kg m .- find high or bmi .- kg m reference significant difference bmi .- kg m .- kg m. conclusion study demonstrate non linear u shape relationship bmi fatal illness subject bmi /=  kg m high risk fatal illness maintain healthy weight important prevent chronic cardiometabolic disease improve outcome covid-
224,liver involvement indicate elevated liver function test result common hospitalize patient coronavirus disease  covid- link disease severity outcome dual pattern elevated liver function test observe especially patient severe critical covid- characterize increase aminotransferase early course disease follow increase cholestasis associate biochemistry marker later stage dual pattern associate inflammatory response marker poor outcome current notion mechanism liver injury covid- include direct cytopathic effect virus hepatocyte cholangiocyte ischemic hypoxic liver damage drug induce liver injury activation hepatic immune cell excess cytokine production exacerbation pre exist liver disease patient obesity relate non alcoholic fatty liver disease particular patient cirrhosis high risk liver injury fatal outcome covid- contrast individual receive stable immunosuppressive medication autoimmune liver disease long term follow liver transplantation high case infection ratio fairly favourable outcome present review describe epidemiology characteristic potential pathological mechanism covid relate liver injury influence pre exist liver disease susceptibility severity liver injury covid- discuss
226,importance prone positioning improve clinical outcome moderate severe acute respiratory distress syndrome widely adopt treatment patient acute respiratory distress syndrome coronavirus disease little know effect prone positioning patient severe acute respiratory distress syndrome obesity treat pulmonary vasodilator objective characterize change oxygenation respiratory system compliance dead space tidal volume ratio response prone positioning patient coronavirus disease  acute respiratory distress syndrome range severity subset analysis patient treat inhale nitric oxide subsequent prone positioning explore influence pulmonary vasodilation physiology prone positioning design setting participant retrospective cohort study consecutively admit adult patient acute respiratory distress syndrome coronavirus disease  treat mechanical ventilation prone positioning icu academic hospital march main outcomes measures respiratory system mechanic gas exchange episode prone positioning result  patient median interquartile range age  year yr median body mass index kg m kg m  patient female ratio pao fio improve prone positioning patient prone positioning associate significant increase ratio pao fio median   p change dead space tidal volume ratio respiratory system compliance supine ratio pao fio respiratory system compliance positive end expiratory pressure body mass index correlate absolute change ratio pao fio prone positioning patient ratio pao fio  experience great relative improvement oxygenation prone positioning patient ratio pao fio great equal  median percent change ratio pao fio  vs  p  patient inhale nitric oxide prior prone positioning associate significant increase ratio pao fio median   p decrease dead space tidal volume ratio p subsequent prone positioning subgroup improve ratio pao fio   p change dead space tidal volume ratio conclusion relevance prone positioning improve oxygenation acute respiratory distress syndrome severity spectrum irrespective supine respiratory system compliance positive end expiratory pressure body mass index great relative benefit patient severe disease prone positioning confer additive benefit oxygenation patient treat inhale nitric oxide
227,background major complication covid- hypoxaemic respiratory failure capillary leak alveolar oedema experimental early clinical datum suggest tyrosine kinase inhibitor imatinib reverse pulmonary capillary leak method randomised double blind placebo control clinical trial  academic non academic teaching hospital netherlands hospitalised patient aged /= year covid- confirm rt pcr test sars cov- require supplemental oxygen maintain peripheral oxygen saturation great eligible patient exclude severe pre existing pulmonary disease pre existing heart failure undergo active treatment haematological non haematological malignancy previous  month cytopenia receive concomitant treatment medication know strongly interact imatinib patient randomly assign receive oral imatinib give loading dose  mg day  follow  mg daily day placebo randomisation computer base clinical datum management platform variable block size contain patient stratify study site primary outcome time discontinuation mechanical ventilation supplemental oxygen  consecutive hour alive -day period secondary outcome include safety mortality  day need invasive mechanical ventilation efficacy safety analysis randomised patient receive dose study medication modify intention treat population study register eu clinical trials register eudract finding march jan  patient screen  eligible randomly assign imatinib group n= placebo group n= total  patient median age  year iqr receive dose study medication include modify intention treat population time discontinuation ventilation supplemental oxygen  h significantly different group unadjusted hazard ratio hr ci day   patient die imatinib group compare   patient placebo group unadjusted hr adjust baseline imbalance group sex obesity diabetes cardiovascular disease hr mortality ci hr mechanical ventilation imatinib group compare placebo group p=. median duration invasive mechanical ventilation  day iqr imatinib group compare  day placebo group p=.   patient imatinib group   patient placebo group grade  high adverse event safety evaluation reveal imatinib associate adverse event interpretation study fail meet primary outcome imatinib reduce time discontinuation ventilation supplemental oxygen  consecutive hour patient covid- require supplemental oxygen observe effect survival attenuate adjustment baseline imbalance duration mechanical ventilation suggest imatinib confer clinical benefit hospitalise patient covid- study require validate finding funding amsterdam medical center foundation nederlandse organisatie voor wetenschappelijk onderzoek zonmw european union innovative medicines initiative
228,objective investigate risk factor contribute severity admission additionally risk factor bad severity fatality study factor compare base point early severity bad severity fatality design observational cohort study datum enter japan nationwide covid- inpatient registry coviregi jp setting  september  case  facility register participate facility cover wide range hospital patient covid- admit japan participant participant positive test result applicable sars cov- diagnostic test admit participate healthcare facility total  case identify  january   case include study primary secondary outcome measure primary outcome severe nonsevere admission determine requirement mechanical ventilation oxygen therapy spo respiratory rate secondary outcome bad severity hospitalisation judge requirement oxygen orinvasive mechanical ventilation extracorporeal membrane oxygenation result risk factor severity admission old age man cardiovascular disease chronic respiratory disease diabetes obesity hypertension cerebrovascular disease liver disease renal disease dialysis solid tumour hyperlipidaemia influence severity admission influence bad severity fatality rate obesity hypertension hyperlipidaemia relatively low conclusion study segregate comorbiditie influence severity death possible risk factor severity admission bad severity fatality consistent propel different factor specifically hypertension hyperlipidaemia obesity major effect bad severity impact mild fatality japanese population study contradict result detailed analysis consider hospital treatment need validation trial registration number umin
229,background vitamin d deficiency suggest favor poor outcome coronavirus disease- covid- aim assess -hydroxyvitamin d ohd level associate interleukin  il- level disease severity mortality covid- method prospectively study  patient admit northern italian hospital age year  male severely symptomatic covid- subject sars cov- infection mild covid- symptom mildly symptomatic covid- patient  subject sars cov- infection control measure ohd il- level admission focus respiratory outcome hospitalization result severely symptomatic covid- patient low ohd level ng ml mildly symptomatic covid- patient non sars cov infected control ng ml ng ml respectively p comparison ohd il- level respectively low high severely symptomatic covid- patient admit intensive care unit icu ng ml pg ml respectively require icu admission ng ml p pg ml p respectively similar difference find compare covid- patient die hospital ng ml pg ml survivor ng ml p pg ml p respectively ohd level inversely correlate il- level rho p ii subsequent need icu admission relative risk rr confidence interval ci p regardless age gender presence  comorbidity obesity diabetes arterial hypertension creatinine il- lactate dehydrogenase level neutrophil cell lymphocyte platelet count iii mortality rr ci .- p regardless age gender presence diabetes il- c reactive protein lactate dehydrogenase level neutrophil cell lymphocyte platelet count conclusion covid- patient low ohd level inversely correlate high il- level independent predictor covid- severity mortality
230,discovery manifest zn deficiency increase number study demonstrate association alter zn status multiple disease chapter provide review recent advance role zn health disease special focus role zn neurodegenerative neurodevelopmental disorder diabetes obesity male female reproduction covid- parallel reveal tight association asd risk severity zn status particular mechanism link zn(+ asd pathogenesis like modulation synaptic plasticity prosap shank scaffold neurotransmitter metabolism gut microbiota elucidate increase body datum indicate potential involvement zn(+ metabolism neurodegeneration systemic zn level alzheimer parkinson disease find reduce sequestration brain result modulation amyloid beta alpha synuclein processing subsequent toxic effect zn(+ show possess adipotropic effect role zinc transporter zinc finger protein zn alpha glycoprotein adipose tissue physiology underlie particular role pathogenesis obesity diabetes mellitus type recent finding contribute understanding role zn+ spermatogenesis sperm function oocyte development fertilization finally zn(+ show potential adjuvant therapy management novel coronavirus infection covid- underline perspective zinc management old new threat
231,end  novel coronavirus identify wuhan china disease cause severe acute respiratory distress syndrome coronavirus  sars cov- designate covid- corona virus disease world health organization early patient covid- experience mild symptom severe critical disease occur remain severe disease manifest development pneumonia hypoxia radiographic lung involvement critical disease indicate multiorgan involvement significant respiratory cardiac compromise current estimate case fatality rate covid- approximately epidemiological study show advanced age male gender previous chronic lung disease cardiovascular kidney disease obesity diabete risk factor severity disease course current focused review present overview acute cardiovascular complication covid- detection impact prognosis
232,objective coronavirus disease  covid- novel pandemic considerable difference disease severity mortality rate observe different part world present study investigate characteristic outcome patient hospitalize covid- iran method establish retrospective cohort study hospitalize covid- patient iran epidemiological imaging laboratory clinical characteristic outcome record medical document chi square test t test logistic regression model analyze datum p. mortality show significant relationship body mass index age history hypertension chronic kidney disease ckd ischemic heart disease cerebrovascular accident cva pulmonary disease cancer abnormal high resolution compute tomography hrct finding p cancer high odd ratio conclusion comorbiditie especially cancer ckd cva severe obesity old age abnormal hrct finding affect health outcome patient hospitalize covid-
233,objective explore predictor severe covid- disease patient diabetes hospitalize covid- method retrospective observational study adult diabetes admit covid- bivariate test multivariable cox regression identify risk factor severe covid- define composite endpoint intensive care unit admission intubation hospital death result  patient diabetes admit covid- severe disease associate old age hr p male sex hr p=. asian race hr p=. reference white great obesity moderate obesity hr p=. severe obesity hr p=. reference normal body mass index outpatient diabetes medication associate outcome conclusion age male sex asian race obesity associate increase risk severe covid- disease adult type  diabetes hospitalize covid- summary patient type  diabetes hospitalize covid- disease observe age male sex asian race obesity predict severe covid- outcome intensive care unit admission intubation hospital death risk confer obesity increase worsen obesity outpatient diabetes medication observe significant predictor study outcome
234,importance information underlying condition severe covid- illness child limited objective examine risk severe covid- illness child associate underlie medical condition medical complexity design setting participant cross sectional study include patient age  year young international statistical classification diseases tenth revision clinical modification code u. covid- b. coronavirus emergency department inpatient encounter march  january datum collect premier healthcare database special covid- release include datum  hospital multivariable generalized linear model control patient hospital characteristic estimate adjusted risk severe covid- illness associate underlie medical condition medical complexity exposure underlie medical condition medical complexity ie presence complex noncomplex chronic disease main outcomes measures hospitalization severe illness hospitalize ie combine outcome intensive care unit admission invasive mechanical ventilation death result  patient covid- aged  year young median interquartile range age  year  .% female patient  .% underlying medical condition common diagnose condition asthma .% neurodevelopmental disorder .% anxiety fear relate disorder .% depressive disorder .% obesity strong risk factor hospitalization type  diabetes adjust risk ratio arr ci obesity arr ci .- strong risk factor severe covid- illness type  diabetes arr ci cardiac circulatory congenital anomaly arr ci prematurity risk factor severe covid- illness child young  year arr ci chronic complex chronic disease risk factor hospitalization arrs ci ci .- respectively severe covid- illness arrs ci ci .- respectively conclusion relevance cross sectional study find high risk severe covid- illness child medical complexity certain underlying condition type  diabetes cardiac circulatory congenital anomaly obesity health care practitioner consider potential need close observation cautious clinical management child condition covid-
235,current outbreak coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- study publish determine spectrum illness risk factor prevention treatment strategy relatively few case child compare adult paucity clinical datum available fully understand risk factor disease course pediatric population understanding evolve limited datum show increase risk severe critical disease child year age certain underlie medical condition recognition emerge risk factor morbidity mortality paramount anticipate provide appropriate clinical care specific pediatric population obesity recently identify risk factor severe covid- disease child case report essential understand pathophysiologic association associated disease severity clinical outcome attribute obesity covid- infection child
236,despite ubiquity body mass index bmi discourse health ambiguity use biomarker current abnormality versus future risk distinction consequential knowledge relationship body size health individual deem abnormal unhealthy body consequently purpose review threefold differentiate biomarker perspective extant critique bmi proxy health behaviour define characteristic obesity disease second highlight shift treat bmi measure attain unhealthiness probabilistic indicator risk finally abolition bmi paper argue continue use number keep push weight neutrality research practice review conclude demonstrate riskiness unhealthiness body size conflate public health messaging covid- bmi marker risk use surrogate covid- severity equate body size health shape belief vulnerability personal responsibility amid ongoing pandemic
237,coronavirus disease  covid- pandemic evidence pandemic obesity currently study document association obesity covid- severity mechanism underlie increase risk complication mortality obese patient covid- diverse nature inflammation play central role obesity metabolic alteration see obese patient relate inflammatory response study report elevated level circulate inflammatory cytokine obese patient deregulate expression adipokine leptin resistin increase expression vascular adhesion molecule  intercellular adhesion molecule  contribute increase vascular leukocyte adhesiveness additional oxidative stress additionally recognize chronic impairment systemic vascular endothelial function patient cardiovascular metabolic disorder include obesity intensify detrimental effect sars cov- endothelium explain bad outcome covid- fact vascular endothelial dysfunction contribute unfavorable response endothelium infection sars cov- alteration cardiac structure function prothrombotic environment obesity provide link increase cardiovascular event patient
238,elderly patient comorbiditie experience severe case coronavirus disease  covid- healthy patient underlie medical condition unclear people prone develop alveolar pneumonia rapid exacerbation death hypothesize people comorbiditie genetic predisposition make vulnerable factor example likely severely ill infect severe acute respiratory syndrome coronavirus  sars cov- test hypothesis search literature extensively polymorphism gene encode angiotensin convert enzyme  ace associate numerous comorbiditie cardiovascular disease hypertension diabetes chronic kidney disease obesity potential mechanism explain association e.g. dd type carrier great ace activity patient genetic alpha- anti trypsin aat deficiency lack control inflammatory mediator comorbiditie associate chronic inflammation closely relate renin angiotensin aldosterone system raas individual mild ace ace imbalance viral infection increase risk develop severe case covid- debate association ace d polymorphism comorbiditie good explanation discrepancy d allele dd subtype associate comorbiditie dd genotype exceptionally large effect expect ace d polymorphism intron marker discuss polymorphism aat gene involve comorbiditie severity sars cov- infection presumably combination multiple gene non genetic factor involve establishment comorbiditie aggravation covid-
239,covid- coronavirus disease pandemic pose threat community healthcare system worldwide malnutrition form negatively impact susceptibility severity sars cov- severe acute respiratory syndrome coronavirus infection child old adult undernutrition obesity evoke condition associate high susceptibility infection poor prognosis turn covid- infection worsen nutritional status highly catabolic condition expose individual risk malnutrition muscle wasting nutritional deficiency accordingly relationship malnutrition covid- likely bidirectional furthermore modification nutritional behavior physical activity require limit spread virus pose challenge health extreme life far advanced healthcare system fail address alarming consequence malnutrition pose pandemic properly address run risk new old generation experience consequence covid- relate malnutrition
240,duchenne muscular dystrophy dmd common childhood muscular dystrophy result progressive muscle weakness pulmonary function decrease second decade life lung disease contribute significantly morbidity mortality patient corticosteroid current standard care patient dmd despite know adverse effect obesity immunosuppression past year novel coronavirus covid-/sars cov outbreak cause global pandemic restrictive lung disease low lung volume chronic immunosuppressive treatment corticosteroid obesity potential risk factor contribute severe course disease  duchenne becker muscular dystrophy patient treat tertiary neuromuscular center patient dmd advanced becker muscular dystrophy find positive covid- infection dmd patient admit hospitalization dependent daily nocturnal non invasive ventilation patient recover complication despite obesity steroid treatment severe restrictive lung disease
241,background recent study coronavirus disease  covid- demonstrate obesity significantly associate increase disease severity clinical outcome mortality association hepatic steatosis frequently accompany obesity pneumonia severity score pss evaluate compute tomography ct prevalence steatosis patient covid- remain elucidate aim assess frequency hepatic steatosis chest ct covid- patient association pss methods chest ct image  patient admit emergency department suspect covid- retrospectively evaluate patient divide group covid positive ct- reverse transcriptase polymerase chain reaction rt pcr)-positive control ct- rt pcr negative ct image group evaluate pss ratio volume involved lung parenchyma total lung volume hepatic steatosis define liver attenuation value  hounsfield unit hu result  patient n define covid positive group n control group average age covid positive group significantly high control group year vs year p frequency hepatic steatosis positive group significantly high compare control group .% vs .% p average hepatic attenuation value significantly low positive group compare control group hu vs hu p logistic regression analysis show adjust age hypertension diabetes mellitus overweight obesity time great odd hepatic steatosis covid positive group control odd ratio confidence interval p conclusion prevalence hepatic steatosis significantly high covid- patient compare control adjustment age comorbiditie finding easily assess chest ct image
242,investigate mechanism underlie sars cov- infection severity observe patient obesity perform prospective study  patient evaluate impact multiple immune parameter  week admission vital organ function accord body mass index bmi category high dimensional flow cytometric characterization immune cell subset perform admission  systemic cytokine chemokine level sequentially measure thirteen endothelial marker determine admission zenith cytokine compute tomography scan admission quantify lung damage hepatic steatosis n abnormal bmi observe .% patient associate high rate intensive care unit hospitalization p sars cov- rnaaemia peripheral immune cell subset cytokine chemokine similar bmi group significant association inflammatory cytokine liver renal endothelial dysfunction observe patient obesity bmi contrast early sign lung damage ground glass opacity correlate th m inflammatory cytokine normal weight patient later lesion pulmonary consolidation correlate bmi independent cytokine level study reveal distinct physiopathological mechanism associate sars cov- infection patient obesity important clinical implication
243,declare global pandemic world health organization coronavirus disease  covid- illness cause severe acute respiratory syndrome coronavirus  sars cov- devastating effect global health world economy virus primarily affect respiratory system spread person person respiratory particle cough sneeze majority transmission occur close contact presymptomatic asymptomatic symptomatic carrier early course pandemic characterize rapid spread virus create urgency mitigate new viral illness experimental therapy drug repurpose intense global research effort significant progress result development novel therapeutic vaccine unprecedented speed lead favorable patient outcome currently variety therapeutic option include antiviral medication monoclonal antibody immunomodulatory agent available management covid- therapeutic potential clinical use drug limit specifically base stage illness pathogenesis covid- illness occur distinct phase early stage characterize profound sars cov- viral replication follow late phase characterize hyperinflammatory state induce release cytokine tumor necrosis factor alpha tnf alpha granulocyte macrophage colony stimulate factor gm csf interleukin il il- interferon ifn)-gamma activation coagulation system result prothrombotic state antiviral therapy antibody base treatment likely effective early phase illness immunomodulating therapy combination antiviral antibody base therapy effective later stage combat cytokine mediate hyperinflammatory state cause severe illness individual age risk infection severe disease individual age /= year underlie medical comorbiditie obesity cardiovascular disease chronic kidney disease diabetes chronic lung disease smoking cancer solid organ hematopoietic stem cell transplant recipient increase risk develop severe covid- infection percentage covid- patient require hospitalization time high preexisting medical condition medical condition .% vs. .% base analysis stokes confirm case report centers disease control prevention cdc january  promising approach address covid- associate mortality prevent increase utilization healthcare resource terminate progression viral replication prevent progression hyperinflammatory stage covid- cause severe illness high risk nonhospitalize patient initially focus treatment direct mainly hospitalize patient covid- illness clinical focus pandemic expand combat illness early reduce viral load patient early disease attempt halt disease progression monoclonal antibody target spike protein sars cov- yield positive vitro result consider promising approach manage nonhospitalize patient mild moderate covid- high risk develop severe illness review discuss mechanism action monoclonal antibody sars cov- current clinical indication monoclonal antibody therapy nonhospitalized patient mild moderate covid- illness high risk develop severe illness accord national institutes health nih management nonhospitalize patient covid- include supportive symptomatic care reduce risk transmission advise patient seek person medical evaluation advise patient dyspnea seek person medical evaluation anti sars cov- monoclonal antibody recommend mild moderate severity outpatient high risk progress severe disease patient discharge emergency department supplemental oxygen recommend dexamethasone  mg daily duration oxygen supplementation exceed day patient oxygen therapy recommend use dexamethasone find insufficient evidence use remdesivir patient discharge emergency department supplemental oxygen monoclonal antibodies covid- monoclonal antibody mabs immune system protein develop single cell lineage demonstrate high affinity target cell monoclonal antibody develop kohler milstein  hybridoma technology significant progress molecular engineering world enable establishment monoclonal antibody target therapy neoplastic condition autoimmune post transplant immunosuppression infectious disease antiviral therapy neutralize antibody play integral achieve passive antiviral immunity instrumental prevent regulate viral illness year passive immunization viral disease achieve administer polyclonal sera obtain convalescent human donor animal polyclonal antibody preparation increasingly replace monoclonal antibody virtue demonstrate favorable safety profile target specificity different viral disease palivizumab antiviral monoclonal antibody approve food drug administration fda prophylaxis respiratory syncytial virus rsv high risk infant year significant development antibody engineering improve understanding biology virus direct indirect effect monoclonal antibody viral infection result development novel monoclonal antibody like antiviral drug monoclonal antibody antiviral agent susceptible develop resistance result alteration viral genome alter pathogenic potential virus result emergence viral escape mutant render virus resistant specific monoclonal antibody counter viral escape phenomenon combination monoclonal antibody commonly refer antibody cocktail propose rationale combine specific monoclonal antibody complement prevent neutralization escape target multiple viral epitope estimated  monoclonal antibody currently development clinical trial treat covid- fda grant agent emergency use authorization eua clinical use combination antibody cocktail agent monotherapy
244,objective study aim describe dynamic change coagulation parameter evaluate relationship longitudinal coagulation parameter abnormality prognosis covid- patient method perform retrospective study  covid- patient longitudinal coagulation parameter clinical outcome analyze result abnormal coagulation parameter observe patient covid- hospital admission inr .% pt .% aptt .% tt .% fdp .% d dimer .% peak hospitalization inr .% pt .% aptt .% tt .% fdp .% d dimer .% compare non severe patient covid- severe patient slightly high inr pt aptt remarkably high fdp d dimer p  year male obesity comorbidity abnormal d dimer hospital admission abnormal peak hospitalization pt aptt fdp d dimer associate covid- severity extreme coagulation parameter abnormality pt s fdp  ug ml d dimer  ug ml associate significantly high mortality conclusion longitudinal coagulation parameter abnormality common patient covid- associate disease severity mortality monitor coagulation parameter advisable improve management patient covid-
245,background aim factor worsen prognosis new coronavirus sars cov- identify obesity diabetes despite nutrition change lockdown situation little know influence malnutrition subject hospitalize covid- study aim assess presence malnutrition patient admit covid- impact clinical outcome compare patient condition nourish method  patient admit hospital covid- analyze cross sectionally subjective global assessment sga complete phone interview clinical parameter include extract electronic medical record result accord sga  admit covid- infection malnutrition patient nourish old patient sga grade vs  year p length hospital stay poorly nourish patient significantly high vs day p mortality rate admission icu great subject degree malnutrition compare nourish patient .% vs p .% vs .% p crp vs mg l p d dimer vs ng ml p ferritin vs l p high group malnutrition haemoglobin vs g dl p albumin vs g dl p low patient degree malnutrition conclusion presence poor nutritional status relate long stay hospital great admission icu high mortality
246,background aim body mass index bmi previously show increase mortality disease severity patient covid- pool effect estimate heterogeneous bmi widely indicator distinguish visceral subcutaneous fat systematic review meta analysis aim investigate association visceral adiposity subcutaneous fat severe covid- method perform systematic literature search database pubmed embase europepmc datum visceral fat area vta subcutaneous fat area sfa total fat area tfa collect outcome interest severe covid- reml random effect model pool mean difference odd ratio result  study comprise  patient patient severe covid- high vta mean difference cm p tfa mean difference cm p significant difference term sfa patient severe non severe covid- mean difference cm p ): pooled or show vta associate severe covid- p ): conclusion visceral adiposity associate increase covid- severity subcutaneous adiposity prospero id crd
247,purpose purpose present study investigate body mass index multi morbidity covid- risk score predictor severe covid- outcome patient patient study characterize patient cohort collect mayo clinic january  confirmed covid- diagnosis define positive result reverse transcriptase polymerase chain reaction rt pcr assay nasopharyngeal swab specimen measures demographic clinical datum extract electronic medical record datum include date birth gender ethnicity race marital status medication active covid- agent weight height body mass index bmi calculate history smoking comorbid condition calculate charlson comorbidity index cci u.s department health human services dhhs multi morbidity score additional covid- risk score include outcome include hospital admission icu admission death result cox proportional hazard model determine impact mortality hospital admission age sex race white latino white non latino disclose adjust model patient high covid- risk scores significantly high likelihood admit hospital hr ci p experience death inpatient admission include icu admission hr ci p age statistically significant demographic predictor obesity significant predictor outcome conclusion age covid- risk scores significant predictor severe covid- outcome work examine property covid- risk factors scale
248,background pregnant woman coronavirus disease  covid- increase risk severe illness compare nonpregnant woman datum assess risk factor illness severity pregnant woman covid- limited study aim determine risk factor associate covid- illness severity pregnant woman severe acute respiratory syndrome coronavirus  sars cov- infection method pregnant woman sars cov- infection confirm molecular testing report  march march  surveillance emerging threats mothers babies network set net criterion illness severity asymptomatic mild moderate severe critical adapt national institutes health world health organization criterion crude adjusted risk ratio moderate severe critical covid- illness calculate select demographic clinical characteristic result  pregnant woman sars cov- infection moderate severe critical covid- illness associate age  year old healthcare occupation prepregnancy obesity chronic lung disease chronic hypertension pregestational diabetes mellitus risk moderate severe critical illness increase number underlie medical pregnancy relate condition conclusion old age have underlie medical condition associate increase risk moderate severe critical covid- illness pregnant woman information help pregnant woman understand risk moderate severe critical covid- illness inform target public health messaging
249,obstructive sleep apnoea osa affect seventh world population treatment mild osa improve daytime sleepiness quality life recent modification uvulopalatopharyngoplasty widely applicable treatment option select patient osa diet exercise effect sleep apnoea severity independent weight loss insomnia increasingly common coronavirus disease  covid- pandemic
250,background inflammatory cytokine upregulate severe coronavirus disease  covid- compare cytokine covid- versus influenza define differentiate feature inflammatory response pathogen association severe disease elevated body mass index bmi know risk factor severe covid- examine relationship bmi cytokine associate severe disease method thirty seven cytokine chemokine measure plasma  patient covid-  patient influenza  healthy control control bmi age sex difference cytokine group determine linear regression random forest prediction determine cytokine important distinguish severe covid- influenza mediation analysis identify cytokine mediate effect bmi age disease severity result interleukin- il- il beta il- tumor necrosis factor alpha tnf alpha significantly increase covid- versus influenza patient granulocyte macrophage colony stimulate factor interferon gamma ifn gamma ifn lambda il- il- monocyte chemoattractant protein  significantly elevate influenza group subgroup analysis base disease severity il- il- tnf alpha elevate severe covid- severe influenza random forest analysis identify high il- low ifn lambda level distinct severe covid- severe influenza finally il ra identify potential mediator effect bmi covid- severity conclusion finding point activation fundamentally different innate immune pathway severe acute respiratory syndrome coronavirus  influenza infection emphasize driver severe covid- focus mechanistic therapeutic investigation
251,background meta analysis seek determine estimate association obesity adverse outcome covid- patient method follow recommend prisma guideline systematic literature search conduct pubmed google scholar sciencedirect publish literature december october datum study pool study contain search term obesity covid- -ncov coronavirus sars cov- icu admission hospitalization disease severity invasive mechanical ventilator death mortality online search supplement reference screening retrieve study additional literature pooled odd ratio confidence interval ci retrieve study calculate random effect model inverse variance method finding study combine sample size patient include meta analysis pool final analysis show patient severely obese likely experience adverse outcome death icu admission need imv hospitalization compare normal patient ci conclusion severe obesity risk factor develop adverse outcome covid- patient finding study signify promotive preventive curative attention accord patient diagnose severe obesity covid-
252,objective december coronavirus disease  covid- spread rapidly world infect age group novel virus manuscript report characteristic child covid- mazandaran province northern iran method  february  july medical record  child diagnose covid- admit hospital mazandaran province collect patient age gender clinical symptom sign addition therapeutic management outcome report result  boy  girl mean age month evaluate  patient transfer picu pediatric intensive care unit  child experience severe form disease pediatric inflammatory multisystem syndrome pims mean duration hospitalization day fever respiratory gastrointestinal neurologic complaint experience patient addition skin rash patient need supplemental oxygen  undergo endotracheal intubation leukopenia report anemia thrombocytopenia  patient  patient underlie disease include chronic renal failure syndrome cerebral palsy morbid obesity die conclusion covid- cause symptom child stage week upper low respiratory symptom occur low severity prevalence compare adult week follow infection symptom mis c multisystem involvement occur covid- consider common indication admission fever rash respiratory problem
253,obesity recognize independent risk factor critical illness major severity subject coronavirus disease  covid- role fat distribution particularly visceral fat link metabolic abnormality unclear adipose tissue represent direct source cytokine responsible pathological modification occur adipose tissue obese subject adipokines crucial connection metabolism immune system dysregulation obesity contribute chronic low grade systemic inflammation metabolic comorbiditie increase visceral fat lead proinflammatory phenotypic shift review analyze interrelation obesity covid- severity cellular key player molecular mechanism implicate adipose inflammation investigate adipose tissue constitute reservoir viral spread contribute immune activation cytokine storm target underlie molecular mechanism therapeutic potential management obesity relate complication covid- patient
254,coronavirus disease  covid- name world health organization february quickly spread  country world declare global pandemic march severity disease make prone severe symptom high mortality rate patient especially comorbiditie include high blood pressure cardiovascular disease obesity diabetes increase concern consequence pandemic initial report clearly describe diabete associated comorbiditie treatment strategy contribute severe prognosis covid- infection clinical trial conduct glucose lower agent date standard treatment protocol approve covid- case pre existing diabete review aim decipher potential risk factor covid- involve exist evidence identification novel therapeutic strategy beneficial combat sars cov- dreadful debilitate people diabete
255,objective rapid review determine magnitude association potential risk factor severity covid- inform vaccine prioritisation canada setting ovid medline(r epistemonikos covid- l.ove platform mcmaster covid- evidence alerts website search  june eligible study conduct high income country multivariate analysis participant pilot screening data extraction quality appraisal perform single experienced reviewer  unique record identify  include report median  range participant aged year good quality outcomes hospitalisation intensive care unit admission length stay hospital intensive care unit mechanical ventilation severe disease mortality result author synthesise finding narratively appraise certainty evidence risk factor outcome association low moderate certainty evidence large magnitude association hospitalisation people covid- obesity class iii heart failure diabetes chronic kidney disease dementia age year male gender black race ethnicity vs non hispanic white homelessness low income age year associate large increase mechanical ventilation severe disease respectively mortality large magnitude association exist liver disease bangladeshi ethnicity vs british white age year age year vs year male gender year old association hospitalisation mortality large age /= year conclusion increase age especially year important risk factor severe outcome high quality primary research accounting multiple confounder need well understand magnitude association severity covid- factor prospero registration number crd
256,rapid outbreak coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- lead infection variable clinical presentation wide clinical spectrum disease report wuhan china  rapidly spread worldwide despite report dynamic change disease progression clinical predictor disease severity difficult identify follow case describe identical twin laboratory confirm covid- different disease course patient reside home share comorbiditie include type  diabetes mellitus hypertension morbid obesity twin  high inflammatory marker white blood cell wbc arguably complicated medical history comparison identical twin patient experience mild short disease course case highlight need identify proper disease marker predictor early clinical course order direct future management guideline timely treatment
257,background risk factor associate stage coronavirus disease- covid- disease progression known aim identify risk factor specific state covid- progression sars cov- infection death method result include participant veteran affairs million veteran program identify characteristic icd code base phenotype electronic health record logistic regression examine association age sex body mass index bmi race prevalent phenotype stage covid- disease progression infection hospitalization intensive care unit icu admission -day mortality separate model model adjust age sex race ethnicity number visit month icd code state infection rate control multiple testing false discovery rate /= vs. kg m. renal failure respiratory failure morbid obesity acid base balance disorder white blood cell disease hydronephrosis bacterial infection associate increase risk icu admission sepsis chronic skin ulcer acid base balance disorder acidosis associate mortality conclusion old age high bmi male patient history respiratory kidney bacterial metabolic comorbiditie experience great covid- severity future study investigate underlie mechanism associate phenotype cluster covid- warrant
258,background nutrient powerful immunomodulatory action potential alter susceptibility coronavirus disease  covid- infection progression symptom likelihood severe disease survival objective aim review late evidence malnutrition form under- overnutrition micronutrient status influence susceptibility progression covid- method synthesize information  nutrition relate component potential interaction covid- overweight obesity diabetes protein energy malnutrition anemia vitamin c d e pufa iron selenium zinc antioxidant nutritional support section provide landscape review pertinent material systematic search literature pubmed embase database include wide range server screen  clinical trial registry original research consider restriction study design include cover severe acute respiratory syndrome coronavirus cov  sars cov- middle east respiratory syndrome cov mers cov sars cov virus disease susceptibility disease progression nutritional component interest search take place   august result  search  article pubmed embase  article server  trial return final narrative synthesis include  publish article  article  trial conclusion currently limited evidence high dose supplement micronutrient prevent severe disease speed recovery result clinical trial eagerly await give know impact form malnutrition immune system public health strategy reduce micronutrient deficiency undernutrition remain critical importance furthermore strong evidence prevention obesity type  diabetes reduce risk covid- outcome review register prospero crd
259,develop world severe malnutrition prevalent cause immunodeficiency affect population impoverished community know severe acute respiratory syndrome coronavirus  sars cov- behave population immunodeficiency cause malnourishment interestingly researcher speculate instance defective cellular immune system paradoxically protective factor severe disease certain patient contract sars cov sars cov- link absence t cell activation base available information present plausible hyperimmune response subsequent cytokine storm associate severe coronavirus disease  covid- counteract defective immune response see individual malnutrition induce leptin deficiency paper propose theory malnutrition link leptin deficiency risk sars cov- infection low risk develop severe covid-
260,background wave covid- pandemic hypothesis angiotensin receptor blocker arb angiotensin convert enzyme inhibitor aceis increase risk and/or severity disease widely spread consequently hospital drug discontinue precautionary measure aim assess hospital discontinuation arb acei real life condition associate reduce risk death compare continuation compare head head continuation arb continuation acei method adult patient pcr confirm diagnosis covid- require admission march  consecutively select  hospital madrid spain identify outpatient user acei arb divide cohort depend treatment discontinuation continuation admission follow discharge hospital death intention treat survival analysis carry hazard ratio hrs ci compute cox regression model adjust propensity score discontinuation control potential mediator result  acei arb user  .% discontinue treatment hospital mortality rate .% discontinuation continuation cohort respectively hr=. ci difference mortality observe arb acei discontinuation .% vs. .% respectively significantly low mortality rate find patient continue arb .% n= compare continue aceis .% n= p=. head head comparison arb vs. acei continuation yield adjust hr ci especially notorious male hr=. ci subject old  year hr=. ci patient obesity hr=. ci diabetes hr=. ci heart failure hr=. ci conclusion discontinuation aceis arb admission improve hospital survival contrary continuation arb associate trend reduce mortality compare discontinuation significantly low mortality risk compare continuation acei particularly high risk patient
261,woman polycystic ovary syndrome pcos insulin action impaired obesity visceral adipose tissue dysfunctional chronic inflammation favor storage contribute development metabolic complication pcos metabolic syndrome metsy non alcoholic fatty liver disease nafld apparently share common pathogenic factor include abdominal adiposity excess body weight insulin resistance alteration gut microbiome note woman pcos compare control lead deterioration intestinal barrier increase gut mucosal permeability immune system activation hyperinsulinemia glucose intolerance hamper normal ovarian function follicular development hallmark pcos propose pcos entail high susceptibility coronavirus disease  covid- associated comorbiditie nafld obesity metsy alteration gut microbiome study find association acute respiratory distress syndrome see severe case covid- intestinal microbiome furthermore apparently severe acute respiratory syndrome coronavirus  sars cov- gain entry gastrointestinal tract locally express angiotensin convert enzyme type  receptor excess body weight associate severe covid- increase mortality robust link sars cov- infection pcos nafld gut microbiome metabolic consequence confirm strategy adapt intestinal microbiome help reduce severity covid- woman pcos nafld metsy obesity
262,coronavirus disease  covid- outbreak draw scientific community attention pre existing metabolic condition aggravate infection cause extend viral shedding prolonged hospitalization high death rate metabolic dysfunction associate fatty liver disease mafld emerge surrogate covid- severity constellation metabolic alteration entail review outline impact mafld exert covid- severity obese subject possible mechanistic link poor outcome datum collect show mafld patient poor covid- outcome non mafld obese subject mafld generally accompany impaired glycemic control systemic arterial hypertension decompensate covid- clinical course mafld subject high plasma inflammatory marker concentration non mafld subject relate intensify cytokine storm syndrome frequently associate need mechanical ventilation death conclusion mafld represent high risk obesity covid- severity result poor outcome progression non alcoholic steatohepatitis hepatologist include mafld subject high risk group intensify preventive measurement prioritize vaccination
263,background objective sars cov- major global public health challenge beginning pandemic different comorbiditie postulate associate spectrum increase severity mortality objective research analyse factor associate sars cov- infection covid- health area northern spain understand possible role influenza vaccination pneumococcal vaccination development covid- materials method test negative case control study conduct variable relate personal vaccination history consider epidemiological definition case vary time reference definition correspond // spain bivariate multivariate analysis perform result sample include  patient  case  control result obesity increase risk suffer infection ic ara- increase ci hand anti pneumococcal vaccination  serotype show result close statistical significance ci .- conclusion obesity use ara- increase risk covid- scientific knowledge factor associate covid- expand author consider present research raise need investigate role vaccine infection possible heterologous property
264,objective previous study unveil relationship severity coronavirus disease  covid- pneumonia obesity aim multicenter retrospective cohort study disentangle association bmi associate metabolic risk factor diabetes hypertension hyperlipidemia current smoking status critically ill patient covid- method patient admit intensive care unit covid-  center europe israel united states enrol study february primary secondary outcome need invasive mechanical ventilation imv -day mortality respectively result total patient enrol median interquartile range age  year .% patient male median bmi kg m total patient .% require imv -day mortality estimate ci adjust mixed logistic regression model show significant linear relationship bmi imv odd ratio ci  kg m adjusted cox proportional hazard regression model show significant association bmi mortality increase obesity class iii /= hazard ratio ci conclusion critically ill covid- patient linear association bmi need imv independent metabolic risk factor nonlinear association bmi mortality risk observe
265,introduction coronavirus disease  covid- great clinical challenge decade clinical factor associate severity disease remain unclear aim study characterize polish patient hospitalize covid- evaluate potential prognostic factor severe course disease material method observational study conduct march july  pulmonology allergology department university hospital krakow poland consecutive patient confirm sars cov- severe acute respiratory syndrome coronavirus infection enrol datum past medical history sign symptom laboratory result image study result hospital management outcome prospectively gather result study sample comprise  patient mean age sd year  .% male  .% die  present respiratory failure  .% transfer intensive care unit  .% develop acute kidney injury  .% sepsis  .% diagnose pulmonary embolism multivariable analysis reveal age ci body mass index bmi ci modify early warning score mews ci high d dimer value ci lactate dehydrogenase ldh ci .- associate severe course covid- conclusion observational study show half hospitalize patient covid- develop respiratory failure course disease increase age bmi mews d dimer value ldh concentration associate severity covid-
266,background covid- completely change daily clinical practice social relation organ biological system involve sars cov- infection direct virus induce damage indirect effect systemic consequence endocrine system exception involvement covid- relevant endocrine phenotype covid- progressively acquire clinical relevance aim appoint european society endocrinology ese update current statement ese member endocrine community emerge endocrine phenotype covid- implication prevention management disease conclusion diabetes major role phenotype frequent comorbiditie associate severity mortality covid- careful management include treatment modification require protect patient know diabetes dangerous consequence covid- hospitalize covid- patient sars cov- induce newly onset diabetes obesity increase susceptibility sars cov- risk covid- adverse outcome adequate nutritional management need grant patient obesity undernourishment order limit increase susceptibility severity covid- infection lack vitamin d hypocalcemia vertebral fracture emerge frequent finding hospitalize covid- population negatively impact outcome patient patient adrenal insufficiency prompt adaptation glucocorticoid dose need update statement role sex hormone peculiar pituitary thyroid aspect covid- include finally view mass vaccination potential implication endocrine patient consider
267,introduction identify risk factor progression severe covid- require urgent medical visit hospitalization umvs patient initially diagnose outpatient setting help inform patient management objective study estimate incidence risk factor covid relate umv outpatient covid- diagnosis positive sars cov- test method datum retrospective cohort study optum((r de identify covid- electronic health record database june  december adult covid- diagnosis positive sars cov- test outpatient setting identify cumulative incidence function analysis stratify risk factor estimate -day incidence covid relate umv compete risk regression model derive adjust hazard ratio ahr confidence interval ci factor associate umvs result patient .% female .% non hispanic caucasian mean sd age year -day incidence ci .- covid relate emergency room er)/urgent care uc)/hospitalization ci .- covid relate hospitalization likelihood hospitalization increase age body mass index age strong risk factor ahr ci patient  year increased likelihood hospitalization observe presentation er uc vs. non er uc outpatient setting ahr ci prior cause hospitalization ahr ci clinical risk factor hospitalization include pregnancy uncontrolled diabetes chronic obstructive pulmonary disease chronic kidney disease autoimmune disease study limitation datum covid- severity symptom capture conclusion predictor covid relate umv include old age obesity comorbiditie finding inform patient management resource allocation follow outpatient covid- diagnosis
268,epidemiological evidence establish obesity independent risk factor increase susceptibility severity viral respiratory pneumonia associate hn influenza sars cov- pandemic give global obesity prevalence well understanding mechanism obese susceptibility infection imperative alter immune cell metabolism function perceive key causative factor dysregulate inflammation contribution adipocyte dominantly alter cell type obesity broad inflammatory property infectious disease pathogenesis remains largely ignore skew adipocyte intrinsic cellular metabolism lead development pathogenic inflammatory adipocyte shape overall immune response contribute premature immunosenescence delay hyperinflammation cytokine storm infection review discuss underappreciated contribution adipocyte cellular metabolism adipocyte produce mediator immune system modulation interplay modify disease susceptibility pathogenesis influenza sars cov- infection obese individual
269,clinical laboratory predictor covid- severity describe combine propose mortality severity score necessitate saturable equipment scanner procedure difficult implement blood gas measure provide easy fast covid- severity risk score hospital admission keep mind limit seek scoring system need limited invasive datum simple blood test co morbidity assessment anamnesis retrospective study  patient bordeaux university hospital external independent cohort  patient paris pitie salpetriere hospital collect clinical biochemical parameter admission stepwise model selection akaike information criterion aic build severity score covichem  test variable obesity cardiovascular condition plasma sodium albumin ferritin ldh ck independent predictor severity covichem accuracy auroc accuracy external validation cohort sensitivity specificity covichem score useful rapid costless easy implement severity assessment tool acute covid- pandemic wave
270,objective severe acute respiratory syndrome coronavirus  sars cov- use host angiotensin convert enzyme  ace cellular entry point modulate ace impact sars cov- viral replication shed coronavirus disease  covid- severity investigate angiotensin ii type  receptor blocker valsartan alter expression renin angiotensin system ras component include ace human adipose tissue skeletal muscle method randomized double blind placebo control clinical trial perform  participant bmi kg m impaired glucose metabolism receive valsartan placebo  week  week treatment abdominal subcutaneous skeletal muscle biopsy obtain gene expression ras component measure quantitative reverse transcription polymerase chain reaction result valsartan treatment significantly impact expression ras component include ace skeletal muscle conclusion give pivotal role ace sars cov- spread clinical outcome covid- patient datum suggest putative beneficial effect angiotensin ii type  receptor blocker clinical outcome patient covid- mediate altered ace expression abdominal subcutaneous
271,clinical evolution covid- pneumonia poorly understand identify metabolic pathway alter early viral infection association disease severity crucial understand covid- pathophysiology guide clinical decision study aim assess critical metabolic pathway alter disease severity hospitalize covid- patient hospitalize patient covid- pneumonia enrol prospective observational single center study barcelona spain demographic clinical analytical datum admission register plasma sample collect  h follow hospitalization patient stratify base severity evolution moderate n severe n critical n panel  biomarker measure target metabolomic order evaluate metabolic change associate subsequent disease severity result obesity respiratory rate blood pressure oxygen saturation analytical parameter radiological finding associate disease severity additionally ceramide metabolism tryptophan degradation reduction metabolic reaction involve nicotinamide adenine nucleotide nad inclusion significantly associate respiratory severity correlate inflammation summary assessment metabolomic profile covid- patient assist disease severity stratification guide clinical decision
272,objective obesity associate severe coronavirus disease  covid- infection disease severity associate high covid- antibody titer covid- antibody titer response patient obesity versus patient obesity compare method datum individual test covid- serology mount sinai health system new york city march december retrospectively retrieve primary outcome peak antibody titer assess binary variable (: highest detect titer versus low patient positive serology test peak titer rate compare bmi group kg m multivariable logistic regression model analyze independent association different bmi group peak titer result overall individual undergo serology testing bmi measurement positive serology test present patient peak titer rate associate obesity bmi p multivariable analysis severe obesity high adjust odd ratio peak titer ci conclusion covid- neutralize antibody titer associate obesity implication understanding role obesity covid- severity
273,background despite covid- identify severe respiratory viral infection progressively relevant endocrine manifestation report greatly contribute severity clinical presentation systemic involvement covid- ubiquitous expression angiotensin convert enzyme  ace receptor responsible entry cell sars cov- report human animal model show significant ace mrna expression hypothalamus pituitary cell high mortality poor outcome widely describe covid- patient obesity diabetes vertebral fracture highly prevalent subject pituitary dysfunction aim review main endocrine manifestation covid- possible implication pituitary disease possible direct indirect involvement pituitary gland covid- impact covid- management establish pituitary disease increase risk bad outcome neurosurgical activity vaccination conclusion review underline specific involvement pituitary gland fit progressively shape endocrine phenotype covid- care pituitary disease need continue despite restriction emergency pituitary disease hypopituitarism cushing disease frequent comorbiditie diabetes risk factor severe covid- affected patient urgent need collect international multicentric effort datum aspect pituitary involvement pandemic order issue evidence drive recommendation management pituitary patient persistent covid- emergency
274,paper aim increase awareness physician concern coronavirus disease  covid- severity especially patient specific underlie comorbiditie obesity second common condition hospitalize covid- patient furthermore major role development obstructive sleep apnoea osa highly involved severe covid- development outcome obese osa patient increase pulmonary embolism pe risk evidence support interaction obesity osa pe development setting covid- patient -year old obese male covid- admit intensive care unit icu acute respiratory failure require high flow nasal oxygenation clinical laboratory diagnostic finding point severe covid- form complicated pe recovery diagnosis osa establish case want alert physician comorbiditie obesity osa condition extent contribute bad covid- clinical presentation
275,background numerous study investigate obesity negative effect coronavirus disease  covid- outcome limited number focus association diabetic patient study analyze association obesity covid- outcome death intensive care unit icu admission mechanical ventilation need quick sequential organ failure assessment score confusion urea respiratory rate blood pressure curb- score hospitalize diabetic patient method prospective hospital base registry patient covid- east azerbaijan iran  consecutive diabetic patient covid- follow admission discharge death self report weight height calculate body mass index kg m admission primary endpoint analyze obesity covid- mortality association assess association obesity disease severity icu admission mechanical ventilation secondary endpoint result analyze datum  patient find significant difference obese non obese patient frequency death invasive mechanical ventilation icu admission curb- qsofa score p adjust confound factor obese diabetic covid- patient time likely die non obese patient ventilator dependence adjust odd ratio aor confidence interval ci .- icu admission aor ci odd significantly high obese patient non obese patient conclusion result present study indicate obesity worsen health outcome diabetic covid- patient
276,sars cov- causative agent covid- infect host cell angiotensin convert enzyme  ace receptor prime host protease include tmprss covid- affect multiple organ system male patient suffer increase severity mortality polycystic ovary syndrome pcos common endocrine disorder reproductive age woman characterize hyperandrogenism ovulatory dysfunction polycystic ovarian morphology pcos associate obesity cardiometabolic comorbiditie risk factor associate severe covid- pathology hypothesize elevate androgen pcos regulate sars cov- entry protein multiple tissue increase risk population female mouse treat dihydrotestosterone dht  day body composition measure echomri fast glucose determine enzymatic method mrna protein level ace tmprss cathepsin l furin tmprss adam quantify rt qpcr western blot elisa tissue serum urine dht treatment increase body weight fat lean mass fast glucose ace mrna upregulate lung cecum heart kidney downregulate brain dht ace protein upregulate dht small intestine heart kidney sars cov- priming protease tmprss cathepsin l furin mrna upregulate dht kidney ace sheddase adam mrna upregulate dht kidney correspond increase urinary ace dht treat mouse result highlight potential increase cardiac renal gastrointestinal dysfunction pcos woman covid-
277,emerge datum suggest obesity major risk factor progression major complication acute respiratory distress syndrome ards cytokine storm coagulopathy covid- understand mechanism underlie link obesity disease severity result sars cov- infection crucial development new therapeutic intervention preventive measure high risk group propose multiple feature obesity contribute prevalence severe covid- complication viral entry facilitate upregulation viral entry receptor like angiotensin convert enzyme  ace second obesity induce chronic inflammation disruption insulin leptin signaling result impaired viral clearance disproportionate hyper inflammatory response elevated ferritin level direct cause ards cytokine storm negative consequence obesity blood coagulation contribute progression thrombus formation hemorrhage review summarize clinical finding relationship obesity covid- disease severity discuss potential mechanism explain risk major complication patient suffer obesity
278,endocrine disrupt chemical edcs hormonally active compound environment interfere body endocrine system consequently produce adverse health effect despite persistent public health concern edcs remain important component common consumer product represent ubiquitous contaminant human scientific evidence confirm contribution severity influenza virus hn animal model role susceptibility clinical outcome coronavirus disease covid- underestimate emergence late clinical report covid- confirm severe disease death occur person age /= year underlie comorbiditie major comorbiditie covid- include diabetes obesity cardiovascular disease hypertension cancer kidney liver disease long term exposure edc contribute significantly onset progression comorbid disease edc play vital role disruption body immune system review recent literature role edcs comorbiditie contribute covid- mortality impact edc immune system recent article link edc covid- risk recommend methodology adopt comprehensively study role edcs covid- risk
279,covid- cause sars cov- result acute respiratory distress syndrome multiple organ failure(- little know pathophysiology generate single cell atlas  lung  kidney  liver  heart autopsy tissue sample spatial atlas  lung sample donor die covid- integrated computational analysis uncover substantial remodelling lung epithelial immune stromal compartment evidence multiple path fail tissue regeneration include defective alveolar type  differentiation expansion fibroblast putative tp(+ intrapulmonary basal like progenitor cell viral rna enrich mononuclear phagocytic endothelial lung cell induce specific host program spatial analysis lung distinguished inflammatory host response lung region viral rna analysis tissue atlas show transcriptional alteration multiple cell type heart tissue donor covid- map cell type gene implicate disease severity base covid- genome wide association study foundational dataset elucidate biological effect severe sars cov- infection body key step new treatment
281,objective describe longitudinal change liver function test association illness severity mortality patient covid- method retrospective cohort study  hospitalize patient covid- conduct longitudinal liver function test clinical outcome analyze result abnormal liver function parameter observe admission alt .% ast .% alp .% ggt .% ldh .% tbil .% dbil .% albumin .% peak hospitalization alt .% ast .% alp .% ggt .% ldh .% tbil .% dbil .% albumin .% patient covid- compare non severe patient severe patient markedly high liver function parameter baseline  day hospital admission abnormal alt ldh hospital admission medication use hydroxychloroquine lopinavir ritonavir traditional chinese medicine associate peak hospitalization alt upper limit unit normal uln multivariate analysis age year male obesity comorbidity abnormal ldh albumin hospital admission peak hospitalization associate progression severe covid- p  uln hr=. p=. ast  uln hr=. p  uln hr=. p associate high mortality conclusion dynamic abnormality liver function parameter common hospitalize patient covid- associate illness severity mortality
282,purpose review grow body evidence suggest obesity increase visceral adiposity strongly independently link adverse outcome death covid- review summarize current epidemiologic datum highlight pathogenetic mechanism association excess body weight covid- compare datum previous pandemic discuss covid- challenge obesity paradox present implication prevention treatment future perspective recent finding datum meta analysis base recent observational study indicate obesity increase risk infection sars cov- severe infection hospitalization admission icu need invasive mechanical ventilation imv risk mortality particularly severe obesity risk imv mortality associate obesity accentuate young individual age  year old meta inflammation obesity intersect exacerbate underlying pathogenetic mechanism covid- follow mechanism factor impaired innate adaptive immune response ii chronic inflammation oxidative stress iii endothelial dysfunction hypercoagulability aberrant activation complement iv overactivation renin angiotensin aldosterone system v overexpression angiotensin convert enzyme  receptor adipose tissue vi associated cardiometabolic comorbiditie vii vitamin d deficiency viii gut dysbiosis ix mechanical psychological issue mechanistic large epidemiologic study big datum source omic datum explore genetic determinant risk disease severity large randomized control trial rct necessary shed light pathway connect chronic subclinical inflammation meta inflammation adverse covid- outcome establish ideal preventive therapeutic approach patient obesity
283,background knowledge sars cov- infection pregnancy newborn scarce objective study analyse clinical epidemiological characteristic cohort woman infect sars cov- pregnancy newborn expose sars cov- gestation method multicentric observational study spanish hospital gesneo covd cohort participant reclip spanish network paediatric clinical assays woman confirm sars cov- infection pcr and/or serology pregnancy diagnose deliver period include epidemiological clinical analytical datum collect result total  pregnant woman median year old iqr  newborn include globally pregnant woman covid- symptom treat sars cov- overall .% pregnant woman pneumonia  .% woman admit intensive care unit need invasive mechanical ventilation rate .% caesarean section associate pneumonia pregnancy ci low gestational age delivery ci prevalence preterm birth prematurity associate pneumonia gestation ci% have positive sars cov- pcr delivery ci% nasopharyngeal pcr newborn negative birth positivized  day life newborn die cause relate prematurity unexpected sudden death early skin skin contact delivery conclusion vertical transmission report cohort prognosis newborn worsen sars cov- infection pregnancy covid- pneumonia increase risk caesarean section delivery preterm birth
284,coronavirus disease  covid- identify end  cluster pneumonia case wuhan china february virus quickly spread global pandemic spectrum symptomatic infection severity range mild severe critical disease correlate comorbiditie establish include smoking socioeconomic background gender male prevalence hypertension obesity cardiovascular disease chronic lung disease diabetes mellitus cancer chronic kidney disease extensive literature search post covid- necrotize staphylococcus aureus pneumonia pneumothorax record present case -year old male present symptom covid- underlying comorbiditie include hypertension hyperlipidemia ventilatory support week hospital receive supplemental oxygenation recover covid- pneumonia nearly month half initial presentation quickly decompensate start supplemental oxygen necessary treatment aid lab work imaging determine develop necrotize staphylococcus aureus pneumonia pneumothorax adequately treat stable discharge home tell continue therapy
286,background large airway epithelial barrier provide line defense respiratory virus include sars cov- cause covid- substantial inter individual variability individual disease course hypothesize partially mediate differential regulation gene interact sars cov- virus involve subsequent host response comprehensively investigate non genetic genetic factor influence covid relevant bronchial epithelial gene expression method analyze rna sequence datum bronchial epithelial brushing obtain uninfected individual relate ace gene expression host environmental factor spiromics cohort smoker chronic obstructive pulmonary disease copd replicate association asthma cohort sarp mast identify airway biology ace binding contribute increase susceptibility gene set enrichment analysis determine gene expression change indicative suppress airway immune response observe early sars cov- infection observe association host factor identify host genetic variant affect covid- susceptibility spiromics perform expression quantitative trait eqtl mapping investigate phenotypic association eqtl variant result find ace expression high relation active smoking obesity hypertension know risk factor covid- severity association interferon relate inflammation drive truncated non binding ace isoform discover expression pattern suppress airway immune response early sars cov- infection compare virus similar pattern associate obesity hypertension cardiovascular disease contribute covid susceptible airway environment eqtl mapping identify regulatory variant gene implicate covid- phewas evidence potential role respiratory infection conclusion datum provide evidence clinically relevant variation expression covid related gene associate host factor environmental exposure likely host genetic variation
287,comorbiditie show associate coronavirus disease  covid- related severity mortality considerable variation prevalence estimate comorbiditie effect covid- morbidity mortality observe prior study systematic review meta analysis aim determine geographical age gender relate difference prevalence comorbiditie associated severity mortality rate covid- patient conduct search pubmed scopus embase include covid- study publish january st  july th  reporting comorbiditie severity mortality include study report confirm diagnosis covid- human patient provide information comorbiditie disease outcome dersimonian laird random effect method calculate estimate  study patient prevalent comorbidity hypertension obesity diabetes cardiovascular disease chronic kidney renal disease cerebrovascular accident cardiovascular disease patient covid- severity mortality respectively considerable variation prevalence comorbiditie associated disease severity mortality different geographic region observe high mortality observe study latin american european patient medical condition old adult  year predominantly male patient study observe high prevalence comorbiditie covid- patient severity covid- comorbid condition high asian study mortality high european latin american country risk stratification effective control strategy covid- accord comorbiditie age gender difference specific geographical location
288,background overburdened healthcare system coronavirus disease covid- pandemic lead suboptimal chronic disease management include pediatric type  diabetes mellitus tdm pandemic cause delayed detection new onset diabetes child increase risk severity diabetic ketoacidosis dka investigate frequency new onset pediatric tdm dka saudi arabia covid- pandemic compare period method conduct multicenter retrospective cohort study include patient age year admit new onset tdm dka covid- pandemic march june period assess factor include age sex anthropometric measure nationality duration diabetes diabetes management hbac level glycemic control cause admission blood gas level etiology dka dka complication length hospital stay covid- test status result lockdown  child compare  admit  pediatric diabetes center admission dka high   vs. p=. risk ratio=. confidence interval adjust age sex dka frequency new onset tdm hbac level diagnosis high   vs. p= vs. p respectively female old patient high risk dka conclusion lockdown implement saudi arabia significantly impact child tdm lead increase dka frequency include child new onset tdm potentially owe delayed presentation
289,coronavirus infectious disease  covid- pandemic hit world affect health medical care economy society furthermore covid- pandemic join increase prevalence metabolic syndrome western country patient suffer obesity type ii diabetes mellitus cardiac involvement metabolic associate fatty liver disease mafld enhance risk suffer severe covid- mortality importantly population western country susceptible suffer mafld covid- approve treatment currently available know exacerbate innate immune response key development severe stage mafld covid- review focus role immune system establishment progression mafld discuss potential implication development severe covid- mafld patient result hope clarify common pathology uncover new potential therapeutic target prognostic biomarker research
290,objective obesity established risk factor severe coronavirus disease  covid- contribution overweight and/or diabetes remain unclear multicenter international study investigate overweight obesity diabete independently associate covid- severity bmi associate risk increase diabetes research design method retrospectively extract datum health care record regional database hospitalize adult patient covid-  site  country standardized definition analysis generate site specific estimate model odd outcome supplemental oxygen noninvasive ventilatory support invasive mechanical ventilatory support hospital mortality bmi category reference overweight obese adjust age sex prespecifie comorbiditie subgroup analysis perform patient preexisting diabetes site specific estimate combine meta analysis result patient .% overweight obese overweight likely require oxygen noninvasive ventilatory support random effect adjust odd ratio aor ci invasive mechanical ventilatory support aor ci association overweight hospital mortality aor ci similar effect observe patient obesity diabetes subgroup analysis aor outcome additionally increase diabetes overweight obesity conclusion adult hospitalize covid- overweight obesity diabete associate increase odd require respiratory support associate death patient diabetes odd severe covid- increase bmi associate risk
291,severe acute respiratory syndrome coronavirus  sars cov disease covid- novel threat hamper life expectancy especially obese individual association clinically relevant underlie mechanism fully elucidate sars cov enter host cell angiotensin converting enzyme  receptor express adipose tissue adipose tissue source proinflammatory mediator adipokine enhance characteristic covid- cytokine storm chronic low grade inflammatory preconditioning obesity dependent thoracic mechanical constraint incise negatively prognosis obese subject covid- review summarize current body knowledge obesity dependent circumstance trigger increase risk covid- severity clinical relevance
292,world include united states man bad outcome covid- woman sars cov- causative virus covid- pandemic use angiotensin convert enzyme  ace gain cellular entry ace member renin angiotensin system ras play important role counteract harmful effect mediate angiotensin type  receptor conduct ovid medline embase database search basic science study investigate impact biological variable sex ace expression regulation year ace discover december publication identify  original research article ace conduct primary cell tissue and/or mammal exclude human majority .% study cite sex animal conduct male .% conduct solely female .% compare ace sex .% report sex animal general finding sex difference tissue specific present dependent gonadal state renal cardiac adipose ace increase sex experimental condition model co morbidity associate bad covid- outcome include hypertension obesity renal cardiovascular disease ace protein generally high male study ace knockout mouse indicate ace play great role protect female develop hypertension male study biological variable sex ace research provide opportunity discovery condition involve ras dysfunction shed light sex difference covid- severity
294,objective severity outcome covid- disproportionately high individual obesity smoker patient hypertension kidney disease chronic pulmonary disease coronary heart disease chd and/or type  diabetes td serum level ace cellular entry point coronavirus sars cov- examine high risk group method association ace level smoker patient hypertension td obesity chd copd investigate single center population base study  icelanders age gene environment susceptibility reykjavik study ages rs elderly mean age   year multiple linear regression analysis result serum level ace high smoker individual td and/or obesity unaffected patient group conclusion ace level high patient group comorbiditie link covid- include obesity td emerge role circulate biomarker severity outcome disease
295,factor contribute increase morbidity mortality sars cov- infection diverse include diabetes obesity chronic obstructive pulmonary disease copd advanced age male sex obvious connection common denominator tendency low urine ph indicate low normal tissue ph. furthermore show low ph important negative influence enhance viral fusion endosomal route facilitate viral multiplication facilitate increase production inflammatory cytokine exacerbate cytokine storm paper discuss publish literature low tissue interstitial ph disease co morbidity know risk factor severe covid- hypothesize small dose baking soda simple cost effective rapid method reduce morbidity mortality covid- patient
296,compare adult child tend low incidence rate hospitalization rate mortality rate coronavirus disease  covid- cause age base difference disease severity remain unclear investigation pathogenesis child help analyze therapy high risk population human angiotensin convert enzyme main receptor severe acute respiratory syndrome coronavirus  limit pulmonary capillary leakage inflammation mediate angiotensin  exert protective effect acute lung injury expression decrease age regular vaccination frequent upper respiratory virus infection child lead regular immune activation combination strong innate immunity help achieve virus clearance early stage infection child covid- strong regeneration repair ability alveolar epithelial cell child help early recovery infection addition risk factor underlying cardiopulmonary disease obesity smoking relatively uncommon child social factor include home quarantine timely closure school help reduce infection rate child child immunodeficiency high risk population closely monitor study need investigate immune protection mechanism covid- child
297,introduction coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- compare adult child sars cov- infection few severe symptom gastrointestinal symptom commonly report child manifestation disease manifest anorexia diarrhea nausea vomiting abdominal pain child asymptomatic mild disease  infect experience critical disease death multisystem inflammatory syndrome rare condition recently report child covid- study indicate child obesity high risk develop severe covid- inflammation associate obesity factor worsen covid- symptom increase inflammatory response involve molecule interleukin tumor necrosis factor alpha monocyte chemoattractant protein hand evidence report high protein expression ace visceral adipose tissue obese malnourished human associate complication severity covid- regulation intake macronutrient micronutrient strategy reduce consequence covid- diet general bioactive compound play important role prevention inflammatory cascade micronutrient evidence suggest role immune support vitamin c d zinc polyphenol
298,severe acute respiratory syndrome coronavirus- sars cov- pandemic prove challenge healthcare system appearance late global spread devastating effect coronavirus disease  covid- patient result countless study risk factor disease progression overweight obesity emerge major risk factor develop severe covid- review biology coronavirus infection relation obesity particular review literature impact adiposity relate systemic inflammation covid- disease severity involve cytokine chemokine leptin growth hormone signal discuss involvement hyperactivation renin angiotensin aldosterone system raas sheer number publication covid- complete apologize publication cite
299,rationale role need extracorporeal membrane oxygenation ecmo population level coronavirus disease covid- pandemic completely establish objective identify cumulative incidence ecmo use pandemic wave describe nationwide chilean cohort ecmo support patient covid- method conduct population base study march  august link datum national agency cumulative incidence ecmo use mortality risk ecmo support patient calculate age standardize addition retrospective cohort analysis perform outcome -day mortality ecmo initiation ecmo associate complication hospital length stay cox regression model explore risk factor mortality time event analysis measurement main results ninety patient covid- support ecmo population positive case .% intubate patient covid-  include cohort analysis median age  interquartile range iqr year .% man .% obesity median number pre ecmo intubation day  iqr median pao fio ratio iqr mm hg .% patient prone positioned  patient refractory respiratory acidosis main complication infection .% bleed .% thromboembolism .%  patient discharge home  die hospital length stay median  iqr day low respiratory system compliance high driving pressure ecmo initiation associate increase mortality duration pre ecmo intubation /= day associate mortality conclusion document nationwide ecmo need help plan ecmo provision future covid- pandemic wave -day mortality chilean cohort ecmo support patient covid- .% comparable previous report
300,purpose chest x ray cxr severity score bmi base obesity predictive risk factor covid- hospital admission relationship abdominal obesity cxr severity score fully explore method retrospective cohort study analyze association different adiposity index include waist circumference body mass index bmi cxr severity score  hospitalize patient covid- result patient abdominal obesity show significantly high cxr severity score high rate cxr severity score  compare abdominal obesity p /=  p p respectively waist circumference waist height ratio whtr correlate closely cxr severity score bmi r p /= vs p multivariate analysis indicate abdominal obesity risk ratio ci p bronchial asthma risk ratio ci p oxygen saturation admission risk ratio ci p independent factor associate high cxr severity score conclusion abdominal obesity phenotype associate high cxr severity score well bmi base obesity hospitalize patient covid- visit patient hospital setting waist circumference measure patient abdominal obesity monitor closely level evidence cross sectional descriptive study level v.
301,factor link high risk mortality coronavirus disease- covid- include male gender increase age hypertension diabetes mellitus obesity cardiovascular disease chronic obstructive pulmonary disease cancer hyperglycemic covid- patient severe clinical problem increase icu admittance machine drive ventilation substantial rise inflammatory marker patient diabetes hyperglycemia two- fold increase mortality severity covid- diabetes primary cause mortality covid- patient diabetes compromise immune response viral infection increased blood sugar level probably affect intracellular degradation bacteria neutrophil chemotaxis phagocytosis improve viral bind affinity entry decrease virus clearance addition significant effect protein induce glycosylation alter composition complement glycosylation render cell susceptible viral inflammation damage treatment covid- patient diabetes require integrated team approach minimize risk medical complication mortality physician adopt proactive strategy care person comorbiditie strategy help reduce frequency complication mortality patient load healthcare system
302,malnutrition common severe patient coronavirus disease  covid- mainly elderly adult patient comorbiditie associate atypical presentation disease despite possible contribution malnutrition acquisition severity covid- clear nutritional screening measure well diagnose malnutrition patient early stage crucial importance give urgency rapid progression disease vulnerable group accordingly review examine available literature different nutritional screening approach implement covid- patient special focus elderly adult literature search select scrutinize  study assess malnutrition covid- patient nutrition risk screening  nrs- demonstrate superior sensitivity traditional screening measure control nutritional status conut score comprise serum albumin level cholesterol level lymphocyte count combined conut lactate dehydrogenase c reactive protein score express predictive capacity superior nrs- .% .% vs. .% midlife elder covid- patient simple measure base routinely conduct laboratory investigation conut score timely cheap valuable alternative identify covid- patient high nutritional risk mini nutritional assessment mna measure detect residual malnutrition high malnutrition risk remit patient mna score correlate hypoalbuminemia hypercytokinemia weight loss old male severe inflammation gastrointestinal symptom pre existing comorbiditie diabetes obesity hypertension prone malnutrition subsequently poor covid- prognosis acute phase convalescence need frequent nutritional monitoring support detect treat malnutrition general public necessary increase resilience covid-
303,coronaviruse lipid envelope require activity fact coronavirus infection provoke formation cubic membrane cm denote convoluted membrane host cell rationalize development antiviral therapy context role bioactive plasmalogen vinyl ether glycerophospholipid completely understand lipid specie display propensity non lamellar phase formation facilitate membrane fusion modulate activity membrane bind protein enzyme receptor organism level plasmalogen deficiency associate cardiometabolic disorder include obesity type  diabetes human straight link perceive susceptibility patient sars cov- severe acute respiratory syndrome coronavirus- infection severity illness related difficulty treatment base correlation coronavirus induce modification lipid metabolism host cell plasmalogen deficiency lung surfactant covid- patient alteration lipid membrane structural organization composition include induction cm emphasize key role plasmalogen coronavirus sars cov- sars cov mers cov entry replication host cell consider plasmalogen enrich lung surfactant formulation improve respiratory process severe infected individual plasmalogen suggest anti viral prophylactic lipid biomarker sars cov sars cov- infection potential anti viral therapeutic component lung surfactant development covid- patient
304,year advent covid- pandemic bring new consideration multidisciplinary science unknown mechanism infection sars cov- absence effective antiviral pharmacological therapy diagnosis method vaccine evoke scientific effort covid- outcome general covid- clinical feature result local systemic inflammatory process enhance preexistent comorbiditie diabetes obesity cardiovascular pulmonary disease biological factor like gender age discrepancy covid- clinical sign observe patient lead investigation critical factor deeply influence disease severity death present viral infection mechanism consequence block angiotensin convert enzyme  ace axis different tissue progression inflammatory immunological reaction especially influence genetic feature differential clinical response furthermore discuss role genotype essential indicator covid- susceptibility consider expression profile polymorphism gene identification epigenetic modification viral entry factor recognition infection effect cell signal molecule expression amplify disease severity
305,gut microbiome alteration play paramount role determine clinical outcome clinical covid- underlie comorbid condition like td cardiovascular disorder obesity etc research warrant manipulate profile gut microbiota covid- employ combinatorial approach use prebiotic probiotic symbiotic prediction gut microbiome alteration sars cov- infection likely permit development effective therapeutic strategy novel targeted intervention manipulate gut microbiota represent promising therapeutic approach covid- immunopathogenesis associated co morbidity impact sars cov- host innate immune response associate gut microbiome profiling likely contribute development key strategy application seldom attempt especially context symptomatic asymptomatic covid- disease
306,emerge datum demonstrate comorbid condition old age contribute factor covid- severity child study involve youth covid- diabete lack report case critically ill adolescent male obesity type  diabetes covid- present hyperglycemic hyperosmolar syndrome hhs case highlight challenge clinician distinguish severe complication covid- see hhs youth obesity type  diabetes represent high risk group severe covid- disease entity date recognize adult remain rare child adolescent
307,objective assess medium term organ impairment symptomatic individual follow recovery acute sars cov- infection design baseline finding prospective observational cohort study setting community base individual uk centre  april  september participant individual year persistent symptom follow recovery acute sars cov- infection age match healthy control intervention assessment symptom standardised questionnaire eq d l dyspnoea- organ specific metric biochemical assessment quantitative mri main outcome measures severe post covid- syndrome define ongoing respiratory symptom and/or moderate functional impairment activity daily living single organ multiorgan impairment heart lung kidney liver pancreas spleen consensus definition baseline investigation result  individual mean age range year female white healthcare worker complete baseline assessment median  day follow sars cov- infection iqr study population low risk covid- mortality obesity hypertension type  diabetes heart disease hospitalise covid- individual  symptom severe post covid- syndrome fatigue muscle ache breathlessness headache frequently report mild organ impairment present heart lung kidney liver pancreas spleen single organ multiorgan impairment respectively hospitalisation associate old age p=. non white ethnicity p=. increase liver volume p pancreatic inflammation p fat accumulation liver p pancreas p severe post covid- syndrome associate radiological evidence cardiac damage myocarditis p conclusion individual low risk covid- mortality ongoing symptom impairment organ  month initial covid- symptom implication healthcare public health assume low risk young people comorbiditie trial registration number nct pre result
308,severe acute respiratory syndrome coronavirus  sars cov- infection present increase disease severity poor clinical outcome diabetic patient compare nondiabetic counterpart diabetes hyperglycemia trigger endothelial dysfunction hyperactive inflammatory immune response correlate twofold threefold higher intensive care hospitalization twice mortality diabetic coronavirus disease  covid- patient comorbiditie obesity cardiovascular disease hypertension worsen prognosis diabetic covid- patient covid- infection associate new onset diabetes severe metabolic complication increase thrombotic event backdrop aberrant endothelial function antidiabetic medication manage blood glucose level discuss multifaceted ability metformin control blood glucose level possibly attenuate endothelial dysfunction inhibit viral entry infection modify inflammatory immune response sars cov- infection action metformin viable candidate drug consider repurpose gain ground sars cov induce tsunami diabetic covid- patient
309,year pass report case severe acute respiratory syndrome coronavirus  sars cov infection city wuhan china hubei province antiviral medication e.g. remdesivir drug target inflammatory complication associate sars cov infection consider safe public health authority end november crisis lead million death reveal high susceptibility people pre existing comorbiditie e.g. obesity diabetes coronary heart disease hypertension suffer severe form disease elderly people find highly susceptible sars cov infection morbidity gastrointestinal manifestation gut microbial alteration observe sars cov infect hospitalize patient raise awareness potential role intestinal mechanism increase severity disease critically important find alternative complementary approach prevent treat disease reduce grow societal economic burden review explore potential nutritional strategy implicate use polyphenol probiotic vitamin d omega- fatty acid focus gut microbiome lead concrete recommendation easily applicable vulnerable people pre existing metabolic comorbiditie elderly general population
310,ongoing coronavirus disease  covid- pandemic cause novel severe acute respiratory syndrome coronavirus  sars cov- global public health challenge patient experience severe complication approximately patient progress acute respiratory distress syndrome ards mortality rate approximately -% clinical finding determine risk factor severe complication mortality covid- patient advanced age smoking obesity chronic disease obesity common health problem worldwide initiate cascade disorder include hypertension cardiovascular disease cvd diabetes mellitus chronic kidney disease ckd presence disorder link severe course covid- give epidemic obesity worldwide importance obesity progression covid- investigate mechanism obesity increase susceptibility severity covid- support selection appropriate therapy individual obesity
311,objective aim study evaluate factor predict severe symptomatic laboratory confirm reverse transcription polymerase chain reaction rt pcr polymerase chain reaction severe acute respiratory syndrome coronavirus  sars cov- reinfection study design nationwide retrospective cohort study conduct mexico method datum  reinfection case  day episode onset analyze risk ratio rrs confidence interval cis evaluate predictor severe dyspnea require hospital admission secondary sars cov- infection result risk severe disease observed overall fatality rate patient primary disease likely develop severe symptom .% vs. .% p reinfection multiple analysis factor associate increase risk severe symptomatic sars cov- reinfection increase age rrper year ci comorbiditie obesity rr ci asthma rr ci type  diabetes mellitus rr ci previous severe laboratory confirm coronavirus disease  rr ci conclusion good knowledge study evaluate disease outcome large set laboratory positive case symptomatic sars cov- reinfection factor associate illness severity characterize result contribute current knowledge sars cov- pathogenicity identify population increase risk poor outcome reinfection
312,background study show health care worker hcw liner coronavirus covid- pandemic high risk psychological symptom study compare symptom infected non infected hcw study compare psychological symptom group method cross sectional study  hcw medical field work leading general hospital alborz province iran select multistage sampling method participant contact covid- patient post traumatic stress disorder- ptsd- validated questionnaire evaluate ptsd symptom subscale include intrusion avoidance hypervigilance depression anxiety stress scale- questionnaire assess severity aforementioned condition hcw multivariate logistic regression compare psychological symptom infected non infected hcw result  include hcw  history confirmed covid- infection prevalence stress anxiety depression intrusion hypervigilance avoidance infected hcw significantly high comparison non infected hcw multivariate logistic model history covid- infection hcw associate significantly increase risk anxiety depression stress intrusion hyper vigilance avoidance conclusion present study show hcw covid- infection high risk display psychological symptom necessary develop psychological support intervention hcw especially got infect virus
313,background understand risk factor poor outcome covid- patient help identify vulnerable population need prioritisation prevention treatment covid- aim critically appraise synthesise publish evidence risk factor poor outcome hospitalise covid- patient method search pubmed covid- literature database study report characteristic covid- patient require hospitalisation include study publish january  report adjusted effect size demographic and/or clinical factor poor outcome mortality intensive care unit icu admission invasive mechanical ventilation appraise quality include study joanna briggs institute appraisal tool quantitatively synthesise evidence series random effect meta analysis aid data interpretation develop interpretation framework indicate strength evidence inform quantity quality evidence result include total  study review include study assess good quality assessment score  find male sex pool odd ratio confidence interval ci  study old age ci year age increase  study obesity ci  study diabetes ci  study chronic kidney disease study ci associate increase risk mortality great strength evidence base interpretation framework find increase risk mortality factor include chronic obstructive pulmonary disease study cancer study current smoker study indicate absence risk limited datum factor conclusion male sex old age obesity diabetes chronic kidney disease important risk factor covid- poor outcome review provide appraisal synthesis evidence risk factor covid- poor outcome data interpretation framework adopt relevant future research
314,introduction dysphonia describe patient affect coronavirus disease  covid- aim study evaluate prevalence dysphonia severity extent voice fatigue dysphagia non hospitalize patient affect covid- lombardy italian region hit explosive outbreak covid- europe method demographic clinical datum  consecutive patient covid- diagnosis confirm nasal swab process reverse transcription polymerase chain reaction gather mean telephone interview perform physician charge daily follow general specific symptom concern voice swallowing impairment investigate dysphonia grade duration grade -point scale voice fatigue grade -point scale result dysphonia report  patient positively associate voice fatigue p  week .% patient month grade duration dysphonia positively associate cough rhinitis p value voice fatigue report patient .% severity correlate dysphonia p cough p rhinitis p dyspnea p loss appetite p dysphagia encounter patient .% associate dysgeusia cough arthralgia myalgia loss appetite dysphonia conclusion dysphonia highly prevalent long last symptom series underestimate date study shed light pathophysiology voice disorder covid- patient
315,high prevalence obesity obesity relate comorbiditie reach pandemic proportion particularly western country obesity increase risk develop chronic noncommunicable disease ultimately contribute reduce survival recently obesity recognize major risk factor coronavirus disease- covid-)-relate prognosis contribute bad outcome established covid- particularly obesity associate high hospitalization rate acute intensive care great risk invasive mechanical ventilation lean people obesity characterize metabolic impairment chronic low grade systemic inflammation cause pro inflammatory microenvironment aggravate cytokine production risk cytokine storm response sars cov sepsis secondary infection metabolic dysregulation closely relate impaired immune system alter response viral infection ultimately lead great susceptibility infection long viral shedding great duration illness severity disease individual obesity maintain healthy diet remain physically active reduce sedentary behavior particularly important covid related quarantine reduce metabolic immune impairment stategie utmost importance reduce risk sarcopenia sarcopenic obesity prevent reduction potentially increase cardiorespiratory fitness know independent risk factor cardiovascular metabolic disease recently find risk factor hospitalization secondary covid- lifestyle strategy ultimately reduce morbility mortality patient infectious disease especially concomitant obesity aim review discuss obesity increase risk covid- potentially affect prognosis covid- diagnose advocate implementation strategy aim prevent obesity place minimize metabolic anomaly lead compromize immune response chronic low grade systemic inflammation especially patient covid-
316,current time rise demand hospital bed important triage covid- patient accord treatment need hospitalization need oxygen therapy important factor determine hospital admission patient retrospective study design identify risk factor associate progression oxygen requirement covid- patient total  patient laboratory confirm covid- admit hospital february august exclude asymptomatic non japanese pediatric pregnant patient need oxygen immediately admission datum remain  patient analyze patient separate require oxygen admission characteristic compare age body mass index bmi lymphocyte count c reactive protein crp lactate dehydrogenase estimate glomerular filtration rate glucose intolerance hypertension dyslipidemia significantly different group multivariate analysis identify significant independent risk factor oxygen requirement include advanced age obesity glucose intolerance lymphocytopenia divide patient subgroup accord number risk factor find patient indicate need oxygen increase high number risk factor individual result suggest presence high number risk factor covid- patient associate future oxygen requirement index potentially useful triage covid- patient stay home context need hospitalization
317,study aim investigate relationship body mass index bmi multiple severe outcome coronavirus disease  covid- pneumonia total  patient hospitalize covid- pneumonia include wuhan china overall n receive invasive mechanical ventilation imv n admit intensive care unit icu n develop acute respiratory distress syndrome ards n die multivariable adjust hazard ratio hrs confidence interval cis imv therapy icu admission ards associate obesity respectively underweight significantly associate death hr ci restrict cubic spline analysis suggest u shape association bmi icu admission death linear relationship bmi imv therapy ards conclusion obesity increase risk imv therapy icu admission ards underweight associate high mortality covid- pneumonia u shape association bmi icu admission death linear relationship bmi imv therapy ards find finding indicate extra caution take treat covid- patient underweight obesity
318,background social physical environment people live affect emergence prevalence severity infectious noninfectious disease limited datum social determinant health include neighborhood socioeconomic condition affect risk severe acute respiratory syndrome coronavirus  infection severity coronavirus disease  pregnancy objective objective determine social determinant health associate severe acute respiratory syndrome coronavirus  infection severity coronavirus disease  illness hospitalize pregnant patient new york global coronavirus disease  pandemic study design cross sectional study evaluate pregnant patient deliver polymerase chain reaction testing severe acute respiratory syndrome coronavirus  march june  hospital northwell health large academic health system new york study period universal severe acute respiratory syndrome coronavirus  testing protocol implement site polymerase chain reaction testing perform nasopharyngeal swab patient exclude follow variable available polymerase chain reaction result race ethnicity zone improvement plan zip code residence clinical datum obtain enterprise electronic health record system patient zip code proxy neighborhood socioeconomic characteristic determine link zip code datum united states census bureau american community survey internal revenue service statistics income division specific variable interest include mean person household median household income percent unemployment percent high school education medical record manually subject positive polymerase chain reaction test result correctly identify symptomatic patient classify subject national institutes health severity illness category classification base high severity illness gestation necessarily time presentation delivery result total  patient include study polymerase chain reaction test positivity rate n= group  patient asymptomatic presymptomatic  mild moderate coronavirus disease  severe critical coronavirus disease multiple logistic regression modeling pregnant patient positive test result severe acute respiratory syndrome coronavirus  likely young high parity belong minoritized racial ethnic group public health insurance limit english proficiency reside low income neighborhood educational attainment ordinal logit regression modeling obesity income education associate coronavirus disease  severity conclusion social physical determinant health play role determine risk infection severity coronavirus disease  illness associate race ethnicity associate maternal obesity neighborhood level characteristic educational attainment household income
319,background covid- affect adult child variable presentation disease severity child present mild symptom fever cough shortness breath rapidly progress severe pneumonia require mechanical ventilation population include child young year old adolescent underlie comorbidity specifically immunosuppression prior cardio respiratory infection review discuss determinant severe disease paediatric patients- primarily asthma immune status obesity multisystem inflammatory syndrome child mis c asthma underlying lung pathology strong predictor ~% prevalence development severe covid- infection irrespective age compare asthma high mortality rate report immune compromise patient weaken immune system immunosuppressed individual time immunocompromised patient time vulnerable develop severe covid- disease similarly evidence suggest bmi great  kg m render individual susceptible develop covid related complication observation base negative impact obesity pulmonary function downplay immune system furthermore possible association covid- mis c report multiple study globe need study strengthen stance scarcity datum compare determinant discuss article author recommend researcher direct attention synthesize evolve evidence fill knowledge void paediatric population well enable paediatrician informed decision
320,aim respiratory infectious disease obesity associate poor outcome coronavirus disease  covid- association obesity severity prognosis require analysis method retrospective single center study hospitalize patient recruit renmin hospital wuhan university january  february datum body mass index bmi obtain follow survive patient accord bmi normal weight define .- kg m overweight .- kg m obesity kg m result total  patient enrol  .% patient normal weight group  .% overweight group  .% obesity group compare normal group obese patient likely high heart rate low finger oxygen saturation high level white blood cell neutrophil count basophil count intravenous glucose triacylglycerol uric acid alanine aminotransferase creatine kinase mb cd+ cell count percentage low level monocyte percentage high density lipoprotein cd+ cell percentage addition proportion hypertension .% vs. .% severe+critical illness vs. significantly high obesity group normal group significant difference observe normal obesity group critical illness organ damage define endpoint mechanical ventilation intensive care unit multiple logistic regression show obesity increase risk develop severe+critical illness odd ratio ci p=. patient covid- affect risk critical illness organ damage endpoint overweight affect risk severity organ damage endpoint patient covid- conclusion obesity risk factor develop severity patient covid-
321,background patient cancer high risk adverse outcome severe acute respiratory syndrome coronavirus  sars cov- infection analyze cohort patient cancer coronavirus  covid- report covid- cancer consortium ccc identify prognostic clinical factor include laboratory measurement anticancer therapy patient method patient active historical cancer laboratory confirm sars cov- diagnosis record  march  november  include primary outcome covid- severity measure ordinal scale uncomplicated hospitalize admit intensive care unit mechanically ventilate die  day multivariable regression model include demographic cancer status anticancer therapy timing covid direct therapy laboratory measurement hospitalize patient result total  patient include median age  year female non hispanic white  hospitalize  die cancer present diagnose treat year prior covid- diagnosis old age male sex obesity cardiovascular pulmonary comorbiditie renal disease diabetes mellitus non hispanic black race hispanic ethnicity bad eastern cooperative oncology group performance status recent cytotoxic chemotherapy hematologic malignancy associate high covid- severity hospitalize patient low high absolute lymphocyte count high absolute neutrophil count low platelet count abnormal creatinine troponin lactate dehydrogenase c reactive protein associate high covid- severity patient diagnose early covid- pandemic january april bad outcome diagnose later specific anticancer therapy e.g. r chop platinum combine etoposide dna methyltransferase inhibitor associate high -day cause mortality conclusion clinical factor e.g. old age hematological malignancy recent chemotherapy laboratory measurement associate poor outcome patient cancer covid- study need caution require utilize particular anticancer therapy clinical trial identifier nct
322,background covid- pandemic spread world particularly develop country obesity widespread high frequency increase bmi patient admit intensive care sars cov- infection major severity patient excess visceral adiposity patient risk severe sars cov- acute respiratory syndrome characterise high prevalence pre existing disease high blood pressure cardiovascular disease diabetes chronic respiratory disease cancer typically present severely obese patient biological role adipose tissue sustain sars cov- infection completely elucidate summary force isolation pandemic containment measure abruptly interrupt rehabilitation program patient severe obesity enrol people affect obesity especially severe obesity continue clinical rehabilitation program take extra measure avoid covid- infection reinforce adoption preventive procedure review available datum obesity covid- discuss evidence base strategy maintain necessary continuous rehabilitation program key message great attention need obese severely obese patient face current covid- pandemic represent huge challenge patient healthcare professional adoption new strategy guarantee adequate continuous multidisciplinary nutritional rehabilitation program crucial control severity sars cov- infection high risk population worsening obesity link complication health authority urge equip hospital tool diffusion telemedicine maintain physician patient communication fundamental chronic complicated obese patient
323,background obesity associate co morbidity worsen effect severe acute respiratory syndrome coronavirus  sars cov- study demonstrate severe form coronavirus disease covid- occur elderly patient patient co morbidity diabetes hypertension cardiovascular disease objective study investigate impact obesity covid- severity irrespective individual factor method retrospective observational study include adult patient confirmed covid- infection admit sheikh khalifa ibn zaid international university hospital march  compare patient obesity term demographic characteristic co morbidity clinical symptom outcome logistic regression model analyze association obesity intensive care unit icu admission examine association obesity icu admission consistent overweight patient result study population include  patient confirmed covid- infection obese patient admit icu patient obesity p value adjust risk factor icu admission find obesity independent risk factor icu admission ci examine association obesity overweight icu admission find obesity significantly associate icu admission ci conclusion study find obesity strongly associate severity covid- risk icu admission great presence obesity physician award need specific early management obese patient covid- disease
324,biological sex affect natural history severe acute respiratory syndrome coronavirus  infection enrol covid- patient admit covid- hospital milan prospective observational study primary outcome death study period secondary outcome critical disease hospital admission association(s clinically relevant noncollinear variable primary outcome assess uni- multivariable logistic regression model total  patient hospitalize  male median age  interquartile range high proportion male present critically ill compare female .% vs. .% p death occur  male  .% female p multivariable analysis age  year adjusted odd ratio aor confidence interval ci p obesity aor ci p critical disease hospital admission aor ci p independently associate high odd death gender conclusion high proportion male present critically ill hospital admission age critical disease hospital admission obesity anemia d dimer estimate glomerular filtration rate lactate dehydrogenase creatine kinase predict death hospitalize covid- patient
325,objective study aim assess diabetes mellitus dm obesity independent risk factor severe coronavirus disease  covid- outcome explore risk confer condition modify method retrospective cohort study inpatient adult covid- multivariable cox regression determine independent effect dm obesity composite outcome intubation intensive care unit admission hospital mortality effect modification dm obesity assess statistical interaction term exploration stratum specific effect result patient total dm obesity  dm obesity independently associate composite outcome hazard ratio hr ci hr ci respectively statistical trend potential interaction dm obesity observe p stratified analysis show potential increase risk obesity compare normal weight patient dm hr ci patient dm hr ci conclusion dm obesity independent risk factor associate covid- severity stratified analysis suggest obesity confer great risk patient dm compare patient dm relationship require exploration
326,introduction risk factor adverse outcome covid- define stratification mortality non laboratory measure score particularly time prehospital sars cov- testing lack method multivariate regression bootstrappe identify independent mortality predictor patient admit acute hospital confirm diagnosis covid- prediction externally validate large random sample isaric cohort n= small cohort aintree n= result  patient median age iqr hospital mortality .% recruit -week study period sequential modelling predictor score term soars spo obesity age respiratory rate stroke history develop correlate covid- severity low moderate high stratum mortality risk score discriminate hospital death area receiver operate characteristic value derivation aintree isaric validation cohort respectively predictive accuracy calibration external cohort consistently high patient mild disease soars individual identify safe outpatient monitoring prediction non fatal outcome group accompany high score sensitivity negative predictive value conclusion soar score use constitutive readily assess individual characteristic predict risk covid- death deployment score potentially inform clinical triage preadmission setting expedient reliable decision making key resurgence sars cov- transmission provide opportunity validate update performance
327,coronavirus disease  covid- cause acute respiratory distress syndrome ards multiple organ damage failure require intensive care lead death male sex advanced age chronic lung disease chronic kidney disease cardiovascular disease hypertension diabetes obesity identify risk factor covid- severity presumably cardiovascular risk factor associate high prevalence multiorgan damage present focus clinical review discuss cardiovascular complication covid- include acute cardiovascular syndrome acute cardiac injury covid cardiomyopathy thromboembolic complication arrhythmia post covid- sequelae preliminary data show cause acute cardiovascular syndrome multifactorial involve direct viral invasion heart vascular system immune inflammation mediate systemic cytokine storm covid- survivor persistently elevate blood pressure sinus tachycardia rest furthermore poor diabetic control persistent renal damage cerebral sequelae persistent cognitive neuropsychiatric alteration frequently report particular attention pay cardiovascular protection covid- patient develop acute cardiovascular syndrome hospitalization and/or permanent semipermanent sequela recovery covid- condition require careful clinical assessment treatment close follow avoid short term long term complication
328,coronavirus disease  covid- worldwide pandemic responsible million death world hypertension identify common comorbiditie risk factor severity adverse outcome patient recent investigation raise question hypertension represent predictor outcome covid- patient independently common comorbiditie diabetes obesity cardiovascular disease chronic kidney liver pulmonary disease impact chronic newly diagnose hypertension covid- patient insufficiently investigate true relationship blood pressure level outcome covid- patient long discussion impact angiotensin convert enzyme inhibitor acei blocker angiotensin receptor arb severity outcome covid- approach end large number original study meta analysis discard initial finding high prevalence acei arb use patient unfavorable outcome controversy relationship hypertension covid- aim review article provide clinical overview currently available evidence predictive value hypertension effect blood pressure level impact previously know newly diagnose hypertension effect antihypertensive therapy severity outcome covid- patient
329,background coronavirus disease  covid- develop severe respiratory syndrome result mortality acute lung inflammatory edema major pathological finding autopsy explain o diffusion failure hypoxemia dexamethasone show reduce mortality severe case support role inflammation disease severity sars cov- enter cell employ angiotensin convert enzyme  ace receptor highly express lung alveolar cell ace component cellular machinery inactivate potent inflammatory agent bradykinin sars cov- infection interfere catalytic activity ace lead accumulation bradykinin method case control study test pharmacological inhibitor kinin kallikrein system currently approve treatment hereditary angioedema icatibant inhibitor c esterase kallikrein group  patient severe covid- result icatibant inhibitor c esterase kallikrein result change time clinical improvement compound safe promote significant improvement lung compute tomography score increase blood eosinophil indicator disease recovery conclusion small cohort find evidence safety beneficial role pharmacological inhibition kinin kallikrein system marker indicate improve disease recovery
330,individual feature metabolic syndrome particularly susceptible severe acute respiratory syndrome coronavirus  sars cov- novel coronavirus associate severe respiratory disease coronavirus disease  covid- despite considerable attention dedicate covid- link metabolic syndrome sars cov- infection remain unclear datum uk biobank investigate relationship severity covid- metabolic syndrome relate serum biomarker measure prior sars cov- infection logistic regression analysis test biomarker level biomarker associate genetic variant sars cov related outcome sars cov positive case negative control  mg dl increase serum hdl cholesterol apolipoprotein level associate approximately reduce risk sars cov- infection adjustment age sex obesity hypertension type  diabetes coronary artery disease evaluation know genetic variant hdl cholesterol reveal individual homozygous apolipoprotein e allele approximately high risk sars cov- infection mortality covid- compare apolipoprotein e homozygote adjustment hdl cholesterol level cumulative effect evaluate hdl cholesterol raise allele mendelian randomization analysis reveal association genetically high hdl cholesterol level decrease risk sars cov- infection result implicate serum hdl cholesterol apolipoprotein level measure prior sar cov- exposure clinical risk factor severe covid- infection provide evidence genetically elevated hdl cholesterol level associate sar cov- infection
331,december novel sars cov- severe acute respiratory syndrome coronavirus- emerge infectious disease pathogen lead global pandemic  million case report worldwide million global death  oct  commonly know coronavirus disease  covid- pathogen present broad spectrum disease progression manifestation symptom acute respiratory distress syndrome lead severe complication death multiple publication report risk disease co morbidity include select underlying medical condition risk old age /= year hypertension htn cardiovascular disease smoking chronic respiratory disease cancer diabetes dm obesity bmi  kg m male sex study researcher find severe obesity bmi  kg m associate intensive care unit icu admission nonetheless risk factor severity disease determine pathogen host environment
332,aim covid- clinical presentation heterogeneous range asymptomatic severe case number early publication relate risk factor covid- infection low sample size heterogeneity study design impact consolidation early finding press need identify factor predispose patient severe case covid- rapid widespread risk stratification factor easily obtainable inexpensive avoid invasive clinical procedure aim study fill knowledge gap systematically map available evidence association clinical demographic lifestyle variable risk specific adverse outcome patient covid- method systematic review conduct standardized methodology search electronic database pubmed scopus relevant literature publish st january  th july include study report characteristic patient covid- report outcome relate disease severity case sufficient comparable datum meta analysis conduct estimate risk variable result seventy study identify total patient  country study highly heterogeneous term sample study outcome risk measure report large number risk factor present covid- commonly report variable adverse outcome covid- comprise patient characteristic include age ci male sex ci severe obesity ci active cancer ci associate increase risk severe outcome number common symptom vital measure respiratory rate spo suggest elevated risk profile conclusion base finding study range easily assess parameter valuable predict elevated risk severe illness mortality result covid- include patient characteristic detailed comorbiditie alongside novel inclusion real time symptom vital measurement
333,background epidemiological study report association diverse cardiometabolic condition include obesity covid- illness causality establish seek evaluate association  cardiometabolic trait covid- susceptibility severity -sample mendelian randomization mr analysis method finding select genetic variant associate exposure include body mass index bmi p  x genome wide association study gwass calculate inverse variance weighted average variant specific estimate summary statistic susceptibility severity covid- host genetics initiative gwas meta analysis population base cohort hospital registry comprise individual self report genetically infer european ancestry susceptibility define test positive covid- severity define hospitalization covid- versus population control case contribute cohort repeat analysis bmi effect estimate uk biobank perform pairwise multivariable mr estimate direct effect indirect effect bmi obesity relate cardiometabolic disease p test declare statistical significance find nonsignificant association genetically high bmi test positive covid- covid- cases/ control p uk biobank odd ratio ci kg m p statistically significant association high risk covid- hospitalization hospitalize covid- cases/ control p x uk biobank odd ratio ci kg m p x imply direct effect bmi abolish conditioning effect type  diabetes coronary artery disease stroke chronic kidney disease cardiometabolic exposure test associate high risk poor covid- outcome small study sample weak genetic instrument limit detection modest association pleiotropy bias effect estimate away null conclusion study find genetic evidence support high bmi causal risk factor covid- susceptibility severity result raise possibility obesity amplify covid- disease burden independently cardiometabolic consequence suggest target obesity strategy reduce risk severe covid- outcome
334,objective determine incidence risk factor acute cardiac injury aci acute kidney injury aki investigate effect severity mortality patient covid- patient method total  patient covid- include retrospective study predictor aci aki investigate multivariable logistic regression model determine association aci aki severity mortality result median age patient  year .% male aci aki observe  .%  .% patient respectively patient age  year chronic heart disease decrease lymphocyte increase crp pct esr hospital admission lopinavir ritonavir use show high odd aci patient age  year male obesity hypertension chronic kidney disease decrease lymphocyte increase crp pct esr hospital admission show high odd aki increased hs ctni  ng l pro bnp  pg ml decrease e gfr  ml min reveal high adjust mortality conclusion aci aki common covid- patient shanghai china patient aci aki high severity rate mortality rate compare aci aki
335,novel corona virus  covid- outbreak start hubei province china spread corner earth pandemic start later africa find african country vary degree think prevalence severity disease influence number non communicable disease ncd increasingly prevalent sub saharan africa ssa addition ssa bear major burden human immunodeficiency virus hiv tuberculosis tb infection datum europe united states child spare severe disease uncertain hold true ssa child suffer sickle cell disease malnutrition addition infectious disease limited datum africa effect condition covid- review discuss epidemiology condition africa possible pathogenesis interaction covid-
336,coronavirus disease  covid- pandemic result worldwide research effort recognize people great risk develop critical illness dying grow number report connect obesity severe covid- illness death exact mechanism obesity lead severe covid- outcome determine mechanism appear multifactorial include mechanical change airway lung parenchyma systemic airway inflammation general metabolic dysfunction adversely affect pulmonary function and/or response treatment covid- continue spread worldwide clinician carefully monitor manage obese patient prompt targeted treatment
337,background recent study show association obesity adverse coronavirus disease  covid- patient outcome paucity large study focus hospitalize patient aim analyze outcome associate obesity large cohort hospitalize covid- patient method perform retrospective study tertiary care health system adult patient covid- admit march  april patient stratify body mass index bmi obese bmi  kg m non obese bmi  kg m cohort primary outcome mortality intensive care unit icu admission intubation -day readmission result total  patient include  .% obesity  .% obesity patient obesity young p likely female p african american p compare patient obesity multivariable logistic model adjust difference age sex race medical comorbiditie treatment modality reveal difference -day mortality -day readmission obese non obese group model patient obesity increase odd icu admission adjust ci p intubation adjust ci p conclusion obesity patient covid- independently associate increase risk icu admission intubation recognize obesity impact morbidity manner crucial appropriate management covid- patient
338,observational study multiple country repeatedly demonstrate association obesity severe covid- define need hospitalization intensive care unit admission invasive mechanical ventilation imv death meta analysis study china usa france odd ratio ci .- obesity severe covid- study ci .- mortality ci .- need imv patient body mass index bmi  kg m obesity modifiable risk factor routinely treat treatment lead improvement visceral adiposity insulin sensitivity mortality risk increase awareness association obesity covid- risk general population medical community serve impetus obesity identification management high priority
339,introduction objectives january  million people infect covid- million people die severe acute respiratory syndrome coronavirus  sars cov- high sofa score d dimer microg ml identify patient high risk mortality high lactate dehydrogenase ldh level admission associate severity mortality different degree alanine aminotransferase alt and/or aspartate aminotransferase ast abnormality report patient association mortality risk remain controversial aim study explore correlation ldh hospital mortality mexican patient admit covid- materials methods perform retrospective multi centre cohort study  hospitalize patient confirm sars cov- centre mexico city mexico year old die discharge april  result total  patient evaluate  .% patient discharge  .% patient die hospitalization non survivor old median age year old patient male alt  u l ci p c reactive protein crp  mg l ci p ldh  u l ci p associate high odd hospital death conclusion result indicate high level ldh crp alt associate high hospital mortality risk mexican patient admit covid-
340,background recent study show obesity associate severity coronavirus disease covid- clinical study clarify obesity relationship covid- severity comorbiditie discuss possible mechanism materials method electronic database include web science pubmed scopus google scholar search study conduct covid- obesity study independently screen reviewer base title abstract result relevant article select text obesity affect respiratory immune system mechanism cytokine adipokine secretion adipose tissue lead pro inflammatory state obese patient predispose thrombosis incoordination innate adaptive immune response inadequate antibody response cytokine storm obese patient long virus shedding obesity associate comorbiditie hypertension cardiovascular disease diabetes mellitus vitamin d deficiency hospitalization intensive care unit admission mechanical ventilation mortality obese patient high normal weight patient obesity alter direction severe covid- symptom young individual reduce physical activity unhealthy eating habit stress fear experience covid- pandemic result weight gain obesity conclusion obesity consider independent risk factor severity covid- pay attention prevent weight gain obese patient covid- infection early level disease crucial pandemic
341,covid- pandemic disease cause coronavirus design sars cov- clinical presentation widely variable patient have mild symptom develop malign disease multi organ failure death accumulate datum different population show obesity risk factor severe evolution disease mechanism explain association clearly understand ominous evolution covid- attribute exacerbate inflammatory response design cytokine storm augment production cytokine chemokine activation toll like receptor tlr pathogen associate molecular pattern trigger inflammatory downstream response mediate adaptor molecule myeloid differentiation factor  myd previous study report increased expression myd tlrs people obesity mainly metabolic complication hypothesize underlying increase myd tlr signaling predispose patient obesity develop exaggerated dangerous inflammatory reaction sars cov- infection explain high severity covid- addition myd tlr signal people obesity role development chronic disease
342,objective recent study suggest obesity possible risk factor covid- disease wake coronavirus sars cov- infection causality especially role body fat distribution context unclear univariable multivariable sample mendelian randomization mr approach investigate time causal impact body composition susceptibility severity covid- method indicator overall abdominal obesity consider measure body mass index bmi waist circumference wc trunk fat ratio tfr summary statistic genome wide association study gwass body composition measure draw giant consortium uk biobank susceptibility severity covid- disease datum covid- host genetics initiative covid- cohort age gender available total direct causal effect estimate calculate single nucleotide polymorphisms snps sensitivity analysis apply robust mr technique mediation effect type  diabetes td cardiovascular disease cvd investigate multivariable mr analysis result genetically predict bmi strongly associate susceptibility or=.  sd increase ci p value= (- hospitalization or=.  sd increase ci p value= adjustment genetically predict visceral obesity trait association mediate substantially td cvd finally total direct effect visceral body fat outcome detect conclusion study provide strong evidence causal impact overall obesity susceptibility severity covid- disease impact abdominal obesity weak disappear adjustment bmi obese people regard high risk group future research necessary investigate underlie mechanism link obesity covid-
343,importance active pediatric covid- pneumonia mis c disease process require rapid diagnosis different treatment protocol objective distinguish active pediatric covid- pneumonia mis c present sign symptom patient characteristic laboratory value design patient diagnose hospitalize active covid- pneumonia mis c children alabama hospital birmingham april  september  identify retrospectively active covid- mis c case define diagnostic code verify accuracy current centers disease control case definition clinical note documentation covid- pneumonia mis c clinical note electronic medical record patient demographic present sign symptom prior exposure test sars cov- virus laboratory datum imaging treatment modality response treatment finding  patient identify  classify mild covid-  patient moderate covid-  patient severe covid-  mild mis c  severe mis c. group male predominance black hispanic patient overrepresente compare demographic alabama mis c patient healthy baseline covid- patient have underlie illness fever rash conjunctivitis gastrointestinal symptom predominant mis c population covid- patient present predominantly respiratory symptom group similar duration symptomatic prodrome exposure history sars cov- virus mis c patient long duration presentation exposure history covid- patient likely positive sar cov- pcr require respiratory support admission mis c patient low sodium level high level c reactive protein erythrocyte sedimentation rate d dimer procalcitonin covid- patient high lactate dehydrogenase level admission mis c patient coronary artery change echocardiography covid- patient conclusion relevance study directly compare covid- mis c pediatric population significant difference find symptom presentation demographic laboratory finding aide health care provider distinguish disease entity
344,report december  wuhan china novel coronavirus disease  covid- rapidly spread world lack effective therapy available covid- patient identification risk factor severe course disease matter urgency aim review report evidence base risk factor affect severity prognosis covid- search pubmed database current literature identify relevant publication concern risk factor covid- severity demographic social factor age gender race center community nursing home clinical factor smoking hypertension obesity diabetes chronic lung disease cardiovascular disease cvd chronic kidney disease ckd malignancy dementia cardiomyopathy immunocompromised state laboratory marker c reactive protein crp leukocytosis ferritin interleukin il)- d dimer lactate dehydrogenase ldh aspartate aminotransferase ast procalcitonin creatinine lymphopenia il- il- il- granulocyte colony stimulate factor g csf know colony stimulating factor  csf interferon gamma inducible protein- ip- monocyte chemoattractant protein- mcp- macrophage inflammatory protein alpha mipa tumor necrosis factor alpha tnf alpha genetic factor relate virus host discuss identification potential risk factor affect severity prognosis covid- provide chance early effective management covid-
345,introduction date effective treatment decrease hospitalization coronavirus disease  covid- infection suggest influenza vaccine attenuate severity covid- method retrospective single center cohort review de identify database  patient age  university florida health care system test positive covid- comorbiditie influenza vaccination status examine primary outcome severity disease reflect hospitalization intensive care unit icu admission logistic regression perform examine relationship influenza status hospitalization result covid positive patient receive influenza vaccination year ci great odd hospitalization ci great odd icu admission compare vaccinate result control account age race gender hypertension diabetes chronic obstructive pulmonary disease obesity coronary artery disease congestive heart failure discussion analysis suggest influenza vaccination potentially protective moderate severe case covid- infection protective effect hold regardless comorbidity literature point potential mechanism natural killer cell activation datum potentially limit generalizability vaccination rate low hold significant relevance give upcoming influenza season simply encourage influenza vaccination decrease morbidity mortality flu help flatten curve covid- pandemic encourage study finding
346,comorbid medical illness obesity diabetes associate severe covid- hospitalization death role immune system mediate clinical outcome determine multiparameter flow cytometry system serology comprehensively profile function t cell antibody target spike nucleocapsid envelope protein convalescent cohort covid- subject hospitalize n hospitalize n avoid confound subject match age sex ethnicity date symptom onset surprisingly find magnitude functional breadth virus specific cd+ t cell antibody response consistently high hospitalize subject particularly medical comorbiditie integrated analysis identify coordination polyfunctional cd+ t cell antibody target s domain spike subject hospitalize datum reveal functionally diverse coordinated response t cell antibody target sars cov- reduce presence comorbid illness know risk factor severe covid-
347,purpose article discern examine causative factor likely influence high consequence health disparity experience pregnant postpartum african american woman covid- understudied pregnancy presence covid- increase risk illness severity datum suggest pregnant woman covid- likely hospitalize admit intensive care unit require life support similarly covid- pose significant challenge maternal obstetric care postpartum recovery period african- american woman bear disproportionately high morbidity mortality burden disease diabetes obesity hypertension pre exist chronic health condition place pregnant postpartum woman high risk develop severe health consequence covid- delivery addition social determinant health hypothesize modulate deleterious impact covid- pregnant postpartum african american woman
348,purpose evaluate use hydroxychloroquine associate reduce likelihood intensive care unit icu admission patient coronavirus disease  covid- early week pandemic method retrospective observational cohort study conduct determine select treatment outcome  patient hospitalize covid- acute care community hospital hudson valley region new york march  april eligibility include admission hospital laboratory confirm diagnosis sars cov- infection need intubation intensive care admission median interquartile range age patient receive hydroxychloroquine n n   year respectively multivariable model include age gender obesity diabetes hydroxychloroquine use patient receive hydroxychloroquine significantly likely treat drug transfer icu odd ratio confidence interval ci significantly likely intubate ci association influence disease severity hospital mortality differ significantly disease severity receive hydroxychloroquine conclusion hydroxychloroquine use significantly associate increase risk icu admission intubation patient mild moderate severe symptom covid- significant group difference mortality use vs nonuse hydroxychloroquine
349,obesity cause wide concern high prevalence patient severe coronavirus disease  covid- coexistence diabetes obesity cause high risk severe outcome immunity dysfunction conduct retrospective study adult patient admit acute hospital wuhan china propensity score match logistic regression estimate risk severe pneumonia require hospital oxygen therapy associate obesity adjustment age sex comorbiditie obesity significantly associate high odd severe pneumonia odd ratio ci p oxygen therapy ci p high or severe pneumonia obesity observe man old adult diabetes patient diabetes overweight increase odd require hospital oxygen therapy time p obesity increase odd time p linear dose response curve bmi severe outcome observe patient u shape curve observe diabetes finding provide important evidence support obesity independent risk factor severe outcome covid- infection early phase ongoing pandemic
350,current review critically analyze obesity important risk factor increase predisposition coronavirus disease  covid- severity causal death current pandemic country high prevalence expose obese individual experience high number mortality analysis prove individual have adipose tissue body high level angiotensin convert enzyme  ace identify functional receptor covid- obese individual bad condition high presence adiposity increase number ace express cell furthermore silico interaction ace different variant coronavirus  cov- spike s protein suggest mutant strain infectious wildtype bind host ace protein high bind affinity certain specific cancer include cervical cancer pancreatic rectal adenocarcinoma expression receptor pose additional risk immunocompromised cancer patient review emphasize obesity covert risk factor covid- infection sensitize calorie restriction immunity building preventive measure
351,objective coronavirus disease  covid- bad pandemic clinical characteristic vary asymptomatic fatal study aim examine association body mass index bmi level severity covid- method study design cohort study include  adult patient confirmed covid- categorize  group bmi level admission kg m obese rate pneumonia severe pneumonia acute kidney injury aki icu stay hospitalization bmi group determine logistic regression analysis determine association bmi severe pneumonia result total patient have bmi kg m .% .% .% respectively rate pneumonia severe pneumonia tend high patient high bmi rate aki icu stay high patient bmi /=  kg m compare patient normal bmi control age sex diabetes hypertension dyslipidemia logistic regression analysis have bmi kg m associate high risk severe pneumonia ci p compare have bmi .- kg m. admission elevated hemoglobin alanine aminotransferase level day   illness associate high bmi level contrast rise serum creatinine level observe underweight patient day   illness conclusion obesity patient covid- associate severe pneumonia adverse outcome aki transaminitis icu stay underweight patient closely monitor aki study body composition warrant explore link adiposity covid- pathogenesis
352,purpose review manuscript review evidence collect covid- pandemic provide information impact body composition severity outcome disease analyse method body composition assessment malnutrition screen tool discuss screen diagnose patient high risk covid- severity relate bad outcome recent finding covid- occur wide range presentation asymptomatic severe form major risk factor bad severity overnutrition undernutrition body composition play role ability respond sars cov- infection excess fat accumulation i.e. obesity lean mass loss functionality i.e. sarcopenia combination i.e. sarcopenic obesity affect body functioning body composition alteration short term influence susceptibility immunological response virus inflammatory reaction metabolic respiratory distress long term modulate disease outcome length stay time require recovery risk icu acquire weakness long term disability potentially increase risk death summary individual malnutrition sarcopenia obesity sarcopenic obesity old adult abnormal body composition malnutrition risk require tailor medical nutrition therapy improve short long term covid- outcome
353,outbreak coronavirus disease  covid- cause novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- pandemic cellular receptor sars cov- entry angiotensin convert enzyme membrane bind homolog angiotensin convert enzyme henceforth bring attention scientific community study interaction covid- renin angiotensin system ras ras inhibitor inhibitor commonly treat hypertension chronic kidney disorder diabete obesity know risk factor heart disease diabetes hypertension diabetes hypertension indirectly relate effect obesity furthermore people hypertension obesity diabetes relate complication like cardiovascular kidney disease high risk severe covid- infection general population usually exhibit poor prognosis severity systemic inflammation compromise immune response ras associate comorbid condition urgent need develop evidence base treatment method affect severity covid- infection effectively manage chronic disease people covid-
354,severe respiratory systemic disease name coronavirus disease- covid- cause severe acute respiratory syndrome coronavirus  sars cov- currently covid- pandemic present huge social health challenge worldwide different risk factor associate disease severity systemic arterial hypertension diabetes mellitus obesity old age co infection respiratory disease chronic obstructive pulmonary disease copd smoking common comorbiditie worldwide previous investigation identify covid- patient smoker copd patient recent investigation question high risk population previous report fail isolate smoker copd patient comorbiditie perform longitudinal evaluation disease course smoker smoker copd patient covid- comorbiditie hospitalization hospital discharge difference group observe hospital admission smoker copd patient present increase covid associate inflammatory marker disease course comparison non smoker smoker result demonstrate smoking copd risk factor severe covid- possible implication ongoing pandemic
355,observational study suggest outpatient metformin use associate reduce mortality coronavirus disease- covid- metformin know decrease interleukin- tumor necrosis factor alpha appear contribute morbidity covid- seek understand outpatient metformin use associate reduce odd severe covid- disease large healthcare datum set retrospective cohort analysis electronic health record ehr datum pool multiple ehr system  hospital  primary care clinic midwest march  december inclusion criterion datum body mass index bmi  kg m positive sars cov- polymerase chain reaction test age  /= year exclusion criterion patient opt research metformin exposure interest death admission intensive care unit admission outcome interest metformin associate decrease mortality covid- p propensity match cohort p metformin associate nonsignificant decrease hospital admission covid- overall cohort p subgroup hemoglobin hbac available n adjust odd hospitalization include adjustment hbac metformin user p outpatient metformin use associate low mortality trend decrease admission covid- give metformin low cost establish safety mount evidence reduce severity covid- disease metformin prospectively assess outpatient treatment covid-
356,objective identify describe mechanism lifestyle characteristic obesity dm hypertension physical inactivity lead severity illness individual covid- data source scoping review conduct search electronic database pubmed scopus december  august inclusion exclusion criterion inclusion criterion study explicitly describe mechanism covid- relationship hypertension type  diabetes mellitus type  dm obesity and/or physical inactivity study epidemiological background descriptive survey interventional study exclude data extraction study characteristic tabulate accord purpose type non communicable disease ncds hypothesis mechanism infestation moi conclusion data synthesis ncd categorize accord type hypothesis mechanism infestation interplay covid- type ncd moi lead severity disease appraise result study identify  unique record study postulate mechanism infestation interaction covid  illness severity obesity  study describe covid- dm study highlight interaction covid- hypertension  study show physical activity restriction suppress immunity conclusion current review identify explicitly describe mechanism lifestyle characteristic increase severity illness people covid-
357,background limited evidence clinical characteristic sars cov- infection latin america present finding nationwide study argentina research question disease severity measure risk factor associate admission intensive care unit mortality study design method datum extract covid- database integrated argentina health information system encompass period march rd october nd standardized case report form include information contact history clinical sign symptom clinical diagnosis information collect initial site care follow conduct call regional healthcare authority confirm case covid- define have positive result sequencing real time reverse transcriptase polymerase chain reaction rt pcr assay nasal pharyngeal swab specimen result rt pcr testing positive case complete dataset available analysis case mean age year .% male frequent co existing condition include hypertension .% diabetes .% asthma obesity common symptom include fever .% cough .% headache .% sore throat death icu admission independently associate old age male coma dyspnea tachypnea seizure underlie co morbidity immunodeficiency chronic renal failure liver disease show strong effect interpretation case covid- diagnose argentina mild favorable outcome fatality rate relatively elevated risk factor adverse outcome include old age male sex coma seizure concurrent presence morbidity datum useful healthcare provider healthcare policy maker low middle income latin american country guide decision optimize care pandemic
358,background coronavirus disease covid- cause severe acute respiratory syndrome coronavirus  strain identify late  china outcome patient affect virus worsen develop acute respiratory failure complication especially old individual people obesity comorbiditie obese patient tend severe course covid- review aim synthesize evidence literature associate covid- severity clinical outcome infect obese patient method protocol design follow preferred reporting items systematic reviews meta analyses protocols statement scientific gray literature systematically select pubmed medline latin american literature health sciences online scientific electronic library scopus sciencedirect web science embase cochrane selection article limit study publish english portuguese spanish december  onwards main clinical outcome clinical severity obese patient covid- tachypnea respiratory rate  breath minute hypoxemia oxygen saturation  lung field involve h diagnosis severe acute respiratory syndrome need invasive mechanical ventilation mortality reviewer independently screen citation text article abstract datum selection bias minimize exclude study publish december conflict resolve reviewer consensus building finding report narrative synthesis tabulation summary discussion give need early detection possible implication treatment patient obesity diagnose covid- scoping review useful capture state current literature identify gap recommendation future research direct conduct optimization therapy patient multiprofessional team systematic review registration open science framework
359,"background aim recent study obesity risk factor hospital admission critical care need patient coronavirus disease  covid- aim determine obesity risk factor unfavourable health outcome patient affect covid- admit icu method result  consecutive patient covid- male  female admit icu include study height weight bmi sequential organ failure assessment sofa acute physiology chronic health evaluation ii apache ii score crp cpk icu hospital length stay comorbiditie evaluate participant obesity low  day survival rate icu admission normal weight subject cox proportional hazard model derive estimate adjust age gender comorbidity confirm result survival analysis hr:.,%c.i obese subject show long hospital icu stay compare normal weight counterpart subject obesity show significantly high crp cpk level normal weight subject conclusion individual obesity careful management prompt intervention case suspect sars cov- infection necessary prevent progression disease severe outcome increase hospital treatment cost"
360,worldwide spread coronavirus disease  covid- generate global health crisis million death far epidemiological clinical characteristic covid- increasingly report potential relationship overweight and/or obesity aim review current scientific literature impact overweight and/or obesity hospitalize patient develop severe critical form covid- follow prisma guideline literature search identify  scientific article keyword obesity covid-  finally select report useful information association overweight obesity disease severity particular   study evaluate association obesity disease severity provide risk estimate i.e. odd ratio value constantly study find heterogeneous term design population sample size endpoint case significant association find obesity risk progress severe covid- illness intensive care unit admission and/or death conclude increase body mass index shall consider negative prognostic factor patient covid- aggressive prevention treatment shall overweight and/or obese patient
361,background lifestyle factor include obesity smoking suggest correlate increase risk covid- severe illness related death relationship causal know relationship covid- severe illness common lifestyle factor physical activity alcohol consumption method genome wide significant genetic variant associate body mass index bmi lifetime smoking physical activity alcohol consumption identify large scale genome wide association study gwas individual select instrumental variable summary statistic genetic variant severe illness covid- obtain gwas analysis  case control sample mendelian randomisation analysis conduct result standard deviation sd increase genetically predict bmi lifetime smoking associate fold increase risk severe respiratory covid- covid- hospitalization p sd increase genetically predict physical activity associate decrease risk severe respiratory covid- odd ratio confidence interval ci p covid- hospitalization ci p evidence association find genetically predict alcohol consumption similar result find robust mendelian randomisation method conclusion evidence find bmi smoke causally increase physical activity causally decrease risk covid- severe illness study highlight importance maintain healthy lifestyle protect covid- severe illness public health value fighting covid- pandemic
362,background severe acute respiratory syndrome coronavirus  sars cov- pandemic remain latin america mexico country high death rate worldwide datum hospital mortality risk factor impact hospital overcrowding latin america thoroughly explore method finding prospective cohort study enrol consecutive adult patient hospitalize severe confirm covid- pneumonia sars cov- referral center mexico city february th june th total  patient admit confirmed diagnosis mean age year male obese overweight hypertension type  diabetes  recover .%  die survivor  receive invasive mechanical ventilation imv  manage outside intensive care unit icu mortality icu non survivor n receive support lack icu bed availability subgroup main cause death acute respiratory distress syndrome ards case non survivor receive n support main cause death septic shock follow ards main risk factor associate hospital death male sex rr ci obesity rr ci particular morbid obesity rr ci oxygen saturation admission rr ci conclusion study find similar hospital icu mortality risk factor mortality compare previous report patient survive justified admission icu receive imv icu care unavailability icu bed furthermore mortality rate time mainly availability icu bed indirectly suggest overcrowding main factor contribute hospital mortality
363,aging obesity relate condition worsen effect coronavirus disease  covid- study assess possible role metabolic obesity phenotype vitamin d status increase great severity covid- study uk biobank participant england mean age year metabolic obesity phenotype define combination metabolic component hypertension high cholesterol diabetes obesity multivariate logistic regression analysis perform test addition metabolic disorder vitamin d insufficiency increase obesity association covid- hospitalization confirm covid- severe covid- metabolically unhealthy obesity muho represent .% total analytic sample .% .% .% include subpopulation covid- hospitalization confirm covid- severe covid- respectively vitamin d insufficiency phenotype represent .% total analytic sample .% .% .% include subpopulation covid- hospitalization confirm covid- severe covid- respectively multivariate logistic regression muho vitamin d insufficiency combination significantly associate covid- illness severity odd ratio covid- hospitalization confidence interval ci .- confirmed covid- ci severe covid- ci elderly man prone high risk covid- woman finding show muho vitamin d insufficiency associate significantly increase risk covid- severity especially adult  year old susceptible individual aware condition avoid contact new coronavirus
364,increase prevalence obesity diabetes cardiovascular risk factor people hospitalize severe covid- illness engender considerable interest metabolic aspect sars cov induce pathophysiology update concept inform metabolic disorder co morbidity modify susceptibility natural history potential treatment sars cov- infection focus human biology new datum inform genetic predisposition epidemiology immune response disease severity therapy covid- people obesity diabete highlight emerge relationship metabolic disorder viral induce immune response viral persistence putative importance adipose islet ace expression glycemic control cholesterol metabolism glucose- lipid lower drug attention controversy unresolved question rapid progress area inform grow understanding sars cov- infection people diabetes obesity refine therapeutic strategy research priority vulnerable population
365,low plasma estrogen vitamin d deficiency obesity diabetes cardiovascular disease thromboembolism impaired microcirculation link severity covid- study suggest comorbiditie relate erythrocyte factor link increase blood viscosity microcirculation erythrocyte aggregation erythrocyte deformability increased blood viscosity microcirculation lead decrease oxygenation nutrition tissue erythrocyte aggregation erythrocyte deformability involve covid- severity lead tissue hypoxia decrease drug concentration affected organ relationship demonstrate erythrocytes factor monitor treatment improve microcirculatory fluidity decrease covid- severity lifestyle improvement treatment vitamin d estrogens supplementation possible approach improve microcirculation covid- prevention treatment
366,effect immunosuppressant treatment incidence coronavirus disease covid- remain largely unknown study association pre exposure disease modify antirheumatic drug dmard decrease immunological response incidence covid- explore possible effect treatment early manifestation disease purpose perform cross sectional study include patient immunomediate inflammatory disease imid recruit outpatient rheumatology dermatology gastroenterology service hospital del mar. primary outcome clinical diagnosis covid- perform physician hospital primary care center march multivariable poisson regression model fit estimate covid- relative risk rr adjust comorbiditie reveal biological rr ci synthetic rr ci dmard imid diminish incidence covid- strike sex difference reveal anti tnfalpha compound rr ci high effect woman rr ci treatment low glucocorticoid dose reveal sex difference decrease incidence covid- predominantly woman rr ci result report decrease incidence covid- patient receive specific dmard different immunodepressor mechanism strike sex difference result underline interest repurpose specific dmard possibility minimize severity disease progression early stage covid-
367,objective determine obesity diabete risk factor severe outcome covid- compare patient outcome condition design retrospective cohort study setting urban tertiary care center new york city participant  patient admit inpatient setting year old laboratory confirm diagnosis covid- nasal pcr swab randomly select patient separate cohort base body mass index hemoglobin ac  patient place non obese non diabetic cohort  patient place corresponding cohort obesity obesity diabetes diabetes measurement primary outcome development acute kidney injury commencement renal replacement therapy aminotransferase elevation troponin elevation lactic acidosis development septic shock use vasopressor presence acute respiratory distress syndrome ards intubation secondary outcome length stay day mortality result patient obesity and/or diabete likely develop ards patient vs  patient p intubate patient vs  patient p=. patient obesity and/or diabete likely require vasopressor patient vs  patient p=. develop lactic acidosis median mmol l iqr mmol l p=. compare patient diabetes obesity patient obesity likely develop ards .% p=. despite finding difference mortality conclusion patient hospitalise covid- obesity and/or diabete likely suffer severe complication negligible difference mortality highlight importance close monitoring patient condition additional area research need explain mortality finding
368,infection severe acute respiratory syndrome coronavirus  sars cov- responsible coronavirus- disease covid- pandemic h- blocker famotidine suggest fda approve drug potentially repurpose treatment covid- famotidine show improve patient outcome reduce symptom severity patient acutely ill covid- study suggest proton pump inhibitor ppis association covid- objective purpose present study determine famotidine antireflux medication prophylactic detrimental effect sars cov- infection take regularly management acid reflux method anonymous web base survey distribute email adult otolaryngology patient collect demographic datum past medical history medication history incidence symptom associate covid- potential exposure sars cov- result pcr serological testing association reflux medication incidence covid- case analyze statistical analysis perform spss chi square fisher exact test point biserial correlation kendall's tau b independent sample t test mann whitney u test appropriate binary logistic regression model fit determine probability covid- case adjustment risk factor result  patient respond survey average age respondent famotidine use associate incidence laboratory confirm p= symptomatically suspect p= covid- reflux medication find significant predictor laboratory confirm suspect covid- p young age odd ratio ci p high risk obesity ci p= use corticosteroid nasal spray ci p= significant predictor symptomatically suspect covid- case conclusion association incidence covid- use reflux medication include famotidine dose orally manage reflux high dose ppi reflux medication protect increase risk covid-
369,background evidence accumulate coronavirus disease  increase risk hospitalization mechanical ventilation pregnant patient preterm delivery impact maternal mortality morbidity differentially affect disease severity delivery trimester infection unknown objective study aim describe disease severity outcome severe acute respiratory syndrome coronavirus  infection pregnancy washington state include pregnancy complication outcome hospitalization case fatality study design pregnant patient polymerase chain reaction confirm severe acute respiratory syndrome coronavirus  infection march june identify multicenter retrospective cohort study  site washington state site capture annual state delivery case fatality rate pregnancy compare coronavirus disease  fatality rate similarly aged adult washington state rate ratio rate difference maternal neonatal outcome compare trimester infection disease severity time delivery result principal study finding follow  pregnant patient washington state severe acute respiratory syndrome coronavirus  infection   develop severe critical disease   hospitalize coronavirus disease   die coronavirus disease -associate hospitalization rate high similarly aged adult washington state .% vs .% rate ratio confidence interval pregnant patient hospitalize respiratory concern likely comorbidity underlying condition include asthma hypertension type  diabetes mellitus autoimmune disease class iii obesity  maternal death .% attribute coronavirus disease  maternal mortality rate  pregnancy confidence interval coronavirus disease  case fatality pregnancy significant confidence interval high pregnant patient similarly age individual washington state absolute difference mortality rate confidence interval preterm birth significantly high woman severe critical coronavirus disease  delivery woman recover coronavirus disease  .% severe critical coronavirus disease  vs .% mild coronavirus disease p conclusion coronavirus disease  hospitalization case fatality rate pregnant patient significantly high similarly aged adult washington state datum indicate pregnant patient risk severe critical disease mortality compare nonpregnant adult risk preterm birth
370,background large inter individual inter population difference susceptibility outcome severe acute respiratory syndrome coronavirus  coronavirus disease  covid- note understand difference influence vulnerability infection disease severity critical public health intervention aim analyze compare profile covid- case china north america region differ environmental host healthcare factor relate disease risk method conduct meta analysis examine compare demographic information clinical symptom comorbiditie disease severity level disease biomarker covid- case clinical study datum china study north america study result covid- patient north america old chinese counterpart high male female ratio fever cough fatigue dyspnea common clinical symptom study region present case region meta analysis prevalence comorbiditie obesity hypertension diabetes cardiovascular disease chronic obstructive pulmonary disease cancer chronic kidney disease covid- patient significantly prevalent north america compare china comorbiditie positively correlate age significantly young age range china compare north american prevalent infection outcome acute respiratory distress syndrome frequent north america china level c reactive protein .-fold high north american case case china conclusion difference profile covid- case china north america relate difference environmental- host- healthcare relate factor region inter population difference intra population variability underline need characterize effect health inequity inequality public health response covid- assist prepare emergence epidemic
371,global spread sars cov- million people affect lead declaration coronavirus disease  covid- pandemic study link severity covid- case increase fatality patient obesity comorbid condition diabetes cardiovascular disease hypertension kidney disease obesity metabolically deranged condition establish low grade chronic inflammation body affect different organ promote development disease way sars cov- infection aggravate overload body organ inflammation vice versa perplex researcher result intensify search clear cut mechanism understand link obesity increase severity covid- obese patient article discuss mechanism link obesity inflammation covid- enhance understanding disease process help clinician scientist develop potential cellular molecular metabolic target clinical intervention management covid- severity obese patient
372,background norwegian hospital operate capacity covid- pandemic present patient management characteristic outcome entire cohort adult years covid- patient admit norwegian intensive care unit icu  march  june method datum collect norwegian intensive care pandemic registry nipar demographic co morbidity management characteristic outcome describe icu length stay los analyse linear regression association risk factor mortality quantify cox regression result total  patient include male female ratio median age  year majority co morbidity frequently cardiovascular disease chronic lung disease diabetes mellitus obesity patient admit acute hypoxaemic respiratory failure ahrf invasive mechanical ventilation mv prone ventilation patient receive tracheostomy vasoactive drug renal replacement therapy median icu los time mv day end follow  patient dead age co morbidity severity illness admission predictive death severity ahrf male gender associate los conclusion national cohort covid- patient mortality low attributable know risk factor importantly prolong length stay take account plan resource allocation surge
373,worldwide population face double burden epidemic covid- obesity alarming obesity increase covid- severity relationship obesity covid- severity complex simple association bmi particular obesity associate low death rate patient acute respiratory distress syndrome fatal comorbidity covid- possibly obesity paradox visceral adiposity major risk factor covid- severity immune activation component release angiotensin convert enzyme  involvement cytokine storm hypercoagulability embolism poor antioxidant nutritional status weaken immune system increase inflammation infection risk covid- lockdown impact lifestyle pattern mental health weight bias worsen obesity coivd- situation hand health care expense productivity loss expect increase concomitant epidemic co occurrence obesity covid- major challenge public health economic level urgently take consideration identification covid- weight relate risk factor development appropriate weight management program need tackle concomitant epidemic
374,covid- pandemic oasi research institute troina italy important hotbed infection fact  patient different level intellectual disability id test positive covid- procedure intervention place oasi research institute covid- pandemic exhaustively report paper description clinical procedure remote person psychological support service provide people id family divide different section phase acute phase phase ii activity planning phase iii activity consolidation section main psycho pathological characteristic patient reaction family member multidisciplinary intervention place describe
375,coronavirus disease covid- priority health problem objective evaluate clinical characteristic evolution severity covid- level hospital province buenos aires argentina conduct retrospective cohort  patient covid- march  june patient divide accord presence absence pneumonia severity disease median age  year woman common symptom fever cough dyspnea fever associate presence pneumonia prevalent comorbiditie hypertension obesity cardiovascular disease chronic respiratory disease presence comorbidity hypertension common severe case frequent laboratory finding lymphopenia elevated d dimer thrombocytopenia severe disease level c reactive protein d dimer high patient pneumonia healthcare worker diagnosis reverse transcriptase polymerase chain reaction rt pcr sample need case moderate high value pneumonia severity index psi prevalent severe mild pneumonia vs. p mortality register ci clinical characteristic severity prognosis similar describe worldwide highlight high proportion healthcare worker sars cov- positive false negative rate rt pcr usefulness psi discriminate severity pneumonia
376,background sars cov- virus cause covid- enter cell mechanism dependent binding angiotensin convert enzyme  ace protein highly express lung putative viral induce inhibition ace result defective degradation bradykinin potent inflammatory substance hypothesize increase bradykinin lung important mechanism drive development pneumonia respiratory failure covid- method phase ii single center arm parallel group open label active control superiority randomized clinical trial eighty eligible patient randomly assign ratio receive inhibitor ce kallikrein  u kg intravenously day  day  plus standard care icatibant  mg subcutaneously dose day  day plus standard care standard care recommend clinical trial publish date include supplemental oxygen non invasive invasive ventilation antibiotic agent anti inflammatory agent prophylactic antithrombotic therapy vasopressor support renal replacement therapy discussion accumulation bradykinin lung common effect ace inhibitor lead cough animal model inactivation ace lead severe acute pneumonitis response lipopolysaccharide lps inhibition bradykinin completely restore lung structure believe inhibition bradykinin severe covid- patient reduce lung inflammatory response impact positively severity disease mortality rate trial registration brazilian clinical trials registry universal trial number utn u-- register may//.
377,pandemic novel coronavirus disease  covid- trigger international crisis result excess morbidity mortality adverse societal economic geopolitical consequence like disease state patient characteristic impact clinical risk determine spectrum severity obesity adiposity base chronic disease emerge important risk factor morbidity mortality covid- imperative stratify risk patient obesity determine optimal mitigation therapeutic preparedness strategy suspect insulin resistance important pathophysiologic cause poor outcome patient obesity covid- independent body mass index explain association type  diabetes mellitus tdm hypertension htn cardiovascular disease poor outcome insulin resistance main driver dysglycemia base chronic disease cardiometabolic base chronic disease end stage disease manifestation stage severity adiposity relate disease complication centric manner htn dyslipidemia metabolic syndrome tdm obstructive sleep apnea etc different ethnic group patient covid- help predict adverse risk adiposity patient health pragmatic actionable manner pandemic
378,foremost mortality cause symptom associate covid- acute respiratory distress syndrome ards significant correlation identify deficiency vitamin d risk develop ards suggest reduce modify ards covid- patient significantly reduce severity covid- symptom associate mortality rate increase mortality dark skin people reduce uv absorption capacity consistent diminished vitamin d status factor associate covid- mortality old age ethnicity obesity hypertension cardiovascular disease diabetes find link vitamin d deficiency base review precautionary measure suggest adoption appropriate safe solar exposure vitamin d enrich food supplement consider reduce possible severity covid- symptom safe sun exposure deem beneficial globally specifically low middle income country cost involve note improve solar exposure vitamin d level reduce impact disease assist maintain general human
379,novel corona virus severe acute respiratory syndrome coronavirus- sars cov- disease cause covid- coronavirus disease- multi faceted effect number life global scale directly indirectly grow body evidence suggest covid- patient experience oral health problem dry mouth mucosal blistering mouth rash lip necrosis loss taste smell periodontal disease pd severe inflammatory gum disease worsen symptom associate covid- routine dental periodontal treatment help decrease symptom covid- pd prevalent patient experience metabolic disease obesity diabetes mellitus cardiovascular risk study show patient highly susceptible sars cov- infection pro inflammatory cytokine oxidative stress know contribute development pd metabolic disease highly elevated covid- patient periodontal health help determine severity covid- infection accumulate evidence show african americans aas vulnerable population disproportionately susceptible pd metabolic disease covid- compare ethnicity united states dentistry dental healthcare professional particularly susceptible virus transferability oral cavity use aerosol create instrument ubiquitous field review attempt provide comprehensive update source information sars cov-/covid- effect dental profession patient visit dental clinic finally review valuable resource management oral hygiene reduction severity infection
380,objective obesity show associate adverse outcome viral infection influenza previous study coronavirus disease  covid- mix result aim systematic review investigate relationship covid- obesity method perform systematic review meta analysis literature search medline embase scopus web science central opengrey server perform restriction language date publication primary outcome study intensive care unit icu admission critical disease severe disease mortality secondary outcome positive covid- test meta analysis perform openmeta analyst software heterogeneity test cochran q test statistic study protocol register prospero crd result total article identify  study patient include pooled prevalence obesity confidence interval ci hospitalise patient obesity significantly associate increase icu admission critical illness odd ratio ci p=. significantly associate severe disease ci p=. mortality ci p=. i()=. positive covid- test ci p conclusion obesity increase risk severe disease mortality infection covid- high body mass index associate icu admission critical disease patient obese susceptible severe acute respiratory syndrome coronavirus  sars cov- infection infect patient monitor closely adverse outcome
381,coronavirus disease  covid- critical pandemic st century severe  influenza pandemic severe acute respiratory syndrome coronavirus  sars cov- infect host bind angiotensin convert enzyme  ace role ace pathophysiology coronavirus disease  covid- topic debate clinical experimental evidence indicate multifaceted relationship ace activity disease severity review mechanism peptidergic substrate product ace ace contribute physiological pathophysiological process hypothesise regulation ace sars cov- cellular entry disrupt homeostasis well understanding endocrinology disease particular neuroendocrinology ace covid- contribute timely design new therapeutic strategy include regulation ace steroid hormone ameliorate severity covid-
382,thromboembolic event frequent patient covid- infection case bilateral renal infarction report present case -year old female patient diabetes mellitus obesity attend emergency department low pain respiratory failure associate covid- pneumonia diabetic ketoacidosis shock patient acute kidney injury require hemodialysis contrast abdominal tomography show bilateral renal infarction anticoagulation start kidney infarction case require high diagnostic suspicion possibility start anticoagulation
383,objective describe outcome different ethnic group cohort hospitalise patient confirmed covid- infection quantify describe impact number prognostic factor include frailty inflammatory marker set acute national health service hospitals east london design prospectively define observational study registry datum participant  patient age  year admit hospital confirmed covid- infection  january  main outcome measures primary outcome -day mortality time hospital admission covid- diagnosis prior admission secondary outcome -day mortality intensive care unit icu admission icu hospital length stay type duration organ support multivariable survival analysis adjust potential confounder result  include analysis  die day   asian  black  white background compare white patient minority ethnic background young differ comorbidity profile frailty asian black patient likely admit icu receive invasive ventilation ci p=. ci p=. respectively adjustment age sex patient asian hr ci p black hr ci p=. background likely die finding persist range risk factor adjust analysis account major comorbiditie obesity smoking frailty abo blood group conclusion patient asian black background high mortality covid- infection despite control previously identify confounder frailty high rate invasive ventilation indicate great acute disease severity analysis suggest patient asian black background suffer disproportionate rate premature death covid-
384,objective latino patient overrepresente case coronavirus disease  covid- increase risk severe disease prevalence covid- latinos rheumatic disease poorly report study undertake characterize covid- clinical feature outcome latino patient rheumatic disease method conduct retrospective study latino patient rheumatic disease exist observational cohort washington dc area patient see april  october  analyze study demographic characteristic body mass index bmi comorbiditie use immunomodulatory therapy exploratory classification regression tree cart analysis logistic regression analysis perform identify risk factor covid- rheumatic disease flare result  latino patient rheumatic disease  identify have covid- incidence rate infection find -fold high general latino population patient require intensive care unit level care cart analysis multivariable logistic regression analysis identify bmi risk factor covid- odd ratio confidence interval ci p covid- positivity risk factor rheumatic disease flare ci p conclusion finding indicate latino patient rheumatic disease high rate covid- compare general latino population obesity risk factor covid- covid- risk factor rheumatic disease flare latino patient risk factor closely follow especially post covid- anticipation disease flare
385,last immunity critical overcome coronavirus disease  covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- factor drive development high titer anti sars cov- antibody long antibody persist remain unclear objective comprehensively evaluate anti sars cov- antibody clinically diverse covid- convalescent cohort define time point determine anti sars cov- antibody persist identify clinical demographic factor correlate high titer novel multiplex assay quantify igg sars cov- antigen receptor bind domain angiotensin convert enzyme  inhibition assay sars cov- neutralization assay find covid- convalescent subject anti sars cov- antibody week symptom resolution n= antibody level decline month symptom resolution n= expect great disease severity old age male sex obesity high charlson comorbidity index score correlate increase anti sars cov- antibody level demonstrate time covid- symptom fever abdominal pain diarrhea low appetite correlate consistently high anti sars cov- antibody level result provide new insight development persistence anti sars cov- antibody
386,enteric symptomology see early stage severe acute respiratory syndrome sars)- covid- evidence virus replication occur intestine liver pancrea aberrant lipid metabolism morbidly obese individual adversely affect covid- immune response increase disease severity observation line importance lipid metabolism covid- point gut site intervention therapeutic target treat disease formation complex lipid membrane palmitoylation coronavirus protein essential viral replication assembly inhibition fatty acid synthase fasn restoration lipid catabolism activation amp activate protein kinase ampk impede replication coronaviruse closely relate sars coronavirus- cov- vitro finding clinical datum reveal fasn inhibitor orlistat ampk activator metformin inhibit coronavirus replication reduce systemic inflammation restore immune homeostasis observation know mechanism action type drug suggest target fatty acid lipid metabolism directly inhibit virus replication positively impact patient response covid-
387,coronavirus disease  covid- declare pandemic exhibit wide range severity worldwide global variation largely affect socio medical situation country high individual level variation attributable elderliness certain underlie medical condition include high blood pressure diabetes obesity elderliness aforementioned chronic condition associate altered gut microbiota result disrupt gut barrier integrity gut symptom consistently associate severe illness covid- patient possible dysfunction gut influence covid- severity article summarize accumulate evidence support hypothesis alter gut microbiota associated leaky gut contribute onset gastrointestinal symptom occasionally additional multiorgan complication lead severe illness allow leakage causative coronavirus circulatory system
388,objective primary objective study evaluate therapeutic potential hydroxychloroquine hcq treatment adult patient pcr confirm covid- infection primary open care setting compare placebo study hypothesis treatment hcq reduce risk hospitalization covid- infection sample size estimate study base need test hypothesis secondary objective study evaluate safety tolerability hcq treatment adult patient pcr confirm covid- infection primary open care setting compare placebo collect experience use hcq treatment covid- infection outpatient order able identify patient characteristic predict specific treatment response favourable unfavourable objective address post hoc subgroup analysis study result meta analysis pool patient datum clinical trial hcq outpatient evaluate impact covid- infection treatment mental health study participant addition datum allow study follow exploratory objective evaluate extent duration sars cov- viral shedding pcr testing nasopharyngeal swab sample study subject treat hcq compare placebo evaluate extent time course sars cov- virus specific antibody response serum study subject treat hcq compare placebo evaluate possible biomarker change blood study subject treat hcq compare placebo explore possible effect genetic variation drug metabolize enzyme hcq relate outcome study population explore association hcq relate outcome variable patient characteristic e.g. hla haplotype hcq concentration demographic variable disease history concomitant medication trial design phase placebo control double blind randomized parallel group treatment trial compare hcq placebo outpatient covid- infection participant randomize ratio treatment arm participant main inclusion criterion male female year age year age follow i. diabetes mellitus type  type ii bmi  kg m valid independent informed consent obtain symptom typical covid- infection accord criterion specify study protocol onset symptom  day enrolment positive sars cov- pcr test result nasopharyngeal swab sample main exclusion criterion suspect severe moderately severe pneumonia present following respiratory rate  breath min significant respiratory distress spo room air require treatment hospital accord treat physician judgement contraindication treatment hcq pregnancy lactation trial conduct seven study site primary public health care setting region satakunta finland intervention comparator participant randomize receive hcq capsule  mg twice day day  mg twice day  day placebo capsule  day main outcome primary endpoint study number hospitalization covid- infection week entry study secondary endpoint study include following duration severity covid related symptom report daily self assessment number intensive care unit treatment episode covid- infection week entry study number death covid- infection week entry study number treatment relate adverse event aes aes saes cause hospitalization mortality month entry study self assess symptom anxiety assess repeat administration generalized anxiety disorder scale gad- exploratory endpoint study include following extent duration sars cov- viral shedding virus specific antibody response serum possible blood biomarker change randomisation eligible study participant randomly allocate treatment arm (: ratio randomization list generate viedoc viedoc technologies ab uppsala sweden electronic data capture system study blinding masking participant study personnel remain blind treatment allocation have imp pack identical container mask treatment perform formulation imp hcq capsule placebo capsule identical appearance number randomised sample size  participant randomise  arm trial status protocol version date  july recruitment expect start december complete june trial registration eudract register  june  protocol protocol attach additional file accessible trials website additional file protocol redact conform privacy regulation delete name contact information individual mention protocol list author communication interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
389,covid- coronavirus disease pandemic researcher seek low cost accessible mean provide protection harm particularly risk individual cardiovascular disease diabetes obesity possible way safe sun exposure and/or dietary supplementation induce beneficial mediator e.g. vitamin d narrative review provide rationale update evidence potential benefit harm sun exposure ultraviolet uv light impact covid- review recent study provide new evidence benefit uv light sun exposure induce mediator vitamin d nitric oxide potential modulate morbidity mortality induce infection sars cov- severe acute respiratory disease coronavirus- identify substantial interest research area commentary review publish focus vitamin d consideration uv light sun exposure mediator nitric oxide datum collect date suggest ambient level uva uvb beneficial reduce severity mortality covid- inconsistent finding currently unresolved nature association blood d covid- measure prospective datum need well consider lifestyle factor physical activity personal sun exposure level short come lack measurement sun exposure potential influence covid- outcome discuss possible mechanism sun exposure uv light induce mediator affect covid- morbidity mortality focus likely effect viral pathogenesis immunity inflammation potential cardiometabolic protective mechanism finally explore potential issue include impact exposure high dose uv radiation covid- vaccination effective safe dose vitamin d supplementation
390,background aim study distinguish independent role overweight obesity associated comorbiditie evolution severe form covid- obesity unify risk factor severe covid- emerge hypothesis aim study evaluate excessive body weight se risk factor develop severe form covid- patient method include  patient hospitalize covid- pneumonia single center internal medicine department marseille france record anthropometric metabolic parameter fast glycaemia insulinemia homa ir lipid clinical criterion link sars cov- infection admission excess body weight define bmi>/=kg m occurrence event define high debit oxygen requirement l min admission intensive care unit death result  patient third n= excess body weight number event significantly high excess body weight patient compare normal weight patient respectively vs p=. excess body weight patient young respectively vs .year old p=. multivariate analysis excess body weight status predictor develop event link sars cov- infection odd ratio ci p=. independently previous obesity associate comorbiditie trend positive association bmi normal weight overweight obesity risk event link covid- marked increase .% .% respectively p=. conclusion excess body weight significantly associate severe form disease independently classical associate comorbiditie physician specialist public health sensitize well protect people excess body weight sars cov- infection
391,introduction obesity worsen clinical outcome coronavirus disease  covid- aim study measure association history bariatric surgery severity covid- method data source include pubmed medline scopus google scholar pre print server january november literature screen select extract relevant datum outcome meta analysis difference mortality hospitalization rate patient sars cov- infection history bariatric surgery random effect model estimate pool effect result systematic review yield  retrospective study  patient risk mortality previous bariatric surgery   case risk previous bariatric surgery   summary ci heterogeneity observe include study p heterogeneity pooled analysis hospitalization rate patient previous bariatric surgery   case rate patient previous bariatric surgery   summary ci heterogeneity observe include study p heterogeneity substantial risk bias study confound selection bias conclusion finding meta analysis observational study suggest prior bariatric surgery associate low rate mortality hospital admission patient obesity infect sars cov- confirmation finding require large study well quality datum
392,background purpose patient infect severe acute respiratory syndrome coronavirus  sars cov- develop spectrum neurological disorder include leukoencephalopathy variable severity aim characterize imaging lab clinical correlate severe coronavirus disease  covid- leukoencephalopathy provide insight sars cov- pathophysiology materials method seven consecutive patient positive sars cov- brain mr imaging follow intensive care unit admission include seven develop unusual pattern leukoencephalopathy reduced diffusivity diffusion weighted mr imaging remain patient exhibit pattern clinical laboratory index neuroimaging finding compare group result reduce diffusivity group significantly high body mass index versus  kg m p patient reduce diffusivity trend frequent acute renal failure versus p low estimate glomerular filtration rate value versus  ml min p time mri patient reduce diffusivity show less mean value low hemoglobin level versus g dl p high serum sodium level versus  mmol l p  hour mr imaging reduce diffusivity group show striking highly reproducible distribution confluent predominantly symmetric supratentorial middle cerebellar peduncular white matter lesion p conclusion finding highlight notable correlation severe covid- leukoencephalopathy reduced diffusivity obesity acute renal failure mild hypernatremia anemia unusual brain mr imaging white matter lesion distribution pattern observation shed light possible sars cov- pathophysiologic mechanism associate leukoencephalopathy include borderzone ischemic change electrolyte transport disturbance silent hypoxia setting know cytokine storm syndrome accompany severe covid-
393,behavioral lifestyle factor associate cardiometabolic disease obesity risk factor coronavirus disease  covid- aim investigate physical activity timing balance physical activity sleep rest associate sars cov- positivity covid- severity datum uk biobank participant accelerometer datum complete covariate link covid- datum july include risk sars cov- positivity covid- severity relation overall physical activity moderate vigorous physical activity mvpa balance activity sleep rest variability timing sleep rest assess adjust logistic regression  individual positive test result  classify have severe infection overall physical activity mvpa associate severe covid- poor balance activity sleep rest odd ratio standard deviation confidence interval ci finding relate high daytime activity associate low risk ci high movement sleep rest associate high risk ci severe infection great variability timing sleep rest associate increase risk ci result test positive broadly consistent conclusion result highlight importance physical activity quality sleep rest regular sleep rest pattern risk covid- finding indicate risk covid- consistently approximately great approximately increase variability timing proxy measure sleep indicative irregular sleeping pattern
394,coronavirus situation covid- continue evolve question concern factor relate diffusion severity disease remain unanswered whilst opinion weight evidence risk factor study publish far inconclusive offer contrast result role comorbiditie risk adverse outcome patient affect covid- appear evident outset hypertension diabetes obesity discussion important factor affect severity disease air pollution consider play role diffusion virus propagation contagion severity symptom poor prognosis accumulate evidence support hypothesis environmental particulate matter pm trigger inflammatory response molecular cellular organ level sustain respiratory cardiovascular dysmetabolic disease well understand intricate relationship pre existing condition pm viral infection examine response molecular level td human breast adenocarcinoma cell expose different fraction pm td cell express receptor include aryl hydrocarbon receptor ahr ace main receptor sars cov- entry pm sample collect urban background site locate northern area city bologna emilia romagna region northern italy winter td cell expose organic aqueous inorganic extract final concentration  m -hour duration concentration exposure time choose resemble average outdoor exposure rna extract cell purify hybridise k microarray slide agilent list differentially express gene pm organic extract evaluate metacore enrichment analysis perform identify pathway map process network disease biomarker alter td treatment analysis modulate gene give evidence involvement pm dysmetabolic disease include diabetes obesity hypertension activation aryl hydrocarbon receptor ahr canonical pathway basis current knowledge exist datum exploratory experimental evidence tease likely molecular interplay ultimately tip disease outcome severity look ace additional key marker identify disruption target worsen pre existing condition and/or exacerbate adverse effect induce sars cov- infection whilst appropriately design epidemiological study need investigate association base hypothesis investigation review recent experimental epidemiological evidence speculate provide new insight possible role environmental pollution exacerbation effect sars cov- respiratory virus work intend assist development appropriate investigative approach protect public health
395,coronavirus disease  covid- rapidly expand worldwide short period relationship chronic comorbiditie unclear aim determine effect chronic comorbiditie clinical outcome patient covid- analysis patient suspicion viral respiratory disease sars cov- positive sars cov- negative january   national administrative healthcare open datum mexico sars cov- infection confirm reverse transcriptase polymerase chain reaction general characteristic chronic comorbiditie explore clinical outcome interest hospital admission pneumonia intensive care unit admission endotracheal intubation mortality prevalence chronic comorbiditie multivariate logistic regression analysis show effect age male sex bronchial asthma diabetes mellitus chronic kidney disease clinical outcome similar sars cov- positive negative patient adverse clinical outcome associate time symptom onset medical contact chronic obstructive pulmonary disease hypertension obesity sars cov- positive patient cardiovascular disease sars cov- negative patient p value comparison chronic comorbiditie commonly find patient suspicion viral respiratory disease knowledge impact comorbiditie adverse clinical outcome well define covid- patient high risk different impact specific type chronic comorbidity clinical outcome patient sars cov- infection require research finding need confirmation datum source
396,december covid- arouse global attention study link obesity severe outcome influenza covid- aim compare impact obesity severity mortality influenza covid- perform meta analysis systematic search perform medline emase clinicaltrials.gov web science january  july protocol register prospero crd selection  study include meta analysis pooled odd ratio ors confidence interval cis analyze find obesity risk factor severity mortality influenza orsevere outcome ci ormortality ci covid- obesity significant risk factor severe outcome ci mortality ci compare obesity morbid obesity link high risk severity mortality influenza ci covid- ci obesity recommend risk factor prognosis assessment covid- special monitoring early treatment implement patient obesity covid-
397,objective aim investigate clinical characteristic risk factor severe case coronavirus disease  covid- comparison non severe patient method search pubmed embase web science cnki collect relevant study publish july total  paper include meta analysis result severe covid- patient ci male ci  year old ci obese ci comorbiditie prevalent comorbiditie hypertension ci diabetes ci cardiovascular disease cvd ci common blood test abnormality elevate c reactive protein crp -% decrease lymphocyte count -% increase lactate dehydrogenase ci addition abnormal laboratory finding reveal organ dysfunction frequently observe severe case include decrease albumin ci increase aspartate aminotransferase ci alanine aminotransferase ci troponin troponin t tni tnt ci serum cr scr ci conclusion male elderly obese patient comorbiditie especially hypertension diabetes cvd likely develop severe case association hypertension diabetes cvd severity covid- decline increase age significant elevation cardiac tni tnt hepatic enzyme scr reduction lymphocyte elevated crp important marker severity specific attention give elderly male obese patient indication severe immune injury combination bacterial infection indication multi organ dysfunction damage
398,persistence symptom development new symptom relate sars cov- infection late course covid- increasingly recognise problem face globally infect population health system long covid covid long hauler generally describe person covid- experience symptom gt day diagnosis laboratory confirm clinical symptom markedly heterogeneous see acute covid- constant fluctuate appear replace symptom relate system vary frequency multisystem involvement require holistic approach management long covid description cohort low- middle income country eagerly await person long covid manage primary care require great input rehabilitation medicine expert eventuality planning urgently require ensure south african public health service ready able respond
399,coronavirus disease  covid- epidemic spread globally study reveal obesity affect progression prognosis covid- patient aim meta analysis identify prevalence impact obesity covid- study obese covid- patient obtain search pubmed cochrane library database web science database date  june prevalence rate odd ratio obesity confidence interval ci comprehensive indicator analysis random effect model total  patient  study include prevalence obesity patient covid- ci -% obese patient time likely develop severe covid- non obese patient ci p obesity associate death covid- patient ci p dose response analysis estimate covid- patient increase risk invasive mechanical ventilation ci p increase risk admission icu ci p  kg m increase bmi conclusion obesity covid- patient associate severity mortality
400,objective conestat alfa recombinant human c esterase inhibitor multi target inhibitor inflammatory cascade include complement kinin kallikrein contact activation system study objective investigate efficacy safety conestat alfa improve disease severity short term outcome covid- patient pulmonary disease trial design study investigator initiate randomized (: ratio open label parallel group control multi center phase clinical trial participant trial conduct  hospital switzerland  hospital brazil  hospital mexico academic non academic patient confirm sars cov- infection require hospitalization  calendar day severe covid- screen study eligibility inclusion criteria sign informed consent age year evidence pulmonary involvement ct scan x ray chest duration symptom associate covid- /=  year obesity bmi  kg m history cardiovascular disease chronic pulmonary disease chronic renal disease c reactive protein mg l oxygen saturation rest breathe ambient air exclusion criterion incapacity inability provide informed consent contraindication class drug investigation c esterase inhibitor treatment tocilizumab il r il- inhibitor enrolment history suspicion allergy rabbit pregnancy breast feeding active anticipate treatment complement inhibitor liver cirrhosis child pugh score admission icu day anticipate  hour enrolment invasive non invasive ventilation participation study investigational drug  day prior enrolment enrolment study investigator family member employee closely relate dependent person intervention comparator patient randomize experimental arm receive conestat alfa addition standard care soc conestat alfa u follow  u  hour administer slow intravenous injection minute period i.e.  administration total conestat alfa treatment administer day enrolment control group receive soc soc treatment administer accord local institutional guideline include supplemental oxygen antibiotic corticosteroid remdesivir anticoagulation main outcomes primary endpoint trial disease severity day  enrolment assess adapt ordinal scale clinical improvement score  omit score   combine  limitation activity  death secondary outcome include time clinical improvement time randomization improvement point ordinal scale discharge hospital  day enrolment ii proportion participant alive having require invasive non invasive ventilation  day enrolment iii proportion subject acute lung injury define pao fio ratio  day enrolment exploratory outcome include virological clearance c esterase inhibitor pharmacokinetic change routine laboratory parameter inflammatory protein randomisation subject randomise ratio treatment conestat alfa addition soc soc randomization perform interactive web response system secutrial(r blind masking open label trial participant caregiver outcome assessor blind group assignment number randomised sample size randomise approximately  individual active treatment arm  soc group interim analysis   patient plan accord pocock adjusted level alphap result interim analysis allow adjustment sample size lehmacher wassmer trial status protect covid- protocol version july  participant recruitment start july  center basel switzerland participant include august  study center patient actively recruit participation fifth study center mexico anticipate mid december completion trial recruitment depend development sars cov- pandemic trial registration clinicaltrials.gov number nct register  june  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
401,coronavirus disease  covid- pandemic challenge healthcare system time excellent catalyzer promoter successful translational research covid- simple viral infection bronchial system pandemic hyperinflammatory multiorgan disease cardiovascular system play causal role context severe acute respiratory syndrome coronavirus  sars cov- invade host cell angiotensin convert enzyme  ace- enzyme renin angiotensin system furthermore cardiovascular comorbiditie risk factor hypertension diabetes obesity play important role severity course disease additional risk factor gender age genetic air pollution modulate severity sars cov infection cardiovascular disease sequelae covid- increase thrombosis myocardial infarction myocardial inflammation vasculitis occur directly damage cardiovascular system substantially contribute high morbidity mortality knowledge gain study course disease patient infect sars cov lead improve treatment possibility second wave partly standardized particular adapt complication cardiovascular system review provide short overview pathophysiology sars cov general specifically cardiovascular system furthermore summarize current treatment approach pathophysiological principle status november
402,obesity emerge significant risk factor severe covid- worldwide give covid- infection obesity associate increase systemic inflammation evaluate inflammatory marker obese non obese individual hospitalize covid- massachusetts general hospital hypothesize obese patient exuberant inflammatory response evidence high initial peak inflammatory marker bad clinical outcome  patient  obese obese individual high initial peak level crp esr high peak d dimer p comparison non obese individual il- ferritin similar addition obese individual high odd require vasopressor use ci p develop hypoxemic respiratory failure ci p death ci p  day presentation care finally high baseline level crp d dimer associate bad clinical outcome adjustment bmi finding suggest great disease severity obese individual characterize exuberant inflammation
403,disease covid- novel coronavirus pandemic far infect million result death million people oct infect covid- mild symptom rest infected case severe symptom result significant mortality age emerge major factor predict severity disease mortality rate significantly high elderly patient patient underlying condition like type  diabetes cardiovascular disease hypertension cancer increase risk severe disease death covid- infection obesity emerge novel risk factor hospitalization death covid- independent study observe people obesity great risk severe disease death covid- review publish datum relate obesity overweight assess possible risk outcome covid- patient base body weight explore obese host provide unique microenvironment disease pathogenesis result increase severity disease poor outcome
404,background limited information association upper respiratory tract urt viral load host factor disease severity sars cov infected patient method study  patient mean age  year diagnose polymerase chain reaction pcr urt viral load measure pcr cycle threshold categorize high moderate low result  patient comorbiditie  patient .% high  moderate  .% low viral load univariate analysis compare patient moderate low viral load patient high viral load old comorbiditie develop symptomatic disease covid- intubate die patient high viral load long stay intensive care unit long intubation compare patient low viral load p value comparison patient chronic cardiovascular disease hypertension chronic pulmonary disease immunosuppression obesity chronic neurological disease high viral load p value comparison multivariate analysis high viral load associate covid- level viral load associate outcome conclusion urt viral load identify patient high risk morbidity severe outcome
405,background coronavirus disease  covid- infection cause alteration coagulation mechanism conditioning thrombotic phenomenon acute limb ischemia ali manifestation infection aim study describe clinical surgical characteristic group patient infect severe acute respiratory syndrome coronavirus  present ali context covid- pandemic lima peru method multicenter observational retrospective study perform general hospital march july variable consider pathological history associated habit laboratory test severity covid- infection ali anatomic location lesion treatment evolution discharge condition result thirty patient ali infect covid- evaluate mean age   year condition frequent man main comorbiditie arterial hypertension .% obesity diabetes mellitus  .% asymptomatic patient manifestation ali rutherford iia iib stage include .% patient frequent location thrombosis low limb vs. .% thrombectomy perform .% patient amputation primary secondary perform patient mortality rate acute respiratory distress syndrome conclusion ali vascular pathology associate embolic thrombotic process covid- infection cause severe alteration coagulation mechanism lead patient present severe acute arterial complication thrombosis associate manifestation report young cohort describe study high frequency amputation despite adequate surgical treatment
406,introduction currently diabetes mellitus dm coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- major public health issue worldwide background suggest patient dm vulnerable sars cov- infection suffer severe form disease method literature search perform pubmed scopus google search engine result angiotensin convert enzyme- ace major receptor sars cov- human host differential expression ace lung patient dm make susceptible covid- additionally acute chronic hyperglycemia render individual immune suppressive state impaired innate adaptive immunity function contribute severity covid- infection patient dm factor contribute severe course covid- include coexistence obesity tdm endothelial inflammation induce sars cov- infection aggravate endothelial dysfunction observe tdm tdm hypercoagulability present covid- infection increase thrombotic tendency dm conclusion review summarize pathophysiologic mechanism underlie coexistence pandemic current recommendation future perspective optimal treatment inpatient outpatient dm era sars cov- infection notably currently recommend drug treatment severe covid- dexamethasone remdesivir cause hyperglycemia adverse effect physician bear mind care patient dm covid-
407,background angiotensin convert enzyme  ace identify entry receptor coronaviruse human cell include severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease  covid- hypertension ht lead comorbidity non survivor covid- test association ace gene ht interaction specific pre existing condition know associate covid- severity method genetic analysis ace gene conduct french canadian fc british population result fc individual t allele single nucleotide polymorphism rs ace gene risk factor ht adult obese male odd ratio confidence interval ci obese male smoke ci lean male non smoker male female t allele significantly associate severity ht early penetrance ht obese smoking male significant interaction t allele obesity present sex association ace rs genotype blood pressure see adolescent interaction obesity present female variant ace gene find associate ht obese smoke male british individual uk biobank addition observe severe outcome covid- association ace risk allele obese smoke male conclusion report ace variant associate early penetrance severe ht severe outcome covid- obese smoking male
408,objective understand risk factor predictor clinical presentation coronavirus disease  covid- pediatric patient severe disease method conduct retrospective chart review pediatric patient admit march large health network new jersey positive test result severe acute respiratory syndrome coronavirus  reverse transcriptase polymerase chain reaction rapid testing serum immunoglobulin g testing include demographic characteristic clinical feature outcome result total  patient year old admit positive test result severe acute respiratory syndrome coronavirus  reverse transcriptase polymerase chain reaction and/or serum immunoglobulin testing seven patient .% admit management acute covid- infection  .% admit management multisystem inflammatory syndrome child mis c  hospitalize patient  .% require intensive care majority patient .% admit acute covid- infection mis c hispanic underlie chronic health condition present patient obesity mean bmi note patient mis c require icu care statistically significant absolute lymphopenia elevated level inflammatory marker statistically significant patient mis c treat icu conclusion study add grow literature potential risk factor severe disease pediatric patient covid- infection mis c. patients hispanic ethnicity represent majority patient acute covid- infection mis c despite represent population hospital serve infant patient chronic health condition increase risk severe disease absolute lymphopenia elevated level inflammatory marker associate severe disease
409,introduction pregnant woman report increase risk severe coronavirus disease  covid- underlying immunosuppression pregnancy clinical course covid- pregnancy risk vertical horizontal transmission remain relatively unknown aim describe evaluate outcome pregnant woman covid- singapore method prospective observational study  pregnant patient admit covid-  tertiary hospital singapore outcome include severe disease pregnancy loss vertical horizontal transmission result  patient .% .% .% infect second trimester respectively gravida age year .% develop severe pneumonia patient body mass index m require transfer intensive care median duration acute infection  day patient remain reverse transcription polymerase chain reaction rt pcr positive week diagnosis maternal mortality pregnancy produce term live birth  spontaneous miscarriage occur   week rt pcr breast milk maternal neonatal sample take birth negative placenta cord histology show non specific inflammation severe acute respiratory syndrome coronavirus  sars cov-)-specific immunoglobulin elevate pair maternal umbilical cord blood n= conclusion majority covid- infect pregnant woman mild disease  woman risk factor obesity old age severe infection represent slightly high incidence observe age match non pregnant woman woman deliver definitive evidence mother child transmission breast milk placenta
410,introduction coronavirus infectious disease  covid- currently important public health crisis affect global human population continue spread widely world lack specific treatment vaccine virus scenario covid- yemen obscure lack adequate datum develop electronic questionnaire distribute online yemeni people aim study understand covid- epidemiological situation yemen well currently limited publish datum limited availability covid- testing methodology -question web base survey distribute social medium outlet target people yemen datum aggregation analysis visualization perform tableau microsoft excel result individual report symptom concern covid- infection .% report chronic medical condition diabetes hypertension asthma immune deficiency associate increase severity disease obesity cardiovascular disease kidney disease liver disease  individual .% confirmatory covid- pcr test presence high fever dyspnea chest pain dysphagia symptom tend correlate bad clinical outcome conclusion study provide important information early overspread covid- yemeni community june july show online questionnaire help collect datum pandemic resource limit country testing availability limited
411,objective recently influential article report association hydroxy)chloroquine angiotensin convert enzyme ace inhibitor coronavirus disease  covid- mortality retract significant methodological issue aim analyze clinical issue improved research method find difference retract paper systematically pre existing literature compare result retract paper gain novel insight materials method extract common risk factor identify retract paper conduct relevant publication search june  pubmed analyze risk factor covid- mortality compare retract paper result systematic review demonstrate demographic clinical risk factor covid- mortality similar retract paper retract paper indicate hydroxy)chloroquine monotherapy combination therapy macrolide associate high risk mortality study show combination therapy hydroxychloroquine macrolide associate high risk mortality odd ratio confidence interval .- addition study demonstrate use ace inhibitor angiotensin receptor blocker arb associate reduce risk mortality conclusion analyze clinical issue retract paper systematic review randomized control trial relevant cohort study find hydroxy)chloroquine monotherapy associate high risk mortality use ace inhibitor arb associate reduce risk mortality covid- patient
412,introduction obesity diabetes hypertension age point factor influence progression covid- evidence condition inconclusive objective identify clinical characteristic relate covid- severity determine age act modifier relationship cardio metabolic comorbiditie cmc covid- progression method datum -year old confirm case n analyze hospitalization development pneumonia intubation requirement intensive care unit admission death dependent variable poisson regression model estimation interaction age different cmc independent variable result have cmcs comorbiditie directly relate covid- progression chronic obstructive pulmonary disease relate increase risk die risk covid- severity low age advanced asthma smoking risk factor progression covid- conclusion mexican population risk covid- progression associate comorbiditie high young adult
413,background aim identification sars cov infect patient high risk poor prognosis crucial aim establish predictive model covid- pneumonia severity hospitalize patient method retrospective study  patient admit vall d'hebron hospital barcelona covid- pneumonia model identify patient require high flow oxygen support generate baseline datum follow analytical result calibration perform -bootstrap replication model result  male mean age year overall  .% require high flow oxygen support baseline predictive model show roc base spo fio adjust hazard ratio ahr chest x ray ahr prior immunosuppressive therapy ahr obesity ahr il- ahr platelet ahr cut  present specificity .% second model include change analytical parameter ferritin ahr ml il- ahr  ml plus chest x ray ahr show roc cut  exhibit negative predictive value conclusion spo fio chest x ray admission change inflammatory parameter il- ferritin allow early identification covid- patient risk high flow oxygen support benefit intensive disease management
414,background verify prevalence low zinc level critically ill patient infect severe acute respiratory syndrome coronavirus  sars cov- intensive care unit icu require invasive mechanical ventilation association severity acute respiratory distress syndrome ards method observational study compose patient admit icu demographic anthropometric datum calculate body mass index bmi laboratory datum obtain admission blood count ferritin arterial blood gas serum zinc level c reactive protein arterial oxygen tension pao divide fractional inspire oxygen fio calculate arterial blood gas intubation diagnosis severe ards determine pao ratio mm hg low zinc level establish zinc level mug dl. result total  patient meet inclusion criterion .% man median age  year .% elderly median bmi kg m .% patient have overweight obesity prevalence low zinc level severe ards association low zinc level severe ards odd ratio ci p adjust baseline variable ci p conclusion critically ill patient infect sars cov- severe ards high prevalence low serum zinc level
415,give global health burden cause coronavirus disease  covid- numerous study aim understand clinical course determine risk factor impact prognosis pre exist medical condition link covid- severity particularly cardiometabolic disease increase evidence link metabolic associate fatty liver disease mafld severe covid- illness review different publish clinical datum relate association mafld covid- severity review show publish study consistently support association mafld severe covid- adjustment confound factor observe increase hepatic fibrosis score correlate increase severity covid- finally young age obesity mafld patient lead great risk severe illness
416,current covid- pandemic great challenge worldwide researcher human microbiota area mechanism long term effect infection gi level deeply understand current review scientific literature include original research article clinical study epidemiological report review type article concern human intestinal infection sars cov- possible consequence microbiota follow aspect pertain covid- discuss transmission resistance human body impact nutritional status relation intestinal microbiota impact comorbid metabolic disorder inflammatory bowel disease ibs obesity type diabetes td article investigate health age nutritional status associate specific community bacterial specie gut influence clinical course covid- infection fecal microbiota alteration associate fecal concentration sars cov- covid- severity patient suffer metabolic gastrointestinal gi disorder think moderate high risk infection sars cov- indicate direct implication gut dysbiosis covid- severity additional effort require identify initial gi symptom covid- possible early intervention
417,increase prevalence obesity grow awareness impact infectious disease past epidemic influenza middle east respiratory syndrome mers coronavirus obesity identify risk factor influence severity illness infected person severe acute respiratory syndrome coronavirus  sars cov- responsible large number death health damage worldwide increase number report link obesity severe covid- disease death review focus impact obesity patient covid- comprehensively analyze mechanism obesity affect severity disease addition basis vulnerability people obesity covid- epidemic summarize individual level hospital level prevention management measure covid- patient obesity discuss impact isolation people obesity
418,retrospectively investigate  consecutive hospitalise covid- patient aged   year  male prognostic value ct derive subcutaneous adipose tissue visceral adipose tissue vat metric test predictive model admission intensive care unit icu pre existing comorbiditie multivariate logistic regression identify vat score good icu admission predictor odd ratio non relevant contribution comorbiditie receiver operate characteristic analysis area curve ct base model include comorbiditie highlight potential stop shop prognostic role ct derive lung adipose tissue metric
419,background aim observational study recently report outcome non insulin anti diabetic agent ada patient tdm coronavirus disease  covid- seek review literature appraise clinician outcome method literature search specific keyword carry database pubmed google scholar till december  apply boolean method text relevant article report outcome ada patient tdm covid- retrieve subsequently appraisal literature report narratively present result available study report outcome ada case series retrospective cohort prospective observational study absence randomized control trial rct result observational study suggest non insulin ada metformin user prior hospitalization improve outcome compare non user datum dipeptidyl peptidase- inhibitor dpp encouraging inconsistent documentation harm benefit observe sulfonylureas sus sodium glucose co transporter- inhibitor sglt glucagon like peptide receptor agonist glp ras data available pioglitazone conclusion metformin dpp continue patient tdm hospitalization contraindicate evidence harm suggest sus sglt glp ras stop sick hospitalize contraindicate result rct need claim meaningful benefit metformin dpp patient tdm covid-
420,background scarcity datum consequence coronavirus disease- covid- infection kidney transplant recipient ktrs emerge country method present cohort study  transplant center india include  ktr living  deceased donor polymerase chain reaction confirm covid- positivity march september detail demographic immunosuppression regimen clinical profile treatment outcome result median age transplant recipient  year recipient present median year transplant common comorbiditie include arterial hypertension diabetes present symptom time covid- include fever cough sputum production clinical severity range asymptomatic mild moderate severe strategy modify immunosuppressant include discontinuation antimetabolite change calcineurin inhibitor steroid risk factor mortality include old age dyspnea severe disease obesity allograft dysfunction covid- infection acute kidney injury high level inflammatory marker include c reactive protein interleukin- level procalcitonin chest x ray abnormality intensive care unit ventilator requirement overall patient mortality .% hospitalize patient intensive care unit patient .% patient require ventilation ktr mild covid- symptom n manage outpatient optimize utilization scarce resource covid- pandemic conclusion mortality rate covid positive ktr appear high nonimmunosuppressed patient high mortality note require intensive care ventilator
421,background prognosis patient covid- infection uncertain derive validate new risk model predict progression disease severity hospitalization admission intensive care unit icu mortality patient covid- infection gal covid- score method retrospective cohort study patient covid- infection confirm reverse transcription polymerase chain reaction rt pcr galicia spain datum extract electronic health record patient include age sex comorbiditie accord international classification primary care code icpc- logistic regression model estimate probability disease severity calibration discrimination evaluate assess model performance result incidence infection  patient total  patient .% require hospitalization  .% admit icu  .% die variable include model predict severity include age gender chronic comorbiditie cardiovascular disease diabetes obesity hypertension chronic obstructive pulmonary disease asthma liver disease chronic kidney disease haematological cancer model demonstrate fair good fit predict hospitalization auc area receiver operating characteristic roc curve confidence interval ci admission icu auc ci death auc ci conclusion gal covid- score provide risk estimate predict severity covid- patient ability predict disease severity help clinician prioritize high risk patient facilitate decision making health authority
422,owe limited datum conduct meta analysis evaluate relationship obesity coronavirus- covid- literature publish  january   august  comprehensively analyse revman datum analysis total  study include datum  patient available obesity associate high risk severe acute respiratory syndrome coronavirus  sars cov infection odd ratio confidence interval ci p increase severity covid- hospitalisation rate ci p severe case ci p need intensive care unit admission ci p need invasive mechanical ventilation ci p mortality ci p find non linear association bmi severity covid- conclusion find obesity increase risk sars cov infection aggregate severity covid- study need explore possible mechanism association
423,background syndrome ds characterize series immune dysregulation interferon hyperreactivity important responsible surge antiviral response possible initiation amplify cytokine storm biological condition attribute immune regulator encode chromosome ds characterize coexistence obesity cardiovascular respiratory anomaly risk factor coronavirus disease covid- cause severe acute respiratory syndrome coronavirus  sars cov- case presentation total  child admit pediatric ward bergamo february  covid- describe case child ds confirm covid- diagnosis severe course addition case involve comorbiditie include cardiovascular anomaly obesity and/or obstructive sleep apnea conclusion observation indicate child ds risk severe covid- disease course
424,severe acute respiratory syndrome coronavirus  sars cov- infection able produce excessive host immune reaction lead severe disease- life threaten condition occur patient suffer comorbiditie hypertension diabetes obesity infection human corona virus highly depend host microrna mir involve regulation host innate immune response inflammation modulatory mir mirs induce immune reaction virus recent analysis show mir- predict target sars cov- genome dominant regulator toll like receptor tlrs downstream signal mir limit excessive inflammatory response virus downregulation circulate mir find diabetes obesity hypertension reflect enhanced inflammation fibrosis systemic effect accompany severe covid- hypothesize mir deficiency contribute severe covid- state observe diabetes obesity hypertension investigation need
425,objective emergence coronavirus disease covid- death toll increase daily risk factor associate high mortality rate covid- establishment common pathway risk factor improve understanding covid- severity mortality review aim establish common pathway possible effect covid- mortality material method current review execute consecutive stage start determine risk factor covid- mortality try find common pathway depend available literature follow propose mechanism explain common pathway increase mortality finally potential role manage covid- propose result review identify common pathway low baseline reduce glutathione i.e. gsh level particular review provide depth discussion pathophysiology covid- lead gsh depletion tissue damage acute respiratory distress syndrome addition current review demonstrate gsh depletion result failure immune system render end organ vulnerable damage oxidative stress conclusion preclinical study show gsh depletion central role covid- mortality pathophysiology elevate gsh level tissue decrease severity mortality rate covid-
426,emerge evidence reveal strong association covid- obesity term disease severity need hospitalisation risk mortality review discuss cellular molecular mechanism potentially contribute pathophysiology covid- obese patient understand relationship covid- obesity pertinent clinical management patient
427,objective measure association race ethnicity comorbiditie insurance status need hospitalization symptomatic emergency department ed patient severe acute respiratory syndrome coronavirus  sars cov- infection method study retrospective case series symptomatic patient present single ed laboratory confirm sars cov- infection march -august collect patient level information demographic public insurance status medicare medicaid comorbiditie level care mortality structured chart review compare demographic comorbiditie patient able convalesce home require admission general medical service require admission intensive care unit icu die  day index visit multivariable logistic regression analysis perform report adjusted odd ratio aor associated confidence interval ci hospital admission versus ed discharge home result total  patient present ed symptom include analysis  .% patient require hospital admission  patient require icu care patient require admission likely black african american hispanic latino public insurance medicaid medicare multivariable logistic regression analysis compare patient require hospital admission african american race aor ci hispanic ethnicity aor ci .- associate need admission public insurance medicaid aor ci medicare aor ci medicaid medicare aor ci presence hypertension aor ci diabetes aor ci obesity aor ci heart failure aor ci hyperlipidemia aor ci .- identify independent predictor hospital admission conclusion comorbiditie public insurance predictor severe illness patient sars cov- study suggest disparity severity see covid- african americans hispanics likely closely relate low socioeconomic status chronic health condition reflect independent predisposition disease severity
428,severe acute respiratory syndrome coronavirus  sars cov- affect million people worldwide pandemic wane despite associated significant morbidity mortality definitive cure fully preventative measure combat sars cov- urgency identify pathobiological mechanism underlie increase risk severity sars cov- infection mount contribute factor accumulation damage associate molecular pattern molecule lead trigger activation nuclear factor kb irf interferon regulatory factor irf activation pathway particularly lung organ heart contribute burst cytokine release predispose significant tissue damage loss function mortality receptor advanced glycation end product rage bind damage associate molecular pattern express lung heart prime organ blood vessel diabetes adipose tissue obesity transduce pathological signal emit damage associate molecular pattern propose damage associate molecular pattern rage enrichment prime tissue lung heart active infection contribute widespread tissue damage induce sars cov- accordingly rage axis play seminal role target therapeutic intervention sars cov- infection
429,background covid- pandemic risk stratification decide patient eligibility inpatient critical domiciliary care seek validate msl covid- score originally develop predict covid- mortality mexicans adaptation formula propose prediction covid- severity triage setting nutri cov method include patient evaluate march th august th  instituto nacional de ciencias medicas y nutricion define severe covid- composite death icu admission requirement intubation n validate msl covid- prediction mortality severe disease elastic net cox regression train n validate n model prediction severe covid- msl covid- clinical assessment obtain triage setting result variable include msl covid- pneumonia early onset type  diabetes age  year chronic kidney disease form immunosuppression copd obesity diabetes age year msl covid- good performance predict covid- mortality c statistic ci severity c statistic ci nutri cov score include msl covid- plus respiratory rate pulse oximetry tool well performance training c statistic ci validation cohort c statistic ci compare severity score conclusion msl covid- predict inpatient covid- lethality nutri cov score adaptation msl covid- triage environment score deploy web base tool clinical use triage setting
430,background cohort severely ill patient covid- describe country globe date publish report united kingdom uk understand characteristic affected population admit intensive care unit icu uk crucial inform clinical decision making research planning future wave infection method conduct prospective observational cohort study patient covid- admit large uk icu march  follow june datum collect health record standardised template multivariable logistic regression analyse factor associate icu survival result  patient include  male  overweight obese  ethnic minority  aged  year age  receive mechanical ventilation  intubate place prone position  intubate receive neuromuscular blockade  patient require cardiovascular support  require renal replacement therapy  patient complete icu episode  die  discharge alive icu multivariable model age ci obesity ci low p f ratio day admission ci paco ci independently associate icu death conclusion age obesity severity respiratory failure key determinant survival cohort multiorgan failure prevalent finding important guide future research take consideration future healthcare planning uk
431,evidence relation sars cov- mortality underlie medical condition scarce conduct observational retrospective study base romanian official datum location age gender comorbiditie covid- fatality finding indicate male hypertension diabetes obesity chronic kidney disease frequent covid- fatality burden disease low prognosis survival probability high sample evidence show age dependent pair comorbiditie negative prognosis factor severity disease sars cov  infection
432,background rapid spread coronavirus disease  covid- reveal significant constraint critical care capacity anticipation subsequent wave reliable prediction disease severity essential critical care capacity management enable early target intervention improve patient outcome purpose study develop externally validate prognostic model clinical tool predict covid- critical disease presentation medical care method retrospective study prognostic model prediction covid- critical disease critical disease define icu admission ventilation and/or death derivation cohort develop multivariable logistic regression model covariate include patient comorbiditie present vital sign laboratory value model performance assess validation cohort concordance statistic model develop consecutive patient covid- present university california irvine medical center orange county california external validation perform random sample patient covid- emory healthcare atlanta georgia result total  patient test derivation cohort positive covid- clinical datum include past medical history present laboratory value available patient median age  year range year male common comorbiditie include obesity hypertension diabetes critical disease present backward stepwise selection follow factor associate great increase risk critical disease number comorbiditie body mass index respiratory rate white blood cell count lymphocyte serum creatinine lactate dehydrogenase high sensitivity troponin ferritin procalcitonin c reactive protein total  patient validation cohort median age  year range year male critical disease present model discrimination validation cohort high concordance statistic confidence interval .- web base tool develop enable clinician input patient datum view likelihood critical disease conclusion relevance present model accurately predict covid- critical disease risk comorbiditie present vital sign laboratory value derivation validation cohort different institution validate additional cohort patient model clinical tool provide useful prognostication critical care need
433,march world health organization declare  coronavirus disease covid- cause novel coronavirus sars cov pandemic virus infect million individual result death worldwide june discuss spatial correlation county population health ranking incidence covid- case covid- relate death united states analyze spread disease base multiple variable county level publicly available datum number confirm case death intensive care unit bed socio demographic healthcare resource u.s. result indicate substantial geographical variation distribution covid- case death county significant positive global spatial correlation percentage black americans case covid- moran p similar result find global spatial correlation percentage black american death covid- county level u.s. moran p significant spatial correlation hispanic population covid- case death high percentage non hispanic white significantly negatively spatially correlate case moran p death moran p disease study show significant weak spatial autocorrelation number intensive care unit bed covid- case moran p death moran p respectively finding provide detail interplay infectious disease healthcare relate characteristic population understand relationship possible mitigate rate spread severity disease
434,introduction global public health challenge concurrent epidemic covid- obesity consider global prevalence obesity explore relationship covid- clinical importance aim provide comprehensive summary recommendation relationship covid- obesity method literature search perform prepare narrative review covid- obesity result obesity state promote chronic inflammation vitamin d deficiency hinder immunity cause mechanical lung compression increase susceptibility covid- infection complication include requirement invasive ventilation exist co morbidity enhance complication preventive measure social distancing self isolation increase stigmatisation psychological deterrent special recommendation target vulnerable population require conclusion obese population covid- vulnerable group require special attention pandemic avoid complication healthcare system burden lack covid- vaccination regular physical activity healthy diet recommend attention mental health prolonged quarantine duration administration prophylactic vitamin d consider
435,covid- pandemic affect  million people worldwide mortality exceed patient risk factor associate severe disease mortality include advanced age hypertension diabetes obesity risk factor pathologically disrupt lipidome include immunomodulatory eicosanoid docosanoid lipid mediator lms hypothesize dysregulation lms define feature severity covid- examine lms polyunsaturated fatty acid precursor lipid serum hospitalize covid- patient demonstrate moderate severe disease separate specific difference abundance immune regulatory proinflammatory lms difference lm balance correspond decrease lm product alox cox increase lms product alox cytochrome p. give important immune regulatory role lms datum provide mechanistic insight immuno lipidomic imbalance severe covid-
436,number investigation efficacy safety etanercept study perform obtain long term drug survival datum ie time drug discontinuation etanercept reason discontinuation study population consist patient psoriatic arthritis psoriasis follow clinic register turkish psoriasis registry psr tr treat etanercept  week january january efficacy etanercept evaluate term psoriasis area severity index pasi pasi  pasi  response rate  week annually behavior patient respect use etanercept outcome continue use covid- pandemic investigate
437,backgroundin march covid- outbreak declare pandemic world health organization aimour objective identify risk factor predictive severe disease death france methodsin prospective cohort study include patient  year old confirmed covid- hospitalise strasbourg mulhouse hospital france march respectively compare patient develop severe disease admission intensive care unit icu death patient die day  hospitalisation resultsamong patient  severe disease include  admit icu  die mean age  year range  man patient body mass index bmi datum n bmi  kg m n independent risk factor associate severe disease advanced age odd ratio increase cri credible interval male sex cri bmi kg m cri  cri dyspnoea cri inflammatory parameter elevated c reactive protein neutrophil count low lymphocyte count risk factor associate death advanced age increase cri male sex cri immunosuppression cri diabetes cri chronic kidney disease cri dyspnoea cri inflammatory parameter conclusionsoverweightedness obesity advanced age male sex comorbiditie dyspnoea inflammation risk factor severe covid- death hospitalise patient identify feature patient routine clinical practice improve covid- management
438,increased morbidity mortality coronavirus disease  covid- people obesity illuminate intersection obesity impaired response infection datum mechanism covid- impact health rapidly generate critical need well understand pulmonary vascular metabolic immunologic aspect drive increase risk complication covid- people obesity review provide broad overview intersection covid- physiology obesity order highlight potential mechanism covid- disease severity increase obesity identify area future investigation develop tailored therapy people obesity develop covid-
439,coronavirus disease  covid- global health disaster patient covid- variable clinical feature unpredictable prognosis infectious complication occur organ cause broad spectrum symptom severity pulmonary embolism pe fatal urgent complication occur follow severe infection pathogenesis pe covid- remain uncertain mainly occur patient severe disease pe initial presentation covid- patient mild disease rare understudied describe young woman mild covid- illness significant risk factor pe obesity develop bilateral popliteal vein thrombosis submassive pe case emphasize thrombotic complication occur covid- patient regardless disease severity question role preventive anticoagulant mild covid- case certain risk factor
440,background aim coronavirus disease  covid- know cause broad spectrum illness evidence obesity relate condition increase severity covid- disease especially age limited research mortality rate base body mass index bmi old adult population define age objective study characterize outcome old adult infect covid- base bmi study design method single center retrospective cohort study old adult covid- infection primary outcome hospital mortality secondary outcome assess oxygen requirement need mechanical ventilation duration mechanical ventilation hospital length stay datum analyze student t test fisher exact test multiple logistic regression analysis appropriate result total  patient include study mean age year median bmi kg m. primary outcome hospital mortality occur .% patient bmi find predictor mortality age age  associate increase risk mortality ci ci respectively patient bmi /=  likely require mechanical ventilation ci ci ci respectively past medical history associate mortality conclusion cohort old adult covid- disease bmi independent predictor hospital mortality patient bmi /=  year likely require mechanical ventilation
441,background obesity widely report associate disease progression coronavirus disease  covid- study report different finding conduct systematic review meta analysis investigate association obesity poor outcome patient covid- pneumonia method systematic review meta analysis study pubmed embase web science database  november    perform study quality assess datum extraction conduct meta analysis carry fix effect random effect model calculate odd ratio ors poor outcome obese non obese covid- patient result study n patient include pooled analysis demonstrate body mass index bmi high severe critical covid- patient mild covid- patient md kg m ci kg m additionally obesity covid- patient associate poor outcome ci comprise severe covid- icu care invasive mechanical ventilation use disease progression ci ci ci ci respectively obesity risk factor great young patient vs. obesity increase risk hospital mortality ci conclusion result potentially critical role obesity determine severity covid- important collect anthropometric information covid- patient especially young group obesity associate hospital mortality effort understand impact obesity mortality covid- patient research priority future
442,previous study find correlation malnutrition prognosis respiratory infection objective determine percentage malnutrition ii prognosis patient admit coronavirus disease  covid- monocentric retrospective study consecutively include adult patient present acute covid-  april  malnutrition diagnose low body mass index bmi weight loss previous month and/or previous month nutritional risk index nri define nutritional risk severe covid- define need nasal oxygen  l min enrol  patient man   year bmi kg m include  .% severe covid- malnutrition find  patient moderate severe nutritional risk  patient malnutrition associate covid- severity nutritional risk associate severe covid- p p adjustment c reactive protein low plasma protein albumin prealbumin zinc level p main cause malnutrition inflammation high percentage malnutrition association nutritional risk covid- prognosis support international guideline advise regular screening nutritional support necessary
443,background scant datum currently available potential link comorbid chronic lung disease cld risk severity coronavirus disease  covid- infection method describe clinical characteristic outcome patient covid- infection include patient comorbid respiratory disease primarily hospitalize pulmonology department strasbourg university hospital france retrospective single center study include confirm case covid- march  april compare symptom biological radiological finding outcome patient cld result  patient enrol median age  year  patient male overall patient n= preexisting cld include chronic obstructive pulmonary disease copd n= asthma n= patient transfer intensive care unit icu patient die unit cld predictive icu hospitalization significantly high total mortality observe vs. .% p patient conclusion result suggest lack representation cld covid- represent patient cohort pulmonology department cld risk factor icu management tendency high global mortality observe covid- patient cld study warrant determine risk covid- patient comorbid cld
444,covid- exact disproportionate toll elderly diabetes patient likely require costly intensive care long hospitalisation die complication nation find extremely difficult lift sustain socially economically politically damaging restriction group people safe vaccine urgent need identify potential modifiable risk factor help manage overall fatality recovery rate case fatality rate highly variable nation nutritional difference propose account significantly disparity vitamin b deficiency common denominator elderly diabetes question hand lie manage b deficiency impact covid- fatality outcome recovery rate review late evidence show b deficiency associate multiple area similar covid- exert damaging effect immunologically microbiologically haematologically endothelial cell signal support hypothesis b deficiency potential modifiable risk factor fight covid-
445,aim obesity diabetes cardiovascular disease associate covid- risk severity epicardial adipose tissue eat express ace want identify main factor associate ace level cleavage enzyme adam epicardial fat materials method epicardial subcutaneous fat biopsy obtain  patient undergo open heart surgery  patient biopsy rna expression analysis real time pcr ace ace adam  patient stromal vascular cell submit adipogenesis study treatment effect gene expression level soluble ace determine supernatant elisa result epicardial fat biopsy express high level ace vs a.u p low adam subcutaneous fat vs a.u p gene increase epicardial fat patient type  diabetes mellitus tdm vs a.u p ace vs a.u p adam logistic regression analysis determine tdm main associated factor epicardial ace level p high ace level find patient diabetes obesity ace ace level upregulate antidiabetic treatment metformin insulin thiazolidinedione cellular level high epicardial subcutaneous stromal cell vs  correlate soluble ace conclusion epicardial fat cell express high level ace comparison subcutaneous fat cell enhance diabetes obesity presence patient cardiovascular disease risk factor sars cov- infection
446,background excess visceral fat vf high body mass index bmi risk factor severe covid- receptor severe acute respiratory syndrome coronavirus  sars cov- express high level vf subcutaneous fat scf obese patient aim visceral fat accumulation well predict severity covid- outcome compare scf amount bmi method select patient symptomatic covid- compute tomography ct scan severe covid- define requirement mechanical ventilation death fat depot quantify abdominal ct scan slice measurement correlate clinical outcome ace  mrna level quantify fat depot separate group non covid- subject rt qpcr result  patient mean bmi .+/-.kg m vf associate severe covid- p=. scf p=. subcutaneous fat different patient mild severe covid- scf vf ratio low patient severe covid- p=. good predictive value severe covid- find vf area roc curve independently associate covid- severity p exploratory analysis ace  mrna positively correlate bmi vf scf non covid- patient r()=. vs conclusion severe form covid- associate high visceral adiposity european adult basis exploratory analysis ace  visceral fat trigger cytokine storm need clarify future study
447,exposure virus bacteria pathogen unavoidable mere presence threat automatically predispose illness susceptibility individual viral bacterial infection dependent immune competence factor interfere functioning immune system epigenetic alteration form lifestyle environmental factor lead impaired immunity example exposure air pollution increase risk complication mortality covid- obesity exacerbate damaging effect air pollution lung enhance association air pollution increase covid- severity poor sleep factor lead impaired immunity likely coincide melatonin depletion melatonin find antiviral immune enhance effect propose hormone beneficial covid- patient zinc vitamin d c study ability shorten duration upper respiratory infection vitamin d find reduce mortality covid- patient cannabidiol directly indirectly improve immunity enhance natural killer cell activity reduce inflammation relieve stress dietary supplement back solid scientific evidence act immune enhancer astragalus yeast fermentate epicor(r olive leaf extract berberine n acetyl cysteine garlic
448,background obesity risk factor poor clinical outcome patient coronavirus disease  covid- objective investigate relationship prior metabolic surgery severity covid- patient severe obesity setting cleveland clinic health system united states method  patient test positive severe acute respiratory syndrome coronavirus  sars cov- march  july  cleveland clinic health system  patient identify prior history metabolic surgery surgical patient propensity match nonsurgical patient assemble cohort control patient n body mass index bmi  kg m time sars cov- testing primary endpoint rate hospital admission exploratory endpoint include admission intensive care unit icu need mechanical ventilation dialysis index hospitalization mortality propensity score matching outcome compare univariate multivariate regression model result average bmi surgical group kg m metabolic surgery time sars cov- testing compare control group bmi kg m univariate analysis  .% patient metabolic surgery group  .% patient control group admit hospital p multivariate analysis prior history metabolic surgery associate low hospital admission rate compare control patient obesity odd ratio confidence interval p  exploratory outcome occur metabolic surgery group  .% patient control group require icu admission p  .% require mechanical ventilation  .% require dialysis  .% patient die conclusion prior metabolic surgery subsequent weight loss improvement metabolic abnormality associate low rate hospital icu admission patient obesity infect sars cov- confirmation finding require large study
449,outbreak covid- raise numerous question interaction occurrence new infection environment climate health european union request h hera project aim set priority research environment climate health identify relevant research need covid- emergence spread sars cov- appear relate urbanization habitat destruction live animal trade intensive livestock farming global travel contribution climate air pollution require additional study importantly severity covid- depend interaction viral infection ageing chronic disease metabolic respiratory cardiovascular disease obesity influence environmental stressor mechanism interaction deserve additional scrutiny pandemic social response disease elicit array behavioural societal change remain long pandemic long term health effect include mental health recovery plan currently discuss implement environmental health impact plan clearly foresee clearly covid- long last impact environmental health field open new research perspective policy need
450,march world health organization declare coronavirus disease  covid- pandemic reality situation finally catch widespread reach disease presentation disease highly variable range asymptomatic carrier critical covid- availability angiotensin convert enzyme  ace receptor reportedly increase susceptibility and/or disease progression covid- comorbiditie risk factor note increase covid- susceptibility paper review evidence pertain ace relationship common comorbiditie risk factor therapy associate susceptibility severity covid- highlight gap knowledge require investigation primary comorbiditie respiratory disease cardiovascular disease renal disease diabetes obesity hypertension strong evidence secondary risk factor age sex race genetic limit moderate evidence tertiary factor ace inhibitor angiotensin ii receptor blocker limit moderate evidence ibuprofen thiazolidinedione limit evidence
451,introduction major clinical factor sex obesity comorbiditie associate covid- severity need identify new epidemiological clinical digital biological characteristic associate severity perform deep phenotyping patient accord severity objective predi covid study identify new determinant covid- severity conduct deep phenotyping patient stratify accord risk complication risk factor infection household member predi covid participant predi covid h ancillary study method analysis predi covid prospective hybrid cohort study compose laboratory confirm covid- case luxembourg follow remotely  year monitor health status symptom predi covid h ancillary cohort study household member index case include predi covid monitor symptom household cluster high risk population subcohort  predi covid  predi covid h participant biological sample include severity infection evaluate occurrence duration hospitalisation admission duration stay intensive care unit equivalent structure provision duration supplemental oxygen ventilation therapy transfer hospital impact infection daily activity follow hospital discharge ethics dissemination study approve national research ethics committee luxembourg study number april informed consent sign study participant scientific article submit international journal press release lay audience major result trial registration number nct
452,background speculation treatment angiotensin convert enzyme inhibitor ace angiotensin ii receptor blocker arb predispose severe coronavirus disease  covid- worsen outcome study assess association ace arb therapy development severe covid- method multi center prospective study enrol patient hospitalize covid- receive antihypertensive agent manage hypertension cardiovascular disease ace arb therapy association severe covid- day hospitalization intensive care unit icu admission mechanical ventilation hospital death follow test multivariate logistic regression model adjust age obesity chronic illness composite outcome mechanical ventilation death examine adjust cox multivariate regression model result  enrol patient  .% ace arb day hospital admission  continue ace arb therapy hospitalization ninety patient severe covid- significantly associate use ace arb ci p prehospitalization ace arb therapy associate icu admission mechanical ventilation hospital death continue ace arb therapy hospitalization associate decrease mortality ci p ace arb use associate develop composite outcome mechanical ventilation hospital death hr ci p versus ace arb conclusion patient hypertension cardiovascular disease receive ace arb therapy increase risk severe covid- admission hospital icu admission mechanical ventilation mortality associate ace arb therapy maintain ace arb therapy hospitalization covid- lower likelihood death clinical trial registration clinicaltrials.gov nct
453,latin america epicenter covid- pandemic region afflict social disparity poor healthcare access inadequate nutrition large prevalence noncommunicable chronic disease obesity comorbiditie increasingly prevalent latin america rapid growth individual low income currently disease associate covid- severity complication death document latin american association obesity societies collaborator present review burden pandemic latin america discuss possible mechanism explain relationship provide public health individual recommendation question future study
454,sars cov- induce novel coronavirus disease covid- outbreak significant medical challenge century covid- associate notable increase morbidity death worldwide preexisting condition like cardiovascular disease cvd diabetes hypertension obesity correlate high severity significant increase fatality rate covid- covid- induce multiple cardiovascular complexity cardiac arrest myocarditis acute myocardial injury stress induce cardiomyopathy cardiogenic shock arrhythmias subsequently heart failure hf precise mechanism sars cov- cause myocardial complication clearly understand propose mechanism myocardial injury base current knowledge direct viral entry virus damage myocardium systemic inflammation hypoxia cytokine storm interferon mediate immune response plaque destabilization virus enter cell angiotensin convert enzyme- ace receptor play central function virus pathogenesis systematic understanding cardiovascular effect sars cov need develop novel therapeutic tool target virus induce cardiac damage potential strategy minimize permanent damage cardiovascular system reduce morbidity review discuss current understanding covid- mediate damage cardiovascular system
455,objective limited information severity covid- infection child comorbiditie investigate effect pediatric comorbiditie covid- severity mean systematic review meta analysis publish literature method pubmed embase medline database search publication pediatric covid- infection publish january st october th article describe child comorbiditie covid- infection report outcome include result  study contain child comorbiditie child comorbiditie include severe covid- present .% child comorbiditie .% comorbiditie random effect analysis reveal high risk severe covid- child comorbiditie healthy child relative risk ratio ci child underlying condition high risk covid associated mortality relative risk ratio ci child obesity relative risk ratio ci conclusion child comorbiditie high risk severe covid- associated mortality child underlie disease additional study require evaluate relationship
456,kidney transplant kt recipient increase risk severe covid- immunosuppressed state -year old kt patient diagnose covid- month kt despite lymphopenia risk factor mild disease course nasopharyngeal real time reverse transcriptase polymerase chain reaction sars cov- negative  day detection sars cov- igg antibody negative day ttv dna load increase onset covid- reduce resolution report ttv dna load measure course covid-
457,history human race face pandemic substantial number fatality covid- pandemic affect planet country moderate strong healthcare support expenditure struggle contain disease transmission casualty country affect covid- different demographic socioeconomic lifestyle health indicator context important find extent parametric variation modulate disease outcome answer study select demographic socioeconomic health indicator e.g. population density percentage urban population median age health expenditure capita obesity diabetes prevalence alcohol intake tobacco use case fatality non communicable disease ncds independent variable country group accord variable influence dependent variable e.g. covid- positive test case fatality case recovery rate statistically analyze result suggest country variable median age significantly different outcome positive test rate p median age p health expenditure capita p show positive relation case recovery increase number test  k population show positive negative relationship number positive  k population p percentage positive test p respectively alcohol intake capita liter p diabete prevalence p ncd mortality p show statistical relation case fatality rate analysis reveal country high healthcare expenditure high median age increase urban population show case fatality well recovery rate investment health sector insufficient control severity pandemic intelligent sustainable healthcare urban rural setting healthy lifestyle acquire immunity reduce disease transmission comorbidity induce fatality respectively
458,recent study show comorbiditie diabetes hypertension obesity contribute severe bad outcome coronavirus disease  covid- suggest metabolic syndrome component associate severity covid- systematically possible association metabolic syndrome susceptibility severe acute respiratory syndrome coronavirus  sars cov- infection severity covid- literature search population base study uk biobank study show patient metabolic syndrome highly susceptible sars cov- infection recent meta analysis show metabolic syndrome significantly associate development severe covid- angiotensin convert enzyme ace  cellular entry receptor sars cov- enhanced ace expression pre existing endothelial dysfunction procoagulant state induce adipocytokine dysregulation metabolic syndrome play crucial role development severe covid-
459,objective getafix trial test hypothesis favipiravir effective treatment covid- infection patient early stage disease compare current standard care study provide important opportunity investigate safety tolerability favipiravir pharmacokinetic pharmacodynamic profile drug mechanism resistance context covid- infection effect favipiravir hospitalisation duration post covid- health psycho social wellbeing patient recruit study trial design getafix open label parallel group arm phase ii iii randomised trial treatment allocation ratio patient randomised arm primary endpoint assess superiority favipiravir plus standard treatment compare standard treatment participant trial recruit adult patient confirm positive valid covid- test pregnant breastfeed prior major co morbidity multi centre trial patient recruit patient outpatient glasgow hospital royal alexandra hospital queen elizabeth university hospital glasgow royal infirmary patient meet following criterion age  time consent exhibit symptom associate covid- positive sars cov- valid covid- test point  covid- ordinal severity scale time randomisation asymptomatic positive valid covid- test symptomatic independent symptomatic assistance need hospitalize oxygen therapy risk death admit hospital define isaricc risk index  able provide write informed consent negative pregnancy test woman childbeare potential able swallow oral medication patient exclude trial meet following criterion renal impairment require likely require dialysis haemofiltration pregnant breastfeed child bear potential woman female partner child bear potential man agree use adequate contraceptive measure duration study  month completion study treatment history hereditary xanthinuria patient judge unsuitable principal investigator sub investigator know hypersensitivity favipiravir metabolite excipient severe co morbidity include patient severe hepatic impairment define great child pugh grade ast alt  x uln ast alt x uln total bilirubin xuln  hour positive covid- test sample take unable discontinue contra indicate concomitant medication multi centre trial patient recruit patient outpatient glasgow hospital royal alexandra hospital queen elizabeth university hospital glasgow royal infirmary intervention comparator patient randomised experimental arm getafix receive standard treatment covid- discretion treat clinician plus favipiravir patient receive loading dose favipiravir day  mg mg  hour apart day patient experimental arm receive maintenance dose favipiravir mg  hour apart total  dose patient randomise control arm getafix trial receive standard treatment covid- discretion treat clinician main outcome primary outcome assess getafix trial efficacy favipiravir addition standard treatment patient covid- reduce severity disease compare standard treatment disease severity assess covid  point ordinal severity scale day   hour randomised participant follow death  day post randomisation whichever soon randomisation patient randomise experimental versus control arm computer generate random sequence allocation minimisation algorithm incorporate random component allocate patient factor minimisation site age -/-/+ history hypertension currently obsess bmi obesity clinically evident yes  day duration symptom yes unknown sex male female covid- ordinal severity score baseline blind masking blinding getafix trial participant assess outcome aware treatment allocation number randomised sample size total  patient randomised getafix trial  control arm  experimental arm optional consent form patient want contribute frequent pk pd sampling maximum number patient undergo testing sixteen male female option offer patient treat hospital time take informed consent patient experimental arm trial able undergo testing trial status current getafix protocol version th september getafix open recruitment th october  recruit patient period approximately month trial registration getafix register european union drug regulating authorities clinical trials eudract database th april reference number  getafix register isrctn th september reference number isrctn  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol study protocol report accordance standard protocol items recommendation clinical interventional trials spirit guideline additional file
460,diabetes important comorbiditie link severity infection cause severe acute respiratory syndrome coronavirus sars cov- prevalence diabetic patient hospitalize intensive care unit covid- threefold high observe non diabetic patient risk progress critical fatal disease increase factor   patient diabetes multiple mechanism link diabetes risk factor severe covid- include diabetes related hyperglycaemia diabetes associated immune dysfunction obesity hypertension component optimise glycaemic control reduce risk severe covid- appear important challenging good choice antidiabetic treatment remain establish early introduction insulin type  diabetes patient covid- encourage admission hospital future investigation necessary improve management prognosis high risk patient
461,purpose describe acute respiratory distress syndrome ards severity ventilation management outcome icu patient laboratory confirm covid- determine risk factor -day mortality post icu admission method covid icu multi center prospective cohort study conduct  hospital france belgium switzerland demographic clinical respiratory support adjunctive intervention icu length stay survival datum collect result february   patient median iqr age  year saps ii  admit icu day- post icu admission status available icu admission standard oxygen therapy high flow oxygen non invasive ventilation apply patient respectively  patient intubate  h overall  receive invasive mechanical ventilation mv point icu stay median iqr positive end expiratory plateau pressure  cmho  cmho respectively mechanical power transmit mv lung j min paralyze agent prone position apply patient intubate day- respectively pulmonary embolism ventilator associate pneumonia diagnose   patient day patient die patient receive invasive non invasive ventilation day icu admission day- mortality increase severity ards icu admission mild moderate severe ards respectively decrease  study period early independent predictor -day mortality old age immunosuppression severe obesity diabetes high renal cardiovascular sofa score component low pao fio ratio short time symptom icu admission conclusion  critically ill patient covid- admit icu -day mortality decrease  study period mortality high old diabetic obese severe ards patient
463,novel coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus- sars cov- declare pandemic  march pandemic associate markedly elevate blood glucose level remarkable degree insulin resistance suggest pancreatic islet beta cell dysfunction apoptosis insulin inability dispose glucose cellular tissue diabetes know pre existing co morbidity associate severity covid- hypertension cardiocerebrovascular disease advanced age male gender recently obesity review focus covid- responsible accelerate development type  diabetes mellitus tdm acute suspect long term complication observation implicate active role metabolic syndrome systemic tissue islet renin angiotensin aldosterone system redox stress inflammation islet fibrosis amyloid deposition beta cell dysfunction apoptosis develop tdm utilize light electron microscopy preclinical rodent model human islet help well understand covid- accelerate islet beta cell injury remodeling result long term complication tdm
464,background coronavirus disease  covid- pandemic expose longstanding racial ethnic inequity health risk outcome united states aim identify racial ethnic difference presentation outcome patient hospitalize covid- method american heart association covid- cardiovascular disease registry retrospective observational registry capture consecutive patient hospitalize covid- present datum  patient race ethnicity treat  hospital united states january july primary outcome hospital mortality secondary outcome include major adverse cardiovascular event death myocardial infarction stroke heart failure covid- cardiorespiratory ordinal severity score bad good death cardiac arrest mechanical ventilation mechanical circulatory support mechanical ventilation vasopressor inotrope support mechanical ventilation hemodynamic support hospitalization multivariable logistic regression analysis perform assess relationship race ethnicity outcome adjust difference sociodemographic clinical presentation feature account clustering hospital result  patient hospitalize covid- .% hispanic .% non hispanic black .% asian .% non hispanic white hispanic black patient young non hispanic white asian patient likely uninsured black patient high prevalence obesity hypertension diabete black patient high rate mechanical ventilation .% renal replacement therapy .% low rate remdesivir use overall mortality death occur black hispanic patient adjusted odd ratio mortality ci .- black patient ci .- hispanic patient ci .- asian patient compare non hispanic white patient median odd ratio hospital ci result similar major adverse cardiovascular event asian patient high covid- cardiorespiratory severity presentation adjust odd ratio ci conclusion hospital mortality major adverse cardiovascular event differ race ethnicity adjustment black hispanic patient bear great burden mortality morbidity disproportionate representation covid- hospitalization
465,background objectives coronavirus disease  covid- associate high risk aki aim describe rate characterize predictor health outcome associate aki national cohort veteran hospitalize covid- design setting participant measurement cohort  veteran hospitalize covid- identify july describe change serum creatinine examine predictor aki association aki health resource utilization death utilize logistic regression characterize geographic temporal variation aki rate estimate variance explain key variable utilize poisson regression result total  participant aki    meet kidney disease improving global outcomes definition stage  aki respectively  receive krt percent participant aki  day hospitalization recover baseline serum creatinine discharge old age black race male gender obesity diabetes hypertension lower egfr significant predictor aki hospitalization covid- aki associate high mechanical ventilation use odd ratio confidence interval long hospital stay additional day confidence interval aki associate high risk death odd ratio confidence interval association strong blacks p value interaction hospital level rate aki exhibit substantial geographic variability range march july aki rate decline proportion aki stage  aki require krt decrease geographic temporal variability predominately explain percentage blacks respectively conclusion aki common hospitalization covid- associate high risk health care resource utilization death nearly half patient aki recover baseline discharge substantial geographic variation temporal decline rate severity aki observe podcast article contain podcast
466,objective characterize demographic clinical feature pediatric severe acute respiratory syndrome coronavirus  sars cov- syndrome identify admission variable predictive disease severity study design conduct multicenter retrospective prospective study pediatric patient hospitalize acute sars cov- infection multisystem inflammatory syndrome child mis c  site new york new jersey connecticut result identify  hospitalize patient sars cov- infection divide  group base clinical feature overall  respiratory disease  mis c  manifestation include gastrointestinal illness fever patient mis c likely identify non hispanic black compare patient respiratory disease vs p seven patient die  admit intensive care unit multivariable analysis obesity ci p hypoxia admission ci p predictive severe respiratory disease low absolute lymphocyte count unit decrease cell l ci p great c reactive protein unit increase mg dl ci p predictive severe mis c. race ethnicity socioeconomic status predictive disease severity conclusion identify variable time hospitalization help predict development severe sars cov- disease manifestation child youth variable implication future prognostic tool inform hospital admission clinical management
467,pandemic coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- cause unprecedented global social economic impact high number death risk factor identify progression covid- severe critical stage include old age male gender underlie comorbiditie hypertension diabetes obesity chronic lung disease heart liver kidney disease tumor clinically apparent immunodeficiency local immunodeficiency early type interferon secretion capacity pregnancy possible complication include acute kidney injury coagulation disorder thoromboembolism development lymphopenia eosinopenia laboratory indicator covid- laboratory parameter monitor disease progression include lactate dehydrogenase procalcitonin high sensitivity c reactive protein proinflammatory cytokine interleukin il)- il beta krebs von den lungen- kl- ferritin development cytokine storm extensive chest compute tomography imaging pattern indicator severe disease addition socioeconomic status diet lifestyle geographical difference ethnicity expose viral load day initiation treatment quality health care report influence individual outcome review highlight scientific evidence risk factor severity covid-
468,background aim verify prevalence hypovitaminosis d obesity elderly patient infect new coronavirus patient develop severe symptom admit intensive care unit icu receive invasive ventilation diagnosis acute respiratory distress syndrome ards method cross sectional descriptive study compose elderly age  year admit icu collect demographic sex age anthropometric datum presence comorbiditie hypertension diabetes heart disease lung neurological oncological disease severity score icu saps iii pao fio ratio analysis c reactive protein crp serum dosage -hydroxy vitamin d ohd day hospitalization identify elderly hypovitaminosis d low value  kg m result total  elderly meet inclusion criterion elderly man mean age year median bmi kg m .% have nutritional diagnosis obesity .% bmi  kg m prevalent comorbiditie hypertension .% diabetes prevalence hypovitaminosis d value  ohd ng ml  ng ml ng ml .% .% respectively prevalence hypovitaminosis d ng ml obese elderly negative significant bivariate correlation bmi level  ohd r p conclusion hypovitaminosis d obesity elderly high prevalence critically ill patient icu infect new coronavirus laboratory investigation vitamin d important especially obese elderly patient
469,global covid- coronavirus disease pandemic complex problem overlap grow public health problem obesity obesity alter different component innate adaptive immune response create chronic low grade state inflammation nutritional status closely relate well bad prognosis viral infection excess weight recognise risk factor covid- complication addition direct risk obesity trigger disease diabetes hypertension increase risk severe covid- present review explain diet induce obesity importance different food process review tissue disruption obesity lead impaired immune response possible mechanism obesity co morbidities increase covid- morbidity mortality nutritional strategy support immune system patient obesity covid- discuss light available datum consider severity infection discussion hold contribute combat global emergency plan specific public health policy
470,increase evidence ace gene polymorphism modulate interaction ace sars cov- spike protein affect viral entry host cell and/or contribute lung systemic damage covid- silico molecular docking predict effect ace missense variant interaction spike protein sars cov- hdock firedock simulation identify  ace missense variant kr ek ta eg high affinity sars cov- spike protein receptor bind domain rbd respect wild type ace  variant iv ek ke ta ek sr yf nd nh ke mi low affinity result support hypothesis ace genetic background represent genetic gateway disease progression
471,direct relation overweight obesity mafld severity sars cov- infection increase number case obesity mafld important risk factor high mortality covid- patient
472,sars cov- cause severe pneumonia covid- affect essentially elderly people covid- macrophage infiltration lung cause rapid intense cytokine storm lead finally multi organ failure death comorbiditie metabolic syndrome obesity type  diabetes lung cardiovascular disease age associate disease increase severity lethality covid- mitochondrial dysfunction hallmark age covid- risk factor dysfunctional mitochondria associate defective immunological response viral infection chronic inflammation review discuss mitochondrial dysfunction associate defective immune response age different age relate disease comorbiditie associate poor prognosis progression covid- suggest chronic inflammation cause mitochondrial dysfunction responsible explosive release inflammatory cytokine cause severe pneumonia multi organ failure finally death covid- patient preventive treatment base therapy improve mitochondrial turnover dynamic activity essential protect covid- severity
473,obesity major risk factor sars cov- infection covid- severity underlying basis association likely complex nature host cell receptor angiotensin convert enzyme  ace type ii transmembrane serine protease tmprss important viral cell entry unclear obesity alter expression ace tmprss low respiratory tract ace expression elevate lung trachea diet induce obese male mouse reduce esophagus obese female mouse relative lean control tmprss expression increase trachea obese male mouse reduce lung elevate trachea obese female mouse relative lean control chow feed lean mouse female high expression ace lung esophagus high tmprss expression lung low expression trachea compare male diet induce obese mouse male high expression ace trachea high expression tmprss lung compare female female high expression tmprss trachea relative male datum indicate diet- sex dependent modulation ace tmprss expression low respiratory tract esophagus give high prevalence obesity worldwide sex bias mortality rate discuss implication relevance result covid-
475,onset human disease infection sars cov- cause covid- reveal risk factor disease severity identify factor high risk infection and/or mortality create disparity age co morbidity race ethnicity gender datum indicate old person and/or presence obesity diabetes cardiovascular disease chronic kidney disease place high risk covid- united states specific race ethnicity particularly african americans native americans strong covid- risk component male gender emerge severity risk factor age racial ethnicity accumulation health co morbidity common precipitate mechanism particular underlie socio economic structure united states likely drive development co morbidity put affected population high risk severe covid- sudden cardiac death trigger common sodium channel variant african americans covid- evaluate cause racial disparity evidence racial ethnic difference covid- cause abo blood group use angiotensin convert enzyme ace inhibitor amino acid substitution sars cov- spike protein grow evidence androgen enable expression ace receptor serine protease tmprss permissive element engage sars cov- spike protein infection contribute severe covid- man overall covid- generate disparity infect severity infection understand mechanism disparity help nullify difference risk covid-
476,covid- associated coagulopathy dysfunction severe sars cov- infection characterize significantly increase fibrinogen d dimer c reactive protein normal near normal prothrombin time activate partial thromboplastin time platelet count hypercoagulopathy hypofibrinolysis coexist detect viscoelastic test feature associate immobilization intrinsic risk factor age obesity comorbiditie drug patient trigger thromboembolic event despite thromboprophylaxis lung severely damage organ date patient exhibit hypercoagulability viscoelastic test detect standard coagulation test high rate thrombotic event report suggest consider cause clinical deterioration intensive care potentially clinical setting advanced stage covid- associated coagulopathy fibrinogen platelet count decrease significantly depend severity clinical status resemble consumptive coagulopathy stage bleed event occur especially patient extracorporeal membrane oxygenation ecmo viscoelastic test useful tool assess hypercoagulability hypofibrinolysis detectable standard coagulation test critically ill sars cov- patient covid- associate coagulopathy look like promising tool anticoagulation management research need carry determine abnormal viscoelastic test combination clinical laboratory finding identify patient increase thrombotic risk clinical trial evaluate hypercoagulability viscoelastic test need personalized dosage anticoagulation sars cov- patientsare quickly emerge
477,emergence new coronavirus severe acute respiratory syndrome coronavirus  sars cov- result global pandemic associated coronavirus disease  covid- result high number death worldwide observational study case report provide insight old age presence chronic disease frequently associate high covid- severity individual high risk mortality covid- review provide insight impact chronic disease associate cardiovascular system obesity diabetes mellitus hypertension cardiovascular disease sars cov- infection covid- additionally review recommendation guidance international scientific association discuss key learning importance future
478,sars cov infection covid- create panic world origin december  wuhan city china covid- pandemic infect million people death immune system play crucial role severity covid- development pneumonia induce acute lung injury ali acute respiratory distress syndrome ards provide protection innate t cell base adaptive immune response dysregulate severe sars cov infection dysregulation pronounced old population patient comorbiditie diabetes hypertension obesity pulmonary autoimmune disease covid- patient develop protective antibody abs sars cov long induction immune response pathogen require metabolic energy generate process immunometabolism change metabolic stage immune cell homeostasis inflammatory infectious environment call immunometabolic reprogramming article describe cellular immunology macrophage t cell b cell dendritic cell nk cell pulmonary epithelial cell pec vascular endothelial cell associated immune response covid- immunometabolism serve cell specific therapeutic approach target covid-
479,background association severity coronavirus disease  covid- presence certain chronic condition suggest unlike influenza virus disease burden covid- patient asthma evident objective understand impact covid- patient asthma method big data analytic artificial intelligence savana manager clinical platform analyse clinical datum patient asthma january  result  patient asthma  .% suffer covid- compare asthmatic individual covid- patient asthma covid- significantly old versus  year predominantly female versus smoke frequently high prevalence hypertension dyslipidaemia diabetes obesity allergy relate factor rhinitis eczema common asthmatic patient covid- p addition high prevalence comorbiditie observe patient covid- require hospital admission use inhale corticosteroid ics low patient require hospitalisation covid- compare non hospitalise patient versus .% ci patient treat biologic n= .% show increase severity comorbiditie ear nose throat level covid relate hospitalisation patient relatively low conclusion patient asthma covid- old increase risk comorbidity relate factor ics biologic generally safe associate protective effect severe covid- infection
480,background report suggest person previously infect severe acute respiratory syndrome coronavirus  sars cov- lack detectable immunoglobulin g igg antibody aim determine proportion igg seronegative predictor seronegativity person previously infect sars cov- method analyze serologic datum collect healthcare worker responder new york city detroit metropolitan area history positive sars cov- reverse transcription polymerase chain reaction rt pcr test result test igg antibody sars cov- spike protein  week symptom onset result  person previously confirm sars cov- infection  .% seronegative  previously symptomatic person proportion seronegative slightly increase   day post symptom onset p proportion seronegative range  person previously hospitalize .%  person asymptomatic infection multivariable model person take immunosuppressive medication likely seronegative .% confidence interval ci .%-.% participant non hispanic black race ethnicity vs non hispanic white .% ci .%-.% severe obesity vs normal weight .% ci .%-.% symptom likely seronegative conclusion population previous rt pcr confirm infection approximately   person lack igg antibody absence antibody vary independently illness severity race ethnicity obesity immunosuppressive drug therapy proportion seronegative remain relatively stable person test  day post symptom onset
481,aim assess impact liver function test lft abnormality prognosis patient coronavirus disease  covid- french cohort hospitalize patient patient method march  april collect computerized anonymize database medical record laboratory datum clinical outcome patient hospitalize confirmed case covid- infection rt pcr and/or ct scan patient follow april  death discharge consider statistical analysis lft abnormality level great time upper limit normal composite endpoint include admission icu mechanical ventilation severe radiologic injury death define disease severity result  patient median age  year covid-  .% abnormal lft hypertension .% diabetes .% main comorbiditie .% take liver toxic drug admission .% give drug know induce hepatic cytolysis hospitalization patient elevated level alt ast significantly severe high rate admission icu .% vs .% p global mortality .% vs .% p= multivariate analysis obesity cytolytic profil associate composite endpoint respectively p= confidence interval p value conclusion liver injury mild transient covid- lft abnormality associate poor prognosis relevant biomarker early detection severe infection
482,covid- recently emerge infectious disease cause novel severe acute respiratory syndrome coronavirus sars cov. sars cov differ previous coronavirus infection sars mers high infectivity reproduction value r typically pre- asymptomatic transmission property contribute current global covid- pandemic identify risk factor disease severity death sars cov infection include old age male sex diabetes obesity hypertension reason association largely obscure evidence emerge sars cov infection exacerbate underlie pathophysiology hyperglycemia people diabetes discuss potential mechanism diabetes affect risk severe outcome covid- additionally diabetic emergency long term pathology aggravate infection virus consider role immune system observed phenomenon microangiopathy severe covid- infection potential direct viral toxicity metabolically relevant tissue include pancreatic beta cell target insulin action
483,background current severe acute respiratory syndrome coronavirus  pandemic unprecedented impact essential shed light patient characteristic predispose severe disease course obesity define bmi kg m suggest characteristic bmi differentiate fat mass lean body mass distribution fat tissue aim present study assess body composition covid- patient admit ward icu identify association severity disease method perform observational cross sectional cohort study bioelectric impedance analysis conduct confirm covid- patient admit ward icu hospital netherlands april  body water measurement derive value recalculate dry weight standard ratio extracellular water total body water datum compare ward icu patient regression model assess association baseline characteristic body composition indicator disease severity include composite score compose mortality morbidity icu admission result patient include  ward  icu mean age  year -ci  male mean bmi kg m differ group body composition value independently associate disease severity multiple logistic regression analysis low phase angle associate covid- severity composite score p conclusion find significant association body composition include fat mass visceral fat area fat free mass disease severity population generally overweight covid- patient low phase angle increase odd severe covid- believe factor body composition play critical role development severe covid-
484,shortly identification novel coronavirus coronavirus disease covid- global pandemic declare conflicting datum severity covid- disease course pregnant woman datum suggest increase severity increase need hospitalization intubation obstetric patient general population disease common racial ethnic minority population severity increase comorbid condition obesity purpose study characterize covid- infection pregnancy population woman get prenatal care urban safety net hospital begin april woman test admission delivery additionally outpatient present covid- symptom month  discrete woman test  .% positive covid- incidence covid- asymptomatic woman screen admission hospital high prevalence obesity comorbid condition .% population patient racial ethnic minority despite risk factor patient uniformly mild asymptomatic disease symptomatic patient require hospitalization infection population pregnant woman high risk severe covid- infection mild disease observe
485,introduction february severe case pneumonia sars cov- diagnose northern italy lombardy study identify obesity risk factor severe disease patient covid- purpose study investigate incidence sars cov- infection severity patient undergo bariatric surgery material method lockdown period contact operate patient phone social network e.g. facebook maintain constant contact addition give patient dedicated phone number emergency produce telemedicine educational video obese bariatric patient submit questionnaire patient undergo bariatric surgery past result total  patient male  female reply questionnaire mean presurgical bmi kg m mean age year mean bmi surgery kg m p february .% patient report suffer symptom identify relate sars cov- infection thirteen patient .% test positive covid- patient .% admit covid department  patient .% admit icu conclusion report rate symptom fever high .% patient test positive covid-  patient undergo bariatric surgery analyze study .% need icu admission
486,study source variation country capita mortality covid- cause sars cov- virus potential predictor capita coronavirus relate mortality  country  examine include age gender obesity prevalence temperature urbanization smoking duration outbreak lockdown viral testing contact trace policy public mask wear norm policy multivariable linear regression analysis perform univariate analysis prevalence smoking capita gross domestic product urbanization cold average country temperature positively associate coronavirus relate mortality multivariable analysis  country duration outbreak country proportion population age  year old positively associate capita mortality duration mask wear public negatively associate mortality p obesity stringent international travel restriction independently associate mortality model control testing policy viral testing policy level associate mortality internal lockdown associate nonsignificant .% reduction mortality week p association contact trace policy mortality statistically significant p country cultural norm government policy support public mask wear capita coronavirus mortality increase average week compare .% week remain country societal norm government policy support wearing mask public international travel control independently associate low capita mortality covid-
487,beginning government health system world tackle infection fatality cause novel severe acute respiratory syndrome coronavirus sars cov- result coronavirus disease  covid- virus pandemic turn complicated individual co morbidity like diabetes cardiovascular condition obesity high risk acquire infection suffering severe course disease prolonged viral infection obesity independently know lower immune response combination result cytokine storm substantial weakening immune system rise obesity case globally chance obese individual acquire infection need hospitalization heighten review discuss obesity low grade chronic inflammation contribute increase severity covid- patient suggest increase inflammation activation renin angiotensin aldosterone system elevated adipokine high ectopic fat factor contribute disease severity particular deteriorate cardiovascular lung function obese individual look lesson learn  hn influenza pandemic relate little fast incoming information available sars cov- infected individual overweight obesity
488,background outcome coronavirus disease  covid- patient neuromyelitis optica spectrum disorder nmosd myelin oligodendrocyte glycoprotein antibody associate disease mogad treat immunosuppressive therapy unknown method conduct multicenter retrospective observational cohort study french expert center neuromyelitis optica relate disorder patient nmosd mogad include study receive confirm highly suspect diagnosis covid-  march   june main outcome covid- severity score assess seven point ordinal scale range  hospitalize limitation activity  death result case mean sd age year  female include patient .% hospitalize receive rituximab -year old patient positive aquaporine- antibody obesity comorbidity need mechanical ventilation outpatient receive anti cd mycophenolate mofetil azathioprine young mean sd age year long disease duration mean sd year low expand disability severity score edss score median range edss relative patient require hospitalization mean sd age year mean sd disease duration year median range edss  conclusion covid- outcome overall favorable cohort large international study need identify risk factor severe covid- recommend personal protective measure reduce risk sars cov- infection immunocompromised population
489,introduction objectives liver function test lft abnormality report covid- patient metabolic comorbiditie associate poor outcome aim study determine prevalence liver steatosis fibrosis patient covid- association clinical outcome material method retrospective study hospitalize covid- patient conduct risk liver steatosis estimate hsi risk advanced liver fibrosis apri nafld fs and/or fib- clinical outcome admission intensive care unit icu mortality result  patient .% male n n obese abnormal lft present n prevalence steatosis n significative liver fibrosis n liver fibrosis fib- associate risk icu admission ci p mortality ci p independent association find conclusion prevalence steatosis significant liver fibrosis high covid- patient associate clinical outcome
490,aim study aim assess body mass index bmi fast plasma glucose fpg level blood pressure bp kidney function associate risk severe disease death patient covid- method datum candidate risk factor extract patient checkup record propensity score match cohort construct logistic regression model adjust age sex comorbiditie primary outcome death severe covid- define require supplementary oxygen high ventilatory support result patient confirmed covid- .% receive checkup severe covid- occur  patient bmi .- associate outcome woman aor ci patient age year aor ci fpg  mg dl associate poor outcome woman aor ci man similarly estimate glomerular filtration rate egfr  ml min/. m risk factor woman aor ci patient age  year conclusion effect bmi fpg egfr outcome associate covid- prominent woman man
491,objective limited datum outcome hospital cardiac arrest coronavirus disease  patient study report outcome hospital cardiac arrest coronavirus disease  patient united states describe characteristic outcome hospital cardiac arrest coronavirus disease  patient rural southwest georgia design retrospective cohort study setting single center multihospital patient consecutive coronavirus disease  patient experience hospital cardiac arrest attempt resuscitation intervention attempt resuscitation advanced cardiac life support measurement main result patient hospitalize coronavirus disease  study period  patient suffer hospital cardiac arrest attempt resuscitation include study median age  year .% male majority patient african americans common comorbiditie hypertension .% obesity .% diabetes .% chronic kidney disease .% eighteen patient .% charlson comorbidity index common present symptom shortness breath .% fever .% cough median duration symptom prior admission  day hospital course .% patient develop septic shock .% acute respiratory distress syndrome prior hospital cardiac arrest ventilator .% vasopressor .% dialysis majority hospital cardiac arrest .% occur icu time initiation advanced cardiac life support protocol  minute hospital cardiac arrest icu  minute remain patient common initial rhythm pulseless electrical activity asystole return spontaneous circulation achieve patient brief hospital mortality conclusion study coronavirus disease  patient suffer hospital cardiac arrest hospital mortality regardless baseline comorbiditie present illness severity location arrest
492,covid- affect million people worldwide global health care encounter increase burden aftermath disease evidence show fifth patient develop fibrotic tissue lung sars outbreak early  result chronic pulmonary fibrosis subset patient correlate reduce lung function force expiratory volume fev similarity corona virus infection cause sars covid- strike novel coronavirus sars cov- prove high communicability translate large number patient seek care clinical sign pulmonary fibrosis give covid- pandemic till sept affect  million people sars cov- dependent bind angiotensin convert enzyme  ace renin angiotensin system ras downregulation ace virus binding disturb downstream activity ras result increase inflammation development fibrosis poor prognosis risk develop pulmonary fibrosis associate increase expression ace risk group obesity heart disorder aging confer plenty binding opportunity virus subsequently internalization ace devoide enzyme act counter inflammatory antifibrotic identify pathway associate covid- severity result pulmonary fibrosis enable early diagnosis individualized treatment patient prevent reduce irreversible fibrotic damage lung
493,recent coronavirus disease  covid- pandemic show different severity disease male female man severely ill high rate woman datum age dependent disease susceptibility mortality elderly suggest sex hormone main factor determine clinical course infection difference age male versus female role sex hormone key phenotype covid- infection describe review recommendation base dimorphic approach male female suggest sex specific management disease
494,coronavirus disease  covid- pandemic strain healthcare system particularly patient severe outcome require admittance intensive care unit icu study investigate potential association obesity diabete covid- severe outcome assess icu admittance medical history demographic patient characteristic retrospective cohort patient hospitalize covid- analyse single centre kuwait univariate multivariate analysis perform explore association different variable icu admittance  hospitalize patient  diabetes  hypertension  require admittance icu patient available measurement  body mass index bmi kg m univariate analysis show overweight obesity class morbid obesity associate icu admittance patient diabetes likely admit icu model multivariate regression analysis assess bmi diabete icu outcome bmi model class morbid obesity associate icu admittance diabetes model diabetes associate increase icu admittance hypertension protective effect icu admittance cohort overweight obesity diabetes patient covid- associate icu admittance increase risk poor outcome
495,infection severe acute respiratory syndrome sars coronavirus- sars cov- causative agent new disease covid- risk severe covid- increase certain underlie comorbiditie include asthma cancer cardiovascular disease hypertension diabetes obesity notably exposure hormonally active chemical call endocrine disrupt chemical edcs promote cardio metabolic disease endocrine relate cancer immune system dysregulation link high risk severe covid- bisphenol bpa common edc exert effect receptor widely distribute human tissue include nuclear oestrogen receptor eralpha erbeta membrane bind oestrogen receptor g protein couple receptor gpr human nuclear receptor oestrogen relate receptor gamma paper focus potential role bpa promote comorbiditie associate severe covid- potential bpa induce effect key sars cov- infection mediator angiotensin convert enzyme  ace transmembrane serine protease  tmprss interestingly gpr appear exhibit great co localisation tmprss key tissue like lung prostate suggest bpa exposure impact local expression sars cov- infection mediator overall potential role bpa risk severity covid- merit investigation
496,clinical spectrum coronavirus disease  covid- remain unclear especially regard presence pneumonia aim describe clinical course final outcome adult patient laboratory confirm covid- spectrum disease severity aim identify potential predictive factor covid- pneumonia conduct retrospective study adult patient laboratory confirm covid- hospitalize bamrasnaradura infectious diseases institute thailand january  april ninety patient include median iqr age year .% male median iqr incubation period day half patient mild disease severity moderate severe critical asymptomatic infection find final clinical outcome  .% recover  .% deceased incidence pneumonia median iqr time onset illness pneumonia detection day bilateral pneumonia prevalent unilateral pneumonia multivariable logistic regression increase age increase  year old ci p obesity ci p high temperature presentation  degree c increase degree c ci p potential predictive factor covid- pneumonia spectrum disease severity patient covid- cohort good final clinical outcome covid- pneumonia find old age obesity high fever presentation independent predictor covid- pneumonia
497,background liberal administration hydroxychloroquine sulphate hcq covid- patient raise concern risk qtc prolongation cardiac arrhythmia particularly prescribe azithromycin evaluate incidence qtc prolongation moderately severely ill covid- patient treat hcq existence concomitant alternative cause method covid- patient treat hcq mar  apr tertiary medical centre include clinical characteristic relevant risk factor collect electronic medical record individual patient qtc interval determine treatment hcq primary outcome measure seek composite end point comprise increase millisecond ms qtc interval compare pre treatment qtc and/or maximal qtc interval ms results ninety patient include median age  year iqr  male thirty patient severely critically ill hypertension obesity common n  qtc prolongation evolve  patient age year congestive heart failure severity disease c reactive protein level hypokalaemia furosemide treatment associate qtc prolongation adjust analysis show qtc prolongation time likely hypokalaemia ci time likely furosemide treatment  ci .- conclusion patient treat hcq qtc prolongation associate presence traditional risk factor hypokalaemia furosemide treatment
498,severe acute respiratory syndrome coronavirus  sars cov- virus lead global public health emergency cause coronavirus disease  covid- initially identify wuhan china cause significant respiratory illness respiratory symptom common present symptom recognize covid- encompass multiple organ system include cardiovascular system acute myocardial injury st elevation myocardial infarction stemi associate covid- covid- patient cardiovascular manifestation risk increase severity illness present case young -year old patient past history hypertension coronary artery disease risk factor coronary artery disease obesity develop stemi hospital
499,world currently face coronavirus disease covid- pandemic place great pressure health care system worker present severe clinical feature require admission intensive care unit derangement nutritional status obesity malnutrition relevant clinical outcome acute illness systemic inflammation immune system impairment sarcopenia preexist associated condition respiratory cardiovascular metabolic disease relate obesity act crucial factor link nutritional status course outcome covid- vitamin trace element play essential role modulate immune response inflammatory status overall evaluation patient nutritional status negligible implication susceptibility course severity responsiveness therapy order perform tailor nutritional intervention integral treatment patient covid- aim study review current datum relevance nutritional status include trace element vitamin status influence course outcome disease  mo world health organization declaration covid- pandemic
500,background give severity scope current covid- pandemic critical determine predictive feature covid- mortality medical resource usage effectively inform health risk base physical distancing work accommodation policy non clinical sociodemographic feature important explanatory variable covid- outcome reveal exist disparity large health care system method finding use nation wide multicenter datum covid- patient brazil predict mortality ventilator usage dataset contain hospitalize patient test positive covid- recover decease march  june total patient deceased include interpretable sparse version logistic regression support vector machines state art non interpretable gradient boosted decision trees random forest classification method employ death covid- strongly associate demographic socioeconomic factor comorbiditie variable highly predictive mortality include geographic location hospital northeast region north region renal liver chronic disease immunosuppression obesity neurological cardiovascular hematologic disease diabetes chronic pneumopathy immunosuppression respiratory symptom range respiratory discomfort dyspnea oxygen saturation hospitalization public hospital self report patient illiteracy validation accuracy auc predict mortality ventilation need reach respectively pre admission variable model use post admission disease progression information reach accuracy auc predict mortality ventilation use respectively conclusion result highlight predictive power socioeconomic information assess covid- mortality medical resource allocation shed light exist disparity brazilian health care system covid- pandemic
501,background angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb increase risk coronavirus disease  covid- infection affect disease severity prior study examine risk medication dose method retrospective cohort study include people age /= year enrol integrate healthcare system  month current acei arb use identify pharmacy datum estimate daily dose calculate standardize medication covid- infection hospitalization identify laboratory hospitalization datum logistic regression estimate odd ratio ors confidence interval cis adjust race ethnicity obesity covariate result individual  develop covid- infection people acei arb develop covid- individual compare acei arb use yield adjust ci use /= ddds ci similar acei arb subgroup age sex people covid- infection hospitalize adjust hospitalization relation acei arb use ci association dose conclusion finding support current recommendation individual medication continue use
502,background old age medical comorbiditie identify risk factor develop severe coronavirus disease limited datum risk stratification clinical laboratory course optimal management coronavirus disease  pregnancy objective study aim describe clinical course coronavirus disease effect comorbiditie disease severity laboratory trend pregnancy outcome symptomatic asymptomatic severe acute respiratory syndrome coronavirus pregnant woman study design case series pregnant postpartum woman receive positive test result severe acute respiratory syndrome coronavirus  march  hospital yale new haven health delivery network chart basic sociodemographic prepregnancy characteristic coronavirus disease  course laboratory value pregnancy outcome result  test pregnant postpartum woman march n= positive severe acute respiratory syndrome coronavirus  result hispanic woman overrepresente severe acute respiratory syndrome coronavirus group n= .% addition hispanic ethnicity associate high rate moderate severe disease non hispanic vs respectively odd ratio confidence interval p=. note  woman .% asymptomatic  .% diagnose universal screening admission delivery n= diagnose delivery n= presentation childbirth n= delivery severe disease diagnose  case  maternal death obese woman likely develop moderate severe disease nonobese woman vs odd ratio confidence interval p=. hypertensive disorder pregnancy diagnose .% woman deliver  week gestation high level c reactive protein antepartum coronavirus disease -relate admission common woman bad clinical course association reach statistical significance conclusion coronavirus disease  pregnancy result severe disease death hispanic woman likely receive positive test result severe acute respiratory syndrome  ethnic group obesity hispanic ethnicity represent risk factor moderate severe disease
503,emergence novel severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease  covid- result pandemic sars cov- highly contagious severity highly variable fatality rate unpredictable amplify factor include advance age atherosclerotic cardiovascular disease diabetes mellitus hypertension obesity large proportion patient condition treat lipid lower medication question safety continue lipid lower medication patient infect covid- arise suggest exacerbate condition important consider know interaction lipid lower agent specific therapy covid- statement aim collate current evidence surround safety lipid lower medication patient covid- offer consensus view base current knowledge rate strength level evidence recommendation pubmed google scholar web science search extensively article search term sars cov- covid- coronavirus lipid statin fibrates ezetimibe pcsk monoclonal antibody nicotinic acid bile acid sequestrant nutraceutical red yeast rice omega fatty acid lomitapide hypercholesterolaemia dyslipidaemia volanesorsen evidence currently lipid lower therapy unsafe patient covid- infection lipid lower therapy interrupt pandemic patient increase risk covid- infection patient confirmed covid- care take avoid drug interaction lipid lower medication drug treat covid- especially patient abnormality liver function test
504,obesity risk factor disease severity individual coronavirus disease covid- increase susceptibility population covid- unclear outline underlie mechanism explain relationship obesity covid- severity obesity adverse effect respiratory physiology increase intra abdominal adipose tissue interfere lung expansion result reduce lung compliance fat accumulation soft tissue pharynx increase inspiratory resistance obesity associate sleep apnea obesity associate defect cell mediate immunity include increase level pro inflammatory cytokine impaired adipocyte mediate immune function result chronically high leptin level low adiponectin level anti inflammatory adipokine reduce physical activity impair step immune response virus obesity promote hypercoagulable state lead severe consequence factor synergistically play role promote severity disease obese individual well understanding mechanism obesity contribute severity covid- important develop effective treatment
505,objective characterize impact obesity disease severity patient coronavirus disease design retrospective cohort study design evaluate association body mass index risk severe disease patient coronavirus disease datum abstract electronic health record primary endpoint composite intubation death setting hospital massachusetts quaternary referral center affiliate community hospital patient consecutive patient hospitalize confirm coronavirus disease  admit march april intervention measurement main result total  patient include study stratify patient body mass index category /=  kg m  kg m  kg m patient total  patient primary endpoint patient intubate die intubation patient body mass index great equal  kg m intubate die adjust cox model demonstrate body mass index great equal  kg m associate .-fold increase risk intubation death ci compare individual body mass index  kg m. diabetes independently associate risk intubation death hazard ratio ci  patient body mass index great equal  kg m diabetes combination diabetes body mass index great equal  kg m associate .-fold increase risk intubation death ci compare patient diabetes body mass index  kg m. conclusion consecutive patient hospitalize coronavirus disease obesity independent risk factor intubation death
506,introduction coronavirus disease  covid- present range symptom mild critical low pulmonary involvement include pneumonia associate severe critical case understand baseline characteristic patient hospitalize covid- illness essential effectively target clinical care allocate resource study aim describe baseline demographic clinical characteristic patient hospitalize covid- pulmonary involvement method patient covid- pulmonary involvement inpatient admission december identify ibm explorys((r electronic health record database baseline  month prior covid- hospitalization demographic clinical characteristic preadmission day  day prior admission pulmonary diagnosis assess patient stratify sex age race geographic region result overall  patient hospitalize covid- pulmonary involvement include mean sd age year .% patient female african american south .% midwest common comorbiditie include hypertension .% diabetes .% hyperlipidemia .% obesity cough .% dyspnea .% common preadmission pulmonary symptom african american patient young mean sd vs. high mean sd body mass index vs. prevalence diabetes .% vs. .% low prevalence chronic obstructive pulmonary disease .% vs. .% smoke tobacco use .% vs. .% white patient conclusion patient primarily south midwest hospitalize covid- pulmonary involvement common comorbiditie hypertension diabetes hyperlipidemia obesity difference observe african american white patient consider context complex factor underlie racial disparity covid-
507,study examine record  consecutive covid- patient massachusetts hospital seek predict level care requirement base clinical laboratory datum classification method apply compare standard pneumonia severity score need hospitalization icu care mechanical ventilation predict validation accuracy respectively pneumonia severity score achieve respective accuracy icu care ventilation prediction limit patient complex disease accuracy icu ventilation prediction model achieve accuracy respectively vital sign age bmi dyspnea comorbiditie important predictor hospitalization opacity chest imaging age admission vital sign symptom male gender admission laboratory result diabete important risk factor icu admission mechanical ventilation factor identify collectively form signature novel covid- disease
508,emerge evidence covid- highlight role individual resistance immune function susceptibility infection severity disease multiple factor influence response human host exposure viral pathogen influence individual susceptibility infection factor nutritional status physical psychosocial stressor obesity protein calorie malnutrition emotional resilience single nucleotide polymorphism environmental toxin include air pollution firsthand secondhand tobacco smoke sleep habit sedentary lifestyle drug induce nutritional deficiency drug induce immunomodulatory effect availability nutrient dense food calorie review examine network interact cofactor influence host pathogen relationship turn determine susceptibility viral infection like covid- evaluate role machine learning include predictive analytic random forest modeling help clinician assess patient risk development active infection devise comprehensive approach prevention treatment
511,mozambique locate east coast africa country affect covid- case report  march  case increase gradually country worldwide environmental population characteristic analyze worldwide understand possible association covid- article seek highlight evolution possible contribution risk factor covid- severity accord available datum mozambique available datum highlight covid- severity magnify mainly hypertension obesity cancer asthma hiv sida malnutrition condition buffer age youthful population covid- epidemic evolution particularly cabo delgado need increase laboratory diagnosis capacity monitor compliance preventive measure particular attention give cabo delgado include isolation province overcome local transmission spread sars cov-
512,background global rate intensive care unit icu admission covid- pandemic vary country main challenge health care system worldwide conflicting result report response coronavirus infection covid- outcome man woman understand predictor intensive care unit admission help future planning management disease method finding design cross sectional observational multicenter nationwide survey italy understand gender relate clinical predictor icu admission patient covid- analyze information  chart italian patient certify covid- admit  hospital ninety patient .% require icu admission covid infection frequently man high prevalence comorbiditie /- vs p multivariable regression model main predictor admission icu male gender ci p presence obesity ci p chronic kidney disease p hypertension p gender specific analysis obesity chronic kidney disease hypertension associate high rate admission icu man woman obesity ci p heart failure ci associate high rate icu admission conclusion study demonstrate gender primary determinant disease severity covid- obesity condition observe admit icu gender trial registration clinicaltrials.gov nct
513,little know clinical feature outcome sars cov- infection africa conduct retrospective cohort study patient hospitalize covid- march  july  seven hospital kinshasa democratic republic congo drc outcome include clinical improvement  day primary hospital mortality secondary  confirm covid- case  .% male median interquartile range iqr age  year ninety patient severe critical disease require admission intensive care unit icu patient .% improve discharge  day admission overall hospital mortality ci icu independent risk factor death age  year ahr ci compare aged year obesity ahr ci chronic kidney disease ahr ci marginal structural model analysis statistically significant difference odd clinical improvement adjust odd ratio aor ci p risk death aor ci compare use chloroquine azithromycin versus treatment drc study high mortality patient age  year severe critical disease great concern require research confirmation target intervention
514,background aim corona virus disease  covid- pandemic spread rapidly grow evidence overweight obesity extent nearly world population associate severe covid- study aim explore association risk increase bmi obesity composite poor outcome covid- adult patient method conduct systematic literature search pubmed embase database include original research article covid- adult patient obesity base classification body mass index bmi composite poor outcome consist icu admission ards severe covid- use mechanical ventilation hospital admission mortality result sixteen study include meta analysis  study present bmi continuous outcome  study present bmi dichotomous outcome cut kg m covid- patient composite poor outcome high bmi mean difference ci .- p obesity associate composite poor outcome odd ratio ci .- p multivariate meta regression show association bmi obesity composite poor outcome affect age gender dm type hypertension conclusion obesity risk factor composite poor outcome covid- hand covid- patient composite poor outcome high bmi bmi important routine procedure assess management covid- patient special attention give patient obesity
515,background aim link diabetes increase risk infectious disease long recognize enter sharp focus follow covid- pandemic method literature search conduct pubmed article english diabetes infection result diabetes predispose infection alteration innate acquire immune defense outcome infection bad people uncontrolled diabetes infection worsen hyperglycemia hitherto control diabetes bidirectional relationship diabetes increase risk infection covid- se predispose severe disease poor outcome covid- link deterioration glycemic control new onset diabetes conclusion clinician care people diabetes aware increase risk infection population possibility worsen hyperglycemia holistic approach frequent monitoring blood glucose level appropriate titration medication close attention nutritional status essential ensure good possible outcome
516,background obesity common patient coronavirus disease  covid- effect obesity clinical outcome covid- warrant systematical investigation objective study explore effect obesity risk severe disease patient covid- method body mass index bmi degree visceral adipose tissue vat accumulation indicator obesity status publication database include preprint search august clinical outcome severe covid- include hospitalization requirement treatment intensive care unit icu invasive mechanical ventilation imv mortality risk severe covid- outcome present odd ratio confidence interval ci cohort study bmi define obesity standardized mean difference smd ci control study vat define excessive adiposity result total  participant  study bmi define obesity  control study vat define adiposity include assess risk severe covid- univariate analysis show significantly high or severe covid- high bmi p=. hospitalization ci p icu admission ci p imv requirement ci p=. death give overall severe covid- ci p multivariate analysis reveal increase or severe covid- associate high bmi ci p=. hospitalization ci p=. require icu admission ci p=. imv support ci p mortality give overall severe covid- ci p compare non severe covid- patient severe covid- case show significantly high vat accumulation smd hospitalization ci p=. ci p require icu admission ci p=. imv support overall smd severe covid- ci p conclusion obesity increase risk hospitalization icu admission imv requirement death patient covid- excessive visceral adiposity appear associate severe covid- outcome finding emphasize need effective action individual public government increase awareness risk result obesity heighten current global pandemic
517,covid- show substantial variation rate severity impact different demographic group specifically show predilection obese patient vulnerable group include predilection male female old age young age black race caucasian one single cell sequencing study highlight role cell polarity co expression protease furin ace genesis coronavirus disease exclusively link tissue involvement ace level think previously forge connection genetic immune cellular mechanism underlie covid infection inflammatory state obese patient offer accurate explanation obese patient increase risk poor covid outcome commonality encompass macrophage phenotype switching genetic expression switch overexpression pro inflammatory cytokine depletion regulatory cytokine situ t cell proliferation t cell exhaustion finding demonstrate necessity single cell sequencing rapid mean identify treat likely need hospital admission intensive care hope precision medicine furthermore study underline use immune modulator leptin sensitizer immune suppressor anti inflammation therapy switch inflammatory response drastic immunological type  response beneficial type  effective
518,severe form covid- mark abnormal exacerbate immunological host response favor poor outcome significant number patient especially obesity diabetes hypertension atherosclerosis chronic inflammatory process find cardiometabolic comorbiditie mark overexpression pro inflammatory cytokine interleukin- il- tumoral necrosis factor alpha tnf alpha product toll like receptor  tlr pathway sars cov- initially infect cell upper respiratory tract patient spread quickly need respiratory support systemically cause collateral damage tissue hypothesize happen sars cov- spike protein interact strongly tlr cause intensely exacerbate immune response host lung culminate cytokine storm accumulate secretion hinder blood oxygenation immune system attack body lead multiple organ failure
519,background coronavirus disease  associate adverse maternal neonatal outcome pregnancy control datum quantify magnitude risk characterize epidemiology risk factor objective study aim quantify association coronavirus disease  adverse maternal neonatal outcome pregnancy characterize epidemiology risk factor study design perform match case control study pregnant patient confirm coronavirus disease  case deliver   week gestation march  june uninfected pregnant woman control match coronavirus disease  case ratio base delivery date maternal demographic characteristic coronavirus disease  symptom laboratory evaluation obstetrical neonatal outcome clinical management chart abstract primary outcome include composite adverse maternal outcome define preeclampsia venous thromboembolism antepartum admission maternal intensive care unit admission need mechanical ventilation supplemental oxygen maternal death composite adverse neonatal outcome define respiratory distress syndrome intraventricular hemorrhage necrotize enterocolitis apgar score persistent category  fetal heart rate tracing despite intrauterine resuscitation neonatal death quantify association exposure mild severe critical coronavirus disease  adverse maternal neonatal outcome unadjusted adjust analysis perform conditional logistic regression account matching match pair odd ratio confidence interval base  bias correct bootstrap resampling effect measure association adjust potential confounder result total  confirm coronavirus disease  case enrol study period mild disease n= severe disease n= critical disease n= odd adverse composite maternal outcome time high case control .% vs .% adjust odd ratio confidence interval odd adverse composite neonatal outcome time higher case group control group .% vs .% adjust odd ratio confidence interval stratified analysis disease severity indicate morbidity associate coronavirus disease  pregnancy largely drive severe critical disease phenotype major risk factor associated morbidity black hispanic race advanced maternal age medical comorbiditie antepartum admission relate coronavirus disease conclusion coronavirus disease  pregnancy associate increase risk adverse maternal neonatal outcome association primarily drive morbidity associate severe critical coronavirus disease black hispanic race obesity advanced maternal age medical comorbiditie antepartum admission relate coronavirus disease  risk factor associated morbidity
520,coronavirus disease  covid- cause global pandemic early infectious disorder heterogeneous course range asymptomatic disorder critical situation need intensive care current study present report affected patient admit single hospital iran eighty hospitalize patient covid- assess demographic clinical paraclinical parameter gather statistically analyze median age iqr patient year primary evaluation fever present .% affect individual common clinical symptom dyspnea .% cough totally  .%  .% patient low high wbc count respectively lymphopenia detect  .% patient  .% patient lymphocytosis high level il- detect  .% patient crp level elevate  .% patient median iqr hospitalization  day totally  patient hospitalize icu patient discharge good health condition patient die current study show heterogeneous clinical manifestation paraclinical parameter covid- patient
521,overall intestinal lipopolysaccharide lps composition individual obesity shift away immunosilent immunoinhibitory bacteroidetes lps subtype favor proinflammatory lps subtype gut microbiome dysbiosis high fat diet obesity se enhance intestinal permeability mechanism result increase paracellular absorption transcellular chylomicron transport endogenous endotoxin circulatory system endotoxemia addition know lipid initiate signal cascade result activation proinflammatory pathway increase oxidative stress bind tool like receptor  tlr take consideration likely gut microbiome dysbiosis endotoxemia represent additional pathophysiological explanation increase covid- severity obesity
522,modern iteration occam razor posit simple explanation usually correct coronavirus disease  involve widespread organ damage uneven mortality demographic deem unexpected originally think straightforward respiratory virus simple explanation expect unexpected aspect covid- share common mechanism silent hypoxia atypical acute respiratory distress syndrome ards stroke olfactory loss myocarditis increase mortality rate elderly man african americans patient obesity diabetes cancer bear fingerprint renin angiotensin system ras imbalance suggest ras common culprit article examine ras work baseline article present evidence suggest ras involvement disparate manifestation covid- understand deep working ras help sense severe covid- addition recognize role ras imbalance suggest potential route mitigate covid- severity
523,coronavirus disease  covid- pandemic disease originate wuhan city china cause severe acute respiratory syndrome corona virus  sars cov- biology poorly understand currently vaccine drug agent reduce severity new disease recent datum suggest patient age relate comorbiditie include cardiovascular disease diabetes obesity hypertension chronic kidney disease dementia highly susceptible severe respiratory illness coronavirus infection recent research reveal aged individual elevated baseline inflammation cause defect t b cell lead decrease body immune response viral infection current article discuss effect sars cov- age relate chronic disease diabetes obesity alzheimer disease article highlight interaction coronavirus immune cell covid- alter mitochondrial activity host cell base new compelling evidence propose mitochondrial fission inhibit fusion promote cause mitochondrial elongation provide receptive intracellular environment viral replication infected cell research need understand cross talk viral replication mitochondria disease progression patient covid-
524,background coronavirus disease- covid- global pandemic obesity associate increase disease severity covid- obesity strongly associate hepatic steatosis hs hs alter natural history covid- characterize especially western population aims characterize impact hs disease severity liver injury covid- method examine association hs disease severity single center cohort study hospitalize covid- patient michigan medicine hs define hepatic steatosis index  asians  non asians liver imaging demonstrate steatosis  day onset covid- primary predictor hs primary outcome severity cardiopulmonary disease transaminitis jaundice portal hypertensive complication result cohort  patient metabolic disease highly prevalent include nearly overweight hs associate increase transaminitis need intubation dialysis vasopressor association hs jaundice portal hypertensive complication sensitivity analysis include patient liver imaging  day onset covid- image evidence hepatic steatosis remained associate disease severity risk transaminitis conclusion hs associate increase disease severity transaminitis covid- hs relevant predict risk complication relate covid-
525,-year old man long history severe haemophilia treat prophylactically efmoroctocog alpha iu twice weekly diagnose covid- infection multiple risk factor covid- severity include obesity diabetes mellitus hypertension require prolonged intensive care unit icu stay severity respiratory failure death day icu stay receive continuous infusion efmoroctocog alpha order maintain factor viii activity  therapeutic dose low molecular weight heparin target anti xa activity iu mol tolerate numerous invasive procedure bleed post mortem examination evidence thrombosis haemorrhage different organ
526,objective case fatality rate cfr coronavirus disease  covid- vary significantly country aim describe association health indicator national cfrs covid- method identify country health indicator potentially associate national cfrs covid- extract datum  variable international administrative datum source  member country organization economic cooperation development oecd exclude collinear variable examine  variable multivariable analysis dynamic web base model develop analyse display association cfr covid- follow guideline accurate transparent health estimates reporting gather result multivariable analysis variable significantly associate increase cfr percentage obesity age year beta ci p tuberculosis incidence beta ci p duration day death covid- beta ci p median age beta ci p covid- test rate beta ci p hospital bed density beta ci p rural population ratio beta ci p decrease cfr conclusion pandemic hit population dense city available hospital bed increase test capacity increase enable effective diagnostic test old patient patient obesity caregiver warn potentially increase risk
527,coronavirus disease  covid- pandemic global health crisis study report association obesity severity covid- meta analysis assess association obesity outcome covid- hospitalize patient datum observational study describe obesity body mass index outcome covid- hospitalize patient december august extract follow prisma guideline consensus independent reviewer adverse outcome define intensive care unit oxygen saturation invasive mechanical ventilation severe disease hospital mortality odd ratio confidence interval ci obtain forest plot create random effect model total  study confirm covid- patient include overall prevalence obesity study meta analysis covid- patient obesity high odd poor outcome compare well outcome pooled ci p heterogeneity study p study suggest significant association obesity covid- severity poor outcome result finding important suggestion clinical management future research obesity covid-
528,coronavirus disease  covid- emerge disease reach pandemic status rapidly spread worldwide elderly individual patient comorbiditie obesity diabetes hypertension high risk hospitalization severe disease mortality acute respiratory syndrome coronavirus  sars cov- infection patient frequently exacerbate secretion proinflammatory cytokine associate overreaction immune system call cytokine storm host nutritional status play pivotal role outcome variety different infectious disease know immune system highly affect malnutrition lead decrease immune response consequent augment risk infection disease severity body composition especially low lean mass high adiposity consistently link worsen prognosis different disease review evidence concern impact nutritional status viral infection outcome discuss
530,importance identify independent risk factor adverse outcome patient infect severe acute respiratory syndrome coronavirus  sars cov- support prognostication resource utilization treatment objective identify excess risk risk factor associate hospitalization mechanical ventilation mortality patient sars cov- infection design setting participant longitudinal cohort study include  patient test sars cov- nucleic acid polymerase chain reaction feburary  follow june department veterans affairs va national health care system include  patient .% test positive exposure sociodemographic characteristic comorbid condition symptom laboratory test result main outcomes measures risk hospitalization mechanical ventilation death estimate time event analysis cox proportional hazard model result  veteran sars cov- predominantly male .% diverse race ethnicity white  black  hispanic mean sd age year compare patient test negative sars cov- test positive high rate -day hospitalization .% vs .% adjust hazard ratio ahr ci .- mechanical ventilation .% vs .% ahr ci .- death .% vs .% ahr ci patient test positive sars cov- characteristic significantly associate mortality include old age eg year vs /= vs /= vs ahr ci .- fever ahr ci .- dyspnea ahr ci .- abnormality certain blood test exhibit dose response association mortality include aspartate aminotransferase u l vs mg dl vs mg dl ahr ci .- neutrophil lymphocyte ratio vs /= vs .- ahr ci .- black race ahr ci .- hispanic ethnicity ahr ci .- chronic obstructive pulmonary disease ahr ci .- hypertension ahr ci .- smoking eg current vs ahr ci death cohort occur patient age  year old .% male sex .% charlson comorbidity index score  .% conclusion relevance national cohort va patient sars cov- death associate old age male sex comorbidity burden factor previously report associate mortality small study confirm obesity black race hispanic ethnicity chronic obstructive pulmonary disease hypertension smoking
531,background detection severe acute respiratory syndrome coronavirus  sars cov- rna blood know rnaemia report prognostic implication poorly understand study aim determine frequency sars cov- rna plasma association coronavirus disease  covid- clinical severity method analytical cross sectional study perform single center tertiary care institution include consecutive inpatient outpatient confirmed covid- prevalence sars cov- rnaemia strength association clinical severity variable examine include intensive care unit icu admission invasive mechanical ventilation -day cause mortality result pair nasopharyngeal plasma sample include  patient median age  year individual rnaemia old undetectable sars cov- rna plasma vs  year p comorbiditie frequent include obesity .% hypertension .% diabetes mellitus rnaemia detect .% patient include .% require hospitalization model adjust age rnaemia detect frequently individual develop severe disease include icu admission vs .% p invasive mechanical ventilation .% vs .% p  death occur individual detectable rnaemia additional  plasma sample  individual rnaemia assess longitudinally rna detect maximum duration  day conclusion study demonstrate high proportion sars cov- rnaemia association rnaemia clinical severity suggest potential utility plasma viral testing prognostic indicator covid-
533,review focus hypothetical mechanism enhance vulnerability african americans sars cov- infection covid- severity increase death disproportionately high number african americans afflict autoimmune inflammatory disease e.g. diabetes hypertension obesity sars cov- help expose health disparity factor include socioeconomic status inferior health care work circumstance contribute disparity identify potential inflammatory biomarker decrease basal level high risk individual comorbiditie preventive measure critical immune cell particularly neutrophils protect pathogen bacteria fungus virus increase generation free radical oxidant neutrophil extracellular trap net ensnare pathogen kill extracellularly continue generation net couple lack prompt removal pose danger host cell net level increase pro inflammatory disease covid- patient exhibit elevate net level depend disease severity conceivably high risk individual elevated basal net level exhibit hyper inflammation infect sars cov- amplify disease severity death drug inhibit oxidant formation vitamin supplement decrease net formation mouse model inflammation conceivable preventive treatment lower net level inflammation high risk individual mitigate sars cov induce complication decrease mortality
534,background risk factor progression coronavirus disease  covid- severe disease death underexplored u.s. cohort objective determine factor hospital admission predictive severe disease death covid- design retrospective cohort analysis setting hospital maryland washington dc area patient  consecutive covid- admission  march  april follow  june measurement patient trajectory outcome categorize world health organization covid- disease severity scale primary outcome death composite severe disease death result median patient age  year range   year woman black latinx nursing home resident patient  die  discharge mild moderate disease  severe disease death  nursing home resident  patient admit mild moderate disease  progress severe disease death  day   day patient markedly different probability disease progression basis age nursing home residence comorbid condition obesity respiratory symptom respiratory rate fever absolute lymphocyte count hypoalbuminemia troponin level c reactive protein level interaction factor factor present admission model predict hospital disease progression area curve day respectively limitation study single health care system conclusion combination demographic clinical variable strongly associate severe covid- disease death early onset covid- inpatient risk calculator circ factor present admission inform clinical resource allocation decision primary funding source hopkins inhealth covid- administrative supplement hhs region  treatment center office assistant secretary preparedness response
537,abstract severe acute respiratory syndrome coronavirus  sars cov- infection emerge global pandemic viral disease primarily cause lung pneumonia wide range clinical manifestation severity infection range asymptomatic mild symptom require hospital admission require ventilator support eventually die depend immunity age comorbiditie exist patient present report attempt study effect physiological environmental factor exist high altitude ha spread sars cov- infection analysis exist datum reveal ha native possess certain physiological advantage improve hypoxic ventilatory response high concentration oxygen carry molecule haemoglobin increase production vitamin d intense solar radiation low rate comorbiditie lung infection obesity etc importantly reduce production angiotensin convert enzyme carrier molecule sars cov- virus entry host cell collectively account improve tolerance sars cov- infection ha native addition environmental factor ha dry chilly wind low air density intense uv radiation inhibit viral growth spread atmosphere conclude high altitude native posses physiological environmental advantage low lander term reduce severity sars cov- infection limited spread graphic abstract gift factor associate covid- spread high altitude
538,gender specific difference prevalence incidence comorbiditie prognosis severity risk factor drug relate aspect outcome medical condition document present literature review extent research field develop year reveal gap gender sensitive awareness clinical portrayal translation gender specific treatment regimen guideline gender orient preventive strategy health policy subsequently lens gender describe domain detail select medical condition asthma obesity overweight chronic kidney disease coronavirus disease key gender difference apparent adolescence focus developmental stage finally propose model base influential issue investigate gender specific medical profile relate health condition single disease dynamic gender disparity developmental stage integrative approach take account additional risk factor ethnicity socio demographic variable minority lifestyle habit etc increase awareness gender specific medicine daily practice tailored guideline adolescent reduce inequity facilitate prediction future trend properly address characteristic need certain subpopulation gender
539,background aim study explore association bmi covid- positive status tertiary care hospital new delhi method seventy adult patient present covid- screen outpatient department hospital interview phone body weight height covid- rt pcr report patient extract hospital information system result mean bmi prevalence obesity observe high individual detect covid- rt pcr positive compare negative unit increment bmi  kg m odd covid- positive increase time patient conclusion finding suggest dose response association bmi odd covid- infection individual excess weight
540,background purpose coronavirus disease  covid- pandemic present unprecedented health crisis entire world report body mass index bmi play important role covid- remain unclear aim study explore association bmi covid- severity mortality method medline pubmed embase web science systematically search august random effect model dose response meta analysis synthesize result combined odd ratio ors confidence interval cis calculate effect covariate analyze subgroup analysis meta regression analysis result total  observational study involve patient covid- include meta analysis pooled result show patient bmi>/=kg m .-fold risk or=. ci=.- pyears associate significantly increase risk critical covid- or=. ci=.- p/=kg m associate significantly increase risk critical covid- hospital mortality covid-
541,result severe acute respiratory syndrome coronavirus  sars cov- infection clinical complication arise characterize hyperinflammatory cytokine profile term cytokine storm protein complex nuclear factor kappa light chain enhancer activate b cell nf kappab intricately involve regulate inflammation immune response follow viral infection reduction cytokine production observe follow decrease nf kappab activity approve asthma drug montelukast find modulate activity nf kappab result corresponding decrease proinflammatory mediator hypothesize repurpose montelukast suppress nf kappab activation result attenuation proinflammatory mediator decrease cytokine production lead reduction symptom severity improve clinical outcome patient coronavirus  covid-
542,background diabetes recognize important comorbidity patient covid- large literature available aim article review literature aspect association diabetes covid- highlight clinically relevant point focus india method search pubmed google scholar database article diabetes covid- publish march  august result diabetes poor glycemic control associate increase severity mortality patient covid- clinical scenario hyperglycemia covid- identify need specific management strategy conclusion prudent maintain good glycemic control patient diabetes order minimize complication covid- need conduct study ass role individual antihyperglycemic therapy covid- behavior new onset diabetes diagnose covid- infection time
543,purpose review old age obesity vitamin d deficiency consider independent risk factor severe course covid- aim review discuss common feature risk factor impact vitamin d. recent finding recently discover relationship vitamin d infection pathway virus renin angiotensin system ras adipokines leptin adiponectin play important role frequency study show relationship low vitamin d status comorbiditie severe covid- course make impact vitamin d effect likely summary direct relationship vitamin d body fat age covid- course age ability skin synthesize vitamin d decrease lead vitamin d deficit skin insufficiently expose sunlight severe deficit develop vitamin d play important role immune system ras point virus attack good vitamin d supply important basis reduce risk severe covid- process treatment vitamin d supplement base severity vitamin d deficiency
544,coronavirus disease  covid- global public health concern classify mild moderate severe critical base disease severity identification critical patient crucial develop effective management strategy evaluate clinical characteristic laboratory datum treatment provide oxygenation identify potential predictor mortality critical covid- pneumonia patient retrospectively utilize datum seven critical patient admit hospital april  require mechanical ventilation primary endpoint clarify potential predictor mortality patient old  year man hypertension ultimately die compare survivor non survivor tend smoker pack year vs.  pack year p high body mass index kg m vs. kg m p require early tracheal intubation symptom onset day vs. day p few lymphocyte admission /mul vs.  p week tracheal intubation non survivor display low value minimum ratio partial pressure oxygen fractional inspiratory oxygen concentration p f ratio mmhg vs.  mmhg p poor response intensive therapy compare survivor summary obesity lymphopenia predict severity covid- pneumonia trend low p f ratio week mechanical ventilation provide useful prognostic information
545,conduct systematic review observational study examine effect body mass index bmi obesity bmi  kg m coronavirus disease  covid- medline embase cochrane library search sixteen article finally include meta analysis random effect model bmi find high patient severe disease mild moderate disease md ci p china heterogeneity high elevated bmi associate invasive mechanical ventilation imv use md ci p western country result consistent study additionally increase odd ratio imv use ci p hospitalization ci p patient obesity substantial heterogeneity conclusion obesity high bmi increase risk hospitalization severe disease invasive mechanical ventilation covid- physician alert early indicator identify critical patient
546,emergency cause covid- pandemic raise interest study lifestyle comorbiditie important determinant poor covid- prognosis datum tobacco smoking alcohol consumption obesity limited datum available role e cigarette heat tobacco product htp clarify role tobacco smoking lifestyle habit covid- severity progression design longitudinal observational study title covid smoke italy cosmo  italian hospital north centre south italy join study main aim quantify role tobacco smoking smoking cessation severity progression covid- hospitalize patient compare smoking prevalence severity disease relation smoke hospitalize covid- patient versus patient treat home quantify association lifestyle factor e cigarette htp use alcohol obesity risk unfavourable covid- outcome socio demographic lifestyle medical history information gather  hospitalize home isolate laboratory confirm covid- patient give current absence vaccine sars cov- lack specific treatment -covid- prevention strategy extreme importance project design highly contribute international scientific debate role avoidable lifestyle habit covid- severity provide valuable epidemiological datum order support important recommendation prevent covid- incidence progression mortality
548,objective report peculiarity spinal epidural abscess covid- patient observe unusually high number patient follow outbreak sars corona virus- method clinical documentation consecutive covid- patient primary spinal epidural abscess surgically manage -month period case analyze concern viral infection spinal abscess result abscess primary case indicate evident infective source find primary abscess represent rare form spinal epidural abscess usually secondary invasive procedure spread adjacent infective site spondylodiscitis generally occur patient diabetes obesity cancer chronic disease case mild lymphopenia spinal abscess occur regardless severity viral disease immunologic state presence bacteremia obesity risk factor report patient patient hypertensive preferred localization cervical thoracic classic abscess generally occur lumbar level patient history pyogenic infection previous asymptomatic bacterial contamination report case conclusion wonder concentration uncommon disease short period knowledge case spinal epidural abscess covid- patient report date hypothesize patient spinal infection depend coexistence initially asymptomatic bacterial contamination know covid relate endotheliitis create condition retrograde bacterial invasion correspondent spinal epidural space furthermore spinal epidural abscess carry significantly high morbidity mortality difficult diagnose especially compromise covid- patient keep mind early diagnosis treatment crucial
549,objective describe dietary characteristic participant nutrinet brasil cohort immediately covid- pandemic method datum stem adult cohort create prospectively investigate relationship diet morbidity mortality chronic non communicable disease brazil study select participant n answer twice simplified questionnaire diet day time enter study january  february second  questionnaire inquirie consumption healthy vegetable fruit legume unhealthy ultra process food eat marker comparison indicator base consumption marker pandemic present study population accord gender age group macro region residence schooling chi square test t test compare proportion mean respectively adopt p identify significant difference result participant find modest statistically significant increase consumption healthy eating marker stability consumption unhealthy food marker favorable pattern dietary change pandemic occur sociodemographic stratum observe favorable change pattern tendency increase consumption healthy unhealthy food marker northeast north macro region people schooling suggest social inequality response pandemic conclusion confirm trend increase consumption ultra process food underdeveloped region people schooling concern eat food increase risk obesity hypertension diabetes presence increase severity lethality covid-
550,introduction patient severe covid- develop ventilator dependent acute hypoxic respiratory failure vdahrf associate high mortality rate evaluate clinical course hospitalize covid- patient compare patient receive invasive mechanical ventilation characteristic intubate patient successfully wean ventilator compare patient fail extubate die hospital objective investigate clinical course hospitalize covid- patient assess possible predictor disease severity lead vdahrf method single center retrospective study  patient year old covid- admit monmouth medical center march st april th  include result  patient n require invasive mechanical ventilation patient successfully wean ventilator multivariable logistic regression analysis show increase odd intubation associate hypoxemia odd ratio ci p elevated d dimer unit mg l feu odd ratio ci p elevated ferritin unit ng ml odd ratio ci p admission adjust covariate conclusion patient require invasive mechanical ventilation likely old age male gender coronary artery disease diabetes obesity patient successfully wean ventilator likely young age heart failure cad
551,obese patient present metabolic dysfunction associate fatty liver disease mafld risk severe presentation coronavirus disease  covid- patient likely hospitalize receive antiviral agent drug require treat acute respiratory distress syndrome systemic inflammation combat bacterial fungal superinfection reverse multi organ failure pharmaceutical antiretroviral lopinavir ritonavir remdesivir antibiotic antifungal agent induce drug induce liver injury dili mechanism understand present article hypothesize obese covid- patient mafld high risk dili non infected healthy individual mafld patient patient present concomitant factor individually favour dili polypharmacy systemic inflammation risk cytokine storm fatty liver nonalcoholic steatohepatitis nash insulin resistance disease link obesity obese covid- patient drug cause severe and/or frequent dili trigger transition fatty liver nash worsen pre existing steatosis necroinflammation fibrosis present main mechanism drug hepatotoxic mafld include impaired activity xenobiotic metabolize enzyme mitochondrial dysfunction alter lipid homeostasis oxidative stress comprehensive investigation need confirm hypothesis believe current epidemic obesity relate metabolic disease extensively contribute increase number case dili covid- patient participate presentation severity death
552,objective study analyze association severe obesity coronavirus disease  covid- hospitalization severe disease method incidence hospitalization laboratory confirm covid- evaluate prospective population base cohort person age   year spain march april person class  obesity compare poisson regression estimate adjust relative risk arr class  obesity covid- hospitalization severe disease intensive care unit admission death difference effect age sex chronic condition evaluate result individual class  obesity high risk hospitalization arr ci develop severe covid- arr ci people young  year effect pronounced arr ci arr ci respectively significant effect observe age   year arr ci arr ci respectively sex chronic condition modify effect class  obesity outcome conclusion severe obesity relevant risk factor covid- hospitalization severity young adult have magnitude similar aging tackle current obesity pandemic alleviate impact chronic infectious disease
553,obesity emerge risk factor covid- disease severity impact pandemic knowledge obesity risk factor live experience people obesity fully understand aim study investigate impact covid- pandemic people live severe obesity bmi kg m currently engage multi modal treatment primary objective examine impact pandemic live experience treatment psychosocial standpoint additionally explore awareness obesity risk factor covid- disease severity depth qualitative study adopt employ semi structured interview open end question interpretive thematic analysis adopt analyse datum identify key theme take ground approach theme emerge perspective impact live experience challenge sustain treatment b psychosocial impact split awareness lack awareness obesity risk factor contribute negative psychosocial impact patient covid- pandemic pose diverse challenge people obesity implication go treatment ethical standpoint need fully elucidate link obesity covid- disseminate information people friendly language imagery manner exacerbate harmful psychosocial response lead stigmatization
554,background identification vulnerable subgroup risk factor associate susceptibility severe acute respiratory syndrome coronavirus  sars cov- infection coronavirus disease  covid- utmost importance pandemic scenario potential interaction renin angiotensin system ras immune marker covid- play role disease outcome specific group patient objective review aim describe particularity ras immune system profile particular subgroup patient method non systematic review summarize evidence sars cov- infection specific subgroup patient possible relationship immune system ras pathophysiology covid- result ras immune system exert role pathogenesis prognosis covid- mainly case hypertension diabetes obesity chronic disease overactivation ace ang ii atr axis enhancement inflammation contribute deleterious effect covid- likewise pregnant woman elderly patient usually display immune response effective withstand exposition virus child relatively protect severe complication covid- woman conversely exhibit strong antiviral response sensitive effect increase ang ii future perspectives recognition vulnerable subgroup risk factor disease severity essential well understand pandemic precision medicine tool include proteomic metabolomics approach identify metabolic pattern severe form disease alternative diagnose evaluate predict prognosis efficiency therapy
556,coronavirus disease  covid- pandemic force consider physiologic role obesity response infectious disease significant disparity morbidity mortality sex weight diabetes status numerous endocrine change drive varied response severe acute respiratory syndrome coronavirus  sars cov- infection include hormone immune mediator hyperglycemia leukocyte response cytokine secretion tissue dysfunction study patient severe covid- disease reveal importance innate immune response drive immunopathology tissue injury review describe impact metabolically induce inflammation meta inflammation characterize obesity innate immunity consider obesity drive dysregulation innate immune response drive organ injury development severe covid- impair viral clearance
557,order describe manifestation patient coronavirus disease  covid- sociodemographic variable previous medical history clinical radiological manifestation treatment evolution patient evaluate take place march th th edgardo rebagliati martins national hospital lima seventeen patient register male average age year range .% return abroad .% refer health facility .% admit mechanical ventilation .% patient die risk factor detect advanced age arterial hypertension obesity main symptom detect cough fever dyspnea frequent laboratory finding elevated c reactive protein lymphopenia predominant radiological presentation bilateral interstitial lung infiltrate experience management patient diagnose severe covid- peru report
558,objective obesity major risk factor severe form coronavirus disease covid- little know post bariatric surgery bs setting prevalence likely covid- risk factor patient follow bs assess method total  patient undergo bs follow university medical center survey retrospective comparison characteristic baseline  year bs time lockdown perform patient covid likely event cl base combination report symptom covid- unlikely result cl occur  patient  .% severe form require hospitalization  .% die cl group high proportion persistent type  diabetes td follow .% vs. .% p bmi time lockdown low cl group vs. kg m p high percent weight loss bs cl group severe form covid- require hospitalization associate persistent td follow visit conclusion bs patient cl associate persistent td low bmi
559,conundrum puzzle covid- investigator morbidity mortality rare infant young child rate morbidity mortality exhibit large variance nation locale city find high rate pneumococcal vaccination nation city low covid- morbidity mortality vaccination rate bacillus calmette guerin poliovirus vaccine correlate covid- risk covid- case death rate correlate number people population diabetes obesity adult infant protection maternal antibody antiviral protein milk lactoferrin know protect coronavirus infection subsequent protection confer correlate rate haemophilus influenzae type b hib universal infant pneumococcal vaccination vary widely geography infant risk adult elderly video abstract
560,early december city wuhan hubei province china infection novel coronavirus report severe acute respiratory syndrome coronavirus  sars cov- spread city country global emerge epidemiological issue quickly reach status pandemic multiple risk factor disease severity mortality identify far include old age male sex smoking obesity concise narrative review highlight important role factor pathobiology clinical landscape coronavirus disease  covid- especially focus significant role disease severity mortality spite intensive research present piece evidence weak need verification
561,aim coronavirus disease  covid- recently encounter disease declare pandemic obesity component metabolic syndrome aggravate severity covid- nonalcoholic fatty liver disease nafld represent hepatic manifestation metabolic syndrome aim study investigate possible association mafld covid- severity method perform retrospective case control study enrol  consecutive covid- patient divide group accord presence absence fatty liver compute tomography scan medical record eligible patient include demographic clinical laboratory parameter datum presence nafld covid- severity result nafld identify study group thirteen suffer severe covid- nafld patient severe covid- compare non nafld subject .% vs. p respectively multiple logistic regression analysis show nafld subject likely severe covid- disease odd ratio confidence interval p conclusion nafld represent high risk severe covid- irrespective gender independent metabolic syndrome specifically male gender obesity hypertension metabolic syndrome significantly associate severe covid-
562,coronavirus disease  covid- pandemic infectious disease cause novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- old age presence comorbiditie include diabetes show associate severe course high fatality rate study affected country include china united states italy indicate prevalence diabetes patient affect covid- high observe general population suggest diabetes risk factor sars cov- infection large body evidence demonstrate diabetes risk factor disease progression critical illness development acute respiratory distress syndrome need mechanical ventilation admission intensive care unit ultimately death mechanism underlie relationship covid- diabete remain elucidate particular unresolved diabetes se especially poorly control comorbiditie complication associate predispose patient covid- bad prognosis fact condition cluster diabetes context metabolic syndrome obesity hypertension complicate chronic hyperglycemia cardiovascular disease chronic kidney disease associate poor prognosis individual available study consistently show diabetes predict disease severity independently
563,obesity chronic disease cause aggravate disease early report suggest important risk factor covid- severity deep understanding relationship vital important inform general public risk ideally offer strategy mitigate risk resolution obesity short term feasible possible small weight loss increase physical activity actually reduce risk context propose term call control obesity study lose maximal weight ideally physically active consider healthy context broad usefulness pandemic evidence point weight loss significant reduce overall health risk irrespective final bmi
564,purpose covid- global threat push health care limit vaccine drug covid- people increase risk severe fatal course disease particularly need protection furthermore factor increase risk interest search potential treatment systematic literature review risk factor severe fatal covid- course present method review carry pubmed publicly available dataset analysis risk factor categorize information study study size location extract result compare risk factor list public authority different country result  record include preprint indicate condition comorbiditie connect poor state health high age obesity diabetes hypertension risk factor severe fatal disease course furthermore severe fatal course associate organ damage mainly affect heart liver kidney coagulation dysfunction play critical role organ damaging time hospital admission tuberculosis inflammation disorder coagulation dysfunction identify risk factor find review mention public authority conclusion factor associate increase risk severe fatal disease course identify include condition connect poor state health organ damage coagulation dysfunction result facilitate upcoming covid- research
565,obesity emerge independent risk factor susceptibility severity coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus- sars cov- previous viral pandemic show obesity particularly severe obesity bmi  kg m associate increase risk hospitalization critical care admission fatality narrative review examine emerge evidence influence obesity covid- challenge clinical management pulmonary endocrine immune dysfunction individual obesity identify potential area research recommend people severe obesity deem vulnerable group covid- clinical trial pharmacotherapeutic immunotherapy vaccination prioritize inclusion people obesity
566,aim poor outcome coronavirus disease  covid- link diabetes relation pre infection glycaemic control unclear materials method address question report association pre infection haemoglobin ac hbac level covid- severity assess need hospitalization cohort  patient diabetes test covid- leumit health services lhss israel  february  april lhs integrate electronic medical record system able collect large clinical information include age sex socio economic status weight height body mass index hbac prior diagnosis ischaemic heart disease depression anxiety schizophrenia dementia hypertension cerebrovascular accident congestive heart failure smoking chronic lung disease result patient include cohort  .% diagnose covid-  admit hospital hospitalize patient female come high socio economic background high baseline hbac prior diagnosis cerebrovascular accident chronic lung disease confer increase risk hospitalization obesity smoking status multivariate analysis control multiple prior clinical condition parameter associate significantly increase risk hospitalization hbac conclusion pre infection glycaemic control datum identify hbac clear predictor covid- severity pre infection risk stratification crucial successfully manage disease efficiently allocate resource minimize economic social burden associate undiscriminating approach
567,novel coronavirus disease covid- global health crisis appearance wuhan china current epidemiological study suggest covid- affect old patient multiple comorbiditie hypertension obesity chronic lung disease difference incidence severity covid- likely multifaceted depend biological social economical factor specifically socioeconomic difference psychological impact covid- affect male female essential pandemic mitigation preparedness previous clinical study show female susceptible acquire viral infection reduce cytokine production female patient high macrophage neutrophil activity antibody production response furthermore vivo study angiotensin convert enzyme  ace show high expression kidney male female patient explain difference susceptibility progression covid- male female patient remain unknown expression ace differ lung male female patient disparity healthcare access socioeconomic status ethnic group influence covid- rate ethnic group high level medical comorbiditie low socioeconomic status increase risk contract covid- weak cell mediate immunity article examine current literature gender racial difference covid- patient examine possible biological mechanism underlie difference
568,sars cov- pandemic currently affect entire world show especially dangerous elderly /= year smoker notably strong comorbidity patient suffer chronic disease type  diabetes cancer chronic respiratory disease obesity hypertension inflammation lung main factor lead respiratory distress patient chronic respiratory disease patient severe covid- study show inflammation lung general type  diabetes accompany degradation glycosaminoglycan gags especially heparan sulfate hs study show importance counter degradation hs lung infection type  diabetes d xylose initiate element different sulfate gag chain especially hs show regeneration property gag d xylose xylitol demonstrate anti inflammatory antiglycemic antiviral antibacterial property lung infection combination antibiotic consider exist research covid- relate d xylose xylitol review offer perspective association d xylose antibiotic contribute significantly reduce duration treatment covid- patient anti inflammatory drug increase severity covid- strong correlation scurvy base gender age ethnicity smoking status obesity status relate effect treatment plant artemisia address chemical compound d xylose xylitol l ascorbic acid d glucuronic acid n acetylglucosamine d n acetylglucosamine n acetylgalactosamine galactose
569,linkage individual obesity covid- controversial lack systematic review systematic search chinese english language literature covid-  study conduct series meta analysis relationship individual obesity covid- spectrum risk mortality systematic review mechanistic pathway covid- individual obesity present pooled analysis individual obesity risk covid- positive high ci p hospitalization high ci p icu admission high ci mortality increase death ci p mechanistic pathway individual obesity present depth factor link covid- risk severity potential diminished therapeutic prophylactic treatment individual individual obesity link large significant increase morbidity mortality covid- mechanism jointly explain impact major concern vaccine effective individual obesity
571,covid- cause severe acute respiratory syndrome coronavirus  sars cov- recognise pandemic host preparation combat virus important strategy avoid covid- severity relationship eat habit nutritional status effect immune response implication viral respiratory infection important topic discuss review malnutrition cause diverse alteration immune system suppress immune response increase susceptibility infection sars cov- hand obesity induce low grade chronic inflammation cause excess adiposity increase angiotensin convert enzyme decrease immune response favour sars cov- virulence promote respiratory distress syndrome present review highlight importance food choice consider inflammatory effect consequently increase viral susceptibility observe malnutrition obesity healthy eating habit micronutrient bioactive compound probiotic strategy covid- prevention diversified balanced diet contribute improvement immune response viral infection covid-
572,impact statement close relationship periodontal disease pds severity covid- infection relationship cause galectin mediate increase immune response increase viral attachment keep pd control maintain rigorous oral hygiene troubled covid- pandemic period important patient old age pre existing condition like cardiovascular disease hypertension diabetes obesity high risk group develop severe covid- infection inflammatory pathway involve condition pathway periodontal disease pds raise significant question pd pre existing condition increase risk develop severe covid- infection study show galectin play key role homeostasis immune cell recently relationship find covid- galectin- gal-).it determine important area spike protein coronavirus- exactly morphology gal- spike protein critical entry virus host cell suspect evidence support close relationship pds severity covid- infection accumulate evidence suggest relationship severity pd risk infection covid- require investigation relationship cause gal mediate increase immune response increase viral attachment context want emphasize importance keep pd control maintain rigorous oral hygiene troubled covid- pandemic period like point possibility have pd pre disposition develop severe covid- infection
573,people infect severe acute respiratory syndrome coronavirus  sars cov mildly symptomatic progress critical illness succumb infection disease severity see associate increase age underlie comorbid condition obesity responsible metabolic disorder appear risk factor determine severity infection despite age group association clinically relevant mechanism underlie fully elucidate sars cov enter host cell angiotensin convert enzyme  receptor expression upregulate visceral fat tissue obese people underscore fact adipose tissue potential reservoir virus adipose tissue source proinflammatory mediator adipokine high baseline c reactive protein interleukin hyperleptinemia leptin resistance hypoadiponectinemia associate obesity explain preexisting inflammatory state obese individual predispose bad outcome fatality
574,objective aim examine association obesity relate trait body mass index bmi central obesity genetic predisposition risk develop severe covid- population base datum research design method analyze datum adult enrol uk biobank population base cohort study exposure interest bmi category central obesity e.g. large waist circumference genome wide genotyping datum compute polygenic risk score prs represent individual overall genetic risk obesity trait outcome severe covid- define hospitalization laboratory confirm covid- result individual normal weight bmi .-.kg m overweight .-.kg m obese m uk biobank identify  patient severe covid- compare adult normal weight high bmi dose response increase risk severe covid- follow adjust or .-.kg m ci p=. .-.kg m ci p/=.kg m ci p likewise central obesity associate significantly high risk severe covid- p furthermore large prs bmi associate high risk outcome adjust bmi prs z score ci p=. conclusion large population base cohort individual severe obesity central obesity genetic predisposition obesity high risk develop severe covid-
576,initial observation show people chronic noncommunicable disease heightened risk severe covid- adverse outcome subsequently datum country reveal obesity independent significant factor people overweight obesity significantly likely hospitalize require icu treatment die notably additional risk apply young people relative general covid- risk profile paper set evidence great risk poor covid outcome people overweight obesity indication reduce treatment support obesity self management exist prior covid- highlight dearth specific guidance measure mitigate impact covid- people obesity identify health social economic impact specific vulnerability create relative covid- outcome reduced national global pandemic resilience high obesity prevalence spur government funder provide urgent specific protection support people overweight obesity commission rapid research identify effective prevention reduction measure set priority action obesity begin compensate year underfunding inadequate policy attention face escalate obesity country income group world region
577,coronavirus disease  covid- pandemic reach worldwide vaccine find continue cause significant morbidity mortality clinical presentation covid- range asymptomatic develop fatal illness characterize multiple organ involvement approximately patient require hospitalization quarter hospitalize patient develop severe covid- require admission intensive care unit frequently acute respiratory failure ongoing effort identify patient develop severe covid- overall patient present  different phenotype nutrition risk frail old patient patient severe ongoing chronic illness patient severe morbid obesity  phenotype represent different nutrition risk diverse nutrition intervention article explore different potential approach nutrition intervention patient covid- evaluate process challenge face implementation guideline write different society
578,severe acute respiratory syndrome coronavirus  sars cov- cause great worldwide pandemic  flu consequence coronavirus disease  covid- devastating represent current major public health issue globe onset sars cov- primarily attack respiratory system represent main point entry host affect multiple organ patient present symptom mildly symptomatic people infect sars cov- experience severe multiorgan dysfunction severity covid- typically combine set comorbiditie hypertension diabetes obesity and/or advanced age seriously exacerbate consequence infection sars cov- cause gastrointestinal symptom vomiting diarrhea abdominal pain early phase disease intestinal dysfunction induce change intestinal microbe increase inflammatory cytokine diagnose gastrointestinal symptom precede respiratory problem covid- necessary improve early detection treatment uncover composition microbiota metabolic product context covid- help determine novel biomarker disease help identify new therapeutic target elucidate change microbiome reliable biomarker context covid- represent overlook piece disease puzzle require investigation
579,objective preliminary datum different cohort small sample size short follow indicate poor prognosis people obesity compare patient study aim precisely describe strength association obesity patient hospitalize coronavirus disease  covid- mortality clarify risk accord usual cardiometabolic risk factor large cohort method prospective cohort study include patient age   year hospitalize february  april paris area confirmed infection severe acute respiratory syndrome coronavirus adjust regression model estimate odd ratio ors ci mortality rate  day bmi class imputation miss bmi value result ninety death occur  day mortality significantly raise people obesity follow or bmi   kg m   kg m kg m ci ci ci respectively kg m reference class increase hold age class conclusion obesity double mortality patient hospitalize covid-
580,background confirm case novel coronavirus -ncov infection united states report state washington january march new york city epicenter outbreak united states method track patient confirmed coronavirus- covid- infection admit intensive care unit icu montefiore medical center bronx ny datum obtain manual review electronic medical record patient  day follow result  icu patient admit march  april majority .% patient man acute respiratory distress syndrome ards document .% patient .% require mechanical ventilation prone positioning employ patient neuromuscular blockade .% mechanically ventilate patient intervention associate decrease mortality vasopressor require .% patient acute kidney injury aki present admission .% patient develop subsequently .% .% patient aki receive renal replacement therapy rrt overall -day mortality rate patient receive mechanical ventilation univariate analysis high mortality rate associate increase age male sex hypertension obesity smoking number comorbiditie aki presentation need vasopressor support representative multivariable model -day mortality present contain patient age gender body mass index aki admission  patient .% remained hospitalize conclusion mortality critical illness associate covid- high majority patient develop ards require mechanical ventilation vasopressor dependent shock aki variation mortality rate report date likely reflect difference severity illness evaluate population
581,covid- pandemic start december  present result death globally approximately death report africa despite high prevalence covid- risk factor hypertension diabetes chronic pulmonary disease cardiovascular disease cvds rheumatic heart disease compromise immunity obesity low case fatality rate record part africa far covid- severity previously show bad patient cvd hypertension observe severity covid- mortality rate africa compare outcome prevalence establish risk factor hypertension cvd stratify datum united nations  african subregion north african country positive association risk factor mortality rate covid- observe discordant pattern relationship covid- cvd hypertension sub saharan african country paper review pathogenesis sars cov- infection worsen cvd postulate difference modulation renin angiotensin aldosterone system raas axis control angiotensin convert enzyme ace)/ace balance important determinant covid- outcome africa
582,evidence emerge increase risk severe acute respiratory syndrome coronavirus  sars cov- bad prognosis elderly male patient obesity blunt growth hormone gh secretion represent feature population subgroup comprehensive review possible link gh insulinlike growth factor  axis impairment coronavirus disease  covid- severity offer unequivocal evidence suggest immune system dysregulation represent key element determine sars cov- severity association adult onset gh deficiency ghd notably gh physiologically involve development maintenance immune system pharmacological replacement ghd patient positively influence inflammatory status addition impaired fibrinolysis associate ghd represent link gh insulin like growth factor  axis impairment covid- severity associate condition conclusion source evidence support relationship ghd covid- shed light potential beneficial effect recombinant gh treatment covid- patient
583,coronavirus disease  covid- pandemic rapidly spread worldwide major public health crisis increase evidence demonstrate strong correlation obesity covid- disease summarize recent study address impact obesity covid- term hospitalization severity mortality patient outcome discuss potential molecular mechanism obesity contribute pathogenesis covid- addition obesity relate deregulate immune response chronic inflammation endothelium imbalance metabolic dysfunction associated comorbiditie dysfunctional mesenchymal stem cell adipose derive mesenchymal stem cell play crucial role fuel systemic inflammation contribute cytokine storm promote pulmonary fibrosis cause lung functional failure characteristic severe covid- obesity compromise motile cilium airway epithelial cell impair functioning mucociliary escalator reduce clearance severe acute respiratory syndrome coronavirus sars cov- obese diseased adipose tissue overexpress receptor protease sars cov- entry implicate possible role virus reservoir accelerator reinforce violent systemic inflammation immune response finally anti inflammatory cytokine like anti interleukin  administration mesenchymal stromal stem cell serve potential immune modulatory therapy supportively combat covid- obesity conversely relate development covid- numerous molecular mechanism individual obesity belong covid susceptible population require protective measure
584,pulmonary embolism pes coronavirus disease  covid- increasingly report observational study limited information describe clinical characteristic outcome exist study aim describe clinical feature risk stratification strategy hospitalize covid- patient pe retrospectively analyze  hospitalize patient covid- infection acute pe clinical outcome measure intensive care unit admission mechanical ventilation bleeding transfusion event acute kidney injury aki mortality pulmonary severity index pesi score risk stratification common comorbiditie hypertension obesity hyperlipidemia cohort baseline d dimer abnormality note admission -fold increase time pe diagnosis p portend bad prognosis high mortality rate length stay conclusion study provide characteristic early outcome hospitalize patient covid- acute pulmonary embolism pesi score utilize risk stratify clinical outcome result serve alert medical community heighted vigilance vte complication associate covid- infection
585,objective comprehensive review focus currently available evidence maternal fetal neonatal mortality case associate coronavirus disease  covid- infection july method systematically search pubmed scopus google scholar web science database identify report case maternal fetal neonatal mortality associate covid- infection reference relevant study hand search result  study screen  study report  maternal  perinatal mortality case fetal demise  neonatal death finally eligible inclusion review maternal death see woman previous co morbidity common obesity diabetes asthma advanced maternal age acute respiratory distress syndrome ards severity pneumonia consider lead cause maternal mortality case die thromboembolism postpartum period fetal neonatal mortality suggest result severity maternal infection prematurity respectively interestingly evidence vertical transmission positive covid- test result expire neonate conclusion current available evidence suggest maternal mortality happen woman previous co morbidity neonatal mortality result prematurity infection report need magnitude maternal perinatal mortality determine precisely
586,objective describe clinical characteristic pregnant postpartum woman severe covid- brazil examine risk factor mortality design cross sectional study base secondary surveillance database analysis setting nationwide brazil population sample  brazilian pregnant postpartum woman notify covid- acute respiratory distress syndrome ards case complete outcome death cure  june method datum abstract brazilian ards surveillance system ards ss database eligible case include datum demographic clinical characteristic intensive care resource use outcome collect risk factor mortality examine multivariate logistic regression main outcome measures case fatality rate result identify  maternal death correspond case fatality rate covid- ards case obstetric population .% comorbidity present .% fatal case compare .% survival case woman die .% admit icu .% invasive ventilation .% respiratory support multivariate logistic regression show main risk factor maternal death covid- postpartum onset ards obesity diabetes cardiovascular disease white ethnicity protective effect conclusion negative outcome covid- population affect clinical characteristic social determinant health play role urgent reinforce containment measure target obstetric population ensure high quality care pregnancy postpartum period tweetable abstract total  covid- maternal death identify brazil symptom onset postpartum comorbiditie risk factor
587,objective impact inflammatory rheumatic disease covid- severity poorly know compare outcome cohort patient rheumatic disease match control cohort identify potential risk factor severe illness method comparative cohort study identify hospital pcr+covid- rheumatic patient chronic inflammatory arthritis ia connective tissue disease ctds non rheumatic control randomly sample match age sex pcr date main outcome severe covid- define death invasive ventilation intensive care unit admission complication assess association outcome potential prognostic variable adjust covid- treatment logistic regression result cohort compose  rheumatic non rheumatic patient equal number mean age  iqr year male sex cohort rheumatic disease ia ctd patient hospitalise risk severe covid- rheumatic .% non rheumatic cohort age male sex previous comorbidity obesity diabetes hypertension cardiovascular lung disease increase risk rheumatic cohort bivariate analysis logistic regression analysis independent factor associate severe covid- increase age ci male sex ci have ctd ci conclusion hospitalise patient chronic inflammatory rheumatic disease have ctd ia previous immunosuppressive therapy associate severe covid-
588,severe acute respiratory syndrome coronavirus  sars cov- coronavirus lead global health outbreak despite high mortality rate sars cov- middle east respiratory syndrome mers)-cov infection spark interest scientific community underlie physiopathology sars cov- infection remain partially unclear sars cov- share similar feature sars cov- notably use angiotensin conversion enzyme  ace receptor enter host cell feature sars cov- pandemic unique work focus association obesity metabolic syndrome type  diabetes hand severity covid- infection great patient discuss adipocyte dysfunction lead specific immune environment predispose obese patient respiratory failure covid- hypothesize ace cleave protein angiotensin beneficial action immune deregulation low expression sars cov- infection explain severity infection introduce angiotensin potential candidate interest therapeutic research cov infection
589,report case coronavirus disease  covid- child aged year appear asymptomatic mild know severe covid- illness require hospitalization child march -july  pediatric covid- case report covid associated hospitalization surveillance network covid net population base surveillance system collect datum laboratory confirm covid associated hospitalization  state base datum cumulative covid associate hospitalization rate child age year march -july population high rate child aged year march -july weekly hospitalization rate steadily increase child weekly high overall hispanic latino hispanic non hispanic black black child high cumulative rate covid associated hospitalization respectively non hispanic white white child  .% hospitalize child complete medical chart review  .% admit intensive care unit icu   .% require invasive mechanical ventilation patient die hospitalization cumulative rate pediatric covid associate hospitalization remain low population compare adult weekly rate increase surveillance period hospitalize child admit icu similar proportion adult continued tracking sars cov- infection child important characterize morbidity mortality reinforcement prevention effort essential congregate setting serve child include childcare center school
590,case covid- appear wuhan china end disease quickly pandemic seriously affect economic health system  country territory world patient mild symptom asymptomatic patient develop complication acute respiratory distress syndrome venous thromboembolism require mechanical ventilation intensive care important identify patient high risk complication timely manner objective paper review hematological laboratory parameter consistently alter covid- identify relationship severity disease accord  select report frequency patient age  year high subject severely affect deceased likewise male predominantly suffer comorbiditie hypertension diabetes obesity retrospective study identify alteration hematological inflammatory parameter host response infection secondary increase risk different thrombotic event alter parameter d dimer c reactive protein interleukin- test prognostic biomarker close relationship severity disease actually reliably indicate use antithrombotic therapy prophylactic therapeutic dose mainly d dimer establish patient individualized assessment appear high risk thrombotic event
591,purpose coronavirus disease  covid- create unprecedented healthcare crisis understand determinant mortality crucial optimise intensive care unit icu resource use identify target improve survival method multicentre retrospective study include  covid- patient admit icu  february  april  categorise accord time disease onset icu admission cox proportional hazard model identify factor associate mortality result median age  year  man main comorbiditie include obesity overweight hypertension .% diabetes median time disease onset i.e. viral symptom icu admission  day miss  .% patient admit week disease onset  .%   day  .%  day disease onset day  mortality decrease time disease onset icu admission increase  respectively patient admit week high sofa score thrombocytopenia acute kidney injury limited radiographic involvement significantly high blood il- level age copd immunocompromised status time disease onset troponin concentration acute kidney injury independently associate mortality conclusion excess mortality patient admit week disease onset reflect great non respiratory severity therapeutic intervention sars cov- impact different clinical endpoint accord time disease onset
592,coronavirus disease  covid- high morbidity mortality associate age male gender comorbiditie chronic lung disease cardiovascular pathology hypertension kidney disease diabetes mellitus obesity condition characterize increase sympathetic discharge exert significant detrimental effect covid- patient action lung heart blood vessel kidney metabolism and/or immune system furthermore covid- increase sympathetic discharge change blood gas chronic intermittent hypoxia hyperpnea angiotensin convert enzyme ace)/ace imbalance immune inflammatory factor emotional distress potential role sympathetic nervous system consider pathophysiology covid- opinion sympathetic overactivation represent far undervalued mechanism vicious circle covid- comorbiditie
593,previous publication atmospheric pollution consider co factor extremely high level sars cov- lethality northern italy conticini hypothesize surplus lethality novel sars cov- northern italy explain evidence high pollution report area severe covid- smog exposure correlate innate immune system hyper activation subsequent lung inflammation injury hypothesis fully explain specific subgroup patient major risk hypothesize obesity link covid- severity high level air pollution obesity predispose factor sars cov- infection bad covid- outcome unequivocal evidence demonstrate fat mass excess independently associate pulmonary disease lung inflammation show obesity intensify detrimental effect air pollution lung surprising consider condition share excessive activation immune system lung inflammatory infiltrate finally fat mass excess speculate consequence air pollutant exposure prove induce metabolic disruption weight gain murine model conclusion variable take account analysis pandemic observation suggest obesity act effect modifier smog induce lung injury concomitant presence factor well explain high virulence fast spread great mortality sars cov- northern italy compare rest country
594,objective identify factor contribute increase susceptibility severity covid- obese child adolescent health consequence source study publish   pubmed medline scopus scielo cochrane database summary findings obesity highly prevalent comorbidity severe case covid- child adolescent social isolation lead increase fat accumulation excessive adipose tissue deficit lean mass insulin resistance dyslipidemia hypertension high level proinflammatory cytokine low intake essential nutrient factor compromise functioning organ system obese individual factor associate damage immune cardiovascular respiratory urinary system modification intestinal microbiota dysbiosis severe acute respiratory syndrome coronavirus  infection organic change obesity increase need ventilatory assistance risk thromboembolism reduce glomerular filtration rate change innate adaptive immune response perpetuation chronic inflammatory response conclusion need social isolation effect cause worsen obesity comorbiditie pediatrician need aware issue face child suspect confirm covid- health professional diagnose excess weight advise health care time isolation screen comorbiditie ensure treatment interrupt measure level immunonutrient guide family understand specific situation refer unit qualified care obese child adolescent necessary
595,introduction severe acute respiratory syndrome coronavirus  sars cov- cause pandemic coronavirus disease  covid- global health crisis possible pancreatic involvement recently observe patient significance unclear aim study evaluate association significantly elevated lipase disease outcome method datum demographic symptom laboratory value clinical outcome collect consecutive patient test positive covid- elevated lipase define great  time upper limit normal x uln baseline characteristic patient elevated lipase compare fisher exact test student t test categorical numerical variable respectively logistic regression evaluate association lipase level primary clinical outcome intensive care unit admission intubation adjust age sex body mass index history diabetes hypertension result patient covid-  available lipase level admit hospital  .% elevate lipase x uln associate high rate leukocytosis p abnormal liver enzyme p compare low lipase level x uln patient elevated lipase high rate icu admission .% vs .% p intubation .% vs .% p multivariable adjust model high lipase level significantly associate admission icu rate intubation discussion lipase elevation see covid- associate bad disease outcome
596,advanced age presence multiple comorbiditie major contributor increase risk severe disease fatal outcome severe acute respiratory syndrome coronavirus  sars cov- disease covid- emerge evidence overweight obesity predispose severe symptom negative prognosis remarkably severity covid- appear rise increase body mass index bmi association covid- outcome overweight obesity biological physiological plausibility potential pathophysiological mechanism explain strong association include chronic pro inflammatory state excessive oxidative stress response impaired immunity commonly report individual role cytokine mammalian target rapamycin mtor alter natural killer cell polarization dangerous liaison covid- obesity discuss pathway favor accelerate deleterious downstream cellular effect sars cov- obesity known associate reduce lung function poor response mechanical ventilation place individual high risk severe illness mortality covid- furthermore obesity lead complication renal failure cardiovascular dysfunction hypertension vascular damage turn accelerate negative clinical outcome covid- obese individual shield potential viral exposure sars cov- consequential consideration compulsory protection device social distancing health care provider aware obesity predispose severe symptom negative prognosis covid- patient
597,se micronutrient essential human health sub optimal se status common occur significant proportion population world include part europe china human animal study show se status key determinant host response viral infection review address question se intake factor determine severity response coronavirus disease  covid- emphasis place epidemiological animal study suggest se affect host response rna virus molecular mechanism se selenoprotein modulate inter link redox homeostasis stress response inflammatory response study indicate se status important factor determine host response viral infection conclude se status likely influence human response severe acute respiratory syndrome coronavirus  sars cov- infection se status risk factor impact outcome sars cov- infection particularly population se intake sub optimal low suggest use appropriate marker assess se status covid- patient possible supplementation beneficial limit severity symptom especially country se status regard sub optimal
598,report suggest beneficial effect nicotine coronavirus disease  covid- severity encourage smoking aim analyze tweet covid- smoking come casual twitter user twitter account represent tobacco industry collect tweet covid- smoke january  twitter application programming interface analyze sentiment like retweet follower ratio post come casual user find piece news affect discourse tweet come industry analyze manually analyze n tweet covid- smoking sentiment tweet negative hit nadir mid march negative april preprint suggest benefit smoke covid- release similar trend observe ratio like retweet follower find  message tobacco industry concern covid- percent mention effort tobacco company support development covid- vaccine tweet include food drug administration statement evidence vaping increase risk covid- occurrence preprint suggest benefit smoking covid- increase sentiment reaction tweet tobacco product virus author potentially controversial article restrain promotion result completion review process twitter present convenient tool monitor e discourse health crisis research community monitor tobacco industry social medium
599,background aim pandemic covid- forward public health system country prepare unprecedented outbreak present time recognition associated risk morbidity mortality imperative fundamental determine prevention strategy target high risk population appropriate therapy method collate analyse online database i.e. pubmed google scholar researchgate highlight demographic mechanistic link obesity associated risk severity covid- result observe change dynamic reporting time initial pandemic china currently report research initially body mass index bmi find mention datum clearly emerge obesity profound risk factor complication covid- conclusion review help clinician health policy maker consider importance obesity make prevention therapeutic strategy covid- extra attention precaution patient obesity covid- pandemic recommend
600,objective coronavirus disease  covid- disproportionately impact african american community study aim identify risk factor severe covid- disease african american patient method retrospective cross sectional analysis african american patient covid- treat march  april single tertiary center primary outcome interest severe disease define require intensive care unit icu admission result study include  consecutive patient mean age  year woman mean sd bmi kg m overall patient admit icu old vs.  year p high bmi kg m vs. kg m p unadjusted adjust analysis factor associate icu admission sample age adjust odd ratio aor ci bmi aor ci lung disease aor ci conclusion study identify risk factor severe disease covid- specifically african american population inclusive research aim optimize clinical care relevant african american population critical ensure equitable response covid-
602,understand pathophysiology sars cov- infection critical therapeutic public health strategy viral host interaction guide discovery disease regulator protein structure function analysis point immune pathway include complement coagulation target coronaviruse determine condition associate dysregulated complement coagulation system impact disease perform retrospective observational study find history macular degeneration proxy complement activation disorder history coagulation disorder thrombocytopenia thrombosis hemorrhage risk factor sars cov associate morbidity mortality effect independent age sex history smoking transcriptional profiling nasopharyngeal swab demonstrate addition type interferon interleukin dependent inflammatory response infection result robust engagement complement coagulation pathway finally candidate drive genetic association study severe sars cov- disease identify putative complement coagulation associate loci include missense eqtl sqtl variant critical complement coagulation regulator addition provide evidence complement function modulate sars cov- infection outcome data point putative transcriptional genetic marker susceptibility result highlight value multimodal analytical approach reveal determinant predictor immunity susceptibility clinical outcome associate infection
603,background population mexico high prevalence rate noncommunicable disease ncds hospitalization death covid- patient country affect pandemic associate chronic comorbiditie objective describe prevalence ncd patient covid- mexico analyze increase risk comorbiditie risk factor hospitalization utilization intensive care unit death method cross sectional study perform confirm covid- case report ministry health june odd ratio perform logistic regression model result .% patient covid- diagnosis report comorbidity hypertension frequent report ncd significantly increase risk death respect patient diagnosis chronic kidney disease increase risk death follow diabetes immunosuppression obesity hypertension chronic obstructive pulmonary disease comorbiditie increase risk icu intubation diabetes immunosuppression obesity conclusion ncd comorbiditie increase severity covid- infection give high ncd prevalence rate mexican population pandemic pose special threat health system society special prevention measure need strengthen person ncd diagnosis short term mid term disease control strategy need improve protect patient covid- severity
605,background mount evidence relate association obesity severity covid- direct relationship increase severe covid- risk factor increase body mass index bmi evaluate aim meta analysis aim evaluate dose response relationship body mass index bmi poor outcome patient covid- method systematic literature search conduct pubmed europe pmc proquest cochrane central database primary outcome composite poor outcome compose mortality severity secondary outcome mortality severity result total patient  study include meta analysis meta analysis demonstrate obesity associate composite poor outcome p ): mortality p=. ): severity p ): patient covid- pool analysis high bmi versus reference bmi indicate high bmi patient associate composite poor outcome aor p ): mortality aor p=. ): severity aor p ): dose response meta analysis show increase risk composite poor outcome aor p kg m increase bmi pnon linearity curve steep increase bmi conclusion dose response meta analysis demonstrate increase bmi associate increase poor outcome patient covid-
607,objective study effect covid- pregnancy neonatal outcome study design prospective cohort study large tertiary maternity unit university hospital average annual birth birth prospectively collect analyse datum cohort  pregnant patient include singleton multiple pregnancy test positive covid- february  april  inclusive assess effect covid- pregnancy neonatal outcome result pregnant patient test positive covid- deliver  baby include set twin ongoing pregnancy time manuscript submission test positive patient asian indian sub continent background severity symptom range mild patient moderate severe total  covid- pregnant patient develop severe adult respiratory distress syndrome complication require icu support lead maternal death patient pre existing co morbidity morbid obesity diabete commonly represent  pregnant patient  trimester pregnancy deliver preterm birth develop adult respiratory distress syndrome delivery pre eclampsia patient deliver c section  new born  singleton set twin conclusion covid- associate high prevalence preterm birth preeclampsia caesarean section compare non covid pregnancy covid- infection find newborn develop severe neonatal complication
608,background identification reliable outcome predictor coronavirus disease  covid- paramount importance improve patient management method systematic review literature conduct  april  article  study select pool assessment cumulative statistic age sex retrieve   case endpoint define composite outcome include death severe presentation hospitalization intensive care unit icu and/or mechanical ventilation b hospital mortality extract numeric datum patient characteristic case adverse outcome employ inverse variance random effect model derive pooled estimate result identify   factor associate composite endpoint death respectively history cvd odd ratio confidence interval cis acute cardiac kidney injury increase procalcitonin d dimer thrombocytopenia .- convey high odd adverse composite endpoint advanced age male sex cardiovascular comorbiditie acute cardiac kidney injury lymphocytopenia d dimer confer increase risk hospital death respect treatment acute phase therapy steroid associate adverse composite endpoint ci mortality conclusion advanced age comorbiditie abnormal inflammatory organ injury circulate biomarker capture patient adverse clinical outcome clinical history laboratory profile help identify patient high risk hospital mortality
609,nrf keap pathway principal regulator antioxidant phase ii detoxification gene activation increase expression antioxidant cytoprotective protein protect cell infection nrf modulate virus induce oxidative stress ros generation disease pathogenesis vital viral life cycle respiratory viral infection severe acute respiratory syndrome coronavirus  sars cov- inflammatory process oxidative stress epithelium lining cell activate transcription factor nrf protect cell oxidative stress inflammation nrf reduce angiotensin convert enzyme  ace receptor expression respiratory epithelial cell sars cov high affinity ace work receptor coronavirus surface spike glycoprotein facilitate viral entry disease severity modulate pre existing condition impaired immune response obesity age decrease level nrf common feature consequently nrf activator increase nrf level enhance antiviral mediator expression initiate antiviral state prime cell viral infection hypothesis paper describe use flavonoid supplement combine vitamin d activate nrf potential target prevent and/or decrease sars cov- infection severity reduce oxidative stress inflammation enhance innate immunity downregulate ace receptor
610,objective exist finding relationship comorbiditie severity coronavirus disease  covid- inconsistent insufficient aim study evaluate association different comorbiditie severity covid- method pubmed embase cochrane library database search identify study report rate comorbiditie covid- patient severe fatal outcome subgroup analysis conduct accord disease severity country residence odd ratio confidence interval ci pool random effect model result total  eligible study identify patient severe fatal covid- prevalent chronic comorbiditie obesity ci -% hypertension ci -% follow diabetes ci -% cardiovascular disease ci -% respiratory disease ci -% cerebrovascular disease ci -% malignancy ci -% kidney disease ci -% liver disease ci order prediction pool or comorbiditie patient severe fatal covid- compare patient non severe fatal covid- follow chronic respiratory disease ci hypertension ci cardiovascular disease ci kidney disease ci cerebrovascular disease ci malignancy ci diabetes ci obesity ci correlation observe liver disease covid- aggravation ci conclusion chronic comorbiditie include obesity hypertension diabetes cardiovascular disease cerebrovascular disease respiratory disease kidney disease malignancy clinical risk factor severe fatal outcome associate covid- obesity prevalent respiratory disease strongly predictive knowledge risk factor help clinician well identify manage high risk population
611,patient severe complication covid- underlying condition obesity diabetes hypertension parallel grow evidence link periodontitis non oral systemic disease oral cavity reservoir respiratory pathogen patient periodontal disease likely develop hospital acquire pneumonia healthy individual hypothesize improve oral health decrease severity covid- symptom reduce associate morbidity
612,background obesity recently identify major risk factor bad covid- severity especially young reason impact pronounced elderly concomitant presence comorbiditie report focus bmi indirect marker body fat aim explore impact covid- severity abdominal fat marker body composition easily collect patient undergo chest ct scan method patient include retrospective study consecutively enrol admit emergency department rome italy test positive sars cov- undergo chest ct scan march datum extract electronic medical record result  patient include .% male mean age visceral fat vat significantly high patient require intensive care p=. age p=. inflammation marker crp ldh p p=. respectively interstitial pneumonia severity assess lung severity score lss p increase age lymphocyte crp ldh d dimer lss total abdominal fat vat find significant univariate association need intensive care multivariate analysis show lss vat independently associate need intensive care ci p=. ci p=. respectively conclusion vat marker bad clinical outcome patient covid- give exploratory nature study investigation need confirm finding elucidate mechanism underlie association
613,globally obesity underweight severe health risk disease current study systematically examine emerge evidence identify association body mass index bmi covid- disease outcome online literature database e.g. google scholar pubmed medline embase scopus medrixv biorixv screen follow standard search strategy have appropriate keyword obesity underweight bmi body mass index -ncov covid- novel coronavirus coronavirus disease study publish till th april  include language restriction study include case report case series cohort report bmi overweight obesity underweight complication covid- disease study observe covid- infection bmi  kg m result current study bmi play significant role covid- severity age group especially old individual panel doctor nursing staff review covid- patient high bmi co morbidity diabetes hypertension give increase vigilance priority testing treatment control associated co morbidity covid- patient illness enter day age  year elevate crp level give additional medical consideration finding show population patient high bmi moderate high risk medical complication covid- health status monitor frequently include monitoring blood pressure blood glucose
614,importance certain individual infect sars cov- tend develop severe form covid- illness reason remain unclear objective determine demographic clinical characteristic associate increase severity covid- infection design retrospective observational study curate datum electronic health record multivariable logistic regression examine association pre existing trait covid- illness severity define level require care need hospital admission need intensive care need intubation setting large multihospital healthcare system southern california participant patient confirmed covid- infection n result patient study require hospitalization require intensive care require intubation multivariable adjust analysis patient require high level care likely old  year p male p african american p obese p diabetes mellitus p high comorbidity index sd p clinical association pronounced young compare old patient pinteraction hospitalize patient male require high level care p irrespective age race morbidity profile conclusion relevance healthcare system great covid- illness severity see patient old male african american obese diabetes great overall comorbidity burden certain comorbiditie paradoxically augment risk great extent young patient hospitalize patient male sex main determinant need intensive care investigation need understand mechanism underlie finding
615,risk severe coronavirus disease  covid-)-associated illness illness require hospitalization intensive care unit icu admission mechanical ventilation result death increase increase age presence underlying medical condition show strong consistent evidence include chronic obstructive pulmonary disease cardiovascular disease diabetes chronic kidney disease obesity identify describe prevalence condition local level help guide decision making effort prevent control severe covid associated illness state level estimate lack standardized publicly available datum underlie medical condition increase risk severe covid associated illness small area estimation approach estimate county level prevalence select condition associate severe covid- disease u.s. adult age year self report datum  behavioral risk factor surveillance system brfss u.s. census population datum median prevalence underlie medical condition resident county  state district columbia dc range county high prevalence concentrate southeast appalachian region estimate number person underlie medical condition high population dense metropolitan area overall prevalence high rural nonmetropolitan area datum provide important local level information estimate number proportion person certain underlie medical condition help guide decision additional resource investment mitigation prevention measure slow spread covid-
616,coronavirus disease  covid- new pandemic originate china december cancer patient immunosuppressed susceptive acquire infection great risk develop severe form covid- people infect covid- display increase plasma level pro inflammatory cytokine excessive inflammation cause damage body tissue potentially contribute alveolar damage severity covid- hypothesize pro inflammatory state worsen covid- prognosis modulate systemic inflammation dietary modification efficacious improve clinical sequela covid- aim review present current nutritional dietary approach context inflammation specific focus cancer patient covid- main topic include nutrition inflammation immunity systematic literature search google scholar medline pubmed database perform march   keyword covid- coronavirus cancer inflammation probiotic vitamin d nutrition prevention healthy dietary habit omega rich diet probiotic use vitamin d supplementation obesity prevention likely efficacious preventive approach control hyperinflammation improve immune function decrease severity inflammatory disease
617,objective describe clinical characteristic predictor major outcome patient treat tocilizumab tcz severe covid- pneumonia patient method case series sequential patient severe covid- pneumonia treat tcz academic spanish hospital march  clinical outcome death length hospital stay early clinical response tcz h administration assess variation respiratory function marker brescia covid respiratory severity scale bcrss inflammatory parameter patient physician opinion association test multiple logistic regression result cohort  patient  patient treat tcz include median age  year iqr .- .% male .% charlson index /= hypertension .% obesity diabetes median follow day patient readmitte icu admission require  .% invasive mechanical ventilation  .%  patient die .% global .% icu admit multivariate adjustment tcz response bcrss p charlson index p identify independent factor associate mortality median hospital stay day bcrss physician subjective d dimer response associate short hospitalization stay conclusion mediterranean cohort use tocilizumab severe covid- mortality early tcz response bcrss low comorbidity associate increase survival early tcz response relate short median hospital stay
618,disease course covid- vary asymptomatic infection critical condition lead mortality identification prognostic factor important prevention early treatment aim examine obesity risk factor critical condition covid- patient perform meta analysis review protocol register prospero crd systematic search perform scientific database  january  selection  retrospective cohort study include qualitative quantitative analysis calculate pooled odd ratio confidence interval cis meta analysis obesity significant risk factor intensive care unit icu admission homogenous dataset ci invasive mechanical ventilation imv ci covid- compare body mass index bmi class find high bmi carry high risk obesity serve clinical predictor adverse outcome inclusion bmi prognostic score improvement guideline intensive care patient elevated bmi highly recommend
619,purpose recent study demonstrate obesity significantly associate increase disease severity hospitalization mortality covid- potential role pathogenesis prevalence new pandemic association hepatic steatosis condition closely relate obesity spectrum systemic metabolic dysfunction remain elucidate aim evaluate frequency hepatic steatosis incidentally detect chest ct examination covid- positive patient comparison non infected control method retrospective study perform  patient rt pcr positive  rt pcr negative chest ct negative steatosis measure placement single roi right lobe liver segment vi vii define liver attenuation value  hu result frequency hepatic steatosis high rt pcr positive group comparison control .% vs. .% p logistic linear regression analysis show time odd steatosis covid- positive group compare control adjust age sex ic .- p conclusion significantly high prevalence steatosis find covid- positive individual finding accordance recent study link obesity covid- infection intricate relationship liver steatosis metabolic syndrome obesity study require confirm association remain account multiple variable possible relationship disease severity bad clinical outcome
620,aim aim study investigate association type- diabetes mellitus underlie disease obesity outcome critically ill covid- patient greece method retrospective observational multi centre study datum outcome  rna confirm critically ill patient  hospital greece analyse report information stand april th results median age patient iqr majority male obesity present .% patient prevalent young  year hypertension prevail comorbidity follow cardiovascular disease .% type- diabetes admission common symptom duration median  iqr day .% patient discharge .% icu .% deceased hospitalise few day survivor iqr vs.  iqr respectively age risk factor diabetes deteriorate outcome obesity pose suggestive burden notable deceased versus survivor conclusion type  diabetes obesity contribute disease severity mortality covid- critically ill patient greece
621,objective study aim assess association adipose tissue distribution severity clinical course patient severe acute respiratory syndrome coronavirus method retrospective study  hospitalize patient confirm coronavirus disease  covid- undergo unenhanced abdominal compute tomography ct scan january march include univariate multivariate logistic regression analysis perform identify risk factor associate severity covid- infection result  patient identify critically ill high visceral subcutaneous adipose tissue area ratio call visceral adiposity odd ratio ci p low mean attenuation skeletal muscle call high intramuscular fat imf deposition odd ratio ci p independent risk factor critical illness furthermore visceral adiposity high imf deposition increase risk mechanical ventilation p p respectively high imf deposition increase risk death p conclusion covid- patient visceral adiposity high imf deposition high risk critical illness patient abdominal obesity monitor carefully hospitalize
622,objective specific comorbiditie old age create great vulnerability severe coronavirus disease  covid- obesity aggravate course disease actual impact bmi cutoff increase illness severity investigation aim study analyze bmi represent risk factor respiratory failure admission intensive care unit icu death research design method retrospective cohort study  consecutive covid- patient hospitalise march  april logistic regression analysis cox proportion hazard model include demographic characteristic comorbiditie carry predict endpoint  day onset symptom result  patient  .% bmi  kg m. logistic regression analysis bmi  kg m significantly increase risk respiratory failure ci p admission icu ci p /=  kg m ci p /=  kg m identify population patient high risk severe illness bmi  kg m dramatically increase risk death
623,background aim overall obesity recently establish independent risk factor critical illness patient coronavirus disease  covid- role fat distribution especially visceral fat associate metabolic syndrome remain unclear study aim investigate association fat distribution covid- severity method thirty patient covid- mean age level medical center berlin germany include present cross sectional analysis covid- confirm polymerase chain reaction pcr nasal throat swab severe clinical course covid- define hospitalization intensive care unit icu and/or invasive mechanical ventilation fat measure level lumbar vertebra routinely acquire low dose chest compute tomography ct result increase visceral fat area vfa square centimeter associate .-fold high likelihood icu treatment high likelihood mechanical ventilation adjust age sex upper abdominal circumference additional centimeter circumference associate .-fold high likelihood icu treatment high likelihood mechanical ventilation conclusion proof concept study suggest visceral adipose tissue upper abdominal circumference specifically increase likelihood covid- severity ct base quantification visceral adipose tissue upper abdominal circumference routine chest ct simple tool risk assessment covid- patient
624,coronavirus disease  covid- recent pandemic cause severe acute respiratory syndrome coronavirus  sars cov- novel coronavirus diabetes type  diabetes mellitus tdm hyperglycemia major comorbiditie patient covid- lead poor outcome report patient diabetes covid- increase risk develop severe complication include acute respiratory distress syndrome multi organ failure death explore potential mechanistic link explain observe high morbidity mortality patient population patient tdm underlying increase level inflammation associate obesity insulin resistance addition comorbiditie include hypertension obesity cardiovascular disease dyslipidemia old review evidence tdm hyperglycemia factor lead elevated expression angiotensin convert enzyme  ace lung tissue ace cellular receptor port viral entry preexist chronic inflammation augment inflammatory response infection increase viral load lead extreme systemic immune response cytokine storm strongly associate increase severity covid- base available evidence recommend panel expert safe stringent control blood glucose blood pressure lipid carry patient tdm measure potentially serve decrease severity covid- patient contract viral infection infection occur attention direct proper glycemic control use insulin frequent monitoring blood glucose level
625,metabolic syndrome increase risk severe disease viral infection study assess pathogenesis respiratory virus high risk population summarize metabolic dysregulation impair immune response define role metabolism influenza virus coronavirus infection discuss use vitro vivo ex vivo model elucidate contribution host factor viral susceptibility immunity disease severity
626,world health organization declare covid- infectious disease cause coronavirus sars cov- pandemic march covid- cause massive health problem economic suffering world european association study obesity easo promptly recognise impact outbreak people obesity emerge datum suggest obesity represent risk factor complicated course covid- adult health emergency cause outbreak divert attention prevention care non communicable chronic disease communicable disease particularly true obesity chronic relapse disease frequently neglect link significant bias stigmatization obesity management task force omtf easo contribute paper highlight key aspect side coin suggest specific action
627,objective describe clinical respiratory characteristic cohort  patient covid- evolutive period  day design prospective single center observational study carry setting intensive care patient patient admit covid- respiratory failure intervention variable automatic recording demographic variable severity parameter laboratory datum assist ventilation hfo high flow oxygen therapy imv invasive mechanical ventilation oxygenation pao pao fio complication patient divide group survivor g deceased g patient remain admission g chi squared test fisher exact test categorical variable mann whitney u test wilcoxon test analyze difference median statistical significance consider p result total  patient include g= g= g= mean age  year range male apache ii  sofa  arterial hypertension .% obesity .% frequent comorbiditie high flow oxygen therapy .% patient failure turn patient require imv receive ventilation prone decubitus general population initial pao fio improve  day vs. p=. way g vs.  p=. g vs.  bacterial coinfection observe incidence imv associate pneumonia high episodes/ day imv conclusion patient covid- require early imv high frequency ventilation prone decubitus high incidence fail hfo lack improvement pao fio  day prognostic marker
628,study conduct assess spread sars cov- russia adaptation population virus march june group investigate  individual prove positive sars cov- clinical information study individual suspect respiratory infection polymerase chain reaction pcr test clinical information study sars cov positive individual comprise .% march .% june viral co infection observe sars cov- rhinovirus account large proportion co infection .% sample sars cov positive follow respiratory syncytial virus .% adenovirus .% metapneumoviruse .% parainfluenza virus enterovirus d .% virus entero- echo- parecho- average sars cov- case fatality rate group  individual determine contrast official russian government statistic .% mortality rate range mortality cause common seasonal respiratory virus .-.% russia  fatality occur individual comorbiditie respiratory virus proportion sars cov- asymptomatic carrier march .% june new pathogen present substantial risk human being contain start outbreak wuhan spread worldwide surveillance prevention treatment strictly evidence base dictate fear
630,coronavirus disease  covid- pandemic spread globe infect million individual dead half infected people recover despite fact subgroup individual affect covid- great risk develop bad outcome experience high rate mortality datum association obesity covid- grow available study report high prevalence overweight obesity patient experience severe covid- course complication require hospitalization admission intensive care unit paper attempt highlight potential mechanism great vulnerability covid- individual obesity presence uncontrolled chronic obesity relate comorbiditie particularly pulmonary disease present primary fertile soil respiratory tract infection combine immune system impairment alteration t cell proliferation macrophage differentiation high pro inflammatory cytokine production adipose organ worsen general condition systemic diffusion infection prevention remain line intervention patient achieve adhere social distancing adopt hygiene precaution combine healthy lifestyle patient obesity require preferential access dedicate primary care service ensure regularly take medication treatment concurrent chronic disease finally physician promptly manage medical sign symptom case suspect severe acute respiratory syndrome coronavirus- sars cov infection prevent risk severe outcome
631,covid- outbreak viral pneumonia global health crisis risk morbidity mortality people obesity high sars cov- pathogen covid- enter cell bind angiotensin converting enzyme ace homolog- ace ace regulator contrary pathway renin angiotensin system ras ace ang ii atr axis ace ang --mas axis viral entry process eventuate downregulation ace subsequent activation ace ang ii atr axis ace ang ii atr axis increase lipid storage reduce white beige fat conversion play role obesity conversely adipose tissue important source angiotensin obesity result increase systemic ras ace ang ii atr axis proinflammatory profibrotic prothrombotic vasoconstrictive effect potential mechanism severe sars cov- infection link obesity severe covid- attribute ace consumption subsequent ace ang ii atr axis activation patient sars cov- infection benefit therapeutic strategy activate ace ang --mas axis ang ii receptor blocker arb ace inhibitor aceis mas receptor agonist ace
632,march world health organization declare sars cov  covid- outbreak global pandemic document community scale transmission region include latin america risk factor associate severity disease include old age diabetes hypertension cardiovascular lung disease immune suppression additional evidence strongly suggest obesity risk factor severe form covid- disease type malnutrition increase risk hospitalization influenza like disease regardless causative agent illness detailed datum available impact nutrition evolution covid- give know inflammatory response cause condition reasonable expect suboptimal immune response high risk severity find obesity
633,introduction recent mount concern multiple report state significantly elevated relative risk covid- mortality black minority ethnic bame population urgent national enquiry investigate possible reason phenomenon issue uk inflammation forefront covid- research disease severity appear correlate pro inflammatory cytokine dysregulation narrative review aim shed light novel pathophysiological role inflammation contribute increase covid- mortality risk bame population method search pubmed medline scopus google scholar perform identify article publish english inception th june database search keyword include covid- black minority ethnic inflammation narrative review synthesize include article result suggest novel pathophysiological mechanism acute inflammation covid- augment exist chronic inflammation order potentiate cytokine storm severe disease phenotype observe bame population obesity insulin resistance cardiovascular disease psychological stress chronic infection genetic predisposition relevant factor contribute elevated chronic systemic inflammation bame population conclusion overall review provide early insight direction ongoing research pathophysiological mechanism explain severe covid- disease phenotype observe bame population suggest personalization chronic disease management intervention order tackle
634,background objective male sex associate severe coronavirus disease  covid- infection examine association male sex severe covid- infection increase risk remain adjustment age comorbiditie method nationwide register base follow study covid- patient denmark  average risk ratio compare composite outcome cause death severe covid- diagnosis intensive care unit icu admission man versus woman standardize age comorbidity distribution patient derive multivariable cox regression include covariate age hypertension diagnosis include obesity alcohol sleep apnea diabetes chronic obstructive pulmonary disease previous myocardial infarction mi ischemic heart disease ihd heart failure hf atrial fibrillation af stroke peripheral artery disease cancer liver rheumatic chronic kidney disease ckd result  covid- patient  .% man median age  -% man versus  woman p  fully adjust average risk ratio ci conclusion man covid- infection high risk cause death severe covid- infection icu admission woman excess risk explain age comorbiditie
635,purpose review provide aid deal increase comorbiditie nonoperating room anesthesia nora recent finding new index assessment comorbiditie describe guideline care patient obesity obstructive sleep apnea chronic obstructive pulmonary disease copd diabetes covid nora summarize summary addition asa classification instrument charlson comorbidity index frailty index surgical complexity score revised cardiac risk supplement prospective assessment risk comorbiditie institutional protocol patient significant obesity obstructive sleep apnea copd diabetes covid safely care nora individual functioning severity important number disease
636,accumulation observational datum show association metabolic co morbidity adverse outcome covid- need disentangle contribution pre existing macro- microvascular disease obesity glycaemia article outline complex mechanistic clinical interplay diabetes covid- clinical research question arise relationship type study need answer question author clinician academic work diabetes obesity medicine article pitch audience generalist clinical experience interest management covid-
637,background sars cov- coronavirus infection range asymptomatic fatal covid- characterize cytokine storm lung failure vitamin d deficiency postulate determinant severity objective review evidence relevant vitamin d covid- method narrative review result regression modelling show northerly country northern hemisphere currently show relatively high covid- mortality estimate .% increase mortality  degree latitude north  degree north p adjustment age population support role ultraviolet b acting vitamin d synthesis factor associate bad covid- prognosis include old age ethnicity male sex obesity diabetes hypertension associate deficiency vitamin d response vitamin d deficiency link severity childhood respiratory illness experimentally vitamin d increase ratio angiotensin convert enzyme  ace ace increase angiotensin ii hydrolysis reduce subsequent inflammatory cytokine response pathogen lung injury conclusion substantial evidence support link vitamin d deficiency covid- severity indirect community base placebo control trial vitamin d supplementation difficult evidence come study covid- outcome large cohort information prescribe datum vitamin d supplementation assay serum unbound oh vitamin d level vitamin d supplementation strongly advise people likely deficient
638,objective study aim explore association obesity type  diabetes hypertension severe coronavirus disease  covid- admission method present study total patient sample evaluate laboratory mexican institute epidemiological diagnosis reference negative covid- positive covid- positive respiratory virus severe type respiratory disease define presence pneumonia organ failure require intensive care multivariable logistic regression model explore factor associate severe covid- admission result patient test positive covid- high proportion obesity .% diabetes .% hypertension .% compare confirm diagnosis compare patient obesity obesity show .-fold high odd develop severe covid- admission subject diabetes hypertension show .-fold high odd develop severe covid- admission respectively conclusion obesity diabetes hypertension significantly associate severe covid- admission association obesity strong patient  year age
639,ongoing coronavirus disease  covid- pandemic cause novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- individual metabolic syndrome increase risk poor disease outcome mortality covid- pathophysiologic mechanism observation fully elucidate critical interaction sars cov- angiotensin convert enzyme  ace facilitate viral entry host cell ace express pancreatic islet vascular endothelium adipose tissue sars cov- -ace interaction tissue factor govern spectrum severity clinical manifestation covid- patient metabolic syndrome pro inflammatory milieu observe patient metabolic syndrome contribute covid mediate host immune dysregulation include suboptimal immune response hyperinflammation microvascular dysfunction thrombosis review describe spectrum clinical feature likely pathophysiologic mechanism potential implication management metabolic syndrome covid- patient
640,whilst covid- infection generally run mild course affect number pre existing co morbidity determine severity infection outcome individual patient important co morbidity consistently emerge study globe patient age sex important co morbidity adversely affect outcome include pre existing diabetes obesity hypertension chronic lung disease malignancy comprehensive review discuss impact co morbidity role laboratory predictor poor patient outcome
641,objective study aim explore indicator severity coronavirus disease  covid- young patient age   year method retrospective cohort study include  consecutively admit patient covid-   year old zhongnan hospital wuhan university wuhan china  moderate case  severe critical case epidemiological clinical laboratory characteristic treatment datum collect multivariate logistic regression analysis implement explore risk factor result patient severe critical case obviously high bmi average vs. kg m low liver compute tomography value average vs. mu group moderate case patient severe critical case high fasting glucose alanine aminotransferase aspartate aminotransferase creatinine compare patient moderate case p severe critical case .% vs. .% positive urine protein level severe critical case experience significant process serum albumin decline logistic regression analysis show male sex high bmi especially obesity elevate fast blood glucose urinary protein positivity risk factor young patient severe covid- conclusion obesity important predictor covid- severity young patient main mechanism relate damage liver kidney
642,background covid- disproportionate impact old adult mexico population young covid- impact old adult comparable country old population structure aim identify health structural determinant increase susceptibility covid- old mexican adult chronological aging method analyze confirm covid- case old adult datum general directorate epidemiology mexican ministry health model risk factor increase covid- severity mortality mixed model incorporate multilevel datum concern healthcare access marginalization evaluate structural factor comorbidity profile compare chronological age covid- mortality risk prediction result analyze  confirm sars cov- case adult aged  old male sex smoking diabetes obesity associate pneumonia hospitalization intensive care unit icu admission old adult ckd copd associate hospitalization high social lag index access private care predictor covid- severity mortality age predictor covid- severity individual comorbiditie combination structural factor comorbiditie well predictor covid- lethality severity compare chronological age covid- baseline lethality hazard heterogeneously distribute mexican municipality particularly compare urban rural area conclusion structural factor comorbidity explain excess risk covid- severity mortality chronological age old mexican adult clinical decision making relate covid- focus away chronological aging comprehensive geriatric care approach
643, january world health organisation identify covid- cause virus sars cov- global emergency risk factor identify develop complication covid- infection age gender comorbiditie diabetes hypertension obesity cardiovascular disease risk factor account death arise covid- seemingly healthy individual paper investigate potential link sars cov- bacterial load question bacteria play role bacterial superinfection complication pneumonia acute respiratory distress syndrome sepsis connection covid- complication oral health periodontal disease examine comorbiditie high risk covid- complication cause imbalance oral microbiome increase risk periodontal disease explore connection high bacterial load mouth post viral complication improve oral health reduce risk complication covid-
644,importance risk factor associate severity coronavirus disease  covid- patient multiple sclerosis ms unknown disease modify therapy dmts modify risk develop severe covid- infection identify risk factor age comorbiditie objective describe clinical characteristic outcome patient ms covid- identify factor associate covid- severity design setting participant covisep registry multicenter retrospective observational cohort study conduct ms expert center general hospital neurologist collaborate ms expert center member societe francophone de la sclerose en plaque study include patient ms present confirm highly suspect diagnosis covid- march exposure covid- diagnose polymerase chain reaction test nasopharyngeal swab thoracic compute tomography typical symptom main outcomes measures main outcome covid- severity assess -point ordinal scale range  hospitalize limitation activity  death cutoff  hospitalize require supplemental oxygen collect demographic neurological history expand disability severity scale score edss range  cutoff  comorbiditie covid- characteristic outcome univariate multivariate logistic regression model estimate association collect variable covid- outcome result total  patient mean sd age year  woman mean sd disease duration year analyze seventy patient .% covid- severity score   patient .% die covid- median edss range  patient .% receive dmt high proportion patient covid- severity score  patient dmt relative patient receive dmt .% vs .% p /= ci obesity ci independent risk factor covid- severity score  indicate hospitalization high severity edss associate high variability covid- severe outcome r follow age r obesity r conclusion relevance registry base cohort study patient ms age edss obesity independent risk factor severe covid- association find dmts exposure covid- severity identification risk factor provide rationale individual strategy clinical management patient ms covid- pandemic
645,outbreak coronavirus disease  covid- evolve worldwide health crisis rise prevalence obesity diabetes come increase awareness impact infectious disease include increase risk infection post infection complication mortality critical infection epidemiological clinical characteristic covid- constantly report article systematically illustrate role obesity diabetes covid- covid- affect obesity diabetes special treatment risk population present synthesis recent advance understanding relationship obesity diabetes covid- underlie mechanism provide special treatment guidance risk population
646,recent report suggest obesity risk factor severe coronavirus disease article summarize available scientific evidence role obesity covid- focus implication young patient propose biological mechanism explain high risk observe possible high contagiousness people obesity consider implication pandemic people obesity relation difficulty manage hospitalize patient implication confinement control treatment obesity stigma people obesity suffer increase relationship obesity covid- confirm understand role obesity covid- public health priority give high prevalence condition country
647,background regional information characteristic patient coronavirus disease covid)- need well understanding pandemic objective objective study describe clinical feature covid- patient diagnose tertiary care center mexico city assess difference accord treatment setting ambulatory vs. hospital need intensive care ic method conduct prospective cohort include consecutive patient covid- february  april result identify  patient inpatient  outpatient median age  year interquartile range .% man .% healthcare worker center median body mass index bmi kg m .% obesity compare outpatient inpatient old comorbiditie cough dyspnea frequently .% inpatient require treatment ic unit icu history diabetes type  abdominal pain common icu patient compare non icu patient icu patient high bmi high respiratory rate low room air capillary oxygen saturation icu patient show severe inflammatory response assess white blood cell count neutrophil platelet count c reactive protein ferritin procalcitonin albumin level end study period  inpatient discharge improvement  continue hospitalize die conclusion patient comorbiditie middle age obese elderly complaining fever cough dyspnea likely admit admission patient diabetes high bmi clinical laboratory finding consistent severe inflammatory state likely require ic
648,covid- crisis last late  present day severity disease positively correlate factor age coexist disease furthermore obesity increasingly consider risk factor particularly observe people suffer excessive body weight experience severe course covid- infection basis current research nonsystematic review investigate extent obesity affect sars cov- course identify potential mechanism disease describe role proper nutrition physical activity aspect relevant management obesity
650,corona virus disease  covid- pandemic attract increase worldwide attention metabolic associate fatty liver disease mafld affect quarter world population impact covid- severity characterize identify  mafld patient covid- match age sex obesity status non aged severe acute respiratory syndrome coronavirus  sars cov-)-infected patient mafld result demonstrate patient age  year covid- mafld associate approximately fourfold increase adjust odd ratio confidence interval .- p probability severe disease adjust confounder healthcare professional care patient covid- need aware positive association mafld severe illness covid-
651,objective knowledge severe acute respiratory syndrome coronavirus  sars cov- infection liver transplant recipient lack particularly term severity disease aim study describe demographic baseline clinical characteristic early outcome european cohort liver transplant recipient sars cov- infection design conduct international prospective study europe liver transplant recipient sars cov- infection confirm microbiological assay outbreak covid- pandemic baseline characteristic clinical presentation management immunosuppressive therapy outcome collect result  patient include male median iqr age diagnosis  year    patient cardiovascular disease arterial hypertension diabetes mellitus respectively common symptom fever cough dyspnoea fatigue myalgia gi symptom immunosuppression reduce  recipient discontinue  regard impact outcome observe subject hospitalise  develop acute respiratory distress syndrome overall estimate case fatality rate ci increase ci hospitalise patient seven patient die history cancer conclusion european multicentre prospective study liver transplant recipient covid- associate overall hospital fatality rate ci ci respectively history cancer frequent patient poor outcome
652,current datum suggest infection severe acute respiratory syndrome coronavirus  sars cov- cause corona virus disease- covid- follow severe clinical course patient cardiovascular disease cvd hypertension overweight obesity appear lipid lower pharmacological intervention particular statin reduce risk cardiovascular complication cause covid- potentially additional antiviral activity show high cholesterol level associate lipid raft subdomain plasma membrane harbour angiotensin convert enzyme  ace receptor s protein sars cov- evidence importance cholesterol viral entry host cell suggest role cholesterol lower therapy reduce viral infectivity addition lipid lowering plaque stabilisation effect statin possess pleiotropic effect include anti inflammatory immunomodulatory antithrombotic activity low rate mortality intubation report study investigate statin therapy influenza infection statin therapy show increase viral clearance blood chronic hepatitis c infection statin serve potential sars cov- main protease inhibitor contribute control viral infection review elaborate role cholesterol level process coronavirus infection provide critical appraisal potential statin reduce severity duration complication covid-
653,coronavirus disease  covid- cause severe acute respiratory distress coronavirus  sars cov rapidly evolve pandemic challenge world pose unprecedented public health issue current datum covid- associate increase disease severity individual obesity obesity usually associate dysregulate renin angiotensin aldosterone raas axis raas implicate acute lung injury myocardial injury attract interest potential regulator covid- severity whilst research world struggle provide detailed characterization biology sars cov associated disease profile evident sars cov use membrane bind form angiotensin convert enzyme  ace receptor cell internalization ace protective component raas axis downregulate sars cov infection raas axis link obesity covid- severity accurate understanding underlie mechanism need hope propose efficient therapeutic intervention
654,covid- infection induce sars cov- coronavirus severe form lead acute respiratory distress syndrome ards require intensive care unit icu management severe form associate coagulation change mainly characterize increase d dimer fibrinogen level high risk thrombosis particularly pulmonary embolism impact obesity severe covid- highlight context standard dose low molecular weight heparin lmwh inadequate icu patient obesity major inflammation hypercoagulability urgently develop proposal prevention thromboembolism monitoring hemostasis hospitalize patient covid-.four level thromboembolic risk define accord severity covid- reflect oxygen requirement treatment body mass index risk factor monitoring hemostasis include fibrinogen d dimer level  h propose standard dose lmwh e.g. enoxaparin  iu/ h sc propose case intermediate thrombotic risk bmi  kg unfractionate heparin ufh renal insufficiency iu kg/ h iv propose thrombotic risk define high obese patient ards add risk factor thromboembolism case extracorporeal membrane oxygenation ecmo unexplained catheter thrombosis dialysis filter thrombosis mark inflammatory syndrome and/or hypercoagulability e.g. fibrinogen  g l and/or d dimers  mug ml icu patient difficult confirm diagnosis thrombosis curative anticoagulant treatment discuss probabilistic basis situation therapeutic dose lmwh ufh case renal insufficiency monitoring anti xa activity propose conclusion intensification heparin treatment consider context covid- basis clinical biological criterion severity especially severely ill ventilate patient diagnosis pulmonary embolism easily confirm
655,coronavirus disease  covid- global pandemic cause novel coronavirus severe acute respiratory syndrome coronavirus- datum country show high morbidity mortality individual chronic metabolic disease diabetes mellitus review explore contribute factor poor prognosis individual significant proportion patient covid- diabetes mellitus add layer complexity management explore potential interaction antidiabetic medication renin angiotensin aldosterone system inhibitor covid- suggest recommendation use antidiabetic medication covid- patient diabetes mellitus provide review pertinent clinical consideration management diabetic ketoacidosis covid- patient addition aim increase clinician awareness metabolic effect promise drug therapy covid- finally highlight importance timely vaccination patient diabetes mellitus
656,background datum nonrandomized study suggest hydroxychloroquine effective therapeutic agent coronavirus disease  covid- method conduct observational retrospective cohort study involve hospitalize adult patient confirm mild severe covid- french university hospital patient receive hydroxychloroquine mg  time daily dosage  day compassionate basis addition standard care soc compare patient contraindication hydroxychloroquine receive soc propensity score weighted analysis perform control confounder age sex time symptom onset admission  day charlson comorbidity index medical history arterial hypertension obesity national early warning score  news score admission pneumonia severity primary endpoint time unfavorable outcome define death admission intensive care unit decision withdraw withhold life sustain treatment whichever come result datum  patient laboratory confirm covid- analyze  consider primary analysis  patient treat hydroxychloroquine  patient treat soc admission mean age patient  year median charlson comorbidity index median news severity score propensity score weighting treatment hydroxychloroquine associate significantly reduce risk unfavorable outcome hazard ratio confidence interval p overall survival significantly different  group hazard ratio p conclusion hospitalize adult covid- significant reduction risk unfavorable outcome observe hydroxychloroquine comparison soc unmeasured confounder persist despite careful propensity weight analysis study underpowered ongoing control trial patient vary degree initial severity large scale help determine place hydroxychloroquine treatment covid- hospitalize adult covid- significant reduction risk unfavorable outcome observe hydroxychloroquine comparison soc
657,renin angiotensin system ras long appreciate major regulator blood pressure recently recognize mechanism modulate inflammation concern covid- patient use drug target system ras explore fully druggable target abbreviated description ras suggest dysregulation center covid-
658,objective describe characteristic birth outcome woman severe acute respiratory syndrome coronavirus  sars cov- infection community spread new york city detect march method perform prospective cohort study pregnant woman laboratory confirm sars cov- infection give birth march  april identify new york city medical center demographic clinical datum delivery hospitalization record collect follow complete april result cohort woman evolve criterion testing .% woman asymptomatic coronavirus disease  covid- time admission delivery hospitalization .% woman meet world health organization criterion mild covid- .% severe critical cesarean birth mode delivery .% woman severe .% critical covid- singleton preterm birth rate admission intensive care unit report  woman .% .% intubate delivery hospitalization maternal death body mass index bmi  high associate covid- severity p=. nearly newborn test negative sars cov- infection immediately birth conclusion month sars cov- outbreak new york city evolve testing criterion woman laboratory confirm infection admit delivery symptom covid- woman asymptomatic admission symptomatic delivery hospitalization obesity associate covid- severity disease severity associate high rate cesarean preterm birth
659,background centers disease control prevention advise patient moderate severe asthma belong high risk group susceptible severe coronavirus disease  covid- association asthma covid- establish objective primary objective determine prevalence asthma patient covid- major health system assess clinical characteristic comorbiditie asthmatic nonasthmatic patient covid- determine risk hospitalization associate asthma and/or inhale corticosteroid use method medical record patient covid- search computer algorithm march  april chart review validate diagnosis asthma medication prescribe asthma patient pcr confirm covid- demographic clinical feature characterize regression model assess association asthma corticosteroid use risk covid related hospitalization result  patient identify covid-  classify have asthma asthma associate increase risk hospitalization relative risk ci adjust age sex comorbiditie ongoing use inhale corticosteroid increase risk hospitalization similar adjust model relative risk ci conclusion despite substantial prevalence asthma covid- cohort asthma associate increase risk hospitalization similarly use inhale corticosteroid systemic corticosteroid associate covid related hospitalization
660,background risk severe covid- individual infected know high old individual underlie health condition understand number individual increase risk severe covid- vary country inform design possible strategy shield vaccinate high risk method estimate number individual increase risk severe disease define condition list increase risk severe covid- current guideline age age group sex country  country prevalence datum global burden diseases injuries risk factors study gbd  un population estimate list underlying condition relevant covid- determine map condition list gbd  list guideline publish public health agency uk usa analyse datum large multimorbidity study determine appropriate adjustment factor clustering multimorbidity help interpretation degree risk increase risk estimate number individual high risk define require hospital admission infect age specific infection hospitalisation ratio covid- estimate mainland china make adjustment reflect country specific difference prevalence underlie condition frailty assume male twice likely female high risk calculate number individual underlying condition consider increase risk age minimum age   year generate uncertainty interval uis estimate run low high scenario low upper confidence limit country population size disease prevalence multimorbidity fraction infection hospitalisation ratio plausible low high estimate degree clustering inform multimorbidity study finding estimate billion ui .- people comprise ui global population underlie condition put increase risk severe covid- infect range age  year old estimate  million people global population high risk severe covid- require hospital admission infect range young  year approximately age  year old estimate male high risk compare female share population increase risk high country old population african country high hiv aids prevalence small island nation high diabetes prevalence estimate number individual increase risk sensitive prevalence chronic kidney disease diabetes cardiovascular disease chronic respiratory disease interpretation individual worldwide increase risk severe covid- infected underlie health condition risk vary considerably age estimate uncertain focus underlie condition risk factor ethnicity socioeconomic deprivation obesity provide starting point consider number individual need shield vaccinate global pandemic unfold funding uk department international development wellcome trust health data research uk medical research council national institute health research
661, coronavirus disease covid- pandemic disrupt social economical medical system worldwide strictly infectious disease intricate bidirectional relationship non communicable metabolic disease endocrinological factor observe diabetes hypertension obesity find independent risk factor covid- disease severity mortality inclination sedentary lifestyle psychosocial stress critical time harbinger metabolic syndrome endocrinologist great opportunity play role combat pandemic paper examine endocrinological disorder influence dynamic covid- vice versa intend review clinical guideline adopt practice endocrinology try time
662,clozapine available treatment refractory schizophrenia use involve frequent physical contact healthcare worker purpose mandatory blood monitoring covid- pandemic patient take clozapine self isolate reduce risk infection patient high risk illness fatality high rate diabetes obesity pulmonary disease increase risk pneumonia problem arise clozapine induce myocarditis neutropenic sepsis share sign symptom covid- fever chest pain dyspnoea etc recommend decrease frequency physical contact extend blood monitoring interval  week patient take clozapine  year distinguish covid- clozapine relate physical adverse effect suggest urgent antigen test alongside blood count take clozapine develop covid- suggest continue clozapine possible ventilation reduce dose necessary line blood assay result blood monitoring continue clozapine cease significant fall neutrophil covid- link lymphopenia neutropenia protect likelihood severity respiratory infection recommend use vitamin d clozapine patient initiation clozapine likely remain problematic risk infection remain give degree physical contact require assure safety
663,background aim liver involvement common covid- elevated aspartate alanine amino transaminase ast alt borderline increase serum bilirubin serum alkaline phosphatase alp common finding patient associated co morbid condition like obesity cardiovascular disease renal disease malignancy hypertension old age prone develop severe disease limited datum available patient covid- metabolic dysfunction associate fatty liver disease mafld).the aim review analyse effect mafld severity covid- method systematically search pubmed database till  retrieve article publish covid- fatty liver mafld nafld result limited study show fold high risk severe covid- patient mafld patient mafld associated obesity severe fibrosis age yr prone develop severe covid- conclusion mafld associate fold increase severity covid- compare non mafld patient physician hepatologist follow patient cautiously preventive measure take strictly high risk patient
664,background aim patient coronavirus disease  covid- comorbiditie relate metabolic syndrome ms disease course presence different ethnicity continent place ms important risk factor covid- adequate understanding interplay ms covid- propose therapy require optimum management patient method systematically search pubmed google scholar database june st  access text covid- ms prepare narrative review topic result patient metabolic disorder like obesity diabetes cardiovascular liver disease face high risk infection covid- greatly affect development prognosis disease associate significantly bad outcome patient propose drug clinical trial covid- treatment carefully consider clinical use especially patient ms conclusion ms risk factor influence progression prognosis covid- drug currently evaluate infection treatment promise need study prove efficacy safety adverse effect exacerbate combination therapy viral infection development vaccine immunization good long term solution
665,current coronavirus disease- covid- pandemic present huge challenge health care system worldwide different risk factor associate disease severity old age diabetes hypertension recently obesity incidence obesity rise past  year reach  billion people world obesity consider pandemic review summarize aspect involve obesity change immune response nutritional factor physiological factor gut lung axis impact viral response covid- prognosis
666,comorbiditie associate severe coronavirus disease covid- unclear increase susceptibility covid- case control mexican study find obesity represent strong predictor covid- follow diabetes hypertension sex chronic renal failure female active smoking associate decrease odd covid- finding indicate comorbiditie associate severity disease predispose get covid- future research need establish mechanism involve comorbidity apparent protective effect cigarette smoking
667,little know covid- outcome specific population adult congenital heart disease achd patient report case adult patient similar underlying disease completely different clinical severity time covid- infection patient severe clinical course obese diabetic suggest covid- mortality morbidity adult congenital heart disease patient independent anatomic complexity
668,background type pneumonia coronavirus disease covid- cause new coronavirus severe acute respiratory syndrome coronavirus sars cov- spread world pandemic patient covid- admit university hospital aachen outbreak strike heinsberg district february method comparative presentation clinical feature  covid- patient acute respiratory distress syndrome ards hospitalize university hospital aachen result  intubate patient treat intensive care unit ards vary degree severity  patient breathe spontaneously ards need supplemental oxygen treat separate isolation ward median age patient  iqr median latency symptom onset hospitalization day iqr patient ards preexisting respiratory disease commonly patient ards confidence interval versus commonly overweight obese versus group differ viral burden display significant difference laboratory finding ards patient persistently elevate value leukocyte interleukin- lactate dehydrogenase creatine kinase d dimer period observation patient ards persistently elevate inflammatory parameter fever week accompany need supplemental oxygen patient ards die multiorgan failure non ards group die respiratory insufficiency conclusion initial description cohort covid- patient ards germany reveal ards commonly preexisting respiratory disease obesity persistently elevated inflammatory marker covid- patient ards likewise require prolonged hospitalization persistently elevate inflammatory value simultaneous need supplemental oxygen
669,objective primary objective determine efficacy single dose ivermectin administer low risk non severe covid- patient  hour symptom onset reduce proportion patient detectable sars cov- rna polymerase chain reaction pcr test nasopharyngeal swab day  post treatment secondary objective assess efficacy ivermectin reduce sars cov- viral load nasopharyngeal swab day  post treatment assess efficacy ivermectin improve symptom progression treat patient assess proportion seroconversion treat patient day assess safety ivermectin propose dose determine magnitude immune response sars cov- assess early kinetic immunity sars cov- trial design saint single centre double blind randomized placebo control superiority trial parallel arm participant randomize receive single dose  mug kg ivermectin placebo number patient treatment placebo group (: ratio participant population study patient positive nasopharyngeal swab pcr test sars cov- non severe covid- disease risk factor progression severity vulnerable population pregnant woman minor i.e.  year old senior i.e.  year old exclude inclusion criterion patient diagnose covid- emergency room clinica universidad de navarra cun positive sars cov- pcr resident pamplona basin cuenca de pamplona patient age   year age negative pregnancy test woman child bear age patient representative give informed consent participate study patient pi opinion able comply requirement clinical trial include home follow isolation exclusion criterion know history ivermectin allergy hypersensitivity component ivermectin covid- pneumonia diagnose attend physician identify chest x ray fever cough present  hour positive igg sars cov- rapid diagnostic test age   year follow co morbidity disease interfere study eye pi immunosuppression chronic obstructive pulmonary disease diabetes hypertension obesity acute chronic renal failure history coronary disease history cerebrovascular disease current neoplasm recent travel history country endemic loa loa angola cameroon central african republic chad democratic republic congo ethiopia equatorial guinea gabon republic congo nigeria sudan current use cyp p gp inhibitor drug quinidine amiodarone diltiazem spironolactone verapamil clarithromycin erythromycin itraconazole ketoconazole cyclosporine tacrolimus indinavir ritonavir cobicistat use critical cypa substrate drug warfarin woman child bear age participate use safe contraceptive method entire period study month woman consider childbearing capacity post menopausal minimum  year menstruation undergo surgical sterilization month study trial currently plan single center clinica universidad de navarra navarra spain immunology sample analyze barcelona institute global health isglobal barcelona spain participant recruit investigator emergency room and/or covid- area cun remain trial period  day home patient mild disease interest public health contain transmission infection follow visit conduct participant home clinical trial team comprise nursing medical member home visit assess clinical laboratory parameter patient intervention comparator ivermectin administer treatment group mug kg dose include eu approve label stromectol scabioral control group receive placebo current datum efficacy ivermectin virus vivo use placebo control group ethically justified main outcomes primary proportion patient positive sars cov- pcr nasopharyngeal swab day  post treatment secondary .mean viral load determine pcr cycle threshold ct baseline day proportion patient fever cough day  proportion patient progress severe disease death trial proportion patient seroconversion day proportion drug relate adverse event trial median level igg igm iga measure luminex frequency innate sars cov specific t cell assess flow cytometry median level inflammatory activation marker measure luminex transcriptomic median kinetic igg igm iga level trial day randomisation eligible patient allocate ratio randomization list generate trial statistician block ensure balance group study identification code format saint-  generate sequence random number randomization number match subject identifier sequence code keep encrypted file accessible trial statistician physical copy keep locked cabinet cun accessible person administer drug enrol attend patient care separate set  envelope emergency unblinding keep study file blinding masking clinical trial team patient blind placebo visibly identical administer staff involve clinical care participant follow number randomised sample size sample size  patient  participant randomised treatment group  participant control group trial status current protocol version date  april recruitment envision begin th end june th trial registration eudract number register april st clinicaltrials.gov submit pende number protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
670,geriatric patient vulnerable group covid- patient usually characterize impaired mobilization malnutrition addition obesity correlate increase mortality rate covid- infection highlight role nutrition prognosis covid- past index nutritional status gnri functional status ecog performance status barthel index handgrip strength demonstrate prognostic ability hospitalize patient influenza like respiratory infection coronavirus metapneumovirus parainfluenza rhinovirus hypothesis suggest previously mention nutritional functional status index combine pneumonia severity index crb- useful prognosis morbidity mortality elderly novel covid- infection hypothesis literature suggest prognostic association nutritional status patient covid- infection offer quick low cost prognostic tool covid- elderly
671,aim severity outcome covid- disproportionately high obese male smoker suffer hypertension kidney disease coronary heart disease chd and/or type  diabetes td examine serum level ace cellular entry point coronavirus sars cov- alter high risk group method association serum ace level hypertension td obesity chd smoker male single center population base study  icelanders age gene environment susceptibility reykjavik study ages rs elderly mean age years result smoker male individual td obesity alter serum level ace influence productive infection sars cov- high risk group conclusion ace level upregulate patient group comorbiditie link covid- emerge role circulate biomarker severity outcome covid-
673,objective describe course time severe acute respiratory syndrome coronavirus  sars cov- infection french woman beginning pandemic mid april risk profile woman respiratory complication short term pregnancy outcome method collect case series pregnant woman covid- research network  french maternity unit march  april case sars cov- infection confirm positive result real time reverse transcriptase polymerase chain reaction test nasal sample and/or diagnose compute tomography chest scan include analyze primary outcome measure covid- require oxygen oxygen therapy noninvasive ventilation critical covid- require invasive mechanical ventilation extracorporeal membrane oxygenation ecmo demographic datum baseline comorbiditie pregnancy outcome collect result active case covid- increase exponentially march number fall april lockdown impose march shape curve active critical covid- mirror active case april  pregnant woman covid-  woman  ci require oxygen therapy   ci critical form covid- severity disease associate age old  year obesity preexisting diabetes previous preeclampsia gestational hypertension preeclampsia woman critical covid- die  ci woman give birth rate preterm birth woman non severe oxygen requiring critical covid-  week  week respectively neonate  ci .- critical group die prematurity conclusion covid- responsible significant rate severe acute potentially deadly respiratory distress syndrome vulnerable pregnant woman comorbiditie benefit particularly prevention measure lockdown
674,severity coronavirus  infection covid- determine presence pneumonia severe acute respiratory distress syndrome sars cov- myocarditis microvascular thrombosis and/or cytokine storm involve underlying inflammation principal defence uncontrolled inflammation viral infection general provide t regulatory lymphocyte tregs treg level report low covid- patient increase vitamin d supplementation low vitamin d level associate increase inflammatory cytokine significantly increase risk pneumonia viral upper respiratory tract infection vitamin d deficiency associate increase thrombotic episode frequently observe covid- vitamin d deficiency find occur frequently patient obesity diabetes condition report carry high mortality covid- vitamin d fact reduce severity covid- regard pneumonia ards inflammation inflammatory cytokine thrombosis opinion supplement offer relatively easy option decrease impact pandemic
675,pandemic coronavirus disease covid- global threat public health functional impairment multiple organ report covid- include lung heart kidney liver brain vascular system patient metabolic associate precondition hypertension obesity diabetes susceptible experience severe symptom recent emerge evidence coagulation disorder covid- suggest vasculopathy appear independent risk factor promote disease severity mortality affected patient recently find decrease level low density lipoprotein cholesterol ldl c correlate disease severity covid- patient indicate pathological interaction dyslipidemia vasculopothy patient covid- clinical manifestation unintentionally underestimate physician scientific community metabolic associate morbidity generally accompany endothelial cell ec dysfunction pre existing condition ec vulnerable sars cov- attack mini review summarize metabolic vascular manifestation covid- emphasis association change ldl c level development severe symptom pathophysiologic mechanism underlie synergistic effect ldl c sars cov- ec injury vasculopathy
676,face worldwide pandemic covid- aim identify potential pathophysiological mechanism lead increase covid- susceptibility severity obesity special emphasis give increase susceptibility infection obesity relate low grade chronic inflammation high expression angiotensin convert enzyme- pathway associate component decrease vitamin d bioavailability provide easy way virus enter host cell replicate stunt adequate immune response
677,severe presentation covid- characterize hyperinflammatory state attribute massive pro inflammatory cytokine release call cytokine storm specific anti inflammatory immunosuppressive agent evaluate ongoing clinical trial currently insufficient evidence efficacy safety covid- treatment give role phosphodiesterase  pde  cyclic adenosine monophosphate inflammatory response hypothesize selective pde inhibition attenuate cytokine storm covid- upstream inhibition pro inflammatory molecule particularly tnf alpha regulation pro inflammatory anti inflammatory balance conversely anti cytokine agent lead downstream inhibition specific target il- il- tnf alpha efficient block cytokine storm trigger mechanism action target early stage inflammatory response ameliorate lung inflammation believe selective pde inhibitor represent promising treatment option early phase covid- pneumonia cytokine storm severe multiorgan dysfunction place furthermore pde inhibitor present advantage include excellent safety profile oral route administration convenient dosing beneficial metabolic property interestingly obesity diabetes mellitus type  report risk factor severity covid- randomized clinical trial pde inhibitor necessary explore potential therapeutic effect adjunct supportive measure therapeutic regiment
678,background morbidity mortality covid- cause novel coronavirus sars cov- accelerate worldwide novel clinical presentation covid- report range human cell tissue target sars cov- potential receptor associated regulating factor largely unknown aim study analyze expression known potential sars cov- receptor related molecule extensive collection primary human cell tissue healthy subject different age patient risk factor know comorbiditie covid- method perform rna sequencing explore available rna seq database study gene expression co expression ace cd bsg cd dpp direct indirect molecular partner primary human bronchial epithelial cell bronchial skin biopsy bronchoalveolar lavage fluid blood peripheral blood mononuclear cell pbmcs monocyte neutrophil dcs nk cell ilc ilc ilc cd(+ cd(+ t cell b cell plasmablast analyze material healthy child adult adult relation disease covid- risk factor status result ace tmprss coexpresse epithelial site lung skin cd bsg cyclophilin ppia andppib cd dpp relate molecule express epithelium immune cell observe distinct age relate expression profile gene pbmc t cell healthy child adult asthma copd hypertension smoking obesity male gender status generally lead high expression ace- cd relate gene bronchial biopsy bal blood additionally cd relate gene correlate positively age bmi interestingly observe high expression cd relate gene lesional skin patient atopic dermatitis conclusion datum suggest different receptor repertoire potentially involve sars cov- infection epithelial barrier immune cell alter expression receptor relate age gender obesity smoking disease status contribute covid- morbidity severity pattern
680,widely believe infection sars cov- virus trigger disproportionate immune response cause devastating systemic injury particularly individual obesity chronic multi organ inflammatory disease immune cell accumulate visceral adipose tissue paracrine adipocyte release wide range biologically active cytokine include il beta il il il result local pulmonary systemic inflammation intense cytokine storm postulate mechanism extreme immune response see severe covid- strike dangerous combination obesity covid- result great risk icu admission high mortality furthermore patient bame background appear increase mortality sars cov- infection high prevalence central obesity metabolic complication absence effective vaccine therapeutic potential immune modulate drug priority development new drug expensive time consume pragmatic solution seek repurpose exist drug particularly suppress heightened cytokine activity see obesity major risk factor poor prognosis covid- montelukast cysteinyl leukotriene receptor antagonist license treat asthma allergic rhinitis show diminish pulmonary response antigen tissue eosinophilia il- expression inflammatory cell show decrease elevated level il beta il human viral upper respiratory tract infection compare placebo treat patient addition silico study demonstrate high bind affinity montelukast molecule terminal site virus main protease enzyme need virus rna synthesis replication montelukast cheap safe widely available appear potential ideal candidate drug clinical trial particularly early stage disease irreparable tissue damage occur hypothesis direct anti viral effect suppression heighten cytokine release response sars cov- montelukast reduce severity immune mediate multiorgan damage result covid- particularly patient central obesity metabolic syndrome
681,importance description coronavirus disease  covid- experience pediatric help inform clinical practice infection prevention control pediatric facility objective describe epidemiology clinical laboratory feature patient covid- hospitalize child hospital compare parameter patient hospitalize severe disease design setting participant retrospective review electronic medical record tertiary care academically affiliate child hospital new york city new york include hospitalize child adolescent /= year test base suspicion covid- march  april positive result severe acute respiratory syndrome coronavirus  sars cov- exposure detection sars cov- nasopharyngeal specimen reverse transcription polymerase chain reaction assay main outcomes measures severe disease define requirement mechanical ventilation result  patient  boy  hispanic median day onset symptom admission  day interquartile range day patient fever respiratory symptom  patient gastrointestinal tract presentation identify obesity prevalent comorbidity respiratory support require  patient include  patient require mechanical ventilation patient die  infant   immunocompromised patient severe disease obesity significantly associate mechanical ventilation child  year old  vs   p lymphopenia commonly observe admission differ significantly severe disease severe disease significantly high c reactive protein median mg dl convert milligram liter multiply vs mg dl procalcitonin level median ng ml vs ng ml admission p elevated peak interleukin ferritin d dimer level hospitalization hydroxychloroquine administer  patient complete prolonged test positivity maximum  day observe  patient conclusion relevance case series study child adolescent hospitalize covid- disease diverse manifestation infant immunocompromised patient increase risk severe disease obesity significantly associate disease severity elevated inflammatory marker see severe disease
682,objective estimate proportion total number general adult population high risk severe covid- brazil method include participant nationally representative household base health survey pns conduct brazil estimate proportion number adult  year risk severe covid- sex educational level race ethnicity state base presence follow risk factor age  year medical diagnosis cardiovascular disease diabetes hypertension chronic respiratory disease cancer stroke chronic kidney disease moderate severe asthma smoking status obesity results adult risk severe covid- brazil vary million million nationwide educate adult present high prevalence risk factor compare university graduate find difference sex race ethnicity sao paulo rio de janeiro minas gerais rio grande sul vulnerable state absolute relative term adult risk conclusion proportion total number adult risk severe covid- high brazil wide variation state adult subgroup finding consider design implement prevention measure brazil argue result support broad social isolation measure particularly testing capacity sars cov- limited
683,coronavirus disease  covid- pandemic cause public health emergency worldwide risk severity mortality disease associate non communicable chronic disease diabetes mellitus accumulated evidence cause great concern country high prevalence morbidity brazil text show picture diabetes brazil follow epidemiological datum explanatory hypothesis association diabetes covid- emphasize burden morbidity middle income country aggravate pandemic scenario comprehension association biological plausibility help face pandemic future challenge
684,lymphopenia exhibit patient covid- associate bad prognosis development disease understand factor associate bad evolution covid- analyze comorbiditie indicator inflammation crp ratio neutrophil lymphocyte count blood cell t lymphocyte subtype  hospitalize patient covid- pneumonia patient group accord need mechanical ventilation icu care comorbiditie study obesity associate great severity icu admission percentage absolute number neutrophil high patient need icu care non icu patient absolute lymphocyte count especially percentage lymphocyte present deep decline critical patient difference group patient cd t lymphocyte percentage lymphocyte absolute number cd t cell difference significant parameter decline icu patient firm correlation high value inflammation indicator decrease percentage cd t lymphocyte effect see cd cell obesity lymphopenia especially preferentially affect cd t- lymphocyte factor predict poor prognosis patient covid-
685,novel coronavirus severe acute respiratory syndrome coronavirus sars cov- cause coronavirus disease  covid- exhibit widespread community transmission world previous report evaluate risk illness civilian diagnose covid- similar report compile army active component ac population covid- reportable condition department defense  february morning  april total  case report disease reporting system internet army installation case total  .% identify army ac service member majority case require hospitalization n= .% common comorbiditie present nonhospitalize case include chronic illness .% neurologic disorder obesity overall  case require hospitalization hospitalize case history obesity .% neurologic disorder .% chronic illness .% hypertension comorbiditie present n= nonhospitalized case n= hospitalize case
686,severity outcome coronavirus disease  covid- largely depend patient age adult  year age represent hospitalization great risk death clinic covid- patient commonly present fever cough dyspnea disease progress acute respiratory distress syndrome lung consolidation cytokine release syndrome endotheliitis coagulopathy multiple organ failure death comorbiditie cardiovascular disease diabetes obesity increase chance fatal disease explain age independent risk factor present molecular difference young middle aged old people explain covid- mild illness life threaten discuss biological age clock conjunction genetic test identify mechanism disease individual risk finally base mechanism discuss treatment increase survival old people simply inhibit virus restore patient ability clear infection effectively regulate immune response
687,objective  novel coronavirus disease covid- trigger rapidly expand global pandemic patient exhibit wide spectrum disease severity give high prevalence obesity united states hypothesize presence obesity play role clinical course patient covid- method retrospective review adult patient admit confirm severe acute respiratory syndrome coronavirus demographic clinical characteristic laboratory datum clinical outcome abstract bmi kilogram meter square analyze regard composite outcome intensive care unit icu admission death intubation rate result  patient include male mean age year patient obesity likely present fever cough shortness breath obesity associate significantly high rate icu admission death rr p adjust age race troponin level conclusion patient obesity increase risk critical illness lead icu admission death compare normal weight individual study confirm obesity major risk factor covid- disease severity significantly impact disease presentation critical care requirement
688,objective clinical manifestation coronavirus disease covid- run asymptomatic disease severe acute respiratory syndrome old age comorbiditie associate severe disease role obesity suspect method patient hospitalize medical covid- ward severe acute respiratory syndrome coronavirus -relate pneumonia enrol primary outcome study assess relationship severity covid- obesity class accord bmi result total  patient .% male age year enrol patient overweight obesity young patient normal weight year vs. year p high need assist ventilation pure oxygen support invasive mechanical ventilation noninvasive ventilation high admission intensive semi intensive care unit observe patient overweight obesity p p respectively adjust sex age comorbiditie p p respectively patient dementia advanced cancer remove analysis p conclusion patient overweight obesity admit medical ward severe acute respiratory syndrome coronavirus -relate pneumonia despite young age require frequently assist ventilation access intensive semi intensive care unit normal weight patient
689,recent report show strong association obesity severity covid- infection absence comorbiditie infect host cell severe acute respiratory syndrome coronavirus  sars cov- cause hyperinflammatory reaction excessive release cytokine condition know cytokine storm induce lymphopenia disrupt immune response obesity associate chronic low grade inflammation immune dysregulation exact mechanism exacerbate covid- infection fully clarify production increase amount cytokine tnfalpha il- il- monocyte chemoattractant protein mcp- lead oxidative stress defective function innate adaptive immunity activation nod like receptor family pyrin domain contain  nlrp inflammasome play crucial role pathogenesis infection endothelial dysfunction arterial stiffness favor recently discover infection endothelium sars cov- alteration cardiac structure function prothrombotic microenvironment obesity provide link increase cardiovascular event patient successful use anti inflammatory agent il- il- blocker similar hyperinflammatory setting like rheumatoid arthritis trigger discussion agent administrate select patient covid- disease
690,setting coronavirus disease  covid- pandemic datum lung pathology induce severe acute respiratory syndrome coronavirus  sars cov- available especially medical intervention interfere natural evolution disease present case forensic autopsy covid- fatality occur young woman community diagnosis necropsy lung histology show diffuse alveolar damage edema interstitial pneumonia geographically heterogeneous pattern affect central lung death relate covid- pathology highlight heterogeneity severity central lung lesion natural evolution disease
693,objective investigate patient characteristic management outcome critically ill population admit icu severe acute respiratory syndrome coronavirus disease  pneumonia cause acute respiratory distress syndrome design retrospective case control study setting icu tertiary hospital patient  coronavirus disease  acute respiratory distress syndrome patient compare historical control group  consecutive acute respiratory distress syndrome patient admit icu coronavirus disease  crisis intervention measurement main result obesity frequent comorbidity exhibit coronavirus disease  patient n vs n control p despite severity illness level hypoxemia admission coronavirus disease  patient fail high flow oxygen nasal cannula challenge n vs n control p intubate n vs n control p paralyzed n vs n control p require high level positive end expiratory pressure vs  cm ho control p prone positioning n vs n control p dialysis n vs n control p hemodynamic support vasopressor n vs n control p prolonged weaning mechanical ventilation n vs n control p result frequent resort tracheostomy n .% vs n control p intensive management require staff patient position coronavirus disease  subject vs  control p yield icu survival rate group n vs n control p conclusion severe form coronavirus disease  pneumonia strike preferentially vulnerable obese population evolve multiple organ failure require prolonged mechanical ventilatory support result high workload caregiver
694,diabetes mellitus challenge context covid- pandemic prevalence diabetes patient hospitalize intensive care unit covid- two- threefold higher mortality rate double non diabetes patient population diabetes highly heterogeneous major interest determine risk factor progression life threaten covid- infection brief review discuss main finding coronado prospective observational study france specifically address issue related observation country mainly china prognostic factor old age identify example increase body mass index major risk factor require respiratory assistance obesity combine risk factor include impaired respiratory mechanic presence comorbiditie inappropriate inflammatory response partly ectopic fat deposit previous diabetic microvascular renal macrovascular complication increase risk death quality past glucose control independent influence hospitalize diabetes patient outcome quality glucose control modulate risk covid- non hospitalize diabetes patient unknown addition negative sign use raas blocker dpp- inhibitor outcome covid- identify hyperglycaemia time hospital admission associate poor outcome simply consider marker severity infection impact glucose control hospitalization outcome relate covid- investigate coronado study certainly deserving specific investigation
695,novel small envelop rna virus typical characteristic family belong crown coronavirus appear december  wuhan china subdue world influence particular severity disease high mortality rate patient associate morbidity include hypertension obesity diabetes increase concern consequence pandemic review feature sars cov- address reason pose particular challenge diabetic patient highlight recent treatment strategy explore control pandemic emerge evidence demonstrate correct management diabetes patient infect sars cov- utmost importance viral disease progression importance blood glucose control address
697,background aim covid- emerge pandemic droplet infection coronavirus rapid transmission high case fatality rate recognition risk prognostic factor important obesity associate impaired immune system increase susceptibility infection aim study impact obesity prognosis disease severity covid- method systematic search handsearching conduct database cochrane medline embase pubmed identify article screen choose eligibility criterion obtain retrospective cohort study wu j light j simonnet critically appraise newcastle ottawa scale result finding include study consistent state contribution obesity risk factor increase requirement advanced medical care study high quality simonnet report increase need invasive mechanical ventilation covid- patient body mass index high  kg m p associate high mortality rate obese population infect covid- conclusion obesity independent risk prognostic factor disease severity requirement advanced medical care covid- systematic review highlight particularly vulnerable group obese emphasise importance treatment aggression disease prevention population group
698,goal column help mental health care professional understand coronavirus disease  covid- well explain complexity current crisis patient line column covid- infect virtually human population susceptible severe infection require admission intensive care unit and/or cause fatal outcome population identify basis comorbid medical illness and/or age number base experience china united states europe table  present analysis conduct centers disease control prevention cdc support source article population risk severe infection individual comorbid medical illness  year age old comorbid medical illness identify risk factor preexist respiratory cardiovascular disease immunocompromised status morbid obesity ie body mass index /= diabetes mellitus possibly significant kidney liver impairment parenthetically news report literature cite age  year old risk factor age   year likely surrogate have  comorbid medical condition initially like small number potentially represent million people give united states population  million tremendous number people require intensive care unit admission and/or potentially die individual population overwhelm health care system hotspot reason column suggest take risk population account mitigation strategy attempt open economy column address follow question  aspect race minimize damage cause covid- datum currently available help guide decision strategy employ date successful risk stratification exposure viable strategy minimize damage cause virus race minimize damage cause covid- require obtain knowledge disease treatment prevention well safeguard public health avoid overwhelm health care system minimize societal damage cause substantial disruption economy datum gather past  month covid- virus emerge human pathogen provide guidance decision go forward widely adopt strategy deal covid- pandemic date involve epidemiological approach encourage good hygiene practice social distancing include order shelter place quarantine high risk individual isolation infected individual goal epidemiological approach flatten curve reduce height peak infection avoid overwhelm health care system society general buy time learn disease find effective way deal know covid- portion population risk adverse outcome include death possible shelter place approach entire population focus risk facilitate gradual rational phase reduction social restriction reopen economy graduate opening base region country meet specific criterion term able contain virus couple vigorous monitoring look outbreak follow case monitoring isolation infected individual quarantine expose individual increase use testing active disease immunity take datum high risk individual account allow gradual lifting restriction majority population maintain stringent safeguard protect vulnerable portion population entire population need continue practice good hygiene social distancing simultaneously vigorously focus shelter vulnerable population adequate community immunity achieve prevent spread virus accomplish natural exposure addition safe effective vaccine(s available year continue widespread testing antibody help determine far close country country develop effective community immunity
699,covid- appear wuhan hubei province china december think zoonotic origin name sars cov- covid- spread rapidly april million case record worldwide inflammatory process cytokine storm lung injury associate covid- patient increase risk thrombosis total incidence thrombotic event covid- patient currently uncertain severe disease risk factor include increase age male sex obesity cancer comorbiditie intensive care unit admission high risk event little international guidance manage risk covid- patient paper explore current evidence theory surround thrombosis unique patient reflect experience center
700,diabetes frequently report comorbiditie patient infect covid- accord current datum diabetic patient appear increase risk contract sars cov- compare general population hand diabetes risk factor develop severe critical form covid- require admission intensive care unit and/or use invasive mechanical ventilation high mortality rate characteristic diabetic patient risk develop severe critical form covid- prognostic impact diabetes course covid- current investigation obesity main risk factor incident type  diabetes common patient critical form covid- require invasive mechanical ventilation hand covid- usually associate poor glycemic control high risk ketoacidosis diabetic patient currently recommendation favour discontinue antihypertensive medication interact renin angiotensin aldosterone system metformin sglt inhibitor discontinue patient severe form covid- owe risk lactic acidosis ketoacidosis finally advise systematic screening pre)diabetes patient prove covid- infection
701,world face coronavirus disease- covid- pandemic cause large number death burden intensive care facility cause severe acute respiratory syndrome coronavirus- sars cov- originate wuhan china see few child contract covid- infected child severe disease insight pathophysiological mechanism severity child important devise therapeutic high risk adult elderly early closing school day care center lead frequent exposure low infection rate child expression primary target receptor sars cov- i.e. angiotensin convert enzyme- ace- decrease age ace- lung protective effect limit angiotensin- mediate pulmonary capillary leak inflammation severe covid- disease associate high persistent viral load adult child strong innate immune response train immunity secondary live vaccine frequent viral infection lead probably early control infection site entry adult patient suppress adaptive immunity dysfunctional active innate immune response severe infection see child relate immune senescence elderly excellent regeneration capacity pediatric alveolar epithelium contribute early recovery covid- child frequently risk factor co morbidity smoking obesity young infant child pre existing illness high risk group need careful monitoring study describe immune pathogenesis covid- lack child need urgent attention
702,coronavirus disease  covid- risk severe acute respiratory syndrome coronavirus  sars cov- pose particular risk people live preexisting condition impair immune response amplify pro inflammatory response low grade chronic systemic inflammation common people obesity associate development atherosclerosis type  diabetes hypertension know comorbiditie adversely affect outcome patient covid- risk stratification base edmonton obesity staging system eoss classify obesity base presence medical mental and/or functional complication body mass index bmi show well predictor cause mortality eoss stage well describe risk hyperinflammation patient covid- infection analyze group metabolic ill patient obesity eoss  find increase interleukin- linear regression analysis show positive correlation c reactive protein crp p waist hip ratio whr p physician aware finding patient covid- infection early identification possible hyperinflammation fundamental guide decision making hospitalization early respiratory support therapy immunosuppression improve mortality
703,objective patient obesity increase risk exacerbation viral respiratory infection association obesity severity coronavirus disease  covid- unclear examine association datum referral hospital shenzhen china research design method total  consecutively hospitalize patient covid- admit  january   february  follow  march  people hospital shenzhen include underweight define bmi /= kg m result  patient .% normal weight .% underweight .% overweight .% obese admission obese patient tend symptom cough p fever p compare patient obese compare normal weight patient overweight .-fold odd develop severe covid- odd ratio ci p obese .-fold odd develop severe disease ci p adjust age sex epidemiological characteristic day disease onset hospitalization presence hypertension diabetes cardiovascular disease chronic obstructive pulmonary disease liver disease cancer drug treatment additionally similar adjustment man obese versus normal weight increase odd develop severe covid- ci p conclusion study obese patient increase odd progress severe covid- severe acute respiratory syndrome coronavirus  continue spread worldwide clinician pay close attention obese patient carefully manage prompt aggressive treatment
704,background chest radiography validate prognostic utility evaluate patient coronavirus disease  covid- purpose analyze prognostic value chest radiograph severity scoring system young nonelderly patient covid- initial presentation emergency department ed outcome interest include hospitalization intubation prolonged stay sepsis death material methods retrospective study patient age   year present ed urban multicenter health system march  march covid- confirmation real time reverse transcriptase polymerase chain reaction identify patient ed chest radiograph divide zone examine opacity cardiothoracic radiologist score collate total concordant lung zone severity score clinical laboratory variable collect multivariable logistic regression evaluate relationship clinical parameter chest radiograph score patient outcome result study include  patient  man median age  year interquartile range year adjustment demographic comorbiditie independent predictor hospital admission n chest radiograph severity score  odd ratio confidence interval ci p obesity odd ratio ci morbid obesity patient admit chest radiograph score  independent predictor intubation n odd ratio ci p hospital site significant difference find primary outcome race ethnicity history tobacco use asthma diabetes mellitus type ii conclusion patient age year coronavirus disease  present emergency department chest radiograph severity score predictive risk hospital admission intubation c rsna  online supplemental material available article
705,patient diabete coronavirus disease  covid- risk severe disease course mortality factor especially impaired immune response heighten inflammatory response hypercoagulable state contribute increase disease severity contentious issue evidence limited theoretical concern effect different anti hyperglycaemic drug similarly despite recognition angiotensin convert enzyme  ace receptor severe acute respiratory syndrome coronavirus  sars cov- role ace lung injury conflict result use angiotensin convert enzyme ace inhibitor angiotensin receptor blocker arb patient management patient diabetes time restriction mobility pose challenge novel approach like telemedicine useful need study natural course covid- patient diabetes understand individual regional ethnic variation disease prevalence course
707,coronavirus disease  pandemic wreak havoc society especially health care system include disrupt bariatric metabolic surgery current limitation accessibility non urgent care undermine postoperative monitoring patient undergo operation furthermore like elective surgery new bariatric metabolic procedure postpone worldwide pandemic outbreak abate backlog people seek operation exist surgical candidate face prolonged delay beneficial treatment progressive nature obesity diabetes delay surgery increase risk morbidity mortality require strategy mitigate harm risk harm vary patient depend type severity comorbiditie triaging strategy need traditional weight centric patient selection criterion favour case base actual clinical need personal view expert diabetes surgery summit consensus conference series provide guidance management patient surgery delay postoperative surveillance offer strategy prioritise bariatric metabolic surgery candidate basis disease likely ameliorate postoperatively system particularly germane immediate future provide framework long term clinically meaningful prioritisation
708,coronaviruse covs envelop positive sense rna virus group virus cause infection human respiratory tract characterize clinically mild fatal severe acute respiratory syndrome coronavirus  sarscov virus responsible global spread covid describe bad pandemic humanity century date covid infect people worldwide kill people age group infect virus symptom possibly result death observe old people underlie medical condition cardiovascular pulmonary disease novel data report severe symptom negative prognosis obese patient grow body evidence connect obesity covid number mechanism immune system activity attenuation chronic inflammation implicate lipid peroxidation create reactive lipid aldehyde patient metabolic disorder covid affect prognosis finally pregnancyassociated obesity need study connection covid infection pose high risk pregnant woman fetus
709,institution  initial  pregnant patient confirm coronavirus disease  severe infection .% ci .%-.% develop cardiac dysfunction moderately reduce leave ventricular ejection fraction hypokinesis viral myocarditis cardiomyopathy report nonpregnant coronavirus disease  patient case series nonpregnant patient coronavirus disease  find intensive care develop cardiomyopathy datum need ascertain incidence cardiomyopathy coronavirus disease  pregnancy pregnant woman coronavirus disease severe disease eg pneumonia suggest echocardiogram pregnant woman coronavirus disease  pneumonia particular necessitate oxygen critically ill recommend use handheld point care device possible minimize contamination staff traditional large echocardiogram machine
710,background evidence sustained transmission  country coronavirus disease  covid- declare global pandemic datum urgently need risk factor associate clinical outcome method retrospective review  hospitalize patient covid- wuhan conduct patient classify  disease severity group nonsevere severe critical base initial clinical presentation clinical outcome designate favorable unfavorable base disease progression response treatment logistic regression model perform identify risk factor associate clinical outcome log rank test conduct association clinical progression result current standard treatment significant improvement patient outcome univariate logistic regression analysis  risk factor significantly associate clinical outcome multivariate regression indicate age year p pg ml p leukocytosis x p  p predict unfavorable clinical outcome contrast administration hypnotic significantly associate favorable outcome p confirm survival analysis conclusion hypnotic effective ancillary treatment covid- find novel risk factor high hypersensitive troponin predict poor clinical outcome overall study provide useful datum guide early clinical decision making reduce mortality improve clinical outcome covid-
713,objective aim study explore potential association obesity chronic disease severe outcome intensive care unit icu admission invasive mechanical ventilation imv patient hospitalize coronavirus disease  covid- method study analyze retrospective cohort  patient hospitalize covid- demographic datum past medical history hospital course collect analyze multivariate logistic regression analysis implement examine association result february  april  consecutive patient hospitalize covid-  patient .% admit icu  .% require imv prevalence obesity multivariate analysis severe obesity bmi  kg m associate icu admission adjust odd ratio aor ci patient require imv likely heart disease aor ci obesity bmi kg m aor ci severe obesity bmi  kg m aor ci conclusion analysis severe obesity bmi  kg m associate icu admission history heart disease obesity bmi  kg m independently associate use imv increased vigilance aggressive treatment patient obesity covid- warrant
715,coronavirus disease- covid- cause highly pathogenic severe acute respiratory syndrome coronavirus  sars cov- demonstrate high morbidity mortality cause development severe acute respiratory syndrome connect extensive pulmonary fibrosis perspective argue adipocyte adipocyte like cell pulmonary lipofibroblast play important role pathogenic response sars cov- expression angiotensin convert enzyme  functional receptor sars cov upregulate adipocyte patient obesity diabetes turn adipose tissue potential target viral reservoir explain obesity diabete potential comorbiditie covid- infection similar recently establish adipocyte myofibroblast transition pulmonary lipofibroblast locate alveolar interstitium closely relate classical adipocyte demonstrate ability transdifferentiate myofibroblast play integral pulmonary fibrosis significantly increase severity local response sars cov- lung reduce severity mortality associate covid- propose probe clinical response thiazolidinedione peroxisome proliferator activate receptor gamma agonist know antidiabetic drug thiazolidinedione able stabilize lipofibroblast inactive state prevent transition myofibroblast reduce development pulmonary fibrosis stimulate resolution
716,diabetes important comorbiditie link severity know human pathogenic coronavirus infection include severe acute respiratory syndrome coronavirus patient diabetes increase risk severe complication include adult respiratory distress syndrome multi organ failure depend global region -% patient coronavirus disease  covid- pandemic diabetes give importance link covid- diabetes form international panel expert field diabetes endocrinology provide guidance practical recommendation management diabetes pandemic aim briefly provide insight potential mechanistic link novel coronavirus infection diabetes present practical management recommendation elaborate differential need patient group
718,introduction beginning covid- pandemic know severe course disease occur elderly rare child young adult comorbiditie particular diabete hypertension clearly associate age obesity smoke strongly associate need intensive treatment dismal outcome weak immunity elderly propose possible explanation uneven age distribution concern child treat cancer allso risk unfavourable course infection line anecdotal information wuhan china mention severe course covid- child treat leukaemia aim method flash survey covid- incidence severity child anticancer treatment respondent ask email fill short web base survey result receive report  country approximately patient risk follow time survey  child test positive covid- case asymptomatic mild disease diagnose covid- discuss preventive measure place take treatment option immunocompromised child covid- conclusion child receive anticancer chemotherapy mild asymptomatic course covid- underestimate risk develop severe course covid- observe intensity preventive measure cause delay obstruction oncological treatment
719,significant aspect covid- pandemic remain obscure angiotensin convert enzyme  ace component renin angiotensin system expression dominate lung alveolar epithelial cell human cell receptor sars cov- causative agent covid- strongly encourage concept thorough consideration receptor ligand interaction keep heart scientific debate infection idea renin angiotensin system evaluate hypothesize factor relate ethnicity environment behavior associated illness medication involve complex system probably responsible situation regard anomalous epidemiological clinical point view take factor explain aspect current outbreak decide use analogy play speculate possible impact tragedy air pollution interference nitrogen dioxide ace expression dual role nicotine hypothetical involvement ace polymorphism relationship ethnic factor susceptibility cardiovascular disease intriguing impact severity infection hypertension related medication act renin angiotensin system finally possible helpful role chloroquine thank capacity modify ace affinity viral spike protein alter glycosylation hypothesis paper urgent development research program aim question putative protagonist tragedy real life actor covid-
720,background aim high prevalence diabetes make important comorbidity patient covid- seek review analyze datum association diabetes covid- pathophysiology disease diabetes management patient diabete develop covid- infection method pubmed database google scholar search key term covid- sars cov- diabetes antidiabetic therapy april text retrieve article access result evidence increase incidence severity covid- patient diabetes covid- effect pathophysiology diabetes blood glucose control important patient infect covid- disease innovation like telemedicine useful treat patient diabetes today time
721,novel coronavirus disease  rapidly spread new york metropolitan area report case march state epicenter coronavirus disease  outbreak united states case report april previously present early case series  coronavirus disease pregnant patient  diagnose coronavirus disease  initial asymptomatic presentation describe series  test positive case coronavirus disease  present affiliated pair new york city hospital  week march march total  patient .% present coronavirus disease -associate viral symptom identify develop symptom admission implementation universal testing obstetric admission march  patient .% develop symptom coronavirus disease  course delivery admission early postpartum discharge  patient .% present symptomatic coronavirus disease  woman ultimately require antenatal admission viral symptom patient present worsen respiratory status require oxygen supplementation  day postpartum successful labor induction confirm case coronavirus disease  detect neonate initial testing day life base coronavirus disease  disease severity characteristic wu mcgoogan  woman exhibit mild disease  .% severe disease  .% critical disease percentage similar describe nonpregnant adult coronavirus disease  mild severe critical disease
722,objective covid- pandemic rapidly spread worldwide notably europe north america obesity highly prevalent relation obesity severe acute respiratory syndrome coronavirus- sars cov- fully document method retrospective cohort study analyze relationship clinical characteristic include bmi requirement invasive mechanical ventilation imv  consecutive patient admit intensive care sars cov- single french center result obesity bmi severe obesity bmi present .% .% case respectively overall  patient .% require imv proportion patient require imv increase bmi category p  multivariate logistic regression need imv significantly associate male sex p  versus patient bmi  p conclusion present study show high frequency obesity patient admit intensive care sars cov- disease severity increase bmi obesity risk factor sars cov- severity require increase attention preventive measure susceptible individual
723,aim analyze relationship obesity influenza method basal hormone milieu defective response innate adaptive immune system sedentariness major determinant severity influenza viral infection obese patient overweight increase risk infection complication single obese person large prevalence obese individual population increase chance appearance virulent viral strain prolong virus shed total population eventually increase overall mortality rate influenza pandemic result wait development vaccination covid- isolation positive case social distancing primary intervention nonetheless evidence previous influenza pandemic suggest follow intervention aim improve immune response lose weight mild caloric restriction include ampk activator ppar gamma activator drug treatment obesity associate diabetes practice mild moderate physical exercise conclusion prolonged viral shedding quarantine obese subject likely long normal weight individual
725,historically viral respiratory infection pregnant woman show increase risk morbidity mortality regard covid- information limited great risk severe morbidity mortality show compare general population pregnant woman comorbiditie obesity type  diabetes mellitus hypertension show great severity disease consistent general population comorbiditie risk vertical transmission appear low demonstrate case current outbreak covid- china previous epidemic similar coronaviruse sars cov mers cov exist study demonstrate presence virus genital fluid amniotic fluid maternal milk describe case infection newborn probably come horizontal transmission suggest breastfeed respiratory hygiene measure give covid- new disease extend world current knowledge insufficient mandatory continued accumulation datum discover depth action mechanism sars cov- virus responsible disease constant update mean prevention handling disease
